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Abstract 
A large number of optically active drugs and natural products contain α-functionalised ketones 
or simple derivatives thereof. Furthermore, chiral α-alkylated ketones are useful synthons and 
have found widespread use in total synthesis. The asymmetric alkylation of ketones represents 
one of the most powerful and longstanding procedures in organic chemistry. Surprisingly, 
however, only one effective methodology is available, and this involves the use of chiral 
auxiliaries. This is discussed in Chapter 1, which also provides a background of other key topics 
discussed throughout the thesis. 
Expanding on the existing methodology of chiral auxiliaries, Chapter 2 details the synthesis of 
a novel chiral auxiliary containing a pyrrolidine ring and its use in the asymmetric preparation 
of α-alkylated ketones with good enantioselectivity. The synthesis of racemic α-alkylated 
ketones as reference standards for GC chromatography is also reported in this chapter.   
Chapter 3 details a new approach to chiral α-alkylated ketones using an intermolecular chirality 
transfer methodology. This approach employs the use of simple non-chiral dimethylhydrazones 
and their asymmetric alkylation using the chiral diamine ligands, (+)- and (-)-sparteine. The 
methodology described represents the first example of an asymmetric alkylation of non-chiral 
azaenolates. Enantiomeric ratios up to 83 : 17 are observed. 
Chapter 4 introduces the first aldol-Tishchenko reaction of an imine derivative for the 
preparation of 1,3-aminoalcohol precursors. 1,3-Aminoalcohols can be synthesised via indirect 
routes involving various permutations of stepwise construction with asymmetric induction. Our 
approach offers an alternative highly diastereomeric route to the synthesis of this important 
moiety utilising N-tert-butanesulfinyl imines in an aldol-Tishchenko-type reaction. 
Chapter 5 details the experimental procedures for all of the above work. 
Chapter 6 discusses the results of a separate research project undertaken during this PhD. 2-
alkyl-quinolin-4-ones and their N-substituted derivatives have several important biological 
functions such as the role of Pseudomonas quinolone signal (PQS) in quorum sensing. Herein, 
we report the synthesis of its biological precursor, 2-heptyl-4-hydroxy-quinoline (HHQ) and 
possible isosteres of PQS; the C-3 Cl, Br and I analogues. N-Methylation of the iodide was also 
feasible and the usefulness of this compound showcased in Pd-catalysed cross-coupling 
reactions, thus allowing access to a diverse set of biologically important molecules. 
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 stereochemical descriptor 
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E entgegen configuration 
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EQ external quenching 
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Expt experiment 
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HHQ 2-heptyl-4-hydroxy-quinolone 
HIV human immunodeficiency virus 
HMBC heteronuclear multiple-bond correlation spectroscopy 
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HRMS high-resolution mass spectrometry 
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i Iso 
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Inc. incorporated 
IQ internal quenching 
IR infrared 
J coupling constant 
k rate constant 
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L liter 
LC-MS liquid chromatography-mass spectrometry 
LDA lithium diisopropylamide 
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LRMS low resolution mass spectra 
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 micro (10-6) 
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 multiplet 
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 molar 
m/z mass-to-charge ratio 
max maximum 
m-CPBA m-chloroperoxybenzoic acid 
Me methyl 
MHz megahertz 
min minute 
mol mole 
 molecular 
mol% mol percent 
Mp melting point 
MS mass spectrometry 
MTBE methyl tert-butyl ether 
max frequency of maximum absorption 
n nano (10-9) 
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NDA sodium diisopropylamide 
NMR nuclear magnetic resonance 
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    Abbreviations 
viii 
 
 
p para 
P primitive 
P. Pseudomonas 
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Pr propyl 
p-TsOH p-toluenesulfonic acid 
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QSI quorum sensing inhibitor 
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RAMP (R)-1-amino-2-methoxymethylpyrrolidine 
Rf retention factor 
R factor reliability factor 
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RT room temperature 
s second 
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temp temperature 
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1.1 Asymmetric Synthesis and Stereochemistry 
Asymmetric synthesis, also called chiral synthesis, enantioselective or stereoselective synthesis 
is a type of organic synthesis that introduces one or more, new and desired elements of chirality. 
The word chiral comes from the Greek word cheir, which means hand. Our hands are chiral – 
our right hand is a mirror image of our left hand – as are most of life’s molecules.  
Nature yields an enormous variety of chiral compounds, and often only one of the two possible 
enantiomers. Consequently, only one of the mirror image forms of amino acids, and therefore 
peptides, enzymes and other proteins, are found in nature. Carbohydrates and nucleic acids like 
DNA and RNA are other examples.1  
A publication in 2006 states that in the pharmaceutical industry, 56% of the drugs in use are 
chiral products, with 88% of these marketed as racemates, consisting of an equimolar mixture 
of two enantiomers.2  
Although they have the same chemical structure, most enantiomers of racemic drugs exhibit 
marked differences in biological activities such as pharmacology, toxicology, 
pharmacokinetics, metabolism etc. The importance of stereochemical purity in pharmaceutical 
products has been one driving force in the quest for improved control over the stereochemical 
outcome of organic reactions. Biological systems, in most cases, recognise a pair of enantiomers 
as different substances and the two enantiomers will often elicit different responses. Thus one 
enantiomer may act as a very effective therapeutic drug whereas the other enantiomer may be 
highly toxic.3  
The striking example of the drug Thalidomide is well known. A West German Pharmaceutical 
Company, Chemie Grünenthal, first introduced Thalidomide, in 1957, as a sedative or sleep 
aid. It was proclaimed a ‘wonder drug’ for insomnia, coughs, colds and headaches. It was also 
found to be effective in reducing morning sickness and so thousands of pregnant women took 
the drug to relieve their symptoms. During its use, reports began to emerge of instances of 
neuritis. It became evident Thalidomide was having a toxic effect on the nervous system of the 
user. At the time of the drug's development it was not thought likely that any drug could pass 
from the mother across the placental barrier and harm the developing foetus. However while 
Thalidomide was in use from 1957 to 1961 between 10,000 and 20,000 babies were affected. 
Many were born with deformities and there were also cases where the infants were stillborn or 
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died shortly after birth.4 The same birth defects are now being found in second- and third-
generation Thalidomide users.  
It was discovered that the desired physiological activity was found to reside solely with the R-
(+)-enantiomer (R)-1 and the corresponding S-(-)-enantiomer (S)-1 was teratogenic (Figure 
1.1.1). Although, it is now known that the ‘safe’ isomer can be converted to the teratogenic 
isomer once in the human body. 
 
     (R)-1          (S)-1 
Figure 1.1.1 
There are other, less dramatic examples of how two enantiomers can affect our cells differently. 
Limonene (Figure 1.1.2), for example, is chiral and the receptors in our nose can differentiate 
between both enantiomers. One form smells of lemons but the other of oranges.  
 
Figure 1.1.2 
The importance of asymmetric synthesis as a tool to obtain enantiomerically pure or enriched 
compounds has been fully acknowledged to date by chemists in synthetic organic chemistry, 
medicinal chemistry, and the pharmaceutical industries and agricultural industries.  
In order to achieve asymmetric synthesis, at least one component of the reaction must be chiral 
and non-racemic. If there is no asymmetric component in the reaction, then transition states 
which lead to enantiomers will be equal in energy, and a racemate must be formed. In general 
terms, any feature of the reacting system which would cause the transition states to be 
diastereomeric, could lead to the preferential formation of one diastereoisomer or enantiomer. 
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Transition states which are diastereomeric need not be of the same energy and consequently 
one of the possible products could be formed preferentially.5 
The range and scope of the reactions used in asymmetric synthesis are very large and 
consequently they are difficult to classify. However, the following are common types of 
asymmetric synthesis. 
1. Chiral Auxiliaries –This method is based on a three step process. The achiral substrate is 
combined with a chiral reagent known as a chiral auxiliary to form a chiral intermediate. 
Treatment of this intermediate with a suitable reagent produces a compound with a new 
asymmetric centre. The chiral auxiliary causes, by steric or other means, the reaction to 
favour the production of one of the possible stereoisomers in preference to the other. 
Completion of the reaction is followed by removal of the chiral auxiliary, which may be 
recovered and recycled.6  
2. Chiral Reagents – A chiral control element is incorporated into the structure of the reagent 
in order to direct the stereochemistry at newly formed stereocentres in a reaction. The 
reagent is used in stoichiometric quantities in the reaction and is usually not recovered for 
re-use. Examples include chiral reducing agents and chiral bases.  
3. Chiral Catalysts – Similar to chiral reagents, chirality is introduced through the structure 
of the reagent, however one molecule of catalyst can lead to many molecules of chiral 
product by virtue of regeneration of the chiral catalyst during the reaction. 
 Biocatalysis – This method involves the use of natural catalysts, such as enzymes, to 
perform chemical transformations on organic compounds. Biocatalysis is economical 
in its use of chiral material but suffers from the disadvantage that it requires large 
quantities of the enzyme to produce significant quantities of the target compound.6 
 Transition Metal Catalysis – This is an enantiopure organic compound which 
combines with a metal centre by chelation to form an asymmetric catalyst. This 
catalyst engages in a chemical reaction and transfers its chirality to the reaction 
product, which as a result also becomes chiral and potentially enantiomerically 
enhanced. 
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 Organocatalysis – This is the acceleration of chemical transformations with a 
substoichiometric amount of an organic compound which does not contain a metal 
atom.7  
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1.2 α-Substitution of Ketones 
The carbonyl moiety remains among the most utilized and well-studied functional groups in 
organic chemistry. In particular, functionalization of a carbonyl group at the α-position via 
carbon–carbon or carbon–heteroatom bond formation is a powerful transformation in chemical 
synthesis with broad application in the construction of complex organic architecture.  
A large number of optically active drugs and natural products contain α-functionalized ketones, 
or simple derivatives thereof. Furthermore, chiral α-alkylated ketones are very useful synthons 
and have found widespread use in total synthesis.8-10 
The Paterson ketone 2 is a simple chiral ethyl ketone used in the synthesis of polyketide and 
propionate based natural products. It was used in the synthesis of oleandolide 3, the aglycon of 
the macrolide antibiotic oleandomycin 4 (Figure 1.2.1), a 14-membered macrolide antibiotic 
produced by the actinomycete Streptomyces antibioticus.11 
 
 
 
    
 
     2 
3        4 
Figure 1.2.1 
Stigmatellin A, (+)-pectinatone, (+)-maritimol and ulapualide A are all further examples of 
natural products, which use asymmetric alkylation reactions as one of their key synthetic steps 
(Figure 1.2.2).9,10  
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Figure 1.2.2 
Traditionally, carbonyl functionalization typically involves the pre-generation or in situ 
formation of nucleophilic enols, enolates, alkyl/silyl enol ethers, enamines and azaenolates, 
which readily combine with aryl, alkyl, heteroatom, or halogen-centred electrophiles.  
Enolate chemistry is inherently complex because multiple reaction pathways, in addition to the 
desired one may be operative for a given transformation.12,13 As a result, numerous challenges 
have had to be overcome in developing effective asymmetric α-alkylation methods. 
In the case of symmetrical ketone derivatives, a general and widely applicable asymmetric 
method has to control geometry about the double bond of the enolate, as well as the facial 
approach of the electrophile to the enolate. In some non-symmetrical ketones the situation is 
even more complex as the regioselectivity of the deprotonation must also be controlled.8 
In light of these challenges, early attempts suffered from low enantioselectivity and were 
limited in terms of the nature of the alkylating agent. However the field has undergone 
significant development and highly selective asymmetric methods are now available. 
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1.3 Chiral Auxiliaries 
The use of chiral auxiliaries in chemical reactions, in many regards, parallels that of a protecting 
group. The moiety must be attached to the substrate molecule, it must be stable to the reaction 
conditions, and it must be removed at the end of the reaction. However, unlike a protecting 
group that is a passive partner in the reaction, a chiral auxiliary acts as a vehicle for asymmetric 
induction. This induction can also be accomplished by interactive means, such as by sterically 
blocking reaction at one face of the substrate. Unlike chiral catalysts, auxiliaries are used 
stoichiometrically since they add to the substrate molecule via a covalent bond to facilitate 
asymmetric induction in the subsequent reaction.14 An arsenal of chiral auxiliaries have been 
developed over the years for α-alkylation with varying degrees of success.15-19 
Yamada et al. published the first asymmetric synthesis of α-alkyl-cyclohexanone via enamine 
chemistry based on an (S)-proline-derived auxiliary in 1969.16 The enantiomeric excesses for 
the reaction of enamine 5 with Michael acceptors to afford the 1,4-adducts 6 were moderate 
(Scheme 1.3.1). 
 
               5                            6, 17 - 55%, 43 - 59% ee 
Scheme 1.3.1 
Meyers reported in 1976 that the alkylation of metallated azaenolates with an acyclic amino 
acid-based auxiliary 7 gave good yields and very good enantioselectivity of the corresponding 
ketones 8 (82 - 95% ee) (Scheme 1.3.2).18 
 
                      7      8, 50 - 80%, 82 - 95% ee 
Scheme 1.3.2 
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These pioneering studies laid the ground work for the introduction of the now widely used 
auxiliaries, (S)-1-amino-2-methoxymethylpyrrolidine (SAMP) (S)-9 and its enantiomer (R)-1-
amino-2-methoxymethylpyrrolidine (RAMP)  (R)-9 by Enders in 1976.10,20,21  
 
                 (S)-9         (R)-9 
Figure 1.3.1 
SAMP (S)-9 can be obtained on a 1 mol scale in 57% yield in six steps from the cheap 
commercially available amino acid, (S)-proline 10 (Scheme 1.3.3).22 Reduction of 10 with 
lithium aluminium hydride followed by treatment of resulting alcohol (S)-11 with methyl 
formate leads to formamide 12. Methylation followed by removal of the amine protecting group 
with potassium hydroxide yields the pyrrolidine 13. Reaction with potassium cyanate affords 
amide 14 followed by N-amination via Hofmann degradation to give SAMP (S)-9. 
 
10               (S)-11            12 
 
            (S)-9, 57% over 6 steps   14     13 
Scheme 1.3.3 
An alternative four-step procedure is available (Scheme1.3.4), however it is less desirable as it 
proceeds through the highly toxic nitrosamine intermediate 15.  
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         10            (S)-11              15 
 
     (S)-9, 58% yield over 4 steps   (S)-16 
Scheme 1.3.4 
Due to the difficulty in obtaining (R)-proline, its enantiomer, RAMP (R)-9 is best formed from 
(R)-glutamic acid in six steps with 35% overall yield (Scheme 1.3.5).23 The relatively 
inexpensive (R)-glutamic acid (R)-17 is transformed into (R)-pyroglutamic acid 18 by refluxing 
in water and then purification over an ion-exchange column. Although it was possible to reduce 
18 to (R)-11 in 57% yield, this was lowered to ca. 15% in large scale preparations. If however 
18 was first transformed with diazomethane into the methyl ester, the LiAlH4 reduction of the 
lactam and ester moiety in one step works well in 76% yield. Following the procedure used for 
SAMP (S)-9, nitrosation followed by treatment with sodium hydride/methyl iodide in THF 
gives nitrosamine (R)-16. Reduction with LiAlH4 affords RAMP (R)-9 in a 35% yield over six 
steps. 
 
   (R)-17             18       (R)-11 
 
               (R)-9, 35% yield over 6 steps        (R)-16 
Scheme 1.3.5 
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If more steric demand is required the auxiliaries SADP 19, SAEP 20 and SAPP 21 can be 
prepared in a seven step sequence,24 while the even-more sterically demanding RAMBO 22 can 
be prepared from the corresponding amino acid derivative in the usual methods (Figure 
1.3.2).25,26 
 
              19             20 
 
 
                  21           22 
Figure 1.3.2 
The chiral hydrazones are easily obtained by mixing SAMP (S)-9 or its analogues and the 
carbonyl compound.27 The condensation reaction with aldehydes runs quickly at 0°C without 
solvent, while ketones require reflux with a catalytic amount of acid and a solvent such as 
cyclohexane or benzene. Often purification of the hydrazones is unnecessary and they can be 
stored at -20°C under an inert atmosphere without decomposition (Scheme 1.3.6). 
 
             (S)-9              77 - 96% 
 
 
             (S)-9             74 - 95% 
Scheme 1.3.6 
SAMP-hydrazones can be deprotonated with lithium diisopropylamide or other lithium bases 
and the resulting azaenolates can be trapped by electrophiles to obtain diastereomerically 
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enriched compounds. A single reaction pathway makes it possible to predict the orientation of 
the resulting diastereomer. By use of either SAMP (S)-9 or RAMP (R)-9 as the chiral inductor, 
the synthesis of the desired enantiomer can therefore be controlled.  
A compelling feature of the Enders’ asymmetric α-alkylation methodology is the diversity of 
the alkylation agents that can be employed while maintaining high yields and stereoselectivities. 
In the case of ketones complex alkyl halides, Michael acceptors, carbonyl compounds, halide-
substituted esters, epoxides, disulfides, oxiranes, aziridines and cyclopropene acetals can be 
employed. After workup, distillation or column chromatography can be used to purify the crude 
α-substituted hydrazones. Subsequent cleavage of the hydrazones (23), for example, using 
ozone or MeI and HCl/pentane, restores the original carbonyl function to provide substituted 
ketones or aldehydes (24) (Scheme 1.3.7).28 
 
                    23             24, 51 - 99%, 31 - 99% ee 
Scheme 1.3.7 
SAMP-hydrazones have also been successfully used in a wide range of other synthetic 
transformations including aldol reactions, Michael additions, [2,3]-Wittig rearrangements, 
Carroll rearrangements, nucleophilic additions to C=N, Diels-Alder reactions and 
organometallic-mediated chemistry.10 
Investigations into the azaenolate geometry formed when SAMP-hydrazones are deprotonated 
with LDA under standard conditions in diethyl ether, showed that only the ECCZCN-species is 
formed. This has been confirmed by trapping experiments,20,28 spectroscopic investigations29 
and X-ray analysis.30 In the transition state shown in Figure 1.3.3, the lithium atom of the 
enehydrazide is located about 20° below the plane and is intramolecularly chelated by the 
oxygen of the methoxy group. Electrophilic attack is sterically disfavoured from ‘above’ due to 
the rigid 5-membered ring. This diastereofacial differentiation results in diastereomerically 
enriched hydrazones. The configuration of the new stereogenic centre is predictable. The 
SAMP-/RAMP-hydrazone method was therefore also used as a reliable standard procedure for 
the determination of the absolute configuration of chiral compounds.31  
Chapter 1    Introduction 
14 
 
  
Figure 1.3.3 
Monosubstituted hydrazones 25, obtained by α-alkylation of 26, can undergo a second 
regioselective α-alkylation reaction, giving rise to pseudo-C2-symmetric hydrazones 27 with 
complete diastereoselectivity.32 A single diastereomer of the C2-symmetric ketones 28 was 
provided by subsequent treatment with ozone (Scheme 1.3.8).  
 
  26                        25, 56 - 67%, >98% de 
 
          28, 51 - 83%,                 27, 25 - 44, >98% de 
          >98% de, >98% ee 
Scheme 1.3.8 
Extension of the use of SAMP/RAMP auxiliaries to natural product synthesis includes a number 
of elegant transformations. For example, Nicolaou et al. applied the SAMP/RAMP aldehyde 
alkylation in the asymmetric total synthesis of epothilone A 29 (Scheme 1.3.9).33,34 Like Taxol, 
these compounds exhibit potent microtubule destabilizing activity. Propanal-derived hydrazone 
30 is treated with LDA, and the resulting azaenolate undergoes alkylation with 31 to provide 
32, a synthetic precursor to epothilone A 29.    
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    30 
 
 
 
32, 70%, >98% de 
 
 
      31        
 
 
 
 
 
  
 
 
epothilone A 29 
Scheme 1.3.9 
In 2008, Coltart and co-workers introduced the N-amino cyclic carbamate (ACC) chiral 
auxiliaries 33 and  34 (Figure 1.3.4).35 The advantage of these auxiliaries over the 
SAMP/RAMP chiral auxiliaries is twofold: Firstly deprotonation of the hydrazone is rapid, and 
alkylation does not require the extremely low temperatures required by SAMP (S)-9, yet it 
proceeds with consistently high yields and excellent stereoselectivity. Secondly, regioselective 
α,α-bisalkylation is possible. 
 
             33           34  
Figure 1.3.4 
Of the ACCs investigated, the camphor-derived auxiliary 33 proved to be the most versatile 
and successful. A key design feature of these auxiliaries was the placement of a carbonyl group 
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adjacent to the hydrazone moiety for enhanced α-proton acidity and tight chelation at the level 
of the azaenolate.36  
The selectivity in the alkylation of the ACC azaenolate follows a mechanism where the 
formation of the azaenolate from the hydrazone 35 is controlled by the orientation of the 
carbonyl group. The ACC hydrazone prefers to exist in the conformation depicted in Scheme 
1.3.10, where steric interactions between the methyl group and the bulky bicyclo group on the 
auxiliary are minimized. Coordination of LDA to the carbonyl group in a five-membered 
chelate, leads to a ‘syn-directed’ deprotonation and formation of the ECCZCN azaenolate. The 
bottom face of the azaenolate is sterically blocked, and alkylation takes place selectively from 
the top (β) face.37 
 
 
        
  
 
 
    35   
 
 
 
 
 
 
 
 
 
          36, 99%, 92% ee     37 
     
Scheme 1.3.10 
With p-toluenesulfonic acid, hydrazone 37 can be transformed to the corresponding ketone 36 
in almost quantitative yields. 
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The ACC methodology has also been utilized in the synthesis of several biologically important 
compounds,38 for example in the first asymmetric total synthesis of the antiviral agent (+)-
clusianone 38. ACC alkylation of 39 affords 40 in excellent enantiomeric ratios, which is 
converted to the target product 38 (Scheme 1.3.11). 
     
 39             40, 99 : 1 er    (+)-clusianone 38 
Scheme 1.3.11 
Regiocontrol in LDA-mediated deprotonation of ketones, dialkylhydrazones (e.g. 
SAMP/RAMP) and imines is usually derived from the removal of the most sterically accessible 
proton (kinetic deprotonation). As a result, the controlled asymmetric α,α-bisalkylation of 
ketones having indistinguishable α-, αꞌ-protons is not possible. However with ACC hydrazones 
this has been accomplished. In the case of acetone derived hydrazone 41 (Scheme 1.3.12), 
treatment with LDA, followed by the addition of the alkylating agent resulted in 42 with 
regioselective monoalkylation with >99 : 1 α- : -αꞌ ratio. A second alkylation proceeded with 
both regio- and stereochemical control, to afford the α,α-bisalkylated product 43 and cleavage 
of the auxiliary affords 44 in excellent yield and a >99 : 1 dr. Conveniently, in some cases, both 
diastereomers of the bisalkylated hydrazone can be obtained in an equally high dr using the 
same auxiliary, simply by altering the order of addition of the alkylating agents. 
  
 
 
 
 
 
           41  
        42            43               44, 95-98%, 
           >99 : 1 er 
Scheme 1.3.12 
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The reliability, broad substrate tolerance and high levels of efficiency and selectivity, contribute 
to the popularity of the chiral auxiliary strategy. Unfortunately, the multiple steps for the 
preparation, incorporation and removal of the auxiliary in the synthesis render this process 
inefficient, which is undesirable for large-scale processes. The need for stoichiometric amounts 
of the chiral auxiliary means catalysis is never possible.  
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1.4 Homo Chiral Lithium Amide Bases 
Given the growing importance of asymmetric synthesis, it is not surprising that the race for 
simple methods of asymmetric induction is extremely competitive. Optically pure lithium 
amide bases have proven to be a versatile tool in modern asymmetric synthesis. Homo chiral 
lithium amide bases (HCLAs) are a class of compounds usually formed in situ when, for 
example, n-BuLi is added to the corresponding chiral amine. HCLAs have to date enjoyed 
success in mainly three areas: Enantioselective rearrangement of epoxides to allylic alcohols, 
enantioselective deprotonation of prochiral ketones and aromatic and benzyl functionalization 
of tricarbonyl (η6-arene) chromium complexes.39 
It was Koga40 and Simpkins41 who independently recognised that a carefully chosen HCLA 
should be able to distinguish between the conformationally locked, axial α-protons in the 
cyclohexanone ring. In the first report by Koga, a large number of HCLAs were generated and 
used in the asymmetric deprotonation of substituted cyclohexanones 45. The products were 
isolated as their corresponding trimethylsilyl enol ethers 46 (Scheme 1.4.1). 
 
           45         46, 23-89% ee 
Scheme 1.4.1 
Initial experiments by Simpkins in this area involved deprotonation of cis-2,6-
dimethylcyclohexanone 47 using lithium amide 48 and trapping of the resulting enolate with 
allyl bromide. Enantiomeric excesses for the corresponding products 49, were moderate but 
promising (Scheme 1.4.2).41,42 
 
 
 48  
  
                 47               49, 65%, 25% ee 
Scheme 1.4.2 
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The opposite enantiomer 48 and two other HCLA bases 50 and 51 (Figure 1.4.1) were used in 
the deprotonation of dimethylated cyclohexanone.41 
 
          50     51 
Figure 1.4.1 
Using HCLA 50 and quenching with acetic anhydride, resulted in the best selectivity and 
formation of 52 with an ee of 74% (Scheme 1.4.3 and Table 1.4.1).41 
 
               47         52 
Scheme 1.4.3 
HCLA % ee Configuration of 52 
48 29 R 
50 74 R 
51 65 S 
Table 1.4.1 
Having achieved good enantioselectivity with HCLA 50, quenching with different electrophiles 
such as chlorotrimethyl silane opened up new synthetic pathways such as the synthesis of α-
hydroxy ketones 53 via the epoxide intermediate generated by the addition of mCPBA to the 
silyl enol ether 54 (Scheme 1.4.4).43 
 
    50  
   
       47      54          53, 70% ee 
Scheme 1.4.4 
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New bases and reaction methods were quickly being employed in the race to increase 
enantioselectivity. When the internal quenching technique devised by Corey44 was used with 
the new HCLA 55 the enantiomeric excesses improved to an excellent 96% (Scheme 1.4.5).45 
The internal quenching protocol involved having the trimethylsilyl chloride present during the 
deprotonation. Thus, as soon as the enolate is selectively formed it is trapped as the silyl enol 
ether to afford 54. 
 
   
           
                               
55  
   
                 47        54, 96% ee 
Scheme 1.4.5 
The improvement in this reaction was explained by the fact that HCLA 55 contains an internal 
ligation site in the form of a nitrogen atom in the piperazine ring. 
When Koga published the full details of his work on 4-substituted cyclohexanone the 
enantiomeric excesses were, in general very good.46 For example, in the reaction of 4-tert-butyl-
cyclohexanone 56 with the corresponding silyl enol ether using HCLA 57, product 58 was 
isolated in 87% yield with an ee of 77% (Scheme 1.4.6). The reactions were carried out at -
78°C using Corey’s internal quenching method.44 
 
   
          
  
                        57 
 
 
                    56           58, 77% ee 
Scheme 1.4.6 
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When the reaction (Scheme 1.4.6) was carried out at -105°C the enantiomeric excess was 
increased to 89%. Simpkins noted a similar temperature dependence when using the HCLA 59 
in the same reaction (Scheme 1.4.7).42 The enantiomeric excess was raised from 69 to 88% 
upon lowering the reaction temperature from -78 to -90°C. 
 
 
                    59   
       
 
 
                                     
                   56                            58, 
              -78°C = 69% ee 
              -90°C = 88% ee 
Scheme 1.4.7 
Both Simpkins and Koga have shown that in order to obtain high levels of enantioselectivity in 
chiral base-mediated ketone deprotonations, it is necessary to trap the lithium enolates as silyl 
enol ethers using the Corey internal quench protocol. In the above reaction (Scheme 1.4.7) at -
78°C using external quenching conditions the enantiomeric excess was lowered considerably 
to 23% (cf. 69% for internal quench). Similar results were obtained in the conversion of bi-
cyclic ketone 60 to silyl enol ether 61 where the ee was reduced from 82 to 33% when the 
internal quenching technique was replaced by external quenching (Scheme 1.4.8).47 
     
               59  
 
  
        60                         61, 
               IQ = 82% ee 
               EQ = 33% ee 
 Scheme 1.4.8  
When lithium chloride was employed in this reaction (Scheme 1.4.8) under external quenching 
conditions the enantioselectivity was raised from 33 to 84% (Table 1.4.2).   
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LiCl equiv. % ee 
0 33 
0.1 84 
0.7 83 
1.5 84 
Table 1.4.2 
It is therefore shown that similar enantiomeric excesses can be obtained with internal quenching 
without LiCl, and external quenching with LiCl. It was postulated that lithium chloride is 
generated in the case of internal quenching by reaction of the chiral base with trimethylsilyl 
chloride directly or by silylation of the lithium enolate during the course of the reaction.48 
When base 59 was used in the aldol reaction of tropinone 62 and benzaldehyde to give 63 
(Scheme 1.4.9) by Majewski, enantioselectivities increased steadily as up to 1 equiv. of lithium 
chloride was added (Table 1.4.3).49,50 
       
      59 
      62               63 
Scheme 1.4.9 
 
LiCl equiv. % ee 
0 35 
0.25 78 
0.5 85 
1.0 88 
1.0a 95 
aLithium chloride generated by premixing n-butyllithium and the 
hydrochloride of the chiral amine prior to addition of the ketone. 
Table 1.4.3 
With a view to understanding these interesting results Koga carried out two sets of experiments. 
Firstly, he revisited the reaction of the 4-substituted cyclohexanone using chiral base 59 
(Scheme 1.4.10) and various equivalents of LiCl, under external quenching conditions (Table 
1.4.4).47,51 
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   59, LiCl 
 
 
         56            58 
Scheme 1.4.10 
LiCl equiv. % ee 
0 44 
0.5 87 
1.0 88 
3.0 88 
Table 1.4.4 
He found that even the addition of sub-stoichiometric amounts of LiCl greatly improved the 
enantioselectivity. 
Secondly Koga carried out the same reaction with different lithium halide salts introduced as 
the appropriate trimethysilyl halide (Me3SiX) in an internal quench. He found that going down 
group 8 of the periodic table decreases enantioselectivity (Table 1.4.5).51 
LiX % ee 
Cl 90 
Br 65 
I 31 
Table 1.4.5 
Koga has provided an elegant rationalisation of such results.51 He proposed that in the absence 
of any lithium chloride (external quenching conditions) the lithium amide base 59 exists as the 
homo-dimer 64 (Figure 1.4.2). 
 
               64 
Figure 1.4.2 
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6Li and 15N NMR spectroscopic studies on 59 have revealed that dimer 64 was, in fact, the 
major component in a solution of the lithium amide base in THF. This claim was verified by 
crystallographic analysis of crystals of 59 formed from THF and hexane by Simpkins and 
Mair.37 
When 6Li and 15N NMR spectroscopic studies were carried out on 59 containing more than 0.5 
equiv. LiCl it was found that the major component in a solution of THF was mixed-dimer 65 
(Figure 1.4.3). 
 
               65 
Figure 1.4.3 
It was therefore concluded that the mixed-dimer 65 is responsible for the high level of 
enantioenrichment. In the case of lithium bromide and lithium iodide, the equivalent mixed-
dimer may not be as thermodynamically stable, consequently its contribution is small.51 
Koga has also reported the catalytic use of HCLA bases in the asymmetric deprotonation of 4-
substituted cyclohexanones 45. The catalytic cycle that Koga proposed is shown in Scheme 
1.4.11. In this system, the chiral base is regenerated by using a stoichiometric amount of achiral 
lithium amide 66. He suggested that catalysis would be possible since lithium amides with two 
coordinating nitrogen groups (as in 66) are less reactive in ketone deprotonations than those  
such as 67 derived from diamines.  
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    45                 
 
 
 
 
 
 
 
        67                  68 
 
 
 
 
 
 
 
 
 
      69        66 
Scheme 1.4.11 
The optimum conditions required the use of excess DABCO and HMPA as additives and the 
enolate was trapped with Me3SiCl under external quench conditions since N-silylation of 68 
occurred with an internal quench. These conditions were applied using cyclohexanone 56, 0.3 
equiv. of 68 and 2.4 equiv. of 66 resulting in the formation of silyl enol ether 58 in 79% ee and 
83% yield (Scheme 1.4.12).52 The enantioselectivities achieved were slightly lower than that 
obtained using a stoichiometric amount of chiral base, however this result clearly demonstrates 
the success of the catalytic cycle. 
 
 
         68           66 
   
  
    56             58, 83%, 79% ee 
Scheme 1.4.12 
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Koga has also reported the catalytic use of HCLA bases in the alkylation of silyl enol ether 70. 
The lithium enolate is generated in the presence of lithium bromide, and subsequent reaction 
with benzyl bromide using 0.05 equivalents of HCLA 71 and 2.0 equivalents of diamine 72 
gave alkylated product 73 in 96% ee (Scheme 1.4.13).53 
 
 
 
 
70        74 
 
        71, 
           72, 
      , 
 
 
          71 
 
 
 
 
72       73, 76%, 96% ee 
 
 
 
  
 
 75          76, 52%, 90% ee 
Scheme 1.4.13 
Catalysis was possible in this reaction because the lithium enolate 74 is activated to alkylation 
by complexation of diamine 72. In the absence of diamine 72, less than 1% of alkylation product 
was obtained. Cyclohexanone 75 was also successfully alkylated under these catalytic 
conditions (Scheme 1.4.13). 
Even though HCLA bases have been studied extensively they have only been reported in the 
asymmetric α-alkylation of cyclic and conformationally locked ketones. 
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1.5 Other Methods for the α-Alkylation of Ketones 
The Tsuji–Trost reaction employs a chiral palladium catalyst to generate an enantiodefined 
electrophilic palladium π-allyl intermediate.  A nucleophile attacks the catalytic intermediate to 
arrive at carbonyl α-quaternary centres with high levels of enantioselectivity.54 This work was 
first pioneered by Tsuji in 1965.55 Trost and co-workers further developed this process with the 
introduction of phosphine ligands.56 An enantioselective variant was introduced in 1977.57 
In 1999, Trost reported the first enantioselective Pd-catalysed allylic alkylation of tin enolates 
77 of 2-methyl-tetralone 78 (Scheme 1.5.1).58 These were subjected to allylations with a wide 
range of allylic substrates in the presence of the bidentate ligand (S,S)-DPPBA 79 to afford 80. 
  
 
        78              77  
         
                81  
  
                     79  
  
 
 
                      79 
 
  
 
             80, 99%, 88% ee 
Scheme 1.5.1 
The Stoltz group later reported an enantioselective decarboxylative asymmetric allylic 
alkylation using ligand 82, where substrates of the form 83 or 84 undergo decarboxylation 
resulting in the formation of a palladium π-allyl intermediate.59 The transformation works well 
for the formation of quaternary allylic stereocenters such as 85 (Scheme 1.5.2).  
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              82                         82  
   
 
     83             85, up to 99%          84 
          94% ee  
 
 
 
 
 
               82 
Scheme 1.5.2 
A significant limitation of the Stoltz and the earlier mentioned Trost work was its restriction to 
cyclic ketones. In 2005, Trost and Xu provided the first examples of acyclic ketones in these 
allylic alkylations, using the allyl enol carbonate 86 and the bidentate ligand 87, ketones 88 
were obtained in good enantioselectivities (Scheme 1.5.3).60 
 
 
                        87 
 
 
               86            88, 75 - 99%, 73 - 98% ee 
   
 
 
 
 
 
 
   
  
               87 
Scheme 1.5.3 
Also in 2005, Jacobsen and co-workers introduced a general ketone α-alkylation strategy 
employing catalytic chromium-salen complexes 89 (Scheme 1.5.4).61 α-Alkylation to form 
quaternary centres (90) proceeds under mild conditions with very good to excellent selectivities 
and efficiencies using cyclic tin enolates 91. A variety of common alkyl halides, including 
methyl iodide and benzyl bromide, can participate in this reaction. 
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                   91           90, 43 - 91%, 85 - 96% ee 
 
 
 
  
 
 
 
 
 
                               89 
 
Scheme 1.5.4 
A pioneering study by a Merck research group in 1984, triggered the development of 
asymmetric phase-transfer catalysis, for the preparation of enantioenriched α-alkylated cyclic 
ketones.62 Dolling and co-workers utilized the cinchonine-derived quaternary ammonium salt 
92 as the catalyst for the methylation of phenylindanone derivatives 93 under liquid–liquid 
phase-transfer  conditions (toluene : 50% aq. NaOH solution) and succeeded in obtaining the 
alkylated product 94 in excellent yield and high enantiomeric excess (Scheme 1.5.5). 
 
                    92 
 
 
      93                                        94, 95%, 92% ee 
 
 
 
 
 
 
              92 
Scheme 1.5.5 
In 2010, MacMillan and co-workers introduced the first enantioselective organocatalytic α-
allylation of cyclic ketones to give allylated compounds 95, via singly occupied molecular 
orbital (SOMO) catalysis (Scheme 1.5.6).63  
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                              95, 74 - 86%, 83 - 96% ee 
 
  
 
 
 
 
 
 
 
Scheme 1.5.6 
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1.6 Dialkylhydrazone Methodology and Recovery of Carbonyl 
Compounds 
The usefulness of N,N-dialkylhydrazones of the form 96 in synthetic organic chemistry arises 
mostly from the broad reactivity of their organolithium derivatives.64 The hydrazone moiety 
has two bonds which are readily cleaved, yet it is usually stable enough to allow problem-free 
transformations at other parts of the hydrazone molecule. The C=N bond is susceptible to 
hydrolytic, oxidative, and reductive cleavage, to restore the carbonyl group, and the N–N bond 
is predisposed to reductive cleavage to produce primary amines (Figure 1.6.1). 
 
 
 
 
 
               96 
 
 
Figure 1.6.1 
The protons at the α-carbon of the hydrazone are deemed to be less acidic, compared to the α-
carbon of the parent carbonyl, by 10 orders of magnitude.64 Hydrazone conjugate bases are 
generally more reactive towards electrophiles. This is an advantage over synthetically 
equivalent ketone compounds. The acidity of the α-proton and the stability of metallated 
hydrazones (due to coordination of the metal to the nitrogen atoms) usually allows α-metallation 
of the hydrazones with alkali metal amides such as lithium diisopropylamide (LDA) or even 
alkyl lithium bases such as n-BuLi and sec-BuLi.65,66 Furthermore, the acidity of the hydrazone 
α-proton is usually low enough to prevent racemisation of stereogenic centres at the α-carbon 
of chiral hydrazones by typical bases, which is in contrast to the higher racemisation rate in 
equivalent ketones. 
Typically, the regioselectivity for the deprotonation of hydrazones is high and predictable.67,68 
It is known to take place at the less substituted carbon atom unless there is an anion-stabilising 
group present at the competing site.67,68 As a result, subsequent electrophilic attack at the 
formed azaenolates gives regioselectively functionalised or branched hydrazones. Alkylation 
of hydrazones occurs selectively at the α-carbon, unlike ketones where O-alkylation often 
competes with C-alkylation. Dialkylhydrazones offer other advantages such as selective 
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monoalkylation (no problem with polyalkylation), and dialkylhydrazones do not undergo self-
condensation (often a problem with the parent carbonyl compounds).12,13,64 There is also the 
possibility of using the hydrazone moiety as a chiral auxiliary (such as in the SAMP/RAMP 
methodology discussed previously in Section 1.3). 
Simple lithio-N,N-dimethylhydrazones have been shown to form aggregates in solution. For 
example, tetramers have been reported for lithiated cyclohexanone dimethylhydrazone.69 In 
general, complex homonuclear and heteronuclear (with a lithium amide such as LDA) 
aggregation and metal coordination may be expected for metalo-N,N-dimethylhydrazones and 
related simple hydrazones.70 On the basis of the investigation of configurations of lithiated 
SAMP-hydrazone species in solution (NMR of dimethyl- and SAMP-hydrazone)29,71 and by 
crystallography,30 it was confirmed that they form four possible rotational isomers.67,71 The 
most stable configuration is ECCZCN (Figure 1.6.2).  
 
 
 
 
 
           
           (ECCZCN)                     (ZCCZCN)  
 
 
 
 
 
  
 
 
             (ECCECN)          (ZCCECN) 
Figure 1.6.2 
N,N-dialkylhydrazones 96 can be easily formed from simple aldehydes and ketones 97 by 
condensation with dialkyl hydrazines, mixed neat or in benzene, dichloromethane, or hexane 
solutions. Hindered, or less reactive aldehydes and especially ketones may require acidic 
catalysts (AcOH, TFA, p-TsOH) and heating with concomitant removal of water (azeotropic or 
by molecular sieves or other water scavengers) to achieve high conversions or reasonable 
reaction times (Scheme 1.6.1).10,72  
N,N-dialkylhydrazones 96 can be cleaved to the parent carbonyl compound 97 by a multitude 
of methods.9 Recovery of carbonyl compounds 97 from N,N-dimethyl- and SAMP/RAMP-
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hydrazones have been thoroughly reviewed and include oxidative, hydrolytic and reductive 
protocols (Scheme 1.6.1). 
 
 
                
 
 
  97              96 
Scheme 1.6.1 
N,N-dialkylhydrazones did not gain widespread application in synthesis until the pioneering 
work on alkylation of metalated N,N-dimethylhydrazones was published by Corey and Enders 
in the years 1976-1978.65,66,73-77 
Lithium and potassium azaenolates are the most commonly used metalated hydrazones.72,78 
These are prepared by deprotonation of hydrazones with LDA (sometimes with additives such 
as HMPA, LiBr, and TMEDA), n-BuLi (sometimes with additives such as HMPA, TMEDA, 
and DMPU), t-BuLi, LTMP, t-BuOK, NDA,21 KDA (potassium diisopropylamide made from 
diisopropylamine, t-BuOK, and n-BuLi),79 and the Lochmann-Schlosser superbase, i.e., t-
BuOK/n-BuLi.80 
Once formed, azaenolates can react with a number of electrophiles. The known synthetically 
useful C-C bond forming reactions of simple α-metalated hydrazones include Michael-type 
additions, aldol-type reactions, Claisen-type acylations and α-alkylation protocols (Scheme 
1.6.2).72  
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Scheme 1.6.2 
Electrophilic alkylations were among the first synthetically useful transformations of 
hydrazones and still remain the most frequently used reactions of hydrazones. 
  
Chapter 1    Introduction 
36 
 
1.7 Chiral Ligands 
A chiral ligand is an enantiopure organic compound which combines with a metal centre via 
chelation to form an asymmetric reagent. When this catalyst engages in a chemical reaction, it 
can transfer its chirality to the reaction product. In an ideal reaction, only a substoichiometric 
amount of the catalyst would be necessary, enabling the synthesis of a large amount of a chiral 
compound from achiral precursors with the use of a very small (often expensive) amount of 
chiral ligand. 
The first successful, chiral ligand, the diphosphine DiPAMP 98 was developed in 1968 by 
Knowles.81 This ligand was utilised in the industrial production of L-DOPA 99 (Scheme 
1.7.1).82 
 
 
 
   
 
 
 
 
 
        98  
 
 
               L-DOPA 99 
Scheme 1.7.1 
Of the hundreds of chiral ligands prepared so far, a relatively small number of structural classes 
stand out because of their broad applicability. These ‘privileged ligands’ (Figure 1.7.1), as they 
are called, allow high levels of enantiocontrol in many different metal-catalysed reactions. A 
survey of their structures reveals that a surprisingly large number of them possess C2-
symmetry.83 
  
 
  
  
 
 
      BINOL               DuPhos                  TADDOL      BOX   
Figure 1.7.1 
Chapter 1    Introduction 
37 
 
C2-symmetry can have a beneficial effect on enantioselectivity as it reduces the number of 
competing diastereomeric reaction pathways, enables a straightforward analysis of substrate 
catalyst interaction and the simplification of mechanistic and structural studies.84 The key 
design features of successful C2-symmetric ligands are:  
1. They are easy to modify. 
2. They have a rigid chiral pocket. 
3. The stereogenic centres are positioned in close proximity to the coordination site. 
4. They bind to metals strongly. 
Although the concept of C2-symmetry has been well-exploited, there is no fundamental reason 
why C2-symmetric ligands should necessarily be superior to their nonsymmetrical 
counterparts.84 
Diamines have become widely studied by many groups as chiral auxiliaries, chiral reagents and 
chiral external ligands.85 In the chiral diamines, the element of chirality can be located in three 
places: Between the nitrogen atoms (internal chirality), on the nitrogen substituents (external 
chirality), or on the nitrogen atom itself.85  
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1.8 (-)-Sparteine and its Use in Asymmetric Synthesis  
(-)-Sparteine (-)-sp 100 or lupinidine (Figure 1.8.1) is a bitter tasting, lupine alkaloid, obtained 
from the broom Cytisus scoparius or the lupin Lupinus luteus. It is a transparent, oily liquid, 
colourless when fresh, turning brown on exposure to air. It was discovered by Stenhouse in 
1851.86 (+)-Sparteine (+)-sp 100 or pachycarpine is also naturally occurring, but much less 
abundant. It is found in the shrub Sophora pachycarpa.87  
 
 
 
  
    
                           
           (-)-sparteine     (+)-sparteine 
             (-)-sp 100           (+)-sp 100 
 
 
 
 
 
 
 
 (-)-α-isosparteine                  (-)-β-isosparteine  
  (-)-α-101          (-)-β-102 
Figure 1.8.1 
In contrast to its diastereomers, (-)-α-isosparteine 101 and (-)-β-isosparteine 102 (Figure 1.8.1), 
(-)-sp 100 and (+)-sp 100 deviate from C2-symmetry. Diamines (-)-α-101 and (-)-β-102 also 
occur naturally, but they are best obtained by isomerization of (-)-sp 100 via the dehydro 
derivatives 103 and 104 (Figure 1.8.2).88 
 
 
 
 
        103            104 
Figure 1.8.2 
Diamine (-)-sp 100 consists of four rings. The A/B rings form a double chair system and are 
relatively resistant to conformational-configurational changes. The other ring systems (C/D) 
are more susceptible to conformational changes especially at nitrogen atom N-16 and can occur 
in two distinct forms, the trans boat chair or the cis double chair configuration (Figure 1.8.3). 
The position of the two nitrogen atoms N-1 and N-16 makes sparteine an excellent ligand for 
coordination to metal complexes. This alkaloid in a free form shows a transoid conformation 
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and the C-ring adopts the boat conformation and a trans C/D ring juncture.89,90 On protonation 
or formation of metal complexes inversion of configuration on N-16 takes place resulting in 
adoption of cisoid conformation with cis C/D ring juncture,88,91 and a cavity between two 
nitrogen atoms allowing (-)-sp 100 to function as a bidendate ligand (Figure 1.8.3). 
 
 
  
 
  
transoid        cisoid 
Figure 1.8.3 
(-)-Sp 100 has shown itself to be admirably suited as a chiral bidentate ligand.88 The application 
of (-)-sp 100 in organic chemistry ranges from asymmetric synthesis92 and polymerisation 
reactions93 to kinetic resolution of secondary alcohols.94 In almost all of its applications in 
asymmetric synthesis, a stoichiometric amount of the chiral ligand was required for the reaction. 
However, in some reported cases, the use of substoichiometric or a catalytic amount of the 
ligand has been successful. 
Beak et al. has used (-)-sp 100 in the asymmetric deprotonation of N-Boc pyrrolidines 105. 
Deprotonation of 105 leads, through enantiotopic differentiation and removal of the pro-S H 
atom, to the configurationally stable intermediate 106, which can be substituted with retention 
of configuration, by various electrophiles to give 107 (Scheme 1.8.1). 
 
 
  sec-BuLi/100           100 
 
 
         105       106                        107a-d  
 
                       107a EX = MeOSO2OMe, 88%, 94% ee 
            107b EX = CO2, 55%, 88% ee 
          107c EX = Ph2CO, 75%, 90% ee 
          107d EX = Bu3SnCl, 83%, 96% ee 
Scheme 1.8.1  
Diamine (-)-sp 100 was also used in the asymmetric addition of organolithium reagents to 
imines by Denmark and co-workers in 1994.92 The group also compared the efficiency of bis-
oxazoline ligands, e.g. 108, to that of (-)-sp 100 as chiral ligands for lithium. A clear solvent 
effect was observed for the reaction of organolithium reagents in the presence of chiral chelating 
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ligands. It was observed that ethers such as Et2O and i-Pr2O gave the best results. For the 
reaction with a selected imine 109 and n-BuLi, (-)-sp 100 gave the highest enantioselectivity 
for 110, when both catalytic and stoichiometric amounts of the ligand was used, as shown in 
Scheme 1.8.2 and Table 1.8.1. 
 
 
 
 
 
109                  110 
 
 
 
 
 
 
               
 
       108 
         
Scheme 1.8.2 
Ligand Equivalents Solvent Yield %ee (R) 
(-)-sp 100 1 Et2O 90 91 
108 1 i-Pr2O 86 69 
(-)-sp 100 0.2 Et2O 91 79 
108 0.2 i-Pr2O 92 51 
Table 1.8.1 
One distinct disadvantage of (-)-sp 100 as a chiral ligand is the difficulty in accessing the other 
enantiomer. As previously noted, (+)-sp 100 also occurs in nature but is scarce. In an attempt 
to alleviate this problem, O’Brien and co-workers have pioneered the work to find a suitable 
alternative.95,96 They developed a simple and short synthetic sequence that furnished multigram 
quantities of a (+)-sparteine equivalent without recourse to resolution. They reasoned that 
diamine (+)-111 (Figure 1.8.4), which lacks one of the rings and chiral centres of (+)-sp 100, 
would be a good (+)-sparteine mimic. 
 
 
 
(+)-111 
Figure 1.8.4 
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Diamine (+)-111 was tested in Beak’s lithiation/electrophilic trapping of N-Boc pyrrolidine 105 
to give 112. Similar yields and identical enantiomeric ratios were observed for both (-)-sp 100 
and (+)-111 (Scheme 1.8.3). 
     100               111 
 
 
 
          112, 87%,               105                112, 85%, 
          95 : 5 er                      95 : 5 er 
 
Scheme 1.8.3 
In 2008,97 it was also shown that diamine 113 (Figure 1.8.5) (previously developed by the 
Alexakis group)98,99  could serve as another alternative to (-)-sp 100. This time both 
enantiomeric forms were easily accessible.  
 
 
 
 
 
 
 
113 
Figure 1.8.5 
O’Brien has also successfully employed (-)-sp 100 in a catalytic asymmetric deprotonation 
reaction via a ligand exchange protocol.100 Bispidine 114 was discovered to be a slow lithiator. 
Thus, it was used with both (-)-sp 100 and (+)-111 in the lithiation/Me3SiCl trapping of N-Boc 
pyrrolidine 105 (Scheme 1.8.4). 
 
     114 
  100     (+)-111 
 
           105            112 
                      (-)-sp 100 = 76%, 90 : 10 er 
              (+)-111 = 66%, 94 : 6 er  
   
 
 
 
Bispidine 114 
Scheme 1.8.4 
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O’Brien and co-workers hypothesised that a stoichiometric achiral diamine 115 would complex 
with sec-BuLi to give 116. This would displace (-)-sparteine from complex 117 thus producing 
a new organolithium/diamine complex 118. The active sec-BuLi/(-)-sp complex 119 would be 
regenerated and could re-enter the catalytic cycle. Electrophilic trapping of 117 or 118 (or both) 
would then produce 112 (Scheme 1.8.5). For such an approach to work, several criteria must 
be met: (i) Ligand exchange must occur, (ii) Organolithium 117 and 118 must be 
configurationally stable during the ligand exchange and (iii) Deprotonation of 105 using sec-
BuLi/(-)-sparteine complex 119 must be faster than that using the achiral sec-BuLi/diamine 
complex 116. 
 
 
 
 
   (-)-sp 100         112 
       
 
 
         105 
 
 
 
 
 
 
      117 
     119 
 
 
 
 
 
      112    118     116        115 
    
Scheme 1.8.5 
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1.9 Sulfinimines and 1,3-Amino Alcohols 
N-Sulfinyl imines or sulfinimines 120-125 are a special class of imines bearing a sulfinyl group 
attached to nitrogen. They display unique reactivity and stereoselectivity due to the presence of 
the chiral and electron withdrawing N-sulfinyl group.101 Their widespread application over the 
last four decades, has led to the development of an array of chiral sulfinyl motifs, offering the 
opportunity to fine-tune the reactivity of the sulfinimines towards specific requirements (Figure 
1.9.1).102 
 
 
 
 
 
 
           120   121         122   
 
 
 
 
 
 
 
       123                           124      125 
Figure 1.9.1 
Sulfinimines have played an important role in the asymmetric synthesis of a variety of 
structurally diverse nitrogen-containing molecules because they provide a general protocol for 
the asymmetric addition of organometallic reagents to chiral imines. 103 
The C=N is activated for nucleophilic addition by the electron-withdrawing sulfinyl group, 
which facilitates reaction at low temperatures. The chiral N-sulfinyl group exerts a strong 
stereodirecting effect, resulting in the addition of enolates and organometallic reagents to both 
enolisable and nonenolisable sulfinimines with high and predictable asymmetric induction. 
Epimerization of the newly created carbon stereocenter in the sulfinamide product is inhibited 
because the sulfinyl group stabilises anions at nitrogen.101 
The preparation and reaction of sulfinimines, including their applications in asymmetric 
synthesis, have been the subject of several reviews that cover the literature from their first 
preparation.101,102,104,105 
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For any motif to be truly valuable as a synthetic tool, it is vital for it to be readily available. The 
most common and versatile method for the preparation of generic sulfinimines is through the 
condensation of an aldehyde or ketone 126 with an amine 127 in the presence of a mild Lewis 
acid dehydrating reagent such as Ti(OEt)4. This provides access to a diverse range of substituted 
imines 128 (Scheme 1.9.1).105,106  
 
 
 
 
           126            127                  128 
Scheme 1.9.1 
Of these sulfinimines, Ellman’s 2-methyl-2-propanesulfinamide (N-tert-butanesulfinamide) 
120 has proved to be a versatile chiral auxiliary and has found applications in both academia 
and industry. N-tert-butanesulfinyl imines 129 have been used as intermediates in the 
asymmetric synthesis of many versatile building blocks including syn- and anti-1,3107-109 or 1,2-
amino alcohols110,111 130, 131, β-amino acids and esters112-114 132 and α,α-quaternary amines 
133,106,115 α-branched amines 134 and α-amino acids116,117 135 (Scheme 1.9.2).  
 
 
 
   
  126       129 
 
 
 
       anti-130                     135 
  
 
 
 
             
         syn-130            120         134 
 
 
 
 
                       133 
      anti-131                  
 
 
 
     syn-131          132 
Scheme 1.9.2 
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Amino alcohols are of great interest because of their biological and structural importance. For 
example, acyclic 1,3-amino alcohols are key structural components of numerous natural 
products,118-123 potent drugs,124,125 and components of numerous medicinal compounds such as 
HIV-protease inhibitors,126 μ-opioid receptor antagonists,127 potent antibiotic negamycin,128-130 
serotonin reuptake inhibitor and antidepressants.131 1,3-amino alcohols have also been used as 
ligands for asymmetric catalysts and as chiral auxiliaries.132-139 Despite their prevalence and the 
importance of acyclic 1,3-amino alcohols, there are only a few efficient synthetic methods 
reported in the literature to access this important class of compounds.140-143  
Ellman’s preparation of 1,3-amino alcohols is straightforward and can furnish both syn- and 
anti-1,3-amino alcohols.110,111 The metalloenamines derived from the N-tert-butanesulfinyl 
imines 136 of structurally diverse methyl ketones (by the deprotonation and metalation with 
LDA and ZnBr2 or MgBr2) were added to a range of aldehydes with high diastereoselectivities. 
Stereoselective methods were identified for the reduction of the β-hydroxy N-sulfinyl imine 
products 137 to provide both the syn- and anti-1,3-amino alcohol precursors 138 with high 
diastereoselectivities and yields (Scheme 1.9.3). A number of reducing agents were screened. 
Reduction of 137 with lithium triethylborohydride gives the anti-1,3-amino alcohol while 
reduction with catecholborane yields the syn product in the best selectivities. 
            
 
 
 
 
         syn-138, 69 - 94% 
   76 : 24 - 98 : 2 dr 
 
 
       136    137, 50 - 92% 
60 : 40 - 99 : 1 dr  
 
 
 
              anti-138, 69 - 96% 
    88 : 12 - >99 : 1 dr 
Scheme 1.9.3 
The outcomes of the reduction products are controlled by the stereochemistry of the tert-
butanesulfinyl group. According to X-ray data, the ketimine intermediate has an E-geometry. 
The LiBHEt3 will not change this geometry while catecholborane is capable of giving a six-
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membered ring intermediate (Scheme 1.9.4). In result, the E-imine will isomerize to the Z-imine 
to ultimately give the syn product.111 
 
 
 
 
 
   syn-138 
 
           139     
 
 
      137 
 
 
 
 
          140       anti-138 
Scheme 1.9.4 
The N-tert-butanesulfinyl group of the 1,3-amino alcohol precursors syn- and anti-138 is easily 
removed to afford the free amino alcohol using HCl in methanol.144 While this methodology 
provides a simple, general synthesis of a diverse range of 1,3-amino alcohols, there are clear 
limitations. These include the requirement of additives, such as magnesium bromide and the 
necessity for expensive reducing agents, such as superhydride (lithium triethylborohydride).  
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1.10 The Aldol-Tishchenko Reaction 
Nucleophilic substitution of a ketone or an aldehyde is usually very difficult, due to the fact that 
the alkyl and hydrogen substituents involved are poor leaving groups (unlike the leaving groups 
normally employed in carboxylic acid derivatives). The Cannizzaro reaction is one exception 
and was one of the first synthetic hydride transfer reactions.145 The Cannizzaro reaction 
involves nucleophilic attack by the hydroxide on an aldehyde such as 141, followed by 
intermolecular hydride transfer affording the oxidation product, benzoic acid 142 and the 
reduction product, benzyl alcohol 143 (Scheme 1.10.1).  
 
          141    
        
           142   143 
Scheme 1.10.1 
When sodium alkoxide is used as base with benzaldehyde, Claisen found that a similar reaction 
takes place, but benzyl benzoate 144 is formed.146 The likely route involves a hydride transfer 
giving ethyl benzoate 145, followed by transesterification affording 144 (Scheme 1.10.2).  
 
   141      
 
 
       Hydride Transfer 
 
 
 
         144              145  143 
Scheme 1.10.2 
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Tishchenko showed that both aliphatic and aromatic aldehydes can also be condensed in this 
way in the presence of a metal catalyst (Scheme 1.10.3).147 
 
Scheme 1.10.3 
In 1990 Evans and Hoveyda reported the samarium-catalysed intramolecular Tishchenko 
reduction of β-hydroxy ketones 146 affords 147 in excellent yields and stereoselectivity 
(Scheme 1.10.4 and Table 1.10.1).148 
 
            146              anti-147 
Scheme 1.10.4 
R1 R2 Yield anti : syn 
n-hexyl Me 96% >99 : 1 
n-hexyl MeCH2 95% >99 : 1 
n-hexyl Ph 94% >99 : 1 
i-Pr Me 85% >99 : 1 
i-Pr Ph 99% >99 : 1 
Table 1.10.1 
Treatment of the β-hydroxy ketones with between 4 and 8 equiv. of aldehyde in THF at -10°C 
in the presence of SmI2, resulted in the rapid formation of anti-1,3-diol monoesters. A variety 
of aldehydes can be used and the reaction is complete within an hour. The use of excess 
aldehyde is not mandatory but does serve to increase the rate of the reaction. The authors 
suggest a mechanism involving coordination of the hydroxy ketone 146 and the aldehyde to the 
catalyst, hemiacetal 148 formation followed by intramolecular hydride transfer to give 147 
(Scheme 1.10.5). 
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           146                              148 
 
 
             
 
 
 
 
         anti-147, 82 - 96%, >99% de 
Scheme 1.10.5 
Reduction of the hydroxy ketone 149 with CD3CDO (Scheme 1.10.6) resulted in complete 
incorporation of deuterium at the newly generated carbinol centre (150) demonstrating that the 
aldehyde is the exclusive source of the hydride.148 
 
              149              anti-150 
Scheme 1.10.6 
This report by Evans and Hoveyda prompted an interesting communication wherein a similar 
reduction was noticed. Treatment of a racemic sample of epoxide 151 with LDA followed by 
the usual work-up, resulted in a single isomer of alcohol 152 being formed (23%, 
stereochemistry not determined) (Scheme 1.10.7). 149 
 
               151             152, 23% 
Scheme 1.10.7 
Replacement of LDA with LiTMP allowed nucleophilic attack of the enolate on benzaldehyde 
at -78°C resulting in formation of racemic alcohol 153 (Scheme 1.10.8).149 
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   151              153, 58% 
Scheme 1.10.8 
However, allowing longer reaction times and higher temperatures (room temperature, over-
night) a single stereoisomer of ester 154 was isolated (26%) and upon using 3 equiv. of 
benzaldehyde, a single isomer was formed in 63% yield (Scheme 1.10.9). 
 
    151            154, 63% 
Scheme 1.10.9 
The structure of 154 was confirmed by X-ray analysis. An interesting experiment shed some 
light on the mechanistic details. When an isomeric mixture of 1,3-hydroxy ketone 153 was 
deprotonated with a base (LDA) and treated with benzaldehyde, a single isomer of 154 was 
again isolated (Scheme 1.10.10) in 47% yield. 
 
   153       154, 47% 
  Isomeric mixture        Single Isomer 
Scheme 1.10.10 
It having been already noted that addition of the first molecule of benzaldehyde is non-
stereoselective giving 153 as a mixture of stereoisomers, it was proposed that addition of 151 
to the two molecules of aldehyde, as well as hydride transfer all occur in a concerted fashion. 
This would account for the stereoselectivity of the reaction. Because the reaction could not be 
forced to completion, it was suggested that these stages may occur in equilibrium.  
Heathcock noted when excess paraformaldehyde was used to achieve higher conversion of the 
ketone 155 to 1,3-hydroxyketone 156, diol monoformate ester 157 was formed instead (Scheme 
1.10.11).150 
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155 
 
 
 
 
 
 
  
 
 
 
            156      157 
Scheme 1.10.11 
The substrate scope for the synthesis of anti-1,3 diols was still limited at this time prompting 
further work on the aldol-Tishchenko reaction. In 1996, Mahrwald et al. reported, a one-pot 
aldol-Tishchenko reaction of 3-pentanone 158 with aldehydes using substoichiometric amounts 
of titanium ate complexes, to furnish anti-1,3-diol monoesters 159 in a high level of 
stereoselectivity (Scheme 1.10.12).151 
 
           158        anti-159, 63 - 86%, 94 - 98% de 
Scheme 1.10.12 
Hydrolysis of monoesters 159 occurs easily affording the corresponding diastereomerically 
pure 1,3-anti-diols. 
In 1997 Woerpel reported several tandem aldol-Tishchenko reactions of lithium enolates 
including a simple method for the synthesis of polyoxgenated compounds with up to five 
stereocenters, which were generated with excellent diastereoselectivity.152 
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The lithium enolates of a number of ketones 160 were treated with 2.2 equiv. of aldehyde at -
78°C followed by warming to 22°C for 12 h affording, almost exclusively, one diastereoisomer 
of 161 in good yield (Scheme 1.10.13). The stereochemistry of the product was determined by 
comparison to reference compounds and analysis of the derived 1,3-diol 162.153,154 No β-
hydroxy ketones (simple aldol addition products) were isolated in these reactions. 
 
         160      anti-161, 94 - 98% de 
 
              anti-162 
Scheme 1.10.13 
In contrast to aldol addition reactions of 160 to 163 which are known to proceed in extremely 
short reaction times (less than 10 s) at -78°C (Scheme 1.10.14),155 these aldol-Tishchenko 
reactions take place at room temperature over several hours. 
 
160     syn-163          anti-163 
Scheme 1.10.14 
Treatment of syn-aldol adduct syn-164 with LDA followed by 1.1 equivalent of 
propionaldehyde resulted in a 1 : 1 ratio of diol 165 (R=i-Pr) and crossover product 166 (R = 
Et) after hydrolysis (Scheme 1.10.15).   
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       syn-164      syn-167 
 
   anti-165 R = i-Pr       syn-168 
   anti-166 R = Et 
Scheme 1.10.15 
The same ratio was obtained when the anti-isomer of 164 was used. Since the stereochemical 
relationship of the products is not dependent upon the structure of the aldolate, it can be 
concluded that the aldol step is reversible and non-stereodetermining. 
To determine the relative rates of the aldol and Tishchenko reactions a solution of aldolate 167 
was quenched at different temperatures (Scheme 1.10.16). 
 
           156             167    164, 52% 
 
          anti-169, 54% 
Scheme 1.10.16 
When the reaction was quenched after 10 s at -78°C expected aldol products 164 were formed 
as a ca. 1 : 1 mixture of diastereoisomers in a yield of 52%. However, when the reaction mixture 
was allowed warm to room temperature for 12 h, mono-ester 169 was formed along with some 
Chapter 1    Introduction 
54 
 
aldol products 164 (11%). This shows that the rate of the aldol reaction (10 s at -78°C) is greater 
than the Tishchenko reduction (several hours at room-temperature).  
The high stereoselectivity of the reaction can be rationalised by a mechanism involving a 
reversible aldol reaction followed by intramolecular hydrogen transfer via a six-membered 
transition state (Scheme 1.10.17). 
 
      anti-170         171 
           
     
 
 
 
 
   syn-170 
 
 
   161       172 
Scheme 1.10.17 
Attack by lithium enolate 170 on the aldehyde will result in hemi-acetal 171 which can adopt a 
highly structured 6-membered transition state 172 with both the methyl group at C-2 and the 
R2 group at C-3 in the preferred equatorial position. The 1- and 5- positions are fixed via 
coordination to the lithium ion. This model is also in agreement with that proposed by Evans 
and Hoveyda in the samarium catalysed Tishchenko reduction of β-hydroxy ketones.148 
In 2001, Morken and co-workers described the first catalytic asymmetric aldol-Tishchenko 
reaction of two different aldehydes, 173 and 174, catalysed by an yttrium-salen complex 
(Scheme 1.10.18).157   
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          173          174             175       176 
 
177a-f 
Scheme 1.10.18 
The reaction provides two regioisomeric esters 175 and 176 in similar enantiopurity suggesting 
a nonselective intramolecular acyl migration after formation of the aldol-Tishchenko adduct. 
Bulky substituents ortho to the salen oxygen atom (R1) were necessary for reactivity and 
selectivity, whereas the presence of para substituents (R2) were not essential for asymmetric 
induction (Table 1.10.2). The highest enantioselectivities were obtained when ligand 177f was 
employed. 
Ligand R1 R2 R3 Yield  er of 175 
177a t-Bu t-Bu (CH2)4 44% (3.4 : 1) 78 : 22 
177b t-Bu H (CH2)4 36% (3.0 : 1) 78 : 22 
177c Me H (CH2)4 54% (1.6 : 1) 57 : 43 
177d adamantyl Me (CH2)4 42% (3.2 : 1) 83 : 17 
177e t-Bu t-Bu Ph 48% (3.3 : 1) 82 : 18 
177f adamantyl Me Ph 70% (>15 : 1) 87 : 13 
Table 1.10.2 
Mlynarski and Mitura presented the first catalytic asymmetric aldol-Tishchenko reaction of 
aldehydes and simple aliphatic ketones in 2004.158 They employed chiral ytterbium complexes 
to catalyse the condensation of aromatic aldehydes with 3-pentanone 158 (and other ketones) 
giving rise to the anti-1,3-diol monoesters 178 and 179, however yields and enantioselectivity 
were moderate (Scheme 1.10.19). 
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          158              178, 10%, 74% ee      179, 64%, 17% ee 
 
 
Scheme 1.10.19 
Shibasaki disclosed the first catalytic direct aldol–Tishchenko reactions of aryl aldehydes (e.g. 
180) and aryl ketones (e.g. 181) that resulted, after hydrolysis of the intermediate 1,3-diol 
monoesters, in anti-1,3-diols 182 in moderate to good yield and high enantioselectivity (Scheme 
1.10.20).159 
       181          180     182, 96%, 95% ee, >96% de 
Scheme 1.10.20 
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2.1 Introduction 
In this chapter the synthesis of a compilation of racemic ketones is described. It was necessary 
to prepare the target compounds of this project to become familiar with the stability and 
volatility of the α-alkylated products and establish suitable methods for isolation, purification 
and storage before attempting their asymmetric synthesis. 
Moreover, these racemic ketones would serve as reference standards. Optimum separation 
conditions via GC analysis were determined for each compound using these racemic samples, 
which would provide accurate determination of enantiomeric ratios of the enantioenriched 
products. 
The synthesis of a novel chiral diamine-based chiral auxiliary is also detailed in this chapter. 
Its use, in the asymmetric α-alkylation of ketones, was also investigated and the results are 
presented.   
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2.2 Results and Discussion 
2.2.1 Preparation of Racemic α-Alkylated Ketones  
The simple aliphatic ketone 3-pentanone was chosen as the substrate for initial investigations 
in establishing a new route to asymmetric α-alkylated ketones. 3-pentanone was chosen to be a 
suitable substrate as it would be a very useful synthon in the synthesis of polyketide and 
propionate-based natural products.160 2-methyl-3-pentanone and propiophenone would also be 
employed in substrate scope investigations. Therefore α-alkylated products of these ketones 
were prepared as part of a racemic reference library. 
Preparation of the racemic substrates 36 and 183-188 was accomplished by addition of the 
ketone to freshly prepared LDA in THF at -78°C. The reaction was stirred for 1 h at -78°C and 
the electrophile was added slowly. The reaction was then warmed to room temperature 
overnight. The reaction was quenched with saturated NH4Cl, extracted with diethyl ether and 
the organic layers combined, dried and concentrated under reduced pressure. The crude product 
was then purified using column chromatography on silica gel to afford the pure alkylated 
ketones (Scheme 2.2.1). 
 
 
  
 
 
 
 
 
 
  
 
      
  
       
36, 19%           183, 10%     184, 40%      185, 20% 
 
 
 
 
 
 
  
   
  186, 20%         187, 19%      188, 17%  
Scheme 2.2.1 
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Initially ethyl acetate was employed as solvent for extractions and for purification of the ketone 
using column chromatography. However, due to volatility of the ketones, diethyl ether was later 
utilised. 
The yields obtained for α-alkylated ketones using 3-pentanone were poor to modest. It is well 
known that aldehyde and ketone alkylation is challenging due to competing side reactions, such 
as aldol condensations, Cannizzaro and Tishchenko reactions, and O-alkylation.12,13 
Furthermore, Molander and co-workers have demonstrated the allylation of 3-pentanone occurs 
in a poor yield (30%).161 Additionally, these products were very volatile and a notable decrease 
in mass was observed upon rotary evaporation. 
Improved yields were observed for the alkylation of 2-methyl-3-pentanone and propiophenone. 
Benzylation of 2-methyl-3-pentanone resulted in 189 in 40% yield. In the case of 
propiophenone, the products obtained, 190 and 191, were not volatile, however the reactions 
did not go to completion in the timescale of the reaction (Scheme 2.2.2). 
 
           189, 40%              190, 40%     191, 53% 
Scheme 2.2.2    
Having successfully synthesised this range of racemic ketones, each was subjected to chiral GC 
analysis and conditions were determined to achieve baseline resolution of enantiomers. As an 
example, Scheme 2.2.2 shows the chromatograph obtained for the separation of 2-methyl-1-
phenylpentan-3-one 36 using chiral GC chromatography (Figure 2.2.1).  
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                 36 
 
 
 
 
 
 
 
 
Figure 2.2.1 
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2.2.2 Synthesis of a Novel Diamine-based Chiral Auxiliary 
Expanding on the existing chiral ligand methodology, a novel diamine-based chiral auxiliary, 
(S)-192 was synthesised and it use in the asymmetric α-alkylation of ketones was investigated. 
Given that SAMP (S)-9 and its bulkier analogues contain an oxygen at the additional chelation 
site, we were interested in investigating the effect of changing this to a nitrogen (as part of a 
pyrrolidine system) and determine the enantioselectivity of the resulting alkylated products. 
Our auxiliary offers a distinct advantage in that it can be accessed in two steps from the 
commercially available amine (S)-193 (Scheme 2.2.3). 
 
       (S)-193         (S)-192 
Scheme 2.2.3 
To obtain larger quantities of chiral diamine (S)-193 we began with (S)-proline (S)-194. The 
literature procedure described by Amedjkouh et al. was used for the preparation of (S)-193.162 
The first step involved preparation of the bicyclo, oxazolidinone (R,S)-195 (Scheme 2.2.4). 
This was achieved by addition of anhydrous chloral 196 to a stirred solution of the amino acid 
(S)-proline (S)-194, dissolved in chloroform. The resulting solution was then heated for 10 h 
under reflux using a reverse Dean-Stark apparatus to remove water. The mixture was then 
cooled to room temperature and washed with water. The resulting water layers were washed 
with dichloromethane and the combined organic layers were dried and concentrated under 
reduced pressure. The crude product, a brown crystalline solid was purified by recrystallisation 
from ethanol. The bicyclo product (R,S)-195 was produced in a 42% yield as white crystalline 
needles. 
 
    196           (S)-194             (R,S)-195, 42% 
Scheme 2.2.4 
  
Chapter 2    Results and Discussion 
64 
 
The mechanism probably proceeds as outlined in Scheme 2.2.5. 
 
 
 
  
 
 
 
 
 
 
 
 
 
Scheme 2.2.5 
From the analytical data obtained it was possible to conclude that the bicyclo intermediate 
(R,S)-195 was successfully formed.162 In the 1H NMR, a 1H doublet of doublets was observed 
at 4.11 ppm which is indicative of the hydrogen at C-3. A 1H singlet at 5.16 ppm represented 
the proton at C-1, next to the trichloromethyl-carbon. The three adjacent CH2 groups (C-4, C-5 
and C-6) all showed multiplets between 1.80 and 3.50 ppm. In the 13C NMR spectra, the CH2 
carbons appeared at 25.4 (C-5), 29.9 (C-4) and 57.9 (C-6) ppm respectively and the CH of C-3 
was observed at 62.4 ppm. The carbonyl-carbon appeared at 175.5 ppm. A positive mass 
spectrum confirmed the presence of the protonated molecular ion at m/z = 244. An optical 
rotation, [α]20
D
 of + 29.8 was obtained at 20°C, which was consistent with that found in the 
literature and confirmed that the product (R,S)-195 was obtained.  
In the second step of the synthesis, the bicyclo oxazolidinone (R,S)-195 was suspended in 
ethanol. Pyrrolidine 197 was added dropwise at 0˚C and the solution was allowed to stir at room 
temperature. After 4.5 hours, TLC analysis (1 : 1, hexane : ethyl acetate) showed all starting 
material had reacted. Once the solvent had been removed under reduced pressure, the product 
(S)-198 was obtained as a yellow oil and used in the next step without further purification 
(Scheme 2.2.6). 
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             (R,S)-195   197           (S)-198 
Scheme 2.2.6 
The mechanism for this reaction probably proceeds as outlined in Scheme 2.2.7. 
 
 
 
 
 
 
        
   (R,S)-195 
 
 
 
 
 
 
 
 
 
 
 
    (S)-198 
Scheme 2.2.7 
The 1H NMR spectrum was consistent with that in the literature.162 A characteristic doublet of 
doublets was observed at 3.79 ppm for the proton at C-1, due to splitting by the diastereomeric 
protons at C-2. A 4H multiplet between 3.35-3.57 ppm corresponded to the protons at C-6 and 
C-9. In the 13C NMR spectrum, the CH at C-1 was observed at 59.44 ppm. The CH2 groups at 
C-4, C-6, C-9 are more downfield, than the remaining CH2 groups, at 45.8, 45.9, 47.6 ppm 
respectively. The positive mass spectrum confirmed the presence of the protonated molecular 
ion at m/z = 169. 
The next step en route to the chiral auxiliary (S)-192 involved reduction of amide (S)-198 to 
tertiary amine (S)-193 using lithium aluminium hydride. The reducing agent was first dissolved 
in dry THF under a nitrogen atmosphere, the amide was then added dropwise at 0˚C over a 30 
minute period in THF. The reaction mixture was returned to room temperature and allowed to 
stir overnight. It was then heated at reflux for 2.5 h. The mixture was allowed to cool to room 
temperature and quenched by slow addition of water, 15% sodium hydroxide and water. The 
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mixture was stirred until a white precipitate had formed. The reaction mixture was then filtered 
through Celite® and the filtrate concentrated under reduced pressure to give the crude product 
as an orange oil. Kugelrohr distillation was employed, affording the product (S)-193 as a clear 
oil in 40% yield over two steps (Scheme 2.2.8). 
 
      (S)-198          (S)-193, 40% over two steps 
Scheme 2.2.8 
The 1H NMR spectrum confirmed that amide (S)-198 was successfully reduced to amine (S)-
193. All methylene groups of the proline rings appeared as multiplets. The proton at C-1, which 
appeared as a doublet of doublets in (S)-198 was now observed as a multiplet at 3.15-3.29 ppm 
due to additional coupling to protons at C-5, as well as C-2. The carbon spectra confirmed the 
absence of the carbonyl of amide (S)-198, instead a peak was observed at 62.1 ppm, which 
corresponded to the CH2 of C-5. The infrared spectra showed characteristic peaks for (S)-193, 
a strong stretch at 3320 cm-1 for the N-H stretch, peaks between 2961-2793 cm-1 for C-H 
stretches and medium stretches between 1146-1108 cm-1 for the C-N. A positive ESI mass 
spectrum showed the protonated molecular ion at m/z = 155. An optical rotation, [α]20
D
  of + 5.2 
was obtained in ethanol at a concentration of 2.4 g/100 ml and was in reasonable agreement 
with the literature value of + 8.9.162 
The fourth step of the synthesis was the preparation of nitroso intermediate (S)-199. Great care 
was taken in handling nitroso product (S)-199, as it is a possible carcinogen. Three pairs of 
gloves were used at all time, and reactions were carried out with extra caution. Following the 
reaction all glassware was washed in a base bath, then an acid bath followed by water and 
acetone. 
A procedure by Lazny et al. was chosen for the nitrosation reaction of (S)-193 to (S)-199.163 
This involved addition of tert-butyl nitrite to a solution of amine (S)-193 in THF. The mixture 
was stirred for 18 h at room temperature in the absence of light. However TLC analysis showed 
only starting materials remained. The following day the mixture was refluxed for 5 h. The 
solvent and the excess tert-butyl nitrite were removed under reduced pressure to afford a brown 
oil. 1H NMR spectra showed the reaction was unsuccessful and that only the starting material 
remained. 
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As this procedure was unsuccessful, (S)-199 was subsequently prepared using a procedure 
described by Curtin et al.164 The amine starting material (S)-193 was dissolved in water and 
37% hydrochloric acid was added. Acetic acid was then added, followed by sodium nitrite at 
0˚C and the solution left to stir at this temperature for 30 minutes. The reaction mixture was 
then returned to room temperature for 90 minutes. A TLC using 9 : 1, dichloromethane : 
methanol showed all starting material had reacted. The solution was cooled to 0˚C for addition 
of the 10% sodium carbonate until it just turned basic. Ethyl acetate was added, the aqueous 
layer was then removed and washed twice with ethyl acetate. The combined organic layers were 
dried and the solvent removed under reduced pressure to give the product (S)-199 as a yellow 
oil. It was used in the next step without further purification (Scheme 2.2.9). 
 
           (S)-193       (S)-199 
Scheme 2.2.9 
Due to the toxic nature of the compound (S)-199, only 1H NMR analysis was obtained. The 
equivalent hydrogens of C-7 and C-8 of the proline ring were observed at 1.73-1.82 ppm. A 
signal was detected for the proton at C-1, which appeared at 3.15-3.29 ppm for the diamine (S)-
193, but was now seen as a multiplet at 4.56-4.68 ppm for nitroso (S)-199. This is due to the 
electron withdrawing nitroso group causing a deshielding effect. Two 1H doublet of doublets 
were observed for C-5 between 2.80 and 2.99 ppm. 
For the final step of the chiral auxiliary synthesis, lithium aluminium hydride was used to reduce 
nitroso intermediate (S)-199 to hydrazine (S)-192. To a suspension of lithium aluminium 
hydride in dry THF under a nitrogen atmosphere, cooled to 0°C, was added (S)-199 in dry THF, 
slowly over a 30 minute period. The mixture was allowed warm to room temperature and left 
to stir for a period of 6 hours. The reaction was quenched by slow addition of water, 15% 
sodium hydroxide and water. A white precipitate formed, which was filtered through Celite® 
and washed with ethyl acetate and THF. The filtrate was then concentrated under reduced 
pressure to give the crude product as a yellow oil. Purification of (S)-192 was achieved via 
kugelrohr distillation. Pure chiral auxiliary (S)-192  was isolated in 40% yield over two steps 
(nitrosation and reduction) (Scheme 2.2.10).  
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        (S)-199         (S)-192 
Scheme 2.2.10 
The mechanism for this reaction is outlined below in Scheme 2.2.11. 
  
 
 
 
 
  (S)-199   
 
 
 
 
 
 
 
 
  (S)-192         
 
Scheme 2.2.11 
The 1H NMR spectra of (S)-192 showed a characteristic doublet of doublets for the hydrogen 
at C-5 at 2.88 ppm. The 13C NMR spectrum displayed peaks at 20.6 (C-2), 23.7 (C-7 and C-8) 
and 28.7 ppm (C-3) being the most upfield. The only CH in the molecule at C-1 was observed 
at 67.8 ppm, which was confirmed using a DEPT-90 spectrum. The infrared spectra showed a 
medium stretch at 3306 cm-1 for the N-H stretch. The C-H stretches were observed between 
2961-2789 cm-1. A positive high resolution mass spectrum was also obtained for this product 
and showed the protonated molecular ion at m/z = 170.1674 compared to a calculated m/z = 
170.1657. An optical rotation, [α]20
D
  of -11.4 in ethanol, at a concentration of 1 g/100 ml was 
observed. 
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2.2.3 Investigation of a Novel Chiral Auxiliary in the Asymmetric α-Alkylation of 
Ketones 
Chiral auxiliary (S)-192 was investigated in the asymmetric alkylation of 3-pentanone 158. 
Hydrazone (S)-200 was formed by reaction of hydrazine (S)-192 in cyclohexane, followed by 
addition of 3-pentanone 158 and 2 grains of p-toluenesulfonic acid. This mixture was stirred 
for 5 h at room temperature, under a nitrogen atmosphere. NMR analysis showed the reaction 
had gone to completion (Scheme 2.2.12). Diethyl ether was added to the solution and this was 
washed with water. The organic layers were combined, dried and concentrated under reduced 
pressure to give the crude product (S)-200 as a yellow oil. This was used in the next step without 
further purification. We did investigate purification of this hydrazone but found it was 
problematic. Using column chromatography on alumina gel, only 3% of the pure hydrazone 
(S)-200 was isolated. We concluded the hydrazone was being retained on the column. The crude 
product was later deemed to be of sufficient purity for use in the next step. 
 
 
 
 158 
 
 
    (S)-192         (S)-200 
Scheme 2.2.12 
The mechanism of this reaction is depicted on Scheme 2.2.13. 
 
 
 
   
 
 
 
 
 
 
 
 
 
             
    
 
Scheme 2.2.13 
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The 1H NMR spectra showed two overlapping 3H triplets, at 1.06 and 1.08 ppm for the methyl 
groups at C-10 and C-14. The methyl group at C-14 is tentatively assigned as the signal at 1.08, 
being the more downfield of the two methyl groups due to the proximity the nitrogen of the 
auxiliary through space causing a deshielding effect. In the 13C NMR the distinctive C=N 
carbon was observed at 173.3 ppm confirming successful formation of the hydrazone (S)-200. 
The IR spectrum also confirmed the presence of a C=N group with a strong stretch at 1637 cm-
1. The high resolution mass spectrum for the product showed the protonated molecular ion at 
m/z = 238.2283 compared to the calculated value 238.2277. An optical rotation, [α]20
D
  of +114.0 
in ethanol at a concentration of 1 g/100 ml was recorded for hydrazone (S)-200. 
Chiral hydrazone (S)-200 was than alkylated as follows. Lithium diisopropylamide was freshly 
prepared. To dry THF, dry diisopropylamine was added at room temperature. This was cooled 
to 0°C and n-BuLi was added dropwise. The reaction mixture was left to stir for 30 min at 0°C, 
then cooled to -78°C. The hydrazone (S)-200 was added dropwise and stirred for 15 min. The 
reaction was then returned to room temperature and stirred for 4 h. The reaction was cooled to 
-110°C (cryocooler temperature) and benzyl bromide was added and allowed to stir for 30 min. 
The reaction mixture was allowed warm to room temperature overnight. The following day 
saturated NH4Cl was added and left to stir for a few min to quench the reaction. The reaction 
mixture was then extracted with diethyl ether, dried and the solvent removed. 
The resulting oil was hydrolysed, using a biphasic 4M HCl/diethyl ether system and vigorous 
stirring. Once TLC (5 : 1, hexane : diethyl ether) showed the reaction had gone to completion, 
water was added and the mixture extracted with diethyl ether. The combined organic fractions 
were combined and dried over anhydrous magnesium sulphate, filtered, and concentrated under 
reduced pressure. This crude product was then purified using column chromatography on silica 
gel to give the pure product (S)-36 as a clear oil in a poor yield of 15% (Scheme 2.2.14).  
 
 
     
 
 
 
 
      (S)-200    (S)-36  
Scheme 2.2.14 
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All spectroscopic data recorded were consistent with that of (S)-36 obtained previously. GC 
analysis was carried out using the conditions previously established with racemic 36, and 
confirmed that no enantioinduction had occurred and a racemic mixture was obtained (Figure 
2.2.2 (a)). This reaction was later repeated by another member of the group and 61% ee was 
achieved,165 therefore this result was put down to experimental error. 
This reaction was repeated using diethyl ether as the solvent and again the spectroscopic data 
obtained was consistent with that previously obtained.  
We were extremely pleased to obtain an excellent enantiomeric ratio of 6 : 94 when the solvent 
was changed to diethyl ether. Diethyl ether is evidently the best solvent for this reaction 
resulting in improved yields and considerably better enantiomeric ratios (Figure 2.2.2 (b)). The 
results are summarised in the Table 2.2.1. 
(a).   (b).  
Figure 2.2.2 (a). GC chromatograph for reaction carried out in THF. (b). GC chromatograph 
for reaction carried out in diethyl ether. 
 
Entry Solvent Ketone Yielda er R : S % ee 
1 THF 36 14% 50 : 50 Racemic 
1 Et2O (S)-36 33% 6 : 94 88% 
aIsolated yield is over two steps. 
Table 2.2.1 Solvent investigations for asymmetric alkylation using novel chiral auxiliary.  
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The chiral shift reagent, Europium tris[3-(trifluoromethylhydroxymethylene)-(+)-camphorate] 
(+)-201 (Figure 2.2.3) was also used to confirm the enantioselectivity of (S)-36.  
        
(+)-201 
Figure 2.2.3 
Chiral shift reagent (+)-201 was added to a 10 mg sample of racemic 36 in 2 mg increments 
and the NMR spectrum recorded (Figure 2.2.4). We can see the doublet at 1.08 ppm begins to 
split into two doublets corresponding to the (S)- and (R)-enantiomer. The best resolution was 
obtained with an NMR sample containing 8 mg of europium complex (+)-201 and 10 mg of 
ketone in deuterated chloroform. 
 
Figure 2.2.4 
When these conditions were applied to (S)-36, full baseline resolution was not achieved. 
However the good enantioselectivity previously determined by GC was confirmed (Figure 
2.2.5). 
No chiral shift reagent added 
2 mg chiral shift reagent added 
4 mg chiral shift reagent added 
6 mg chiral shift reagent added 
8 mg chiral shift reagent added 
10 mg chiral shift reagent added 
Chapter 2    Results and Discussion 
73 
 
 
Figure 2.2.5 
The mechanism for the hydrolysis step is depicted in Scheme 2.2.15. 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.2.15 
We surmise a similar transition state to the SAMP system, involving the selective formation of 
an ECCZCN intermediate (Figure 2.2.6). Electrophilic attack is sterically disfavoured from 
‘above’ due to the rigid 5-membered ring. This diastereofacial differentiation results in 
(S)-enantiomer 
(R)-enantiomer 
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diastereomerically enriched hydrazones and ultimately enantiomerically enriched α-substituted 
ketones upon cleavage of the chiral auxiliary. 
 
 
 
 
 
 
 
 
            ECCZCN 
 
 
 
Figure 2.2.6 
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2.3 Conclusions and Future Work 
A novel chiral auxiliary (S)-192 with a pyrrolidine arm was successfully prepared in five 
synthetic steps from commercially available (S)-proline (S)-194, without the need for column 
chromatography. This auxiliary (S)-192 successfully effected the asymmetric α-alkylation of 
the simple aliphatic ketone 3-pentanone 158 in an excellent enantiomeric ratio of 94 : 6 using 
diethyl ether as solvent. Given the positive results obtained with (S)-192 and its potential to 
rival the SAMP (S)-9 auxiliary, it was worthy of further optimisation and full substrate scope 
investigations. The work was subsequently carried on by another member of the group. 
Optimisation and a full substrate scope was completed and the results were published.165 
 
 
  
 
  
 
 
 
 
 
 
 
 
Chapter 3  
Intermolecular Chirality 
Transfer using Sparteine as a 
Chiral ligand 
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3.1 Introduction 
While we were delighted with the success of the previously discussed chiral auxiliary (S)-192 
(as discussed in Chapter 2) we felt this work would only have a moderate impact given the 
numerous successful auxiliaries available. This prompted us to explore a new protocol for the 
α-alkylation of ketones. Herein, we present a strategy for the generation of enantiomerically 
enriched α-alkylated acyclic ketones using an intermolecular chirality transfer protocol, and the 
results obtained to date are discussed. 
Many optically active drugs and natural products contain the α-functionalised ketone moiety. 
As previously discussed, enantioenriched α-alkylated ketones are very useful synthons and have 
found widespread use in synthesis.8-10 Thus, the asymmetric alkylation of ketones represents a 
very useful transformation in organic chemistry. Surprisingly however, only one effective 
methodology applicable to simple acyclic ketones exists, and this involves the use of chiral 
auxiliaries (Scheme 3.1.1).35  
 (i) Ender's SAMP Chiral Auxiliary 
 
 
 
 
 
            
 
     
(ii) Coltart's ACC Chiral Auxiliary 
 
 
 
  
 
 
 
 
Scheme 3.1.1 
The well-known, proline derived, SAMP/RAMP auxiliaries have found numerous applications 
in asymmetric alkylation (Scheme 3.1.1) (discussed in Chapter 1, Section 1.3).10 For example, 
Nicolaou et al. employed the SAMP hydrazone of 3-pentanone in an asymmetric alkylation en 
route to swinholide A 202 (Scheme 3.1.2).166,167  
 
 
Chapter 3   Results and Discussion 
80 
 
  
 
 
 
 
 
       
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Swinholide A  202 
Scheme 3.1.2 
More recently Coltart has introduced N-amino cyclic carbamate (ACC) chiral auxiliaries 
(discussed in Chapter 1, Section 1.3). These auxiliaries do not require the extremely low 
alkylation temperatures used with SAMP/RAMP hydrazones. The ACC methodology has 
already been utilised in the synthesis of several biologically important compounds.38 
Despite advances in the use of homo chiral lithium amide bases,53,168-170 transition metal 
catalysis60,171,172 and organocatalysis, none of these areas of research have managed to achieve 
the asymmetric α-alkylation of acyclic ketones.63 
Our approach to enantiomerically enriched α-alkylated ketones involves the use of simple non-
chiral dimethylhydrazones and effecting their asymmetric alkylation using a chiral diamine 
ligand. As we have previous demonstrated (discussed in Chapter 2, Section 2.2.1), the use of 
lithium bases to furnish small aliphatic α-alkylated ketones, via deprotonation and alkylation of 
ketones, often proceeds in poor yield.161 
In light of this, we chose to introduce the dimethylhydrazone methodology into our system, 
(discussed in Chapter 1, Section 1.6).173 Hydrazone 203 would act as a ketone surrogate to 
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facilitate smoother alkylation. We postulated that deprotonation using an alkyl lithium/chiral 
diamine system would furnish a highly structured azaenolate intermediate 204, which would 
benefit from added chelation with the dimethylamino group. In such a rigid system we would 
expect high facial selectivity to provide chiral, alkylated dimethylhydrazones (S)-205. 
Hydrazone cleavage using a biphasic HCl/diethyl ether system would easily return the 
enantioenriched ketone moiety (S)-206 (Scheme 3.1.3). 
Intermolecular Chirality Transfer Methodology           
     Highly 
           structured 
       aza(enolate) 
       intermediate 
 
         158             203               204 
 
 
 
 
 
 
 
 
 
(-)-sp 100 
     
            (S)-206          (S)-205 
 
 An alternative azaenolate structure for 204 could take this form: 
 
 
 
 
 
Scheme 3.1.3 
Of the numerous chiral diamines available,85 (-)-sparteine (-)-sp 100 was chosen as the chiral 
ligand for this work, as its use in enantioselective synthesis has been heavily documented in the 
literature.88 For example, sparteine/lithium systems have proven useful in a number of 
transformations involving asymmetric deprotonations and substitutions.97,100,174-180   
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3.2 Results and Discussion 
3.2.1 Synthesis of N,N-Dimethylhydrazones for Asymmetric α-Alkylation via 
Intermolecular Chirality Transfer 
Initial investigations into this methodology were attempted using the parent ketone, however 
only a trace amount of product, with no enantioenrichment, was detected by GC 
chromatography. In addition the methyl and methylene regions of the 1H NMR showed a 
complex array of peaks due to compounds formed from the multiple reactions pathways viable 
for ketone enolates.12,13 Therefore the intermolecular chirality transfer methodology was 
developed using N,N-dimethylhydrazones. 
During the course of this project a selection of N,N-dimethylhydrazones were prepared in 
excellent yields using N,N-dimethylhydrazine, in the presence of a catalytic amount of AcOH, 
and purified via kugelrohr distillation. (Scheme 3.2.1). 
 
 
 
  
 
        
 
 
 
 
 
 
 
   203, 89%    207, 92% (3 : 1, E : Z)              208, 61% (1 : 4, E : Z)  
 
 
 
 
 
 
 
  
 
                  209, 90% (4 : 1, E : Z)          210, 89% (10 : 1, E : Z) 
Scheme 3.2.1 
Excellent yields were observed for each of these hydrazones with the exception of hydrazone 
208. A decreased yield of 61% for this compound was due to its volatility and some product 
was lost upon purification with high vacuum apparatus. 
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Hydrazone 211 was also prepared during the project for use in the synthesis of a precursor to 
(R)-stigmolone (discussed later in Section 3.2.2).181 To prepare hydrazone 211, hydrazone 207 
was deprotonated in the presence of freshly prepared LDA in THF at -78°C. The reaction was 
allowed warm to room temperature and stirred for 6 h. 2-iodopropane was added slowly at -
78°C and the reaction allowed warm to room temperature overnight with continued stirring. 
The reaction was quenched with saturated NH4Cl, extracted with diethyl ether and the organic 
layers combined, dried and concentrated under reduced pressure. The 1H NMR spectrum of the 
crude reaction mixture showed the reaction had gone to completion. We believe product was 
lost upon work up and purification of this volatile product as only 37% of pure hydrazone 211 
was isolated after column chromatography on silica gel (Scheme 3.2.2). Furthermore, TLC 
analysis also showed evidence for the cleavage of the hydrazone to its parent ketone upon 
chromatography which also contributed to the depleted yield.182 Hydrazone 211 was observed 
as a mixture of two isomers in 8 : 1 ratio (as determined by NMR of the crude material). The 
product quickly isomerised to a 1 : 1 ratio over the timescale of purification. 
  
  
     
                    
         
         207       211, 37% 
Scheme 3.2.2 
All other unsymmetrical hydrazones 11-15 were also clearly visible as two isomers by NMR 
spectroscopy. For example, both isomers of hydrazone 210 were clearly distinguishable in the 
1H and 13C NMR spectra. The ratio of isomers was observed as 10 : 1, E : Z. The major isomer 
for hydrazones is always the least sterically hindered.183 Here also, the less sterically 
encumbered isomer (E-configuration) is shown to be the major isomer. This is the favoured 
configuration as steric interactions between the phenyl group and the dimethyl group are 
minimised (Scheme 3.2.3). 
  
 
 
 
  
 
 
       E-210        Z-210  
Scheme 3.2.3 
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Table 3.2.1 1H and 13C NMR spectra of E-210 and Z-210. 
The striking difference between both isomers, is the difference of 10 ppm in the chemical shift 
of C-8 in the 13C NMR spectrum (Table 3.2.1). It can be seen in Scheme 3.2.3 that the two 
dimethyl groups may have a shielding effect on C-8 of the E-isomer accounting for the up-field 
resonance. However this effect is not observed in the 1H spectra, the reality is probably more 
complex and may involve some form of hyper-conjugation. 
When a proton is radiated, spatially-close protons may experience an intensity enhancement, 
which is termed the Nuclear Overhauser Effect (NOE). The NOE is unique among NMR 
methods because it does not depend upon through-bond couplings but depends only on the 
spatial proximity between protons. 
The NOESY spectrum (Figure 3.2.1) for 210 showed a correlation between the protons of the 
dimethyl groups at 2.54 ppm and the protons of C-8 at 2.88 ppm, for the major isomer. This 
correlation indicates that the dimethyl amino group resides on the side of the alkyl groups, 
confirming E-210 as the major isomer, which is in agreement with a previous report in the 
literature.183  
  
 1H NMR 13C NMR 
 H-8 H-9 H-10 OMe C-7 C-8 C-9 C-10 OMe 
E-210 2.88, q,  J = 7.6 1.08, t,  J = 7.6 2.54, s 3.82, s 169.1 21.5 12.1 47.9 55.3 
Z-210 2.51, q,  J = 7.6 1.01, t,  J = 7.6 2.36, s 3.86, s 166.7 31.4 11.9 47.0 55.4 
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Figure 3.2.1 NOESY sprectrum for E-210 
 
 
   
 
 
 
 
 
 
 
Figure 3.2.2 NOE difference sprectrum for E-210 
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This observation was further supported by NOE difference experiments where irradiation of 
the signal for the dimethyl group protons causes a notable enhancement in the signals for the 
protons C-8 (2.88 ppm) and C-9 (1.08 ppm), in comparison to the signals for the ortho-protons 
C-1 and C-5 (Figure 3.2.2). This also signified the spatial proximity of the dimethyl groups to 
the C-8 protons, and hence supported the E-configuration. However the NOE detected here is 
small for the signals at 1.08 and 2.88 ppm. 
The size of the NOE enhancement for a particular pair of protons is principally a function of 
two variables - the primary one is the distance between the ‘sending’ and ‘receiving’ protons. 
The secondary is consideration of what other protons are contributing to the dipole-dipole 
relaxation of the ‘receiving’ proton. If there are other protons that are closer than the ‘sending’ 
one, then the ‘receiving’ proton will of inevitability show a smaller NOE enhancement. Thus 
when a methyl group, for example, is the receiver, the NOE enhancement is always small (<5%) 
even when the ‘sending’ proton is very close. This is because each methyl proton has two, much 
closer, dipole-dipole coupled partners which provide the primary relaxation pathway, resulting 
in only a small input from more distant protons outside the methyl group.184 This might explain 
the small NOE observed here for E-210 between the dimethyl group protons and the protons of 
C-8 and C-9.  
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3.2.2 Determination of Optimum Reaction Conditions for Asymmetric α-Alkylation via 
Intermolecular Chirality Transfer  
Hydrazone 203 was chosen as our standard substrate for investigations into asymmetric α-
alkylation via intermolecular chirality transfer, because as previously mentioned 3-pentanone 
158 is a very useful synthon in the synthesis of natural products.160,166,167  
These asymmetric alkylation reactions were air sensitive and required a nitrogen environment 
to proceed. Ligand (-)-sp 100 and toluene were distilled prior to use and all equipment had to 
be thoroughly dried. Scheme 3.2.4 shows our model reaction used to establish suitable 
conditions. Hydrazone 203 was deprotonated in the presence of (-)-sp 100 and sec-BuLi to form 
azaenolate intermediate 204. Subsequent reaction with BnBr or iodopentane, yields the 
enantioenriched hydrazone (S)-205. The hydrazone moiety was hydrolysed using a biphasic 
4M HCl/diethyl ether system to afford benzylated ketone product (S)-36 or (S)-188. This 
cleavage method was chosen, as the ketone products could be isolated within 30 minutes.  
 
              (-)-sp 100 
 
 
           203        204             
        (S)-205 
 
 
 
  
 
 
 
 
 
          (-)-sp 100       E = Bn, (S)-36 
         E = n-Pe, (S)-188 
Scheme 3.2.4  
Our initial studies focused on establishing the optimum reaction temperature for 
enantioselectivity to occur. Firstly, keeping the deprotonation constant at room temperature, a 
range of alkylation temperatures were investigated (Table 3.2.2). Since stereoselective reactions 
are usually achieved under kinetic control, lower temperatures usually result in higher 
stereoselectivity.  
Chapter 3   Results and Discussion 
88 
 
 
aIsolated yield is over two steps. 
Table 3.2.2 Alkylation temperature investigations. 
When the reaction was alkylated at -70°C, no reaction occurred (entry 2). Alkylation did take 
place at -55°C with moderate enantioselectivity (28 : 72 er) (entry 3). An improvement in the 
enantiomeric ratio was observed at -30°C when an enantiomeric ratio of 24 : 76 was achieved 
(entry 4). As the temperature was increased enantioselectivities began to drop off  (entries 5-7). 
It was interesting to note that when the alkylating agent was added at -78°C and the reaction 
mixture allowed warm up overnight the best enantioselectivity was achieved (entry 1). However 
attempts to replicate this result failed, reflecting a rather uncontrolled warm-up protocol. 
Therefore, an alkylation temperature of -30°C was chosen as our standard going forward. 
Before continuing with further studies on this methodology we were eager to ensure 
racemisation of the chiral centre was not occurring during the acid hydrolysis used for the 
hydrazone cleavage. To ensure this was not the case, we carried out the hydrolysis for 24 hours 
and no erosion of enantioselectivity was observed. 
We next investigated higher deprotonation temperatures, in an attempt to manipulate the system 
and produce the thermodynamically most stable azaenolate, which could possibly give better 
enantioselectivity (Table 3.2.3). 
 
aIsolated yield is over two steps. 
Table 3.2.3 Deprotonation temperature investigations. 
Entry Ligand Deprot. 
Temp. 
Alkyl. 
Temp. 
Solvent Yielda Ketone er R : S % ee 
1 (-)-sp 100 RT -78°C to RT Toluene 53% (S)-36 20 : 80 60% 
2 (-)-sp 100 RT -70°C Toluene no reaction occurred 
3 (-)-sp 100 RT -55°C Toluene 50% (S)-36 28 : 72 44% 
4 (-)-sp 100 RT -30°C Toluene 57% (S)-36 24 : 76 52% 
5 (-)-sp 100 RT 0°C Toluene 50% (S)-36 27 : 73 46% 
6 (-)-sp 100 RT RT Toluene 55% (S)-36 29 : 71 42% 
7 (-)-sp 100 RT 70°C Toluene 53% (S)-36 30 : 70 40% 
Entry Ligand Deprot. 
Temp. 
Alkyl. 
Temp. 
Solvent Yielda Ketone er R : S % ee 
1 (-)-sp 100 32°C -30°C Toluene 45% (S)-36 23 : 77 54% 
2 (+)-sp 100 40°C -30°C Toluene 32% (R)-36 70 : 30 40% 
3 (-)-sp 100 40°C 40°C Toluene 52% (S)-36 33 : 67 34% 
4 (-)-sp 100 70°C 70°C Toluene 54% (S)-36 36 : 64 28% 
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Unfortunately these efforts did not improve the enantiomeric ratios. While some selectivity is 
observed, it is quite poor compared to our standard conditions (deprotonation at room 
temperature and alkylation at -30°C). A marginal increase in enantioselectivity is observed 
when deprotonation takes place at 32°C, however it was not significant enough to have 
warranted a change in our standard conditions. A deprotonation time of six hours was found to 
be necessary in order to produce satisfactory yields. Later NMR investigations (see Section 
3.2.9) showed deprotonation was complete in 30 minutes, however, although the 
enantioselectivities obtained were the same, we could not replicate the yields achieved with the 
six hour deprotonation. 
Next, we examined the outcome of changing the solvent. Again, hydrazone 203 was subjected 
to sparteine/sec-BuLi deprotonation (room temperature for 6 h) and alkylation with either 
benzyl bromide or 1-iodopentane (-30°C for 22 h), in a range of solvents. The resulting 
alkylated hydrazones were hydrolysed using the HCl/diethyl ether system and the enantiomeric 
excess of the ketones 36 and 188 determined (Table 3.2.4). 
aIsolated yield is over two steps. bYield determined using NMR and 1,3,5-trimethoxybenzene as internal standard. 
Table 3.2.4 Solvent screen. 
The enantioselectivity showed a high solvent dependence. Cumene as solvent gave good 
conversion to alkylated ketone (S)-36 (62% yield by NMR over 2 steps) (entry 2), however 
complete removal of this high boiling point solvent in the presence of volatile ketones proved 
difficult and the ketone product was lost as a result. Use of diethyl ether afforded ketone (R)-
188 in good enantioselectivity (78 : 22 er) and moderate yield (43%) over 2 steps (entry 7). In 
this case, to demonstrate the accessibility of both enantiomers of the chiral ketone, (+)-sp 100 
was utilised. The use of benzene, cyclohexane and MTBE gave lower enantioselectivity (entry 
3, 4 and 8). 
Entry Ligand Electrophile Solvent Yield Ketone er R : S % ee 
1 (-)-sp 100 BnBr Toluene 57%a (S)-36 24 : 76 52% 
2 (-)-sp 100 BnBr Cumene  62%b (S)-36 25 : 75 50% 
3 (-)-sp 100 BnBr Benzene 45%a (S)-36 31 : 69 38% 
4 (-)-sp 100 BnBr Cyclohexane 23%a (S)-36 31 : 69 38% 
5 (-)-sp 100 BnBr THF 40%a (S)-36 Racemic 
6 (-)-sp 100 n-PeI Toluene 46%a (S)-188 17 : 83 66% 
7 (+)-sp 100 n-PeI Et2O 43%a (R)-188 78 : 22 56% 
8 (-)-sp 100 n-PeI MTBE 32%a (S)-188 33 : 67 34% 
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Toluene was found to be the prime solvent for these reactions giving the best enantioenrichment 
of both (S)-36 and (S)-188, 24 : 76 er (entry 1) and 83 : 17 er (entry 6), respectively. While 
conversion to product in toluene was high, yields remained moderate, most likely due to the 
high volatility of the resulting ketones.  
The use of THF as solvent, afforded ketone (S)-36 with no enantioenrichment (entry 5), 
probably due to competing coordination of THF and (-)-sp 100 to the lithium. O’Brien and co-
workers observed a similar effect in the asymmetric deprotonation of N-Boc pyrrolidine in 
THF.185 They discovered, via NMR experiments, there is no complexation of (-)-sp 100 to the 
sec-BuLi in THF until ≥3 equivalents of (-)-sp 100 is used. 
Next we probed the effect of varying the alkyl lithium base. Again, using our standard 
conditions for deprotonation (room temperature for 6 h) and alkylation (benzyl bromide -30°C 
for 22 h) the following alkyl- and aryllithium reagents were tested (Table 3.2.5). 
     aIsolated yield is over two steps. 
Table 3.2.5 Evaluation of alkyl lithium reagent. 
While PhLi gave the best enantioselectivity (20 : 80 er), the yield was very poor (16%) (entry 
1). Therefore, sec-BuLi (entry 3) became the base of choice as it gave the best yield (57 %) of 
all alkyl lithium reagents screened and its enantioselectivity (24 : 76 er) was only marginally 
less than with PhLi. t-BuLi gave the same enantiomeric ratio (24 : 76 er) as sec-BuLi, however 
the yield was much lower (35%) (entry 4). Using n-BuLi resulted in a moderate yield (44%) 
and the lowest enantioselectivity (28 : 72 er) of all the alkyl lithium reagents investigated (entry 
2).  
The variance in enantioselectivities observed for the various alkyl lithium reagents could be 
rationalised by their different aggregate structures when coordinated to sparteine. Strohmann 
and co-workers have published a comprehensive discussion on the solid-state and solution 
structures of organolithium reagents.186 For instance, n-BuLi is described as having a hexameric 
Entry Ligand Electrophile Alkyl Lithium 
Reagent 
Yielda Ketone er R : S % ee 
1 (-)-sp 100 BnBr PhLi 16% (S)-36 20 : 80 60% 
2 (-)-sp 100 BnBr n-BuLi 44% (S)-36 28 : 72 44% 
3 (-)-sp 100 BnBr sec-BuLi 57% (S)-36 24 : 76 52% 
4 (-)-sp 100 BnBr t-BuLi 35% (S)-36 24 : 76 52% 
Chapter 3   Results and Discussion 
91 
 
parent structure (n-BuLi)6 (Figure 3.2.3), which deaggregates to a dimeric species upon 
coordination of sparteine. 
 
(n-BuLi)6 
Figure 3.2.3186 
t-BuLi on the other hand has a tetrameric parent structure (t-BuLi)4 (Figure 3.2.4), but is a 
monomer when coordinated to sparteine (Figure 3.2.4). 
               
          (t-BuLi)4             t-BuLi•(-)-sp 
Figure 3.2.4186 
These different aggregate states can often lead to different reactivity.187 Lower aggregates 
appear to be more reactive in most cases, but the relative reactivity of aggregates has rarely 
been determined.188  
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At this stage we considered the different enantioselectivities observed for each alkyl lithium 
base as evidence for an asymmetric deprotonation mechanism (see Section 3.2.6 for a detailed 
discussion of possible reaction mechanisms). Certainly, if the reaction takes place via an 
asymmetric deprotonation step the structure of the alkyl lithium base (monomer or aggregate) 
would be crucial to the rate and selectivity of deprotonation and thus the enantioselectivity of 
the alkylated product. However the differences are minimal and an asymmetric alkylation was 
not ruled out.  
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3.2.3 Substrate Scope in Asymmetric α-Alkylation via Intermolecular Chirality Transfer  
Having established optimal conditions for the asymmetric alkylation, we then explored the 
scope of the reaction with a range of simple alkyl halides (Scheme 3.2.5).           
            
            
            (-)-sp 100 
 
 
  
  
 
 
 
  
 
 
 
 
 
 
 
 (S)-36, 57%                (S)-186, 28%                (R)-183*, 46%              (S)-212, 22% 
 24 : 76 er (52% ee)          30 : 70 er (40% ee)           66 : 34 er (32% ee)              40 : 60 er (20% ee) 
 
 
 
 
 
 
 
   
 
 
   (S)-213, 26%       (S)-187, 50%        (R)-214*, 62%              (S)-215, 33% 
 30 : 70 er (40% ee) 27 : 73 er (46% ee)        71 : 29 er (42% ee)     33 : 67 er (34% ee) 
 
 
 
 
 
 
  
 
 
 
 (R)-216*, 54%      (S)-185, 20%          (S)-184, 30%              (S)-188, 46% 
 76 : 24 er (52% ee)          35 : 65 er (30% ee)   21 : 79 er (42% ee)             17 : 83 er (66% ee) 
*Note: Change in configuration is due to the use of (+)-sp 100 as the chiral ligand for these substrates. 
Scheme 3.2.5 
Carbonyl α-benzylation, leading to the formation of homobenzylic stereocenters, is a significant 
structural motif incorporated in important biological molecules, including neurotransmitters, 
hormones and complex metabolites.189-191 Also their use in hydrazone chiral auxiliary 
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methodology has been very limited. In fact, no thorough investigation of benzyl based 
electrophiles has been reported using chiral hydrazone methodology. In light of this we chose 
a range of benzyl-derived alkylating agents for our initial substrate scope studies. Benzyl 
bromide gave a moderate yield and enantioselectivity, 57% and 24 : 76 er, respectively. An 
optical rotation of + 31.7 was obtained for this compound. On comparison with a literature 
value of + 70.9 for the S-enantiomer with an er of 0.5 : 99.5,192 we concluded the configuration 
was also S- for our system. This is inferred for other substrates where literature values for optical 
rotations do not exist.  
We also inspected benzyl electrophiles with varying electronic properties. Electron-deficient, 
para-substituted aromatics are interesting from a biological and pharmaceutical stand point as 
they are more stable towards metabolic oxidation and are used in several industries.193 In 
particular nitro-aromatic compounds can resist microbial degradation.194 In our system these 
faster reacting electrophiles resulted in a decrease in both yield and enantiomeric ratio ((S)-186, 
(R)-183, (S)-212 and (S)-213). The para-halogenated benzyl bromides (bromine and fluorine) 
resulted in the same enantiomeric ratios ((S)-186 and (S)-213, 30 : 70 er). The fluorine and 
trifluoromethyl analogues were also chosen due to the growing importance of organofluoro 
compounds in the pharmaceutical industry.195 
The introduction of inductively-electron-donating alkyl groups in the para position of benzyl 
bromides such as (S)-187 (Me), (R)-214 (tert-butyl), also led to a decrease in enantiomeric 
ratio, 27 : 73 er and  71 : 29 er respectively. However, the effect was less dramatic than that 
observed with electron-withdrawing substituents. Also the strongly, resonance donating 
methoxy group (S)-215 resulted in a greater decrease in enantioselectivity (33 : 67 er), as well 
as a decrease in yield. 
2-Methylbenzyl bromide was utilised in order to install a small steric repulsion on approach of 
the electrophile ((R)-216, 76 : 24 er). A slight increase in selectivity was observed for this 
electrophile over its 4-methyl analogue. 
It was interesting that crotyl bromide resulted in poor yield and selectivity ((S)-185, 20%, 35 : 
65 er), but on changing the methyl group of crotyl bromide to a phenyl substituent, a substantial 
increase in enantiomeric ratio was observed ((S)-184, 21 : 79 er). Introduction of the n-pentyl 
moiety required use of an iodide leaving group and we were pleased to discover this slower 
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reacting electrophile resulted in the highest enantioenrichment achieved to date ((S)-188, 17 : 
83 er). 
While the yields remain moderate for most of these substrates, increased yields were observed 
for electrophiles resulting in less volatile ketone products ((R)-214 62%, 71 : 29 er). 
Dimethylhydrazones derived from non-C2 symmetric ketones and aryl ketones were then 
subjected to our optimised conditions. Hydrazone 207 (prepared as discussed in Section 3.2.1) 
was deprotonated using sparteine/sec-BuLi under the standard conditions (room temperature 
for 6 h), and alkylated (-30°C for 22 h), with benzyl bromide to afford the product (R)-189 
(48%, 54 : 46 er) after hydrolysis (Scheme 3.2.6). 
     
 
            (+)-sp 100 
  
  
 207         
  (R)-217 (R)-189, 48%, 
54 : 46 er 
Scheme 3.2.6 
A dramatic decrease in enantioselectivity is observe for this substrate in comparison to the 3-
pentanone analogues. This may be due to its non-symmetrical nature, which may lead to the 
formation of a different aza(enolate), which does not result in the same high facial selectivity 
as observed with 3-pentanone substrates. 
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The use of hydrazones 209 and 210 also led to disappointing results (Scheme 3.2.7). 
 
   (-)-sp 100 
 
 
 
 
 
R = H, 209      
R = OMe, 210     
 
 
 
 
 
 
 
 
                190, 56%               191, 62%                           218, 51%  
         Racemic          Racemic             Racemic                
Scheme 3.2.7 
Here hydrazones 209 and 210 were deprotonated using sparteine/sec-BuLi (room temperature 
for 6 h) and alkylated (-30°C for 22 h) with ethyl iodide or benzyl bromide. After cleavage of 
the hydrazone, the parent ketones were isolated as racemic mixtures, in all cases for 190, 191 
and 218. We believe these disappointing results were due to the unsymmetrical nature of the 
hydrazone, as was observed above for (R)-189. Again a different geometry of the azaenolate 
may arise, resulting in a transition state where facial discrimination does not occur. 
Another possible explanation for this observation could be racemisation of the chiral centre 
during cleavage of the hydrazone. Cleavage of the hydrazone was carried out using the biphasic 
diethyl ether/HCl system. It is possible that the lack of an additional enolisable site alpha to the 
carbonyl on the opposite side of the chiral centre results in racemisation (Scheme 3.2.8). No 
other cleavage protocols were investigated for these substrates. 
 
 
 
Scheme 3.2.8 
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A possible test to investigate this theory going forward, would be to carry out the hydrolysis in 
deuterium chloride (DCl) and deuterium oxide (D2O), and monitoring deuterium incorporation 
at the chiral centre. 
We also extended this methodology to the preparation of (R)-219 from hydrazone 211 (prepared 
earlier in Section 3.2.1). (R)-219 is a precursor in the synthesis of stigmolone (R)-220, an 
aggregation pheromone of the myxobacterium Stigmatella aurantiaca (Scheme 3.2.9).181 
 
 
 
    
   (R)-219      (R)-220 
Scheme 3.2.9 
Hydrazone 211 was alkylated using our intermolecular chirality transfer protocol with 3,3-
dimethylallyl bromide under the standard conditions (deprotonation at room temperature for 6 
h and alkylation at -30°C for 22 h) (Scheme 3.2.10). 
                (+)-sp 100 
  
  
  
    211 
  
 
 
                  (R)-221                 (R)-219, 28%, 
                 65 : 35 er  
Scheme 3.2.10 
Again a decrease in enantioselectivity is observed for this substrate in comparison with the 3-
pentanone analogues. In light of the poor selectivity obtained in the synthesis of (R)-219 we did 
not continue the synthesis of stigmolone (R)-220.  
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3.2.4 Yield Optimisation for Asymmetric α-Alkylation via Intermolecular Chirality 
Transfer 
Given that good yields were observed for ketone (R)-214 (62%, 71 : 29 er), this substrate was 
used to investigate other work up conditions to maximise recovery and further improve yields. 
The standard work-up conditions used to give 62% yield involved addition of saturated 
ammonium chloride to the reaction mixture at -30°C to quench the reaction. The mixture was 
then allowed warm to room temperature. Diethyl ether was added and the mixture was washed 
with ammonium chloride which removes sparteine. The organic layer was dried, and 
concentrated under reduced pressure. The crude hydrazone was subjected to the HCl hydrolysis 
method and the crude ketone purified using column chromatography to give (R)-214 as a clear 
oil in 62% yield and 71 : 29 er. 
Juaristi and co-workers have previously employed a methanol quench in reactions involving 
sparteine/lithium complexes.196 Applying this protocol to our reaction conditions, methanol was 
added to the reaction mixture at -30°C. Once the reaction mixture had warmed to room 
temperature, it was concentrated under reduced pressure. Water was added to the residue and 
following extraction with diethyl ether, the organic layers were combined, dried and 
concentrated under reduced pressure. The crude hydrazone was purified using column 
chromatography to give the pure hydrazone which was immediately subjected to the HCl 
hydrolysis method. The crude ketone was also purified using column chromatography and the 
title compound (R)-214 isolated in 53% yield and the same enantiomeric ratio of 71 : 29 er. 
We also investigated the use of a pH 7 buffer solution to quench the reaction. This protocol had 
previously been utilised by Enders in the synthesis of (E)-(S)-4-methyloct-6-en-3-one (S)-
185.197 Thus a pH 7 buffer solution was added to the reaction mixture at -30°C and allowed 
warm to room temperature. The mixture was then extracted with diethyl ether. The organic 
layers were combined, dried and concentrated under reduced pressure. The crude hydrazone 
was purified using column chromatography to remove the ligand before hydrolysis. The pure 
hydrazone was immediately subjected to the HCl hydrolysis method. The crude ketone was also 
purified using column chromatography and the title compound (R)-214 isolated in 53% yield 
and an enantiomeric ratio of 71 : 29 er. 
Each of the three work-up conditions provided products with the same enantioselectivities for 
the product ((R)-214, 71 : 29 er), however a decreased yield was observed when the methanol 
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quench and pH 7 buffer solution quench methods were employed. The loss of yield for both 
methods can be attributed to the additional chromatography step of the hydrazone. The 
hydrazones from both of these methods required purification to remove the chiral ligand before 
hydrolysis in order to avoid sparteine disrupting the hydrolysis step. In the cases where an 
ammonium chloride wash was incorporated, all traces of sparteine were removed and therefore 
purification of the hydrazone was deemed unnecessary. 
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3.2.5 Further Studies of Hydrazone Cleavage Methods  
Upon reading a report by Smith and co-workers,198 we decided to revisit the issue of 
racemisation during the cleavage of the hydrazone.  
During a synthetic program directed towards the total synthesis of (+)-nodulisporic acid A, 
Smith and co-workers observed epimerisation during the cleavage of the SAMP auxiliary via 
hydrolytic cleavage using oxalic acid. They eventually, successfully cleaved the auxiliary using 
an oxidative protocol using pH 7 buffered peroxyselenous acid conditions.198 Peroxyselenous 
acid, generated in situ from SeO2 and 30% H2O2 (1 : 4) was a superior oxidant for the removal 
of the chiral auxiliary from SAMP hydrazones, however some epimerization was observed.198 
The epimerization problem was alleviated by the introduction of a pH 7 buffer. 
We applied Smith’s optimised conditions for the cleavage of the dimethyl hydrazone of (R)-
216. Hydrazone 203 was subjected to asymmetric alkylation using (+)-sp 100 to form 
hydrazone (R)-222, which was cleaved using SeO2, 30% H2O2 and a pH 7 phosphate buffer. 
(R)-216 was isolated in 46% yield over two steps with the same enantiomeric ratio as that 
observed using the biphasic system of diethyl ether/4 M HCl (76 : 24 er) (Scheme 3.2.11). 
 
 
           (+)-sp 100 
 
  
           203    
            (R)-222          (R)-216 
 
            4M HCl = 55%, 76 : 24 er 
            SeO2 = 46%, 76 : 24 er 
            Amberlyst = 54%, 76 : 24 er 
Scheme 3.2.11 
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The mechanism for the pH 7 buffered peroxyselenous acid cleavage is shown in (Scheme 
3.2.12). 
 
 
 
 
 
 
 
 
 
 
 
      (R)-222      
 
 
 
 
 
 
 
 
 
  
 
 
       (R)-216       
Scheme 3.2.12 
Amberlyst® 15 hydrogen form beads have also been described as an excellent and far superior 
catalyst for regeneration of carbonyl compounds from nitrogeneous derivatives, like 
tosylhydrazones, oximes, 2,4-dinitrophenylhydrazones and semicarbazones.199 In our system 
the use of Amberlyst® 15 refluxing in acetone/water resulted in isolation of (R)-216 in 54% 
yield over the two steps and 76 : 24 er (Scheme 3.2.11). 
Given that the same enantioselectivities were observed for all three cleavage procedures we 
were confident that racemisation was not occurring during hydrolytic cleavage using diethyl 
ether/4 M HCl.   
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3.2.6 Addition of Lithium Salts 
Organolithium reagents are known to exist as aggregated species in solution.186 The degree of 
aggregation strongly depends on the carbanion structure, solvent polarity, and the presence of 
donor ligands like TMEDA, PMDTA and HMPA. Sometimes the observed aggregates are the 
actual reactive species; elsewhere, lower aggregates have been shown to be active.187,200 
If aggregation was a potential problem in our system, we felt using aggregate-breaking 
additives, such as lithium halide salts, in the reactions may improve results (Table 3.2.6). 
 
                   (+)-sp 100 
 
  
        203 
 
 
        (R)-223    (R)-214 
 
 
 
 
 
 
 
 
 
 
aYield determined using NMR and 1,3,5-trimethoxybenzene as internal standard. b2 equiv. lithium bromide 
were added after the deprotonation and allowed to stir for 45 min at room temperature, before cooling to  
-30°C for alkylation. 
Table 3.2.6 Addition of Lithium Additives. 
The addition of the lithium halogen salts had a detrimental effect both on yield and 
enantioselectivity. In the case of entries 1-3, the additive was introduced at the beginning of the 
reaction. In entry 4 lithium bromide was added after deprotonation, and a far less adverse effect 
was observed on both enantioselectivity and yield. This led us to believe that these additives 
prevented deprotonation from taking place, not alkylation. Although aggregate-breaking 
additives have been shown to work well in other systems, lithium halogen salts were not 
amenable to good yields or enantioselectivities in our system. 
  
Entry Ligand Lithium Salt Yielda Ketone er R : S % ee 
1 (+)-sp 100 LiCl 35% (R)-214 69 : 31 38% 
2 (+)-sp 100 LiBr 9% (R)-214 59 : 41 18% 
3 (+)-sp 100 LiI 7% (R)-214 61 : 39 22% 
4 (+)-sp 100 LiBr 59% (R)-214 71 : 29 42%b 
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3.2.7 Mechanistic Investigations 
During the course of this project, we also undertook a mechanistic study in the hope that by 
gaining an insight into how the reaction progresses we would be better equipped to optimise 
and improve enantiomeric induction in these reactions. 
Typically, the introduction of asymmetry in a chiral ligand mediated lithiation-substitution 
requires diastereomeric interactions in an intermediate or transition state. In these types of 
systems the enantiodetermining step can be either the lithiation step, i.e. asymmetric 
deprotonation or a post-deprotonation step, i.e. asymmetric substitution (Scheme 3.2.13).  
In an asymmetric deprotonation, an organolithium reagent is complexed to a chiral ligand. This 
chiral base selectively abstracts an enantiotopic proton from a prochiral substrate 224. The 
enantioenriched organolithium intermediate 225•L is usually configurationally stable and 
reacts with an electrophile maintaining stereochemical integrity and providing the 
enantioenriched product 226. In an asymmetric substitution, the enantiodetermining step occurs 
after deprotonation. This racemic organolithium 225 can afford enantioenriched product 226, 
on reaction with an electrophile, under the influence of the chiral ligand.201 
 
 
 
    225•L 
 
 
  
 
         224                226 
 
 
 
 
     225 
 
Scheme 3.2.13 
In an attempt to distinguish between these pathways in our intermolecular chirality transfer 
alkylations, we undertook an experiment where hydrazone 203 was deprotonated for 6 hours 
using sec-butyllithium, in the absence of any chiral ligand. (-)-Sp 100 was then added to the 
reaction at room temperature and allowed to complex for 45 minutes. Alkylation with benzyl 
bromide at -30°C and hydrazone cleavage resulted in formation of (S)-36 with an enantiomeric 
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ratio that is comparable to that obtained when the chiral ligand is present from the start (Table 
3.2.7). 
 
aIsolated yield over two steps. bLigand was added after the deprotonation and allowed to stir for 45 min, before alkylation @ -30°C. 
Table 3.2.7 Mechanistic Investigations. 
These results show that the enantioselectivity of this reaction can be established after the 
deprotonation. However, it does not explicitly rule out the possibility of an initial asymmetric 
deprotonation followed by formation of a planar azaenolate and asymmetric alkylation, or 
initial asymmetric deprotonation followed by an interconverting species, then an asymmetric 
alkylation. 
While the pathway of asymmetric deprotonation is well documented, transfer of 
stereoinformation in a post-deprotonation step (the pathway of asymmetric substitution) is less 
so. Asymmetric substitutions are applicable to organolithium intermediates regardless of their 
mode of formation and can involve configurationally labile carbanions.202  
Two limiting pathways have been postulated to rationalize enantioselectivities observed in 
asymmetric substitutions. In one pathway deprotonation of 224 followed by complexation with 
the ligand results in the formation of diastereomeric complexes (225•L and epi-225•L) which 
are configurationally stable (not interconverting) with respect to their rate of reaction with the 
electrophile. The diastereomeric complexes (225•L and epi-225•L) are formed in a fixed ratio 
and both react with the electrophile at a similar rate to form the enantioenriched product 226. 
Epi-225•L would also react with EX to give the other enantiomer of 226 (not shown). In this 
case the enantioselectivity of the products is determined by the ratio of the diastereomeric 
Entry Ligand Variation Electrophile Yielda er R : S % ee 
1 (-)-sp 100 
(-)-sp 100 added @ RT after 
deprot.b 
benzyl bromide 25% 23 : 77 54% 
2 (-)-sp 100 (-)-sp 100 present for deprot. benzyl bromide 57% 24 : 76 52% 
Chapter 3   Results and Discussion 
105 
 
complexes established before the substitution step. This is termed Dynamic Thermodynamic 
Resolution (DTR) because the ratio of complexes is dynamically controlled prior to reaction 
with electrophile (Scheme 3.2.14). 
 Dynamic Thermodynamic Resolution 
 
 
 
            224      225         225•L         226 
 
 
 
 
       
 
          epi-225•L 
 
Scheme 3.2.14 
In the other pathway, the diastereomeric complexes (225•L and epi-225•L) are 
configurationally labile (rapidly interconverting) with respect to their rate of reaction with the 
electrophile. Here, the stereogenic reactive centre undergoes rapid epimerization and one of the 
diastereomeric complexes reacts faster with the electrophile than the other epimer, under the 
reaction conditions, to form the enantioenriched 226. In this case, the enantioselectivity is 
determined by the difference in the diastereomeric transition state energies for the reaction with 
the electrophiles, i.e. the rates of reaction will determine the enantioselectivity of 226. This is a 
case of Dynamic Kinetic Resolution (DKR) (Scheme 3.2.15). 
Dynamic Kinetic Resolution 
 
 
            224       225         225•L         226 
 
 
 
 
       
 
 
           epi-225•L 
 
Scheme 3.2.15 
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To distinguish between these pathways in our system, the configurational stability must be 
determined with respect to the rate of reaction with an electrophile. Hoffmann has provided an 
elegant method for determining configurational stabilities in certain conditions. The Hoffmann 
Test takes advantage of the kinetic resolution of diastereomers in a reaction of a racemic 
organolithium reagent with a chiral electrophile in racemic and enantioenriched forms (Scheme 
3.2.16).203-206 
  
Expt 1 
 
 
 
 
 
 
Expt 2 
 
 
Scheme 3.2.16 
If the ratios for Expt 1 and Expt 2 are not equal to each other, it can be concluded that the 
reaction is configurationally stable. Equal ratios of product enantiomers suggest fast 
epimerisation about the benzylic centre relative to the rate of reaction. 
Beak and co-workers described a variant of this test in which organolithium species which are 
diastereomeric by virtue of complexation with a chiral ligand undergo reaction with an achiral 
electrophile via diastereomeric transition states.202 They referred to this as the ‘poor man’s 
Hoffmann Test’, as it does not require a chiral enantioenriched electrophile.201 The tests can be 
carried out either by determining the stereoselectivity with a deficiency and excess of the 
electrophile or by monitoring the stereoselectivity of the substitution product as a function of 
the alkylation progress (Scheme 3.2.17).  
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 Expt 1 :  excess electrophile 
 
        225       225•L             226 
 
 
            Expt 2 :  deficient electrophile 
 
 
         epi-225•L         epi-226 
 
er Expt 1 ≠ er Expt 2 - Configurationally Stable = DTR 
er Expt 1 = er Expt 2  - Configurationally Labile = DKR 
Scheme 3.2.17 
We applied both of Beak’s tests to our intermolecular chirality transfer reactions. Firstly 
deficient and excess electrophile was investigated. The alkylation of hydrazone 203 with 0.2 
equiv. of 2-methylbenzyl bromide provided (R)-216 with an er of 76 : 24, the same level of 
enantioinduction was observed when excess electrophile was used (Table 3.2.8). This result 
disfavours a DTR system where nonequilibrating diastereomeric complexes react with the 
electrophile but does not rule out the possibility of configurationally stable complexes with 
indistinguishable rates of reaction of each diastereomer.    
   
           (+)-sp 100 
 
   
           203    
            (R)-222            (R)-216 
 
aYield determined using NMR and 1,3,5-trimethoxybenzene as internal standard. 
Table 3.2.8 Mechanistic Investigations 
The second test involved treatment of hydrazone 203 with sparteine/sec-BuLi at room 
temperature for 6 hours followed by reaction with 4-tert-butylbenzyl bromide. The reaction 
provided product (R)-214 with an er of 71 : 29, irrespective of the extent of reaction (Table 
Entry Ligand Variation Electrophile Yielda er R : S % ee 
1 (+)-sp 100 Excess electrophile 2-methylbenzyl bromide 54% 76 : 24 52% 
2 (+)-sp 100 0.2 equiv. 
electrophile 
2-methylbenzyl bromide 18% 76 : 24 52% 
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3.2.9). This observation is consistent with a mechanism of rapidly equilibrating diastereomeric 
complexes.  
                      (+)-sp 100 
 
 
      203 
 
 
        (R)-223    (R)-214 
aIsolated yield over two steps. bYield determined using NMR and 1,3,5-trimethoxybenzene as internal standard. 
Table 3.2.9 Mechanistic Investigations 
While these results somewhat suggest a mechanism involving DKR. We feel our system may 
be further complicated by the possible formation of four azaenolate isomer forms.  
DFT calculations carried out prior to the undertaking of this project, show the ECCZCN geometry 
of the azaenolate to be the most stable isomeric form (Figure 3.2.5).207 
 
 
 
 
  
 
            ECCZCN              ZCCZCN 
        Most Stable 
 
 
 
 
 
 
 
         ECCECN               ZCCECN 
Figure 3.2.5 
On this basis it is possible that a mechanism more like that observed for the SAMP/RAMP 
auxiliaries (discussed in Chapter 1, Section 1.3) could be operative. 
Entry Ligand Variation Electrophile Yield er R : S % ee 
1 (+)-sp 100 22 h alkylation 4-tert-butylbenzyl bromide 62%a 71 : 29 42% 
2 (+)-sp 100 2 h alkylation 4-tert-butylbenzyl bromide 43%b 71 : 29 42% 
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During this project we also investigated the possibility of using a catalytic amount of the chiral 
ligand. O’Brien has successfully employed sparteine in catalytic asymmetric deprotonation 
reaction via a ligand exchange protocol (discussed in Section 1.8).100 
In order for catalysis to be possible it would be necessary for the rate of alkylation to be greater 
in the presence of the chiral ligand than when no ligand is present (Scheme 3.2.18).  
 
Scheme 3.2.18 
A second requirement for catalysis is the ability of sparteine to reattach to an azaenolate once 
expelled after alkylation. This would likely involve dislodging coordinating solvent molecules 
or perhaps more likely, the breaking up of aggregate species. 
Firstly we needed to determine the rate of reaction for the alkylation step in the presence of 
sparteine/sec-BuLi verses the rate with sec-BuLi alone (no sparteine present). Both reactions 
were stopped after a set period of time before alkylation was complete. Comparison of the 
extent of conversion indicates that the reaction is faster in the presence of the chiral ligand 
(Table 3.2.10). 
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        203 
 
 
        (R)-223   (R)-214 
Entry Ligand Variation from 
standard conditions 
Electrophile Yielda er R : S % ee 
1 (+)-sp 100 1.5 h alkylation 4-tert-butylbenzyl bromide 20% 68 : 32 36% 
2 No sparteine 
added 
1.5 h alkylation 4-tert-butylbenzyl bromide 10% n/a n/a 
aYield determined using NMR and 1,3,5-trimethoxybenzene as internal standard. 
Table 3.2.10  
Since the reaction fulfilled the first criteria for a catalytic reaction, we tried the reaction using 
0.4 equivalents of (+)-sp 100. The reaction was carried out in the usual manner with the chiral 
ligand present for the deprotonation step.       
 
     (+)-sp 100 
 
 
  
       203 
 
 
        (R)-223    (R)-214 
 
Entry Ligand Variation from 
standard conditions 
Electrophile Yielda er R : S % ee 
1 (+)-sp 100 Standard conditions 4-tert-butylbenzyl bromide 62% 71 : 29 42% 
2 (+)-sp 100 0.4 equiv. (+)-sp 100 4-tert-butylbenzyl bromide 38% 68 : 32 36% 
3 (+)-sp 100 0.4 equiv. (+)-sp 100 
in ether 
4-tert-butylbenzyl bromide 34% 59 : 41 18% 
  aYield determined using NMR and 1,3,5-trimethoxybenzene as internal standard. 
Table 3.2.11  
The target compound (R)-214 was isolated in 32% yield with an enantiomeric ratio of 68 : 32 
(entry 2). Only a slight decrease in enantiomeric ratio was observed, however a considerable 
decrease in yield was noticable. It is clear from these results that sparteine does not reattach to 
and promote the reaction. The slight decrease in enantiomeric ratio is probably due to a 
competing racemic alkylation (Table 3.2.11). 
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The reaction was also carried out using diethyl ether as solvent and a similar effect was observed 
(entry 3). Even lower enantiomeric ratios were witnessed here due to the ineffectiveness of 
diethyl ether in these reactions (discussed earlier in Section 3.2.2). 
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3.2.8 Preparation of Chiral Ligands and their Use in the Asymmetric Synthesis of α-
Alkylated Ketones 
Having exhausted all other avenues in our attempts to improve the enantiomeric ratios. We next 
examined the effect of changing the chiral diamine.  
The use of sparteine as a chiral ligand has been unrivalled, in terms of its breadth of application. 
However, it does suffer from a number of drawbacks: 1) Limited scope for derivatisation or 
modification, 2) Difficulty in accessing both enantiomers and 3) Expensive and limited in 
supply.  
In light of this, we sought to evaluate other chiral ligands with varying structures, in order to 
find a ligand-scaffold suited to our system. By studying the effect of the chiral ligands on our 
system, we hoped to learn more about the structural aspects necessary for stereochemical 
control. 
The following ligands were chosen for our investigations (Figure 3.2.6). 
 
 
 
 
 
 
    (S,S)-227   (S,S)-228           (R,R)-229             
 
 
  
 
 
 
 
      (S)-230               (S,S)-113           (S,S)-231 
Figure 3.2.6 
Bisoxazoline (S,S)-227 was chosen as bisoxazolines (BOX) are a class of privileged chiral 
ligands and have been successful in a wide array of asymmetric reactions. They have been 
extensively reviewed and there are many structural variations commercially available.208 BOX 
ligands also benefit from being C2-symmetric. Ligands possessing C2‑symmetry often improve 
the enantioselectivity in asymmetric transformations, by reducing the number of transition 
states with a unique geometry. The benefits of C2‑symmetry in BOX ligands have been 
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reviewed in depth.209,210 In general, for methylene bridged BOX ligands the stereochemical 
outcome is consistent with a twisted square planar intermediate, which was proposed based on 
crystal structures.211,212 The R-substituent blocks one enantiotopic face of the substrate, leading 
to enantioselectivity (Figure 3.2.7).210 
 
Figure 3.2.7 
(S,S)-227 was synthesised according to Evans’s procedure (Scheme 3.2.19).213   
 
 
 
 
 
           (S)-232                       233        (S,S)-234 
 
 
 
 
  
 
 
 
 
 
             (S,S)-227 
Scheme 3.2.19 
Firstly, amino alcohol (S)-232 was prepared in 97% yield from the corresponding amino acid, 
(S)-phenylgylcine (S)-235 using a method described by Meyers, which employed sodium 
borohydride and boron trifluoride diethyl etherate (Scheme 3.2.20).214   
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   (S)-235               (S)-232, 97% 
Scheme 3.2.20 
We also attempted reduction of (S)-235 using lithium aluminium hydride, however this proved 
unsuccessful. 
The acyl chloride, 233 was prepared from 236 using thionyl chloride as the chlorinating agent 
in 55 % yield (Scheme 3.2.21). 
 
 
 
       236    233, 55% 
Scheme 3.2.21 
While higher yields are reported using oxalyl chloride and DMF for the chlorination,213 we 
avoided this procedure due to the formation of a minor by-product, dimethylcarbamoyl chloride 
237 (Figure 3.2.8) which is a potent carcinogen. 
 
 
 
 
237 
Figure 3.2.8 
The next step involved acylation of amino alcohol (S)-232 with acyl chloride 233 to form the 
bisamide (S,S)-234 in 71% yield (Scheme 3.2.22).  
 
 
 
 
           (S)-232                       233       (S,S)-234, 71% 
Scheme 3.2.22 
Initial isolation of this product proved problematic due to the formation of a solid precipitate. 
However good yields were achieved by adjustment of the work-up as follows: filtration of the 
solid which had formed, followed by washing of the mother liquor with 10% HCl solution. We 
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were surprised by the apparent insolubility of bisamide (S,S)-234. A crystal structure was 
obtained which indicated a dihydrate of the bisamide had been formed, which appeared to 
render the product only partially soluble in dichloromethane but fully soluble in the polar protic 
solvent, methanol (Figure 3.2.9). 
 
Figure 3.2.9 
(S,S)-234 was found to have the space group, P 21, indicating it is primitive (it contains one 
lattice point), monoclinic (it has three different cell lengths), two of the angles in a unit cell are 
90° and the third angle is not 90° (Table 3.2.12). Two molecules are contained in each unit cell. 
The R-factor, (reliability factor) for (S,S)-234 is excellent at 0.0411.  
Chemical formula C20H25NO6 
Space group P 21 
Cell dimensions (Å) a = 8.423 (3) 
b = 11.261 (3) 
c = 11.347 (4) 
α = 90 
β = 91.054 
γ = 90 
No. of molecules (Z) 2 
R (Reliability factor) 0.0411 (2599) 
Table 3.2.12 Crystallograhic data for (S,S)-234 
Clear intermolecular hydrogen bond interactions are evident between the hydrogen of a water 
molecule and the carbonyl oxygen of (S,S)-234 and between the oxygen of a water molecule 
and the hydrogen of the hydroxyl group of (S,S)-234 (Figure 3.2.10). 
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Figure 3.2.10 
We were able to successfully form the oxazoline ring by treatment of bisamide (S,S)-234 with 
para-toluenesulfonyl chloride and triethylamine in the presence of catalytic quantities of 4-
(dimethylamino)pyridine. The bis(tosylate) formed in situ, undergoes cyclisation to provide the 
BOX ligand (Scheme 3.2.23). 
 
 
 
 
      (S,S)-234       (S,S)-227, 10% 
Scheme 3.2.23 
While analysis of the 1H NMR spectrum of the crude material showed complete consumption 
of (S,S)-234 and high mass recovery was achieved, purification using column chromatography 
proved problematic and only a 10% yield of (S,S)-227 was isolated. 
Given the lack of sufficient quantities of BOX ligand (S,S)-227 for investigation in our 
asymmetric alkylation reactions, we decided to employ Fraile’s one pot synthesis of BOX 
ligands.215,216 This approach involved condensation of chiral amino alcohol (S)-232 with 
dimethyl malononitrile 238 using stoichiometric amounts of zinc triflate (Scheme 3.2.24).  
 
 
 
 
   (S)-232         238        (S,S)-227, 41% 
Scheme 3.2.24 
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The reaction was monitored by 1H NMR until all starting material had fully reacted. This 
reaction took seven days to complete. We believe this was due to the zinc triflate being 
displaced to the top of the reaction vessel during stirring, reducing the amount accessible in the 
reaction medium and hindering the reaction. Once the reaction was complete, the crude mixture 
was subjected to purification via column chromatography. Given the difficulty observed in the 
purification of this ligand, we made a slight modification. We found that the addition of 0.4% 
triethylamine to the eluent (4 : 1, hexane : EtOAc) considerably increased the amount of BOX 
ligand (S,S)-227 eluted from the column and 41% yield was achieved. 
As we now had sufficient quantities of BOX ligand (S,S)-227, we investigated its use as a chiral 
ligand in our intermolecular chirality transfer alkylation. BOX ligand (S,S)-227 was subjected 
to our standard conditions for deprotonation (room temperature for 6 h) and alkylation 
(iodopentane, -30°C for 22 h) (Table 3.2.13). We were disappointed to discover that no reaction 
had occurred under these conditions (entry 1). 
             
            (S,S)-227 
 
 
 
            203 
 
 
 
       239     188 
Table 3.2.13 Intermolecular chirality transfer alkylation using bisoxazoline ligand. 
We next increased the temperature of the alkylation step. The reaction was allowed warm room 
temperature overnight but again this did not result in product formation (entry 2). Next, the 
deprotonation temperature was increased to 40°C and the reaction was again allowed warm to 
room temperature during alkylation (entry 3). However these changes failed to promote any 
conversion to product and only starting material was isolated. 
Entry Ligand Electrophile Deprot. Temp. Alkyl. Temp. Yielda 
1 (S,S)-227 n-PeI RT -30°C No reaction occurred 
2 (S,S)-227 n-PeI RT Warm to RT No reaction occurred 
3 (S,S)-227 n-PeI 40°C Warm to RT No reaction occurred 
4 (S,S)-227 n-PeI RT (ligand added 
after deprot.) 
-30°C No reaction occurred 
Chapter 3   Results and Discussion 
118 
 
To ensure deprotonation was occurring, we carried out the deprotonation at room temperature 
for 5 hours using sec-BuLi in the absence of ligand, then the BOX ligand (S,S)-227 was added 
and the reaction was stirred for 1 hour before addition of the alkylating agent at -30°C, however 
this also failed to yield any product (entry 4). We concluded that the BOX ligand (S,S)-227 was 
interrupting the alkylation step. It is possible that the BOX ligand (S,S)-227 formed an 
intermediate with the hydrazone azaenolate where the site of alkylation was blocked and 
rendered unreactive. 
We then chose to test the diphenylethane derivatives, diamine (S,S)-228 and diether (R,R)-229 
(Figure 3.2.11). 
 
 
       
 
         (S,S)-228                      (R,R)-229 
Figure 3.2.11  
These ligands have previously been utilised by Tomioka, in the enantioselective addition of 
organolithium reagent to imines.156,217 The imines used, derived from 1-naphthaldehyde and 
cyclohexylamine, selectively underwent conjugate addition (Scheme 3.2.25). The product was 
directly hydrolysed leading to an aldehyde which is quite sensitive to rearomatisation, and 
therefore was reduced quickly to the stable corresponding alcohol 240. When diamine (S,S)-
228 was used, the alcohol (1S,2R)-240 was obtained in only 11% ee, while diether (R,R)-229 
was much more efficient and afforded (1R,2S)-229 in 91% ee. 
  
 
 
 
   (S,S)-228 or (R,R)-229,  
 
 
 
 
  241                          (1S, 2R)-240, 26%, 11% ee 
                     (1R, 2S)-240, 80%, 91% ee 
Scheme 3.2.25 
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Chiral diether (R,R)-229 was prepared using a procedure described by Tomioka which involved 
dimethylation of optically pure (+)-hydrobenzoin (R,R)-242 using sodium hydride and 
dimethyl sulfate. It was isolated as a stable, non-hygroscopic, colourless crystalline solid in 
68% (Scheme 3.2.26).156 
  
 
 
 
 
       (R,R)-242      (R,R)-229, 68% 
Scheme 3.2.26 
Diamine (S,S)-228 was prepared from (S,S)-243 using an Eschweiler-Clarke methylation using 
excess formic acid and formaldehyde in 45% yield (Scheme 3.2.27).156 
 
  
 
 
 
         (S,S)-243           (S,S)-228, 45% 
Scheme 3.2.27 
This processes does not produce quaternary ammonium salts and chiral amines typically do not 
racemise under the conditions reported. 
Both ligands were then investigated in our asymmetric alkylation under standard conditions 
(deprotonation at room temperature for 6 h and alkylation using benzyl bromide at -30°C for 
22 h) (Table 3.2.14). 
              ligand 
 
 
  
           203   
 
         (S)-244            (S)-36 
 
 
                    aIsolated yield over two steps 
Table 3.2.14  
Entry Ligand Electrophile Deprot. 
Temp. 
Alkyl. 
Temp. 
Yielda er R : S % ee 
1 (S,S)-228 BnBr RT -30°C 31% 45 : 55 10% 
2 (R,R)-229 BnBr RT -30°C 27% 57 : 43 14% 
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We were disappointed to observe poor conversion to product under our standard conditions for 
both ligands, as well as very low enantioselectivities.  
We then examined (S)-230, which is derived from (S)-proline. These types of ligands have 
previously been employed in the enantioselective reduction of ketones 245 to alcohols using 
stannous chloride and DIBAL-H as shown in Scheme 3.2.28.218 The best reported selectivity 
was obtained with diamine (S)-246, which afforded (S)-247 in 78% ee, while diamines (S)-248 
and (S)-230 led to the product in 46% ee and 64% ee, respectively.  
 
 
 
     245             (S)-247 
 
 
 
 
 
 
      (S)-230, 59%, 64% ee    (S)-248, 47%, 46% ee           (S)-246, 71%, 78% ee 
Scheme 3.2.28 
Diamine (S)-230 was chosen for our studies, as it was easily accessible in one step from chiral 
amine (S)-193, used previously in the synthesis of novel chiral auxiliary (S)-192 (discussed in 
chapter 2). If this ligand could induce even moderate enantioselectivity in our system we would 
have considerable scope for optimisation, given the quantity of proline derived ligands 
synthetically accessible.85 
An Eschweiler-Clarke methylation was used for the preparation of (S)-230 from amine (S)-
193,156 however isolation of the product during work-up proved difficult. The portion that was 
isolated was purified using kugelrohr distillation to afford pure ligand (S)-230 in 38% overall 
yield (Scheme 3.2.29).  
 
 
 
 
   (S)-193         (S)-230, 38% 
Scheme 3.2.29 
Given the difficulty in preparing (S)-230, we investigated another synthetic route. (S)-Boc-
proline (S)-249 was reacted with pyrrolidine via a DCC coupling to form the amide (S)-250 in 
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35% yield after a troublesome purification using column chromatography.219 Subsequent 
reduction using lithium aluminium hydride afforded (S)-230 in 51% yield (Scheme 3.2.30). 
  
 
 
 
 
 
         (S)-249          (S)-250, 35%         (S)-230, 51% 
Scheme 3.2.30 
We then investigated the use of (S)-230 as a chiral ligand in our asymmetric alkylation under 
our standard conditions (deprotonation at room temperature for 6 h and alkylation using 
iodopentane at -30°C for 22 h) (Scheme 3.2.31). 
       
              (S)-230  
 
 
 
   203 
 
 
 
             239            188, 16%,  
                    Racemic 
Scheme 3.2.31 
Surprisingly this ligand did not induce any enantioselectivity in our system. We concluded that 
this ligand must either not have complexed with our azaenolate or alternatively did not provide 
any diastereo-discrimination when complexed. 
Given this disappointing result no further investigation or optimisation using this ligand 
scaffold was carried out. 
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Alexakis has reported the synthesis of C2-symmetric diamines, derived from trans-
cyclohexane-1,2-diamine, in which both nitrogens bear two different substituents, e.g. (S,S)-
113 (Figure 3.2.12). In the cyclic complex formed with an organolithium reagent, (S,S)-113-
Li, the nitrogen atom becomes stereogenic and brings the chirality closer to the reactive site 
(Figure 3.2.12).99,220,221 
                 
    (S,S)-113-Li         (S,S)-113 
Figure 3.2.12 
In 2008, it was reported that diamine (R,R)-113 is as effective as (-)-sp 100 for the asymmetric 
deprotonation of N-Boc pyrrolidine 105 (Scheme 3.2.32).97 Thus, (S)-112 was obtained with 
the same degree of enantioinduction using both ligands. 
 
 
 
 
 105             (S)-112 
        (-)-sp 100, 87%, 95 : 5 er 
        (R,R)-113, 72%, 95 : 5 er 
Scheme 3.2.32 
Compared to (-)-sp 100, diamine (R,R)-113 can be prepared in a relatively straightforward 
manner. Also there is ample scope for modification and both enantiomers are accessible. 
Diamine (S,S)-113 was prepared on multigram scale using a reported synthesis.97 First, (-)-
trans-cyclohexane-1,2-diamine was resolved using L- and D-tartaric acid to give both salts 
(R,R)-251 and (S,S)-251 in 76% and 99% yield respectively. Reaction of (S,S)-251 with NaOH 
and methyl chloroformate afforded a bis-methyl carbamate, which was reduced using lithium 
aluminium hydride to give (S,S)-252. Diamine (S,S)-252 was then acylated using tert-
butylacetyl chloride to deliver the crude bis-amide. Reduction using  lithium aluminium hydride 
gave diamine (S,S)-113 after purification by kugelrohr distillation in 41% yield over 4 steps 
(Scheme 3.2.33). 
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         (S,S)-251         (S,S)-252 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
               (S,S)-113, 41% over 4 steps 
Scheme 3.2.33 
Ligand (S,S)-231 was also prepared for comparison, as it was easily accessible via methylation 
of the salt (S,S)-251 in 71% yield (Scheme 3.2.34). 
 
 
 
 
 
 
       (S,S)-251                (S,S)-231, 71% 
Scheme 3.2.34  
With diamines (S,S)-113 and (S,S)-231 in hand, we evaluated them in our asymmetric 
alkylation reactions under our standard conditions (deprotonation at room temperature for 6 h 
and alkylation using iodopentane at -30°C for 22 h) (Table 3.2.15).  
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            ligand  
 
 
 
            203 
 
 
 
       239    188 
 
 
 
 
 
aIsolated yield over two steps 
Table 3.2.15 Intermolecular chirality transfer alkylation using cyclohexane derived ligands. 
Not surprisingly, (S,S)-231 did not perform well and resulted in a poor enantiomeric ratio of 58 
: 42. Interestingly the use of (S,S)-231 gave the opposite sense of chirality than (-)-sp 100 or 
(S,S)-113. It is evident that the introduction of sterically bulkier substituents results in good 
levels of enantioinduction in this reaction. Pleasingly, a moderate enantiomeric ratio of 29 : 71 
er  was achieved using (S,S)-113. While the selectivity observed using (S,S)-113 did not rival 
that of (-)-sp 100, it did provide us with a ligand scaffold suitable for derivatisation in future 
projects.  
  
 
 
  
Entry Ligand Electrophile Yielda Product er R : S % ee 
1 (S,S)-113 n-PeI 53% (S)-188 29 : 71 42% 
2 (S,S)-231 n-PeI 23% (R)-188 58 : 42 16% 
3 (-)-sp 100  n-PeI 34% (S)-188 17 : 83 66% 
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3.2.9 NMR Investigations of Asymmetric Alkylation with (+)-Sparteine 
The formation of monomeric azaenolate species allows for the depiction of four different 
geometrical isomers. This has been thoroughly discussed in the literature for lithiated SAMP-
hydrazone species in solution (Figure 3.2.13).29,71 The preferred configuration is ECCZCN. 
 
 
 
 
     
       
          (ECCZCN)           (ZCCZCN)  
 
 
 
 
 
  
 
 
         (ECCECN)              (ZCCECN) 
Figure 3.2.13 
We hoped it would be possible to identify each of these species by NMR studies and determine 
the most abundant isomer after deprotonation, in our system. If more than one azaenolate was 
present this could explain why only moderate enantiomeric ratios have been achieved to date. 
We envisaged that NOESY experiments could establish the structures of the azaenolates 
present. 
The reaction outlined in Scheme 3.2.35 was carried out in the usual manner except deuterated 
toluene was employed, to allow NMR experiments to be ran without solvent interference. Two 
reactions were carried out, one with (+)-sp 100 present and one without.  
       
                   (+)-sp 100 
 
  
         203  
 
 
         (R)-223     (R)-214 
Scheme 3.2.35 
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An NMR tube, fitted with a rubber septum and wrapped in parafilm, was placed under vacuum 
via a needle connected to a schlenk line.  The tube was heated gently and refilled with nitrogen 
and then the NMR tube was allowed to cool. Using a glass syringe, 0.6 mL of the reaction 
mixture was removed under inert atmosphere (Figure 3.2.14) and transferred to the NMR tube 
(Figure 3.2.15). The samples were analysed at 600 MHz on a Bruker AVANCE 600 instrument. 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Figure 3.2.14 Figure 3.2.15 
Initially we envisaged 1H NMR would allow us to characterise the azaenolates, in a similar 
manner as reported by Enders with SAMP/RAMP hydrazones.28,71 However, when (+)-sp 100 
was employed, we were unable to identify any peaks corresponding to azaenolates in the 1H 
NMR spectra. When (+)-sp 100 was absent from the reaction the 1H NMR spectrum was 
complex and no clear assignments were possible. Given the complexity of the 1H NMR spectra, 
NOESY experiments also proved inconclusive. 
13C NMR spectra for both reactions were more decipherable, since the interesting C=N signals 
appear at low field and do not overlap with the strong solvent and (+)-sp 100 peaks. Figure 
3.2.16 shows a portion of the 13C NMR spectra obtained.  
 
To schlenk line 
To schlenk line 
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Figure 3.2.16 
Spectrum 1 and 2 are samples which were taken from the reaction mixture after 30 minutes. 
Both clearly show the disappearance of the C=N signal of 203 which is present at 174.5 ppm. 
This indicated full deprotonation had occurred in this time. An interesting occurrence in both 
spectrum 1 and 2 is the appearance of a signal between 156 - 156.5 ppm. We assign this signal 
as the C=N carbon of the hydrazone in its azaenolate form, which now appears more upfield 
due to shielding effects. In the case of spectrum 1, where no sparteine was added to the reaction, 
this signal appears as 2-3 peaks, which suggests the possibility of different azaenolate 
intermediates. In spectrum 2, where (+)-sp 100 was present during the deprotonation, the signal 
between 156 - 156.5 ppm was observed as a singlet leading us to believe that either one 
azaenolate or a quickly equilibrating mixture is present when chelated to the lithium and the 
ligand. This observation is agreement with DFT calculations which show the ECCZCN geometry 
of the azaenolate to be the most stable isomeric form when sparteine is present (Figure 3.2.17) 
(discussed in Section 3.2.6).  
Spectrum 1 – azaenolate with no sparteine added 
Spectrum 2 – azaenolate with sparteine present 
deprotonation 
Spectrum 3 – C=N after alkylation 
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                (ECCZCN) 
Figure 3.2.17 
Both reactions displayed identical 13C NMR spectra upon alkylation, with the restoration of the 
C=N moiety in 223, shown in spectrum 3 and indicated by the signal at 174.6 ppm. 
The argument for the preferential formation of the ECCZCN azaenolate when sparteine was 
present, was further supported by the NOESY spectrum (Figure 3.2.18) for (R)-223, which 
showed a correlation between the protons of the dimethyl groups at 2.27 ppm and the protons 
of C-4 at 3.93 ppm, for the major isomer. This correlation indicates that the dimethyl amino 
group resides on the newly substituted side, confirming the Z-geometry for hydrazone (R)-223. 
Since the dimethyl group resides on the side of alkylation this is good evidence for the 
complexation of the dimethylamino group with sparteine during deprotonation.  
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(R)-223 Z-geometry 
 
Figure 3.2.18 
In Figure 3.2.19 we can see, over time the dimethylamino group ‘flips’ to the less sterically 
hindered E-geometry via analysis of the 1H NMR spectra of the crude material. A decrease in 
diagnostic peaks for the Z-hydrazone and increase in the signals which can be assigned to the 
E-hydrazone was observed. Unfortunately, NOSEY experiments to confirm that the dimethyl 
now resides on the side with C-1 and C-2 were inconclusive (E-hydrazone). This observation 
is consistent with our hypothesis of formation of the ECCZCN azaenolate when sparteine is 
present. Corey reported a similar observation in the case of α-silylated cyclohexanone-
dimethylhydrazone, where the Z-hydrazone is formed upon silylation and ‘flips’ to the more 
stable E-hydrazone.76  
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(R)-223 Z-geometry             (R)-223 E-geometry 
 
  Z-hydrazone 
  E-hydrazone 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 3.2.19  
30 mins after work-up 
27 hrs after work-up 
20 hrs after work-up 
6 hrs after work-up 
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3.2.10 Aldol & Michael Reactions using (-)- and (+)-Sparteine 
We also sought to investigate if the scope of the intermolecular chirality transfer methodology 
could extend to the generation of two chiral centres in one pot, such as in the aldol and Michael 
reactions. 
The aldol reaction involves the condensation of a nucleophilic enolate species with an 
electrophilic carbonyl moiety. The product of the reaction is an important synthon used in the 
synthesis of macrolides and polyether antibiotics. Furthermore, this reaction is one of the basic 
biosynthetic transformations. The aldol reaction has been broadly studied with numerous metals 
and many combinations of substrates and reagents in order to synthesise syn or anti aldol 
products with a high level of selectivity.222-225 
Hydrazone 203 was deprotonated in the presence of (-)-sp 100 and sec-BuLi and subsequent 
reaction with benzaldehyde resulted in formation of the diastereomeric hydrazone 253. 
Cleavage of the hydrazone lead to the desired aldol product 254 (Scheme 3.2.36). A test reaction 
was conducted on hydrazone 253 using the biphasic 4M HCl/diethyl ether hydrazone cleavage 
method. However, this method of cleavage afforded the ketone product 254, as a racemic 
mixture. We suspected these more labile substrates may have been epimerised by the HCl. In 
light of this, Amberlyst® 15199 in refluxing acetone/water was employed and aldol product 254 
was formed, as an inseparable mixture of diastereomers after column chromatography in 65% 
yield over two steps. The diastereomeric ratio was 60 : 40 as determined by NMR of the crude 
product, and the enantiomeric ratio was 76 : 24 for the syn and 35 : 65 for the anti- products. 
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            (-)-sp 100 
 
 
 
            203                  
          syn-253      anti-253 
   
 
 
      
      65% yield, mixture of diastereomers, 60 : 40 dr 
 
 
 
 
        syn-254,         anti-254, 
        76 : 24 er          35 : 65 er 
*Note: absolute configuration was not determined. Dashed/wedged notation used to differentiate syn- and anti-products and clarify results. 
Scheme 3.2.36 
The diastereomeric ratio and enantioselectivities were determined on the crude sample 
immediately after work-up (Figure 3.2.20) as the aldol products were observed to epimerise 
rapidly over time as determined using gas chromatography. 
 
 
 
 
 
 
Figure 3.2.20 
 syn anti 
dr 60 40 
er R : S 76 : 24 35 : 65 
% ee 52% 30% 
anti 
syn 
 
syn 
anti 
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While the syn and anti products could not be completely separated using column 
chromatography, sufficient amounts of each were isolated from the racemic mixture to allow 
for them to be distinguished by GC. 1H NMR spectroscopy was used to identify the most 
abundant diastereomer in each of the separated samples by comparison to the known 1H NMR 
data in the literature. The NMR sample was then subjected to GC which determined the 
retention times of each diastereomer. 
The Michael addition of carbonyl compounds to nitroalkenes226 is a challenging benchmark for 
newly developed protocols involving enolates and similar intermediates, owing to its potential 
for the construction of a C-C bond with simultaneous generation of up to three adjacent 
stereogenic centres and because of the pivotal importance of the nitro group as a precursor to 
many functionalities.72 While bifunctional thioureas227 and chiral Brønsted bases228,229 have 
been developed to control the stereochemistry of the process with malonate esters and related 
methylene-active substrates,230 stereocontrol during the reaction involving aldehydes and 
ketones is most often effected from chiral cyclic secondary amines via enamine formation.231 
However, despite the recent efforts in the area, unmet challenges remain with regard to substrate 
generality and reaction selectivity, including both diastereo- and enantioselectivity. We hoped 
our intermolecular chirality transfer methodology could help move towards overcoming some 
of the challenges in this area. 
Hydrazone 203 was deprotonated in the presence of (+)-sp 100 and sec-BuLi and reacted with 
β-nitrostyrene at -70°C, which resulted in the formation of diastereomeric hydrazones, syn- and 
anti-255. Hydrazone cleavage using HCl/diethyl ether afforded the product 256 (Scheme 
3.2.37). Both diastereomers were separable from each other using column chromatography,  
syn-256 was isolated in 45% yield and anti-256 in 8% yield.  
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           (+)-sp 100 
 
 
  
  203 
                   syn-255          anti-255 
 
 
 
 
 
 
 
 
 
              Diastereomeric ratio 88 : 12 dr 
     syn-256, 45%,     anti-256, 8%, 
     51 : 49 er                     51 : 49 er 
Scheme 3.2.37 
The diastereomeric ratio and enantioselectivities were determined on the crude sample 
immediately after work-up using gas chromatography (Figure 3.2.21). 
 
 
 
 
 
 
Figure 3.2.21             
 syn anti 
dr 88 12 
er R : S 59 : 41 59 : 41 
% ee 2% 2% 
syn 
anti 
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The syn and anti peaks were distinguished from each other by comparison of the GC traces with 
those of the separated diastereomers. 1H NMR spectroscopy of the separated diastereomers 
allowed us to assign the syn and anti products in conjunction with the known 1H NMR data in 
the literature.  
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3.3 Conclusions and Future Work 
The α-alkylation of dimethylhydrazones via an intermolecular chirality transfer strategy for the 
preparation of enantioenriched α-alkylated ketones is presented. To the best of our knowledge 
this work details the first example of asymmetric alkylation to a non-chiral acyclic azaenolate. 
To date optimised conditions have been established with enantiomeric ratios up to 83 : 17.  
Key reaction parameters have been investigated including the alkyllithium reagent, solvent, 
temperature and ligand. Both hydrolytic and oxidative cleavage of the hydrazone have been 
explored and substrate scope investigations including a number of benzyl based electrophiles 
have been conducted. Seven chiral ligands have been evaluated, leading to the discovery of a 
useful ligand scaffold suitable for derivatisation and modification. Preliminary mechanistic and 
NMR investigations have also been carried out. 
Future work on this project will focus on the following: 
 Study the effect of changing the metal centre (Na, K, Mg). 
 Synthesis and investigation of other ligands. 
 Expand catalysis investigation to the inclusion of a ligand exchange protocol. 
 Application of this methodology in the α-alkylation of aldehydes and other classes of 
electrophiles. 
 Investigate the use of this methodology in Pd-catalysed arylations. 
  
 
  
 
 
 
 
 
 
 
 
  
Asymmetric α-Alkylation and 
Synthesis of 1,3-Amino 
Alcohol Precursors using 
Chiral Sulfinimines 
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4.1 Introduction 
This chapter describes the use of Ellman’s auxiliary in the preparation of α-alkylated ketones 
and the synthesis of 1,3-amino alcohols using an aldol-Tishchenko protocol. Ellman’s auxiliary, 
2-methyl-2-propanesulfinamide (N-tert-butanesulfinamide) (R)-129 (Figure 4.1.1) has proved 
to be a versatile chiral auxiliary and has been utilised in the preparation of syn- and anti- 1,2107-
109 or 1,3-amino alcohols,110,111 α-branched and α,α-quaternary amines,106,115 α-amino 
acids116,117 and β-amino acids and esters.112-114 
 
(R)-129 
Figure 4.1.1 
Ellman and co-workers have previously employed this auxiliary for the α-alkylation of N-tert-
butanesulfinyl amidines 257 to afforded alkylated sulfinimines 258 in excellent selectivities 
(Scheme 4.1.1).232 
 
 
 
 
 
      257                 
        258, 92%, 99 : 1 dr 
Scheme 4.1.1 
Also detailed in this chapter is the highly diastereoselective synthesis of 1,3-amino alcohols via 
addition of N-tert-butanesulfinyl imines to an aldehyde using an tandem aldol-Tishchenko 
protocol, in high yields and diastereoselectivity. This is also the first known example of an 
aldol-Tishchenko reaction involving hydride addition to a C=N moiety.  
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4.2 Results and Discussion 
4.2.1 Synthesis of N-tert-butanesulfinyl Imines and their Use in Asymmetric α-Alkylation 
Reactions 
The use of N-tert-butanesulfinamide in the alkylation of simple aliphatic ketones has not been 
reported in the literature. We felt we could contribute to the existing chiral auxiliary 
methodology by utilising the N-tert-butanesulfinamide in the alkylation of 3-pentanone and 
propiophenone. 
Firstly a selection of N-tert-butanesulfinyl imines were prepared, by condensation of the (S)-N-
tert-butanesulfinamide with the corresponding ketone in the presence of Ti(OEt)4 in THF 
(Scheme 4.2.1).
105,106  
 
  
 
     
         (S)-129 
 
 
 
 
 
  
 
 
 
 
  (S)-259, 72% (one isomer)   (S)-260, 58% (one isomer)         (S)-261, 32%  
Scheme 4.2.1 
A complicating feature of these ketimines is the possibility of forming two imine isomers E and 
Z (Figure 4.2.1), which directly impacts on the diastereoselective addition of nucleophiles.113  
 
 
 
 
 
 
 
   E-259        Z-259 
 
Figure 4.2.1 
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Fortunately, due to the steric properties of the N-tert-butanesulfinyl group, only the E imine 
isomer was observed for both (S)-259 and (S)-260. 
Asymmetric α-benzylation was attempted using the sulfinimines (S)-260 and (S)-261. However 
both reactions resulted in a complex mixture of products. 
In the case of (S)-260 a mixture of the desired alkylation product 262 and by-products including 
dialkylated product 263, enamine 264 and starting material were observed in the 1H NMR and 
mass spectra of the crude material (Scheme 4.2.2). 
 
 
 
 
 
           (S)-260    
           262        263 
 
 
  
 
 
 
           (S)-260            264 
Scheme 4.2.2 
This result was unexpected, given that α-alkylations of metalloenamines are often performed to 
install a stereocenter at the α-position of carbonyl compounds.10 
We believe the formation of significant amounts of these by-products maybe attributed to the 
strong electron-withdrawing character of the N-sulfinyl group, which attenuates the 
nucleophilicity of the metalloenamine 265.233 This reduces the rate of reaction of the 
metalloenamine 265 with benzyl bromide, allowing deprotonation of 262 to occur. The more 
substituted metalloenamine 266, which is less aggregated, reacts quickly with benzyl bromide 
resulting in formation of  263 (Scheme 4.2.3).234 
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         265    262      266 
  
 
 
 
 
 
 
 
 
 
 
   263 
Scheme 4.2.3 
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4.2.2 Synthesis of 1,3-Amino Alcohol Precursors 
As previously stated in section 1.9, chiral 1,3-amino alcohols and their derivatives containing 
two stereogenic centres are key structural motifs in many natural products and biologically 
active compounds.118-131 The moiety is also found in a number of natural products, such as the 
HIV protease inhibitor, lopinavir 267 (Figure 4.2.2). 
 
 
        
 
 
         267   
Figure 4.2.2 
In addition, they are useful building blocks in asymmetric synthesis.132-139 Various methods 
have been developed for the preparation of enantiomerically enriched 1,3-amino alcohols. 
Recent strategies include diastereoselective reduction of enantiopure 
substrates,110,111,133,134,136,235-238 an iterative organocatalytic approach238 and ring opening of 
chiral piperidines239-243 or tetrahydropyrans.244  
Inspired by their unique biological properties and prevalence in natural products we sought to 
develop a one-pot synthesis of diastereomerically pure 1,3-amino alcohol precursors. 
Ellman previously described the preparation of 1,3-amino alcohols using metalloenamines 
derived from the N-tert-butanesulfinyl imines (R)-136. Reduction of the β-hydroxy N-sulfinyl 
imine products 137 provided both the syn- and anti-1,3-amino alcohol precursors, syn- and anti-
138 with high diastereoselectivities and yields (Scheme 4.2.4). 110,111 
          
 
 
 
         syn-138, 69 - 94% 
   76 : 24 - 98 : 2 dr 
  
          (R)-136                137, 50 - 92% 
60 : 40 - 99 : 1 dr  
 
 
 
              anti-138, 69 - 96% 
    88 : 12 - >99 : 1 dr 
Scheme 4.2.4 
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We felt we could dramatically improve this methodology by employing a tandem aldol-
Tishchenko reaction where an initial aldol reaction would be followed by in situ reduction via 
a hydride transfer from a second equivalent of aldehyde.  
Bodnar and Woerpel previously described the one-pot aldol-Tishchenko reaction of lithium 
enolates with aldehydes. The lithium enolate reacts with one equivalent of aldehyde followed 
by attack of the lithium aldolate on a second equivalent. Transfer of the aldehydic hydrogen as 
a hydride occurs in high diastereoselectivity via an organised 6-membered transition state with 
the bulkiest groups arranged in the equatorial positions (172, Figure 4.2.3) as discussed in 
section 1.10.152  
 
 
 
  
 
 
172 
Figure 4.2.3 
We envisaged the use of Ellman’s tert-butanesulfinyl imines in an analogous reaction could 
provide useful diastereomerically and enantiomerically pure aminoalcohol precursors (Scheme 
4.2.5). 
 
 
          (S)-268        anti-269 
Scheme 4.2.5 
We chose the chiral sulfinamide as substrate for three reasons: 
1. It should provide the required electrophilicity for a Tishchenko hydride transfer (which 
would not be possible with hydrazone 203 used in Chapter 3 for example). 
2. Removal of the group post reaction is easily carried out.  
3. The bulky tert-butyl group on the sulfur could further enhance the diastereoselectivity 
in this transformation and crucially introduce enantioselectivity. 
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Our route to 1,3-amino alcohols would offer distinct advantages over Ellman’s synthesis 
(discussed in section 1.9).110,111 The in situ reduction using an inexpensive extra equivalent of 
aldehyde produces precursors to 1,3-amino alcohols without the use of extra additives such as 
MgBr2. The need for a diastereoselective reduction is also eliminated, avoiding expensive 
reducing agents such as super hydride and catecholborane. Another advantage of our route is 
that we install both chiral centres in one pot. 
Sulfinimine (S)-259 (prepared in section 4.2.1) was initially subjected to the conditions used 
by Ellman for the diastereoselective aldol reaction. Thus (S)-259 was deprotonated for 1 h at -
78°C using LDA, MgBr2 (2 equiv.) was added in one portion and the reaction mixture was 
allowed to stir for a further 45 min. Our procedure then deviates from Ellman’s and 2.2 equiv. 
of pivaldehyde were added to the azaenolate and the reaction allowed warm to room 
temperature (Scheme 4.2.6). 
 
 
 
 
 
 
        (S)-259             (S,S,S)-270,  
        MgBr2 added = 79 : 21 dr, 
        No MgBr2 added = 90 : 10 dr, 
Scheme 4.2.6 
Remarkably, the aldehyde acted as aldol acceptor and hydride donor in this reaction and the 
aldol-Tishchenko product (S,S,S)-270 was isolated in 15% yield after column chromatography, 
as a mixture of diastereomers, with a dr of 79 : 21, anti : syn. This was confirmed by 
spectroscopic and crystallographic analysis. 
The 13C NMR showed a peak at 178.6 ppm, indicative of the carbonyl of the ester. This was 
further supported by the infrared spectrum where a signal at 1725 cm-1 was observed, also 
corresponding to the carbonyl of an ester. Also the 13C NMR spectrum CH signals at 57.3 and 
77.3 were characteristic of the carbons at C-7 and C-9 respectively. The exact structural 
assignment was also confirmed using COSY, HSQC and HMBC experiments. High resolution 
mass spectrometry found the protonated molecular ion at 396.2559 which was in good 
agreement with the calculated value of 396.2572.  
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Further optimisation of the reaction conditions revealed that MgBr2 was unnecessary. In fact, 
when MgBr2 was omitted from the reaction mixture, the yield was raised to 64% (mixture of 
diastereomers) and the diastereomeric ratio was increased to 90 : 10, anti : syn. Again the 
diastereomeric ratio was determined from the crude 1H NMR spectrum (Figure 4.2.4). 
   
Figure 4.2.4 
The major diastereomer and minor diastereomers were isolated separately in 59% and 5% yield 
respectively, after column chromatography. The absolute stereochemistry of the major 
diastereomer was determined using X-ray crystallographic analysis (Figure 4.2.5). 
 
Figure 4.2.5 
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It can be clearly seen from the crystal structure (Figure 4.2.5), the geometry of N-15 and O-22 
are anti to one another in the case of (S,S,S)-270 and all chiral centres could be assigned as the 
S-configuration. (S,S,S)-270 was found to have the space group, P 212121, indicating it is 
primitive (it contains one lattice point), it is orthorhombic (the has three different cell lengths) 
and each angle in a unit cell is 90°. The cell length in the c axis is quiet large, indicating the 
crystals are likely packing in an elongated fashion (Table 4.2.1). 
Chemical formula C20H25NO6 
Space group P 212121 
Cell dimensions (Å) a = 9.6296 (11) 
b = 10.9154 (19) 
c = 23.692 (4) 
α = 90 
β = 90 
γ = 90 
No. of molecules (Z) 4 
R (Reliability factor) 0.0494 (3289) 
Table 4.2.1 Crystallograhic data for (S,S,S)-270 
The R-factor, (reliability factor) which is a measure of the agreement between the 
crystallographic model and the experimental X-ray diffraction data, is very good for (S,S,S)-
270 at 0.0494.  
We were very interested to observe the opposite stereochemistry to that of Ellman at the C-O 
chiral centre (Scheme 4.2.7).  
 
 
 
 
 
              (R)-136               137, 50 - 92%    anti-138, 69 - 96% 
60 : 40 - 99 : 1 dr   88 : 12 - >99 : 1 dr
        
 
 
 
 
 
                (S)-259                  (S,S,S)-270 
Scheme 4.2.7 
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Based on the results published by Ellman110 – and the transition states proposed therein – 
formation of the R-alkoxide (S,R)-274 is most likely favoured initially, subsequently giving the 
adduct (S,R)-271 as the major alkoxide species in the reaction (Scheme 4.2.8). However we 
hypothesised that a six membered transition state (272a and 272b) for the hydride reduction 
step, with the bulkiest substituents arranged in the preferred equatorial positions, similar to that 
proposed by Bodnar and Woerpel,152 would be the key difference in our system. On examining 
these transition states 272a and 272b (using a molecular modelling kit), the more activated 
transition state 272a which would lead to the anti-product (S,R,R)-270, has a very sterically 
unfavourable interaction. In this state, in order for the sulfoxide oxygen to coordinate to the 
lithium, and generate a reactive anionic reducing species, the tert-butyl group of the auxiliary 
has to be directed in towards the centre of the six-membered transition state, giving an 
unfavourable steric interaction with the tert-butyl group at C-9.  
As the final hydride transfer is essentially irreversible, the transition state leading to successful 
transfer will ultimately dictate the final product, with equilibrium effects funnelling all 
intermediates towards this transition state. This means that although the major intermediate is 
likely to be (S,R)-271, it is the activated transition state 272b, arising from intermediate (S,S)-
271, which has the bulky tert-butyl group directed away from the six-membered transition state 
and lacks unfavourable steric interactions, that is more likely to form and successfully lead to 
hydride transfer. This transition state 272b results in faster hydride transfer and leads to the 
stereochemistry observed in the major final product (S,S,S)-270 which is opposite to that which 
would be expected in the major intermediates, as proposed based on Ellman’s work. For our 
hypothesis to hold true we would require the aldol addition step to be reversible. Recent work 
within the group before publication of this thesis has shown that the aldol addition is in fact 
reversible.245 Overall, these transition states 272a and 272b do allow for the influence of the 
chirality of the auxiliary in producing the observed stereochemistry. If the tert -butyl group was 
a purely steric effect and not directed by the initial stereochemistry of the auxiliary, then an 
equal mixture of the two possible anti isomers (S,S,S)-270 and (S,R,R)-270 should be observed 
as the major product. 
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             (S,R)-274           (S,S)-274 
 
 
 
 
 
 
 
 
        (S,R)-271              (S,S)-271  
            
 
  
 
 
 
 
 
 
             272a                       272b 
 
 
 
 
 
 
 
 
 
            (S,R,R)-270              (S,S,S)-270 
            Proposed minor diastereomer                 major diastereomer 
Scheme 4.2.8 
Additionally if we were to look solely at the relationship between the observed vicinal coupling 
constant (H-C-C-H, 3J) and the dihedral angle between coupled protons, i.e. the Karplus 
equation, we can also make an assumption about the stereochemistry of the major and minor 
diastereomers formed in our reaction. The Karplus relationship is based on the observation, 
supported by theoretical considerations, that vicinal H-H couplings will be maximal with 
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protons with 180° and 0° dihedral angles (anti or eclipsed relationship results in optimal orbital 
overlap) and that coupling will be minimal (near 0) for protons that are 90° from each other.  
Looking at the coupling constants for the protons on C-7, C-8 and C-9, of the major 
diastereomer, and the relationship to the dihedral, we can make an assumption about the 
structure of the product in solution. While one might predict the structure of (S,S,S)-270 to lie 
in the chair confirmation indicated in Figure 4.2.6. 
 
 
 
            Newman projection  
          along C-8 to C-7 bond 
 
Figure 4.2.6 
However, while all coupling constants indicated in blue do satisfy the Karplus equation, the 
coupling constants indicated in red, for the coupling between the proton of C-7, H7 and the 
protons of C-8, H8a and H8b, do not agree with predictions from the Karplus equation in this 
particular confirmation. Both H8a and H8b have dihedral angle of 60° with H7 (see Newman 
projection Figure 4.2.6) and therefore should have similar coupling constants of between 2-5 
Hz.246  
For all the observed coupling constants of (S,S,S)-270 to be in agreement with the Karplus 
equation then (S,S,S)-270 would have to adopt a boat confirmation (Figure 4.2.7), where C-7 
is flipped down resulting in H7 having a dihedral angle of 180° with H8a (J = 8-15 Hz) and 60° 
(J = 2-5 Hz) with H8b.246  
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Figure 4.2.7 
Given that the minor diastereomer has the same coupling constant pattern it is possible that it 
assumes as similar structure where C-7 and C-9 have an anti- relationship. This observation 
provides further evidence for our proposed mechanistic pathways discussed earlier. 
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During the purification of (S,S,S)-270, impurity (S)-273 was isolated in 25% yield. Analysis of 
the spectroscopic data and X-ray crystallographic analysis, identified (S)-273 as the compound 
in Figure 4.2.8. 
 
 
 
 
 
 
                (S)-273 
 
Figure 4.2.8 
(S)-273 was found to have the space group P 21, indicating it is primitive (it contains one lattice 
point), it is monoclinic (has three different cell lengths two of the angles in a unit cell are 90° 
and the third angle is not 90°) (Table 4.2.2). Two molecules are contained in each unit cell. The 
R-factor, (reliability factor) for (S)-273 is excellent at 0.0411.  
Chemical formula C20H25NO6 
Space group P 21 
Cell dimensions (Å) a = 10.200 (9) 
b = 9.406 (8) 
c = 10.462 (9) 
α = 90 
β = 116.167 (13) 
γ = 90 
No. of molecules (Z) 2 
R (Reliability factor) 0.0632 (1776) 
Table 4.2.2 Crystallograhic data for (S)-273 
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For (S)-273, a characteristic peak was observed in the infrared spectrum at 1558 cm-1 indicative 
of a carbonyl group. In the 1H NMR spectrum a peak at 5.69 ppm suggested the presence of an 
alkenyl proton and in the 13C NMR spectrum the peak at 207.7 ppm further confirmed the 
presence of a ketone carbonyl group. High resolution mass spectrometry indicated a protonated 
molecular ion of 308.1684, which was in good agreement with the calculated value of 308.1688. 
We rationalised this impurity may have been a result of a Meerwein–Ponndorf–Verley 
reduction/Oppenauer oxidation (Scheme 4.2.9).247,248 Traditionally achieved using an 
aluminium metal centre,247,248 there is also precedent for the use of lithium in this 
transformation.249 
 
 
 
 
Scheme 4.2.9 
We believe this transformation occurs in competition with the formation of (S,S,S)-270. We 
propose the following mechanism for the formation of (S)-273 (Scheme 4.2.10). 
 
 
 
 
 
 
 
274         275             
 
 
 
 
 
 
 
 
 
 
 
 
 (S)-273         (S)-277 
Scheme 4.2.10 
Lithium aldolate 274 undergoes an Oppenauer oxidation to form the keto-imine (S)-277, via 
which tautomerises to the enamine (S)-273. The aldehyde 275 undergoes Meerwein–Ponndorf–
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Verley reduction to the alcohol. At this stage we surmise that reducing the final temperature 
during the warm up stage may limit the formation of (S)-273. Certainly avoiding the formation 
of the by-product (25%) would significantly improve our yields and enhance the applicability 
of our reaction. 
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Cleavage of the ester group to afford the β-hydroxy amine was investigated next. Pivalate esters 
can be cleaved by a range of methods,250 including bases such as potassium hydroxide or 
potassium tert-butoxide. 
To further enhance the synthetic utility of this synthesis we wanted to establish a simple 
cleavage method which would be efficient and low cost. 
For this reason the relatively inexpensive strong base, potassium hydroxide was investigated 
for the removal of the pivalate ester (S,S,S)-270. Potassium hydroxide was added to (S,S,S)-
270, in a 1 : 1 mixture of ethanol and water. After 24 hours the desired product (S,S,S)-278 was 
not formed and only starting material was isolated (Scheme 4.2.11). 
  
 
 
(S,S,S)-270         (S,S,S)-278   
Scheme 4.2.11 
The reaction was repeated with potassium carbonate in methanol and heated at reflux 
overnight.251 Again only starting material was isolated. 
We believe both of these procedures failed due to the steric bulk surrounding the carbonyl of 
the pivalate ester. With two tert-butyl groups in close proximity, attack of the nucleophile 
necessary in the cleavage mechanism is hindered and therefore unsuccessful. 
Cleavage of the pivalate group was achieved using a DIBAL-H reduction (Scheme 4.2.12). 
 
 
 
 
 
        (S,S,S)-270    (S,S,S)-278, 51%   
Scheme 4.2.12 
Pivalate ester (S,S,S)-270 was added to DIBAL-H in anhydrous dichloromethane, under N2 
atmosphere at -78°C. The reaction was allowed warm to room temperature overnight. The 
reaction was cooled to 0°C and methanol was added slowly to quench the excess DIBAL-H. 
The reaction was allowed warm to room temperature and aqueous 10% HCl solution was slowly 
added to hydrolyse the aluminium salts. After work-up, the cleaved β-hydroxy amine, (S,S,S)-
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278 was successfully isolated in 51% yield. Subsequent work by others in the group has shown 
other esters (e.g. i-Pr) are easily cleavage using potassium hydroxide.245 
Analysis of the spectroscopic data confirmed successful cleavage of the ester moiety. Most 
notably, the absence of the peak at 178.6 ppm for the ester carbonyl in the 13C NMR spectrum 
and the presence of the broad singlet at 2.77 ppm for the alcohol proton suggested the formation 
of (S,S,S)-278. The exact structural assignment was determined using COSY, HSQC and 
HMBC experiments. Using the HMBC spectrum (Figure 4.2.9) it was possible to assign the 
signal which corresponds to the carbon of C-7. The quaternary carbon of the aromatic ring 
showed a correlation with the peak at 4.71 ppm, i.e. a 2-bond coupling to the protons of the 
adjacent carbon, C-7. A correlation was also observed with the peak at 1.89 ppm, i.e. a 3-bond 
coupling to the protons at C-8. 
 
 
 
(S,S,S)-278 
 
Figure 4.2.9 HMBC spectrum for (S,S,S)-278 
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In the COSY spectrum, the peak at 4.71 ppm also showed a correlation with the peaks at 1.89 
(H-8) and 3.94 (N-H) ppm, which further confirmed the assignment of the C-7 (Figure 4.2.10). 
 
Figure 4.2.10 COSY spectrum for (S,S,S)-278 
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The successful cleavage of pivalate esters, using hydrochloric acid in 1,4-dioxane, has been 
reported.252 Given that hydrochloric acid is also used for the cleavage of the N-tert-
butanesulfinyl auxiliary,144 we hoped that the removal of both the auxiliary and the ester could 
be achieved in one step.  
To (S,S,S)-270 in 1,4-dioxane was added 4 M HCl. The reaction mixture was heated at reflux 
overnight. The reaction mixture was then cooled to room temperature and concentrated under 
reduced pressure. Ethyl acetate was added, at which point the product crashed out of solution. 
The formed solid was filtered and dried. Analysis of the spectroscopic data confirmed the 
auxiliary was successfully cleaved, however the ester group remained and (S,S)-279 was 
isolated as the HCl salt in 85% yield (Scheme 4.2.13).  
 
 
 
 
 
 
  (S,S,S)-270                 (S,S)-279 
 
Scheme 4.2.13 
The 13C NMR spectrum showed a distinctive peak at 179.1 corresponding to the presence of an 
ester carbonyl group. High resolution mass spectrometry found the protonated molecular ion at 
292.2276 which was in good agreement with the calculated value of 292.2277.  
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4.3 Conclusions and Future Work 
A new method for the preparation of chiral anti-1,3-amino alcohols is described. The first 
application of a tandem aldol-Tishchenko reaction on C=N is reported resulting in anti-1,3-
amino alcohol precursors in high levels of diastereoselectivity. Also to the best of our 
knowledge this is the first synthesis of 1,3-amino alcohols that installs both chiral centres (C-N 
and C-O) concomitantly in one pot. 
Expanding on this successful work, we would hope to optimise the reaction conditions in an 
attempt to improve yields and minimise formation of the impurity (S)-273. We also intend to 
perform substrate scope investigations, which would include changing the N-tert-
butanesulfinamide and varying the aldehyde. The tert-butyl ester is a particularly difficult 
functional group to cleave using simple bases and we would hope to showcase our methodology 
with the avoidance of DIBAL-H in future reactions. Mechanistic studies will also be carried 
out, as well as extension of the methodology to the formation of three and five chiral centres in 
one pot. Future work will also focus on the investigation of the use of catalysts such as 
samarium diiodide previously utilised by Evans.148 
 
  
 
  
 
 
 
 
 
 
 
 
  
Experimental 
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5.1 General Procedures 
Solvents employed were distilled prior to use as follows:  
Cyclohexane was distilled from calcium hydride. THF, diethyl ether (Et2O) and toluene were 
distilled from sodium benzophenone ketyl. Methyl tert-butyl ether (MTBE), benzene and 
cumene were purchased as anhydrous solvents from Sigma Aldrich. Sparteine was distilled 
prior to use, using a Kugelrohr distillation apparatus. (-)-Sparteine (-)-sp 100 was purchased 
from Santa Cruz Technologies Inc. (+)-Sparteine (+)-sp 100 was purchased from Beta Pharma. 
All other reagents were purchased from Sigma Aldrich unless otherwise noted. 
Wet flash column chromatography was carried out using Kieselgel silica gel 60, 0.040-0.063 
mm (Merck). Thin layer chromatography (TLC) was carried out on pre-coated silica gel plates 
(Merck 60 PF254). Visualisation was achieved by potassium permanganate staining. 
Melting points were measured on a Thomas Hoover Capillary Melting Point apparatus. 
Infrared (IR) spectra were recorded on a Perkin-Elmer FT-IR Paragon 1000 spectrophotometer. 
Liquid samples were examined as thin films interspersed between sodium chloride plates. Solid 
samples were dispersed in potassium bromide and recorded as pressed discs. The intensity of 
peaks were expressed as strong (s), medium (m) and weak (w).  
NMR spectra were run in CDCl3 using tetramethylsilane (TMS) as the internal standard, unless 
otherwise specified. 1H NMR spectra were recorded at 300 MHz on a Bruker AVANCE 300 
spectrometer and 13C NMR spectra were recorded at 75 MHz on a Bruker AVANCE 300 
instrument, unless otherwise stated. All spectra were recorded at University College Cork. 
Chemical shifts δH and δC are expressed as parts per million (ppm), positive shift being 
downfield from TMS; coupling constants (J) are expressed in hertz (Hz). Splitting patterns in 
1H NMR spectra are designated as s (singlet), br s (broad singlet), d (doublet), dd (doublet of 
doublets), dt (doublet of triplets), t (triplet), q (quartet), quin (quintet), sext (sextet), sept 
(septet), and m (multiplet). For 13C NMR spectra, the number of attached protons for each signal 
was determined using the DEPT pulse sequence run in the DEPT-90 and DEPT-135 modes. 
The terms C, CH, CH2, and CH3 are used to designate the signals as C(H)n ; n = 0, 1, 2, 3. 
HSQC, COSY and HMBC experiments were routinely performed to aid the NMR assignment 
of novel chemical structures. 
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Low resolution mass spectra (LRMS) were recorded on a Waters Quattro Micro triple 
quadrupole instrument in electrospray ionization (ESI) mode using 50% acetonitrile- water 
containing 0.1% formic acid as eluent. Samples were made up in acetonitrile. High resolution 
precise mass spectra (HRMS) were recorded on a Waters LCT Premier Tof LC-MS instrument 
in electrospray ionization (ESI) mode using 50% acetonitrile-water containing 0.1% formic 
acid as eluent. Samples were prepared in acetonitrile. 
Enantiopurity of the chiral compounds was determined by chiral gas chromatography 
performed on an Astec CHIRALDEXTM G-TA, fused silica capillary column, 20 m x 0.25 mm 
x 0.12 µm film thickness. GC analysis was performed on an Agilent Technologies 7820 A GC 
system. All chiral columns were purchased from Sigma-Aldrich Supelco. Conditions for 
separation were determined using the following operating conditions as standard, flow rate: 1 
mL/min, injection volume: 0.2 µL, split ratio: 10 : 1, front inlet temperature: 150°C, detector 
temperature: 155°C. 
Optical rotations were measured on a Perkin-Elmer 141 polarimeter at 589 nm in a 10 cm cell. 
Concentrations (c) are expressed in g/100 mL. α𝑇
𝐷
 is the specific rotation of a compound and is 
expressed in units of 10−1 deg cm2 g−1.   
The Microanalysis Laboratory, National University of Ireland, Cork, performed elemental 
analysis using a Perkin-Elmer 240 and Exeter Analytical CE440 elemental analysers. 
Single crystal X-ray analysis was conducted by Dr. S.E. Lawrence, Department of Chemistry, 
National University of Ireland, Cork, or other members of his group using a Nonius Mach 3 
diffractometer with graphite monochromatised Mo-Ka radiation.  Calculations were performed 
on a PC with the maXus (C.J. Gilmore et al, University of Glasgow, 1998), SHELXL-97 (G.M. 
Sheldrick, University of Gottingen, 1998) and Platon (A.L. Spek, University of Utrecht, 1998) 
suite of programs 
1H NMR spectra, 13C NMR spectra, LRMS and melting point (if solid) analyses were recorded 
for all previously prepared compounds.  For novel compounds, in addition to the previously 
mentioned analysis, IR, HRMS and elemental analysis (if possible) were also obtained. Optical 
rotations were used to assign absolute stereochemistry for known compounds.  
An arbitrary numbering system was employed to aid the assignment of 1H NMR and 13C NMR 
spectra. 
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5.2 Synthesis of Racemic α-Alkylated Ketones 
General Procedure for Synthesis of Racemic α-Alkylated Ketones 
To a schlenk tube under N2 atmosphere, containing diisopropylamine (1.2 equiv.) in anhydrous 
THF (5 mL), was added n-BuLi (1.1 equiv.) at 0°C. The mixture was allowed to stir at 0°C for 
30 min. The reaction mixture was cooled to -78°C, the ketone (1 equiv.) was added dropwise 
and allowed to stir for 1 h. The electrophile (1.2 equiv.) was added dropwise and the reaction 
was allowed warm to room temperature and stirred overnight. The reaction was quenched with 
saturated NH4Cl (1.5 mL), Et2O (10 mL) and NH4Cl (10 mL) were added and the mixture was 
extracted with Et2O (3 x 30 mL). The organic layers were combined and dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure. 
 
2-methyl-1-phenylpentan-3-one 36 
Prepared following the general procedure outlined above using 3-
pentanone and benzyl bromide. The crude product was purified using 
column chromatography (10 : 1, hexane : Et2O) on silica gel to give the 
title compound 36 as a clear oil (0.365 g, 19%).  
Spectroscopic characteristics were consistent with previously reported 
data.192 Rf = 0.45 (5 : 1, hexane : Et2O). 
1H NMR (300 MHz, CDCl3): δ 0.95 (3H, t, J = 7.3 Hz, 
H-1), 1.08 (3H, d, J = 6.0 Hz, H-5), 2.25 (1H, dq, J = 17.9, 7.3 Hz, H-2), 2.44 (1H, dq, J = 17.9, 
7.3 Hz, H-2), 2.57 (1H, dd, J = 7.2, 14.2 Hz, H-6), 2.78-2.89 (1H, m, H-4), 2.97 (1H, dd, J = 
7.2, 14.2 Hz, H-6), 7.12-7.30 (5H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 7.6 (C-1), 
16.6 (C-5), 35.2 (C-2), 39.3 (C-6), 47.9 (C-4), 120.2 (Ar-CH), 128.4 (2 x Ar-CH), 128.9 (2 x 
Ar-CH), 139.9 (Ar-C), 214.8 (C-3) ppm; MS (ESI) m/z: 177 [M + H]+. 
GC analysis: tR = 7.4 and 7.8 min (120°C hold for 10 min, ramp 10°C/min to 140°C, hold for 
5 min). 
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2-methyl-1-(4-(trifluoromethyl)phenyl)pentan-3-one 183 
Prepared following the general procedure outlined above using 3-
pentanone and 4-trifluoromethylbenzyl bromide. The crude product 
was purified using column chromatography (15 : 1, hexane : Et2O) 
on silica gel to give the title compound 183 as a clear oil (0.237 g, 
10%). 
Spectroscopic characteristics were consistent with previously reported data.253 
Rf = 0.45 (10 : 1, hexane : Et2O). 
1H NMR (300 MHz, CDCl3): δ 0.98 (3H, t, J = 7.5 Hz, H-1), 
1.10  (3H, d, J = 6.9 Hz, H-5), 2.26 (1H, dq, J = 17.7, 7.5 Hz, H-2), 2.48 (1H, dq, J = 17.7, 7.5 
Hz, H-2), 2.62 (1H, dd, J = 7.2, 12.9 Hz, H-6), 2.79-2.91 (1H, m, H-4), 3.05 (1H, dd, J = 7.2, 
12.9 Hz, H-6), 7.25 (2H, d, J = 7.9 Hz, Ar-H), 7.53 (2H, d, J = 7.9, Ar-H) ppm; 13C NMR (75.5 
MHz, CDCl3): δ 7.6 (C-1), 16.8 (C-5), 35.1 (C-2), 38.7 (C-6), 47.6 (C-4), 124.2 (q, JC-F = 277.5 
Hz, C-13), 125.3 (q, 3JC-F = 3.8 Hz, C-9, C-11), 128.6 (q, 
2JC-F = 32.5 Hz, C-10), 129.3 (C-8, 
C-12), 144.1 (C-7), 214.7 (C-3) ppm; MS (ESI) m/z: 245 [M + H]+.  
GC analysis: tR = 10.4 and 12.1 min (120°C hold for 10 min, ramp 5°C/min to 140°C, hold for 
5 min). 
 
(E)-4-methyl-7-phenylhept-6-en-3-one 184 
Prepared following the general procedure outlined above using 3-
pentanone and 3-bromo-1-phenyl-1-propene. The crude product was 
purified using column chromatography (15 : 1, hexane : Et2O) on 
silica gel to give the title compound 184 as a clear oil (0.8 g, 40%). 
Spectroscopic characteristics were consistent with previously 
reported data.254 
Rf = 0.4 (10 : 1, hexane : Et2O). 
1H NMR (300 MHz, CDCl3): δ 1.05 (3H, t, J = 7.2 Hz, H-1), 
1.13 (3H, d, J = 6.9 Hz, H-5), 2.19-2.29 (1H, m, H-6), 2.40-2.59 (3H, m, H-2, H-6), 2.63-2.74 
(1H, m, H-4), 6.06-6.17 (1H, m, H-7), 6.40 (1H, d, J = 15.9 Hz, H-8), 7.25-7.33 (5H, m, Ar-H) 
ppm; 13C NMR (75.5 MHz, CDCl3): δ 7.7 (C-1), 16.4 (C-5), 34.6 (C-2), 36.3 (C-6), 46.1 (C-4), 
126.1 (2 x Ar-CH), 127.2 (C-7), 127.6 (C-8), 128.5 (2 x Ar-CH), 131.9 (Ar-CH), 137.4 (C-9), 
214.6 (C-3) ppm; MS (ESI) m/z: 203 [M + H]+. 
GC analysis: tR = 25.2 and 26.5 min (130°C hold for 30 min, ramp 10°C/min to 140°C, hold 
for 5 min). 
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(E)-4-methyloct-6-en-3-one 185 
Prepared following the general procedure outlined above using 3-pentanone 
and crotyl bromide. The crude product was purified using column 
chromatography (50 : 1, hexane : Et2O) on silica gel to give the title 
compound 185 as a clear oil (0.275 g, 20%). 
Spectroscopic characteristics were consistent with previously reported 
data.197 
Rf = 0.57 (20 : 1, hexane : Et2O). 
1H NMR (300 MHz, CDCl3): δ 1.03 (3H, t, J = 7.4 Hz, H-1), 
1.05 (3H, d, J = 7.3 Hz, H-5), 1.59-1.68 (3H, m, H-9), 1.93-2.07 (1H, m, H-6), 2.19-2.38 (1H, 
m, H-6), 2.38-2.72 (3H, m, H-2, H-4), 5.26-5.38 (1H, m, H-7), 5.38-5.52 (1H, m, H-8) ppm; 
13C NMR (75.5 MHz, CDCl3): δ 7.7 (C-1), 16.1 (C-5), 17.9 (C-9), 34.4 (C-2), 36.1 (C-6), 46.2 
(C-4), 127.3 (C-7), 128.1 (C-8), 214.9 (C-3) ppm; MS (ESI) m/z: 141 [M + H]+. 
GC analysis: tR = 4.0 and 4.4 min (90°C hold for 5 min, ramp 10°C/min to 140°C, hold for 5 
min). 
 
1-(4-bromophenyl)-2-methylpentan-3-one 186 
Prepared following the general procedure outlined above using 3-
pentanone and 4-bromobenzyl bromide. The crude product was 
purified using column chromatography (10 : 1, hexane : Et2O) on silica 
gel to give the title compound 186 as a clear oil (0.19 g, 20%). 
Spectroscopic characteristics were consistent with previously reported 
data.35 
Rf = 0.58 (5 : 1, hexane : Et2O). 
1H NMR (300 MHz, CDCl3): δ 0.97 (3H, t, J = 7.5 Hz, H-1), 
1.08 (3H, d, J = 6.9 Hz, H-5), 2.24 (1H, dq, J = 17.9, 7.2 Hz, H-2), 2.45 (1H, dq, J = 17.9, 7.2 
Hz, H-2), 2.51 (1H, dd, J = 7.2, 13.3 Hz, H-6), 2.72-2.86 (1H, m, H-4), 2.91 (1H, dd, J = 7.2, 
13.3 Hz, H-6), 6.97-7.04 (2H, m, Ar-H), 7.35-7.5 (2H, m, Ar-H) ppm; 13C NMR (75.5 MHz, 
CDCl3): δ 7.6 (C-1), 16.7 (C-5), 35.2 (C-2), 38.5 (C-6), 47.7 (C-4), 120.0 (Ar-C), 130.7 (2 x 
Ar-CH), 131.4 (2 x Ar-CH), 138.9 (Ar-C), 214.3 (C-3) ppm; MS (ESI) m/z: 255 [M + H]+. 
GC analysis: tR = 15.7 and 16.7 min (140°C hold for 20 min). 
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2-methyl-1-p-tolylpentan-3-one 187 
Prepared following the general procedure outlined above using 3-
pentanone and 4-methylbenzyl bromide. The crude product was 
purified using column chromatography (20 : 1, hexane : Et2O) on 
silica gel to give the title compound 187 as a clear oil (0.365 g, 
19%). 
Rf = 0.42 (10 : 1, hexane : Et2O). IR (NaCl) ?̅?max: 2974-2876 (C-H stretch, s), 1713 (C=O stretch, 
s), 1515 (Aromatic C=C stretch, s), 1458 (C-H bending, m) cm-1; 1H NMR (300 MHz, CDCl3): 
δ 0.97 (3H, t, J = 7.2 Hz, H-1), 1.06 (3H, d, J = 6.9 Hz, H-5), 2.26 (1H, dq, J = 17.8, 7.2 Hz, 
H-2), 2.30 (3H, s, H-13), 2.43 (1H, dq, J = 17.8, 7.2 Hz, H-2), 2.52 (1H, dd, J = 7.2, 13.2 Hz, 
H-6), 2.74-2.74 (1H, m, H-4), 2.92 (1H, dd, J = 7.2, 13.2 Hz, H-6), 7.00-7.10 (4H, m, Ar-H) 
ppm; 13C NMR (75.5 MHz, CDCl3): δ 7.6 (C-1), 16.6 (C-5), 21.0 (C-13), 35.1 (C-2), 38.9 (C-
6), 47.9 (C-4), 128.8 (2 x Ar-CH), 129.1 (2 x Ar-CH), 135.7 (Ar-C), 136.7 (Ar-C), 214.9 (C-3) 
ppm; HRMS (ESI) m/z calcd for C13H19O [M + H]
+: 191.1436, found 191.1428. GC analysis: 
tR = 12.2 and 12.8 min (120°C hold for 5 min, ramp 10°C/min to 140°C, hold for 5 min). 
 
4-methylnonan-3-one 188 
Prepared following the general procedure outlined above using 3-
pentanone and 1-iodopentane. The crude product was purified using 
column chromatography (10 : 1, hexane : Et2O) on silica gel to give the 
title compound 188 as a clear oil (0.03 g, 17%). 
Rf = 0.68 (4 : 1, hexane : Et2O). IR (NaCl) ?̅?max: 2960-2858 (C-H stretch, 
s), 1716 (C=O stretch, s), 1460 (C-H bending, s) cm-1; 1H NMR (300 
MHz, CDCl3) δ: 0.88 (3H, t, J = 6.9 Hz, H-10), 1.04 (3H, t, J = 7.3 Hz, H-1), 1.06 (3H, d, J = 
6.8 Hz, H-5), 1.13-1.41 (7H, m, H-6, H-7, H-8, H-9), 1.52-1.73 (1H, m, H-6), 2.35-2.61 (3H, 
m, H-2, H-4) ppm; 13C NMR (75.5 MHz, CDCl3): δ 7.8 (C-1), 14.0 (C-10), 16.5 (C-5), 22.5, 
27.0, 31.9, 33.1, 34.2 (C-2, C-6, C-7, C-8, C-9), 46.1 (C-4), 215.5 (C-3) ppm; HRMS (ESI) m/z 
calcd for C10H21O [M + H]
+: 157.1592, found 157.1588. 
GC analysis: tR = 3.6 and 3.8 min (105°C hold for 10 min, ramp 10°C/min to 140°C, hold for 
5 min). 
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2,4-dimethyl-1-phenylpentan-3-one 189 
Prepared following the general procedure outlined above using 2-
methyl-3-pentanone and benzyl bromide. The crude product was 
purified using column chromatography (10 : 1, hexane : Et2O) on silica 
gel to give the title compound 189 as a clear oil (0.076 g, 40%). 
Spectroscopic characteristics were consistent with previously reported 
data.255 
Rf = 0.74 (5 : 1, hexane : Et2O). 
1H NMR (300 MHz, CDCl3): δ 0.87 (3H, d, J = 6.9 Hz, H-1), 
1.01 (3H, d, J = 6.9 Hz, H-1), 1.08 (3H, d, J = 6.9 Hz, H-5), 2.43-2.61 (2H, m, H-2, H-6), 2.88-
3.10 (2H, m, H-4, H-6), 7.09-7.32 (5H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 17.2 
(C-5), 17.7 (C-1), 18.0 (C-1), 39.5 (C-6), 40.4 (C-2), 46.5 (C-4), 126.2 (Ar-CH), 128.4 (2 x Ar-
CH), 128.9 (2 x Ar-CH), 139.9 (C-7), 214.8 (C-3) ppm (Note: Exact structural assignment 
confirmed using COSY and HSQC); MS (ESI) m/z: 191 [M + H]+. 
GC analysis: tR = 10.8 and 11.1 min (110°C hold for 20 min, ramp 10°C/min to 140°C, hold 
for 5 min). 
 
2-methyl-1-phenylbutan-1-one 190 
Prepared following the general procedure outlined above using 
propiophenone and ethyl iodide. The crude product was purified using 
column chromatography (10 : 1, hexane : Et2O) on silica gel to give the 
title compound 190 as a clear oil (0.651 g, 40%). 
Spectroscopic characteristics were consistent with previously reported data.256 
Rf = 0.62 (4 : 1, hexane : Et2O). 
1H NMR (300 MHz, CDCl3): δ 0.92 (3H, t, J = 7.4 Hz, H-11), 
1.19 (3H, d, J = 6.9 Hz, H-9), 1.40-1.58 (1H, m, H-10), 1.75-1.93 (1H, m, H-10), 3.33-3.48 
(1H, m, H-8), 7.41-7.51 (2H, m, Ar-H), 7.51-7.59 (1H, m, Ar-H), 7.91-7.99 (2H, m, Ar-H) 
ppm; 13C NMR (75.5 MHz, CDCl3): δ 11.8 (C-11), 16.8 (C-9), 26.7 (C-10), 42.1 (C-8), 128.3 
(2 x Ar-CH), 128.6 (2 x Ar-CH), 132.8 (Ar-CH), 136.8 (C-6), 204.5 (C-7) ppm; MS (ESI) m/z: 
163 [M + H]+. 
GC analysis: tR = 14.0 and 14.9 min (100°C hold for 20 min, ramp 5°C/min to 140°C, hold for 
5 min). 
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2-methyl-1,3-diphenylpropan-1-one 191 
Prepared following the general procedure outlined above using 
propiophenone and benzyl bromide. The crude product was purified 
using column chromatography (10 : 1, hexane : Et2O) on silica gel 
to give the title compound 191 as a clear oil (0.48 g, 53%). 
Spectroscopic characteristics were consistent with previously 
reported data.256 
Rf = 0.56 (4 : 1, hexane : Et2O). 
1H NMR (300 MHz, CDCl3): 1.18 (3H, d, J = 6.9 Hz, H-9), 
2.68 (1H, dd, J = 6.9, 13.7 Hz, H-10), 3.16 (1H, dd, J = 6.9, 13.7 Hz, H-10), 3.66-3.80 (1H, m, 
H-8), 7.13-7.31 (5H, m, Ar-H), 7.35-7.57 (3H, m, Ar-H), 7.86-7.99 (2H, m, Ar-H) ppm; 13C 
NMR (75.5 MHz, CDCl3): δ 17.5 (C-9), 39.4 (C-10), 42.8 (C-8), 126.2 (Ar-CH), 128.3 (2 x Ar-
CH), 128.4 (2 x Ar-CH), 128.7 (2 x Ar-CH), 129.1 (2 x Ar-CH), 132.9 (Ar-CH), 136.5 (Ar-C), 
140.0 (Ar-C), 203.7 (C-7) ppm; MS (ESI) m/z: 245 [M + H]+. 
GC analysis: tR = 53.2 and 57.2 min (90°C hold for 5 min, ramp 10°C/min to 140°C, hold for 
5 min). 
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5.3 Synthesis of a Novel Diamine Chiral Auxiliary 
5.3.1 Synthesis of (2R,5S)-trichloromethyl-1-aza-3-oxabicyclo-[3.3.0]-octan-4-one  
(2R,5S)-trichloromethyl-1-aza-3-oxabicyclo-[3.3.0]-octan-4-one (R,S)-195 
To a stirred solution of (S)-proline (30 g, 0.26 mol) in chloroform (350 mL) 
was added anhydrous chloral (57.6 g, 0.39 mol). The reaction mixture was 
heated at reflux for 10 h using a reverse Dean-Stark apparatus. The water 
collected was measured (4.5 mL) and the reaction mixture was cooled to room 
temperature. The cooled mixture was washed with water (2 x 100 mL) and the resulting water 
layers were washed with CH2Cl2 (2 x 50 mL). The organic layers were combined and dried 
over anhydrous MgSO4, filtered, and concentrated under reduced pressure. The residue was 
crystallized from EtOH to give the product (R,S)-195 as white needles (26.21 g, 41%). Mp 106-
109°C (lit.162 107°C). 
Spectroscopic characteristics were consistent with previously reported data.162  
[α]20
𝐷
 + 29.8 (c 2, C6H6) (lit.
162 [α]20
𝐷
 + 32.7 (c 2, C6H6) for R,S-enantiomer). 
1H NMR (300 MHz, 
CDCl3): δ 1.64-1.79 (1H, m, H-5), 1.84-1.99 (1H, m, H-5), 2.02-2.30 (2H, m, H-4), 3.02-3.20 
(1H, m, H-6), 3.32-3.50 (1H, m, H-6), 4.11 (1H, dd, J = 4.7, 8.8 Hz, H-3), 5.14 (1H, s, H-1) 
ppm; 13C NMR (75.5 MHz, CDCl3): δ 25.4 (C-5), 29.9 (C-4), 57.9 (C-6), 62.4 (C-3), 100.6 (C-
7), 103.7 (C-1), 175.5 (C-2) ppm; MS (ESI) m/z: 244 [M+H]+ (for 35Cl).  
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5.3.2 Preparation of (S)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-amine 
(S)-prolyl-pyrrolidine (S)-198 
 To (2R,5S)-trichloromethyl-1-aza-3-oxabicyclo-[3.3.0]-octan-4-one 
(R,S)-195 (8.032 g, 0.0327 mol), dissolved in EtOH (120 mL), was added 
pyrrolidine (6.975 g, 0.98 mol), dropwise. The resulting mixture was 
allowed to stir for 4.5 h at room temperature, until all starting material had 
reacted (determined by TLC analysis (1 : 1, hexane : EtOAc)). The reaction mixture was 
concentrated under reduced pressure to give the product (S)-198 as a yellow oil. The crude 
product was used in the next step without further purification. 
Spectroscopic characteristics were consistent with previously reported data.162 
Rotamers were observed for this compound. The minor rotamer was not observed in this case. 
1H NMR (300 MHz, CDCl3): δ 1.60-2.22 (8H, m, H-2, H-3, H-7, H-8), 2.77-2.89 (1H, m, H-
4), 3.13-3.25 (1H, m, H-4), 3.33-3.59 (4H, m, H-6, H-9), 3.79 (1H, dd, J = 6.3, 8.1 Hz, H-1), 
8.10 (1H, bs, N-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 24.0, 25.9, 26.1, 30.4, 45.8, 45.9, 
47.6 (C-2, C-3, C-4, C-6, C-7, C-8, C-9), 59.4 (C-1), 172.7 (C-5) ppm; MS (ESI) m/z: 169 
[M+H]+. 
 
(S)-(1-pyrrolidinylmethyl)-pyrrolidine (S)-193 
To LiAlH4 (3.10 g, 0.0817 mol) in anhydrous THF (100 mL), under a N2 
atmosphere at 0°C, was added (S)-prolyl-pyrrolidine (S)-198 (max. 
0.0327 mol) in anhydrous THF (100 mL). The reaction mixture was 
brought to room temperature and allowed to stir overnight. The reaction 
mixture was heated at reflux for 2.5 h. The mixture was allowed cool to room temperature and 
quenched by the slow addition of water (14 mL), 15% NaOH solution (14 mL) and water (42 
mL) and allowed to stir for 1 h, until a white precipitate had formed. The mixture was filtered 
through a pad of Celite® to remove the inorganic salts and washed with EtOAc (100 mL). The 
filtrate was dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to 
give the crude product as an orange oil. The product was further purified by kugelrohr 
distillation to give (S)-193, as a colourless oil (2.73 g, 54% over two steps). 
Spectroscopic characteristics were consistent with previously reported data.162 
[α]20
𝐷
 + 5.188 (c 2.4, EtOH) (lit.162 [α] 20
𝐷
 + 8.9 (c 2.4, EtOH) for S-enantiomer). 1H NMR (300 
MHz, CDCl3): δ 1.26-1.42 (1H, m, H-2), 1.62-1.84 (6H, m, H-2, H-3, H-7, H-8), 1.84-1.94 (1H, 
m, H-3), 2.34 (1H, dd, J = 5.2, 11.9 Hz, H-5), 2.41-2.63 (5H, m, H-5, H-6, H-9), 2.81 (1H, bs, 
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N-H), 2.85 (1H, dt, J = 7.1, 10.2 Hz, H-4), 2.98 (1H, dt, J = 6.6, 10.2 Hz, H-4), 3.15-3.29 (1H, 
m, H-1) ppm; 13C NMR (75.5 MHz, CDCl3): δ 23.4 (C-7, C-8), 25.0, 30.1, 41.3 (C-2, C-3, C-
4), 54.5 (C-6, C-9), 57.4 (C-1), 62.1 (C-5) ppm; MS (ESI) m/z: 155 [M + H]+. 
 
(S)-1-nitroso-2-(pyrrolidinylmethyl)-pyrrolidine (S)-199 
 
 
 
Method A 
To a solution of the amine (S)-193 (0.1 g, 0.65 mmol) in THF (1 mL) was added tert-butyl 
nitrite (0.206 g, 2 mmol). The mixture was allowed to stir at room temperature, for 18 h, without 
admission of light. After such time, the reaction mixture was heated at reflux for 5 h, cooled to 
room temperature and allowed to stir again overnight. The solvent and excess tert-butyl nitrite, 
were removed under reduced pressure to give a brown, oily residue. 
1H NMR analysis showed the reaction was unsuccessful and that only starting material 
remained. 
Method B 
To a stirred solution of the amine (S)-193 (5 g, 0.033 mol) in water (100 mL) was added 37% 
HCl solution (8 mL). To the solution, acetic acid (50 mL) was added, followed by NaNO2 (6.4 
g, 0.093 mol) at 0°C. The reaction mixture was allowed to stir for 30 min at 0°C and at room 
temperature for 2 h, until all starting material had reacted (determined by TLC analysis (9 : 1, 
CH2Cl2 : MeOH)). The solution was cooled to 0°C and 10% Na2CO3 (50 mL) was added slowly. 
EtOAc (50 mL) was added and the aqueous layer extracted and washed with EtOAc (2 x 50 
mL). Additional 10% Na2CO3 was added to the aqueous layer, until it was basic. The aqueous 
was extracted again with EtOAc (2 x 150 mL). The organic layers were combined and dried 
over anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the product 
(S)-199, as a yellow oil (4.51 g, 75%). The crude product was used in the next step without 
further purification. 
1H NMR (300 MHz, CDCl3): δ 1.71-1.86 (4H, m, H-7, H-8), 1.86-2.28 (4H, m, H-2, H-3),  
2.51-2.69 (4H, m, H-6, H-9), 2.80 (1H, dd, J = 7.0, 12.3 Hz, H-5), 2.99 (1H, dd, J = 7.7, 12.3, 
H-5), 3.51-3.62 (1H, m, H-4), 3.62-3.75 (1H, m, H-4), 4.56-4.68 (1H, m, H-1) ppm. To limit 
handling of the potential carcinogenic nitroso compound (S)-199 only a 1H NMR spectrum was 
obtained. 
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(S)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-amine (S)-192 
To LiAlH4 (1.25 g, 0.033 mol) in anhydrous THF (60 mL) under a N2 
atmosphere at 0°C, was added (S)-1-nitroso-2-(pyrrolidinylmethyl)-
pyrrolidine (S)-199 (3.01 g, 0.0164 mol) in anhydrous THF (60 mL). The 
reaction was allowed warm to room temperature and allowed to stir for 6 
h, until all starting material had reacted (determined by TLC analysis (9 : 1, CH2Cl2 : MeOH)). 
The reduction was quenched by slow addition of water (1.3 mL), 15% NaOH solution (1.3 mL) 
and water (3.9 mL) and allowed to stir for 1 h, until a white precipitate had formed. The mixture 
was filtered through a pad of Celite® to remove the inorganic salts and washed with EtOAc and 
THF. The filtrate was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure. This was purified using kugelrohr distillation and the pure product (S)-192 was 
isolated as a clear oil (1.37 g, 49% over two steps). 
[α]20
D
  – 11.40 (c 1, EtOH). IR (NaCl) ?̅?max: 3306 (N-H stretch, m), 2961-2789 (C-H stretch, s), 
1591 (N-H bending, m), 1459-1446 (C-H bending, m), 1137 (C-N stretch, m) cm-1; 1H NMR 
(300 MHz, CDCl3): δ 1.38-1.62 (1H, m, H-2), 1.62-1.87 (6H, m, H-2, H-3, H-7, H-8), 1.91-
2.09 (1H, m, H-3), 2.22-2.42 (3H, m, H-4, H-5), 2.42-2.64 (4H, m, H-6, H-9), 2.88 (1H, dd, J 
= 6.3, 11.5 Hz, H-5), 3.06 (bs, N-H2), 3.20-3.29 (1H, m, H-1); 
13C NMR (75.5 MHz, CDCl3): 
δ 20.6 (C-2), 23.7 (C-7, C-8), 28.7 (C-3), 54.9 (C-6, C-9), 59.5, 61.5 (C-4, C-5), 67.8 (C-1) 
ppm; HRMS (ESI) m/z calcd for C9H20N3 [M + H]
+: 170.1657, found 170.1674. 
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5.4 Asymmetric α-Alkylation using Novel Diamine Chiral 
Auxiliary 
5.4.1 Solvent Screen for Asymmetric Alkylation using Chiral Auxiliary 
(S)-N-(pentan-3-ylidene)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-amine (S)-200 
To a solution of hydrazine (S)-192 (1.57 g, 9.29 mmol) in cyclohexane 
was added 3-pentanone (4 g, 46.45 mmol) and 2 grains of p-
toluenesulfonic acid. The mixture was allowed to stir at room 
temperature for 5 h, under a N2 atmosphere, until all starting material 
had reacted (determined by NMR and TLC analysis (2 : 1, hexane : 
EtOAc)). Et2O (80 mL) was added to the solution and the mixture was washed with water (3 x 
30 mL). The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure to give the crude product (S)-200 as a yellow oil (0.86 g, 38%). 
[α] 20
𝐷
 + 114 (c 1, EtOH). IR (NaCl) ?̅?max: 2964-2790 (C-H stretch, s), 1637 (C=N stretch, s), 
1460 (C-H bending, s), 1138 (C-N stretch, m) cm-1; 1H NMR (300 MHz, CDCl3): δ 1.06 and 
1,08 (2 x 3H, t, J = 6.3 Hz, H-10 and H-14), 1.53-1.63 (1H, m, H-2), 1.70-1.85 (6H, m, H-2, H-
3, H-7, H-8), 2.02-2.13 (1H, m, H-3), 2.16-2.51 (11H, m, H-4, H-5, H-6, H-9, H-11, H-13), 
2.97-3.09 (2H, m, H-1, H-5); 13C NMR (75.5 MHz, CDCl3): δ 10.9 (C-10), 11.9 (C-14), 21.8 
(C-2), 23.4 (C-7, C-8), 23.5, 28.6, 28.7, 54.8 (C-3, C-4, C-11, C-13), 54.9 (C-6, C-9), 61.4 (C-
5), 66.1 (C-1), 173.3 (C-12) ppm; HRMS (ESI) m/z calcd for C14H27N3 [M + H]
+: 238.2277, 
found 238.2283. 
 
General Procedure for the Asymmetric Alkylations with Chiral Auxiliary 
To diisopropylamine (1.716 mmol, 0.24 mL) in anhydrous solvent (3 mL) at 0°C, was added 
n-BuLi (1.6 M, 1.87 mmol, 1.17 mL). The reaction mixture was allowed to stir for 30 min, 
cooled to -78°C. The chiral hydrazone (S)-200 (0.37 g, 1.56 mmol) was added dropwise and 
allowed to stir for 15 min. The reaction was allowed warm to room temperature and allowed to 
stir for 4 h. The reaction was cooled to -110°C and benzyl bromide (1.87 mmol, 0.22 mL) was 
added dropwise and allowed to stir for 30 min. The reaction mixture was allowed warm to room 
temperature overnight. 
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After such time, saturated NH4Cl (0.5 mL) was added and allowed to stir for 5 min. The reaction 
mixture was extracted with Et2O (3 x 30 mL). The organic layers were combined and dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure. 
 
Hydrazone cleavage 
The resulting oil was hydrolysed by addition of Et2O (5 mL), followed by 4 M HCl (0.5 mL) 
and allowed to stir vigorously, until all starting material had reacted (determined by TLC 
analysis (5 : 1, hexane : Et2O)). Water (5 mL) was added and the mixture extracted with Et2O 
(3 x 30 mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The crude product was purified using column 
chromatography on silica gel to give the pure product as a clear oil. 
 
(S)-2-methyl-1-phenylpentan-3-one (S)-36 
Spectroscopic characteristics were consistent with previously reported 
data.192 
Enantioselectivity was determined by GC analysis: tR = 7.1 (R-
enantiomer) and 7.3 min (S-enantiomer) (120°C hold for 10 min, ramp 
10°C/min to 140°C, hold for 5 min). 
 
 
Solvent Electrophile Yielda Ketone er R : S % ee 
THF BnBr 14% 188 50 : 50 Racemic 
Et2O BnBr 33% (S)-188 6 : 94 88% 
aIsolated yield is over two steps. 
Table 5.4.1 Solvent investigations for asymmetric alkylation using novel chiral auxiliary. 
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5.5 Synthesis N,N-Dimethylhydrazones for Asymmetric α-
Alkylation via Intermolecular Chirality Transfer 
General Procedure for the Synthesis of Hydrazones 
The ketone, neat, was treated with non-symmetric N,N-dimethylhydrazine (1.5 equiv.) and 
acetic acid (few drops), and the reaction mixture was heated at reflux for 24 h. After cooling, 
water (10 mL) was added and the mixture extracted with Et2O (3 x 30 mL). The organic layers 
were combined and dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure. 
 
1,1-dimethyl-2-(pentan-3-ylidene)hydrazine 203 
Prepared following the general procedure outlined above using 3-pentanone 
256 and N,N-dimethylhydrazine. The crude product was purified using 
kugelrohr distillation to give the title compound 203 as a clear oil (5.01 g, 
83%). 
Spectroscopic characteristics were consistent with previously reported data.257 
1H NMR (300 MHz, CDCl3): δ 1.08 (6H, t, J = 7.6 Hz, H-1, H-5), 2.24 (2H, q, J = 7.6 Hz, H-
2), 2.42 (6H, s, H-6), 2.45 (2H, q, J = 7.6 Hz, H-4) ppm; 13C NMR (75.5 MHz, CDCl3): δ 11.1 
(C-1), 11.6 (C-5), 22.5 (C-2), 28.7 (C-4), 47.6 (C-6), 174.5 (C-3) ppm; MS (ESI) m/z: 129 [M 
+ H]+. 
 
(E)-1,1-dimethyl-2-(2-methylpentan-3-ylidene)hydrazine 207 
Prepared following the general procedure outlined above using 2-methyl-3-
pentanone and N,N-dimethylhydrazine. The crude product was purified using 
kugelrohr distillation to give the title compound 207 as a clear oil (6.5 g, 
92%). 
Spectroscopic characteristics were consistent with previously reported 
data.257 
Mixture of isomers: 3 : 1. 
Major: 1H NMR (300 MHz, CDCl3): δ 1.08 (6H, d, J = 6.9 Hz, H-1), 1.09 (3H, t, J = 7.5 Hz, 
H-5), 2.37 (2H, q, J = 7.5 Hz, H-4), 2.38 (6H, s, H-6), 2.52 (1H, m, H-2) ppm; 13C NMR (75.5 
MHz, CDCl3): δ 11.9 (C-5), 20.4 (C-1), 21.8 (C-4), 34.6 (C-2), 47.5 (C-6), 177.5 (C-3) ppm; 
Minor: 1H NMR (300 MHz, CDCl3): δ 1.05 (6H, d, J = 6.9 Hz, H-1), 1.11 (3H, t, J = 7.5 Hz, 
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H-5), 2.17 (2H, q, J = 7.5 Hz, H-4), 2.39 (6H, s, H-6), 3.62 (1H, m, H-2) ppm; 13C NMR (75.5 
MHz, CDCl3): δ 11.9 (C-5), 20.4 (C-1), 21.8 (C-4), 34.6 (C-2), 47.5 (C-6), 177.5 (C-3) ppm; 
MS (ESI) m/z: 143 [M + H]+. 
 
(Z)-2-(butan-2-ylidene)-1,1-dimethylhydrazine 208 
Prepared following the general procedure outlined above using 2-butanone 
and N,N-dimethylhydrazine. The crude product was purified using kugelrohr 
distillation to give the title compound 208 as a clear oil (6.93 g, 61%). 
Spectroscopic characteristics were consistent with previously reported data.258 
Mixture of isomers: 4 : 1. 
Major: 1H NMR (300 MHz, CDCl3): δ 1.08 (3H, t, J = 7.5 Hz, H-1), 1.94 (3H, s, H-4), 2.21 
(2H, q, J = 7.5 Hz, H-2), 2.43 (6H, s, H-5) ppm; 13C NMR (75.5 MHz, CDCl3): δ 11.5 (C-1), 
15.9 (C-4), 32.2 (C-2), 47.0 (C-5), 168.8 (C-3) ppm; Minor: 1H NMR (300 MHz, CDCl3): δ 
1.09 (3H, t, J = 7.6 Hz, H-1), 1.92 (3H, s, H-4), 2.41 (6H, s, H-5), 2.46 (2H, q, J = 7.6 Hz, H-
2) ppm; 13C NMR (75.5 MHz, CDCl3): δ 10.9 (C-1), 22.1 (C-4), 24.5 (C-2), 47.5 (C-5), 170.3 
(C-3) ppm; MS (ESI) m/z: 115 [M + H]+. 
 
(E)-1,1-dimethyl-2-(1-phenylpropylidene)hydrazine 209 
Prepared following the general procedure outlined above using 
propiophenone and N,N-dimethylhydrazine. The crude product was 
purified using kugelrohr distillation to give the title compound 209 as a 
clear oil (4.73 g, 90%). 
Spectroscopic characteristics were consistent with previously reported 
data.259 
Mixture of isomers: 4 : 1. 
Major: 1H NMR (300 MHz, CDCl3): δ 1.07 (3H, t, J = 7.7 Hz, H-9), 2.56 (6H, s, H-10), 2.90 
(2H, q, J = 7.7 Hz, H-8), 7.32-7.39 (3H, m, Ar-H), 7.61-7.69 (2H, m, Ar-H) ppm; 13C NMR 
(75.5 MHz, CDCl3): δ 11.9 (C-9), 21.8 (C-8), 47.9 (C-10), 127.0 (2 x Ar-CH), 128.3 (2 x Ar-
CH), 129.2 (Ar-CH), 137.8 (C-6), 169.5 (C-7) ppm; Minor: 1H NMR (300 MHz, CDCl3): δ 
1.02 (3H, t, J = 7.5 Hz, H-9), 2.36 (6H, s, H-10), 2.52 (2H, q, J = 7.5 Hz, H-8), 7.32-7.69 (5H, 
m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 11.7 (C-9), 32.5 (C-8), 47.2 (C-10), 127.0 (Ar-
CH), 127.8 (Ar-CH), 127.9 (Ar-CH), 128.3 (Ar-CH), 128.5 (Ar-CH), 132.9 (C-6), 165.2 (C-7) 
ppm; MS (ESI) m/z: 177 [M + H]+. 
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(E)-2-(1-(4-methoxyphenyl)propylidene)-1,1-dimethylhydrazine 210 
Prepared following the general procedure outlined above using 4-
methoxypropiophenone and N,N-dimethylhydrazine. The crude 
product was purified using kugelrohr distillation to give the title 
compound 210 as a clear oil (2.75 g, 89%). 
Mixture of isomers: 10 : 1. 
IR (NaCl) ?̅?max: 2952 (C-H stretch, s), 1606 (C=N stretch, s), 1512 (Aromatic C=C stretch, s), 
1464 (C-H bending, s) cm-1; Major: 1H NMR (300 MHz, CDCl3): δ 1.08 (3H, t, J = 7.6 Hz, H-
9), 2.54 (6H, s, H-10), 2.88 (2H, q, J = 7.6 Hz, H-8), 3.82 (3H, s, OMe), 6.85-6.93 (2H, m, Ar-
H), 7.66-7.69 (2H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 12.1 (C-9), 21.5 (C-8), 47.9 
(C-10), 55.3 (OMe), 116.7 (2 x Ar-CH), 128.4 (2 x Ar-CH), 130.2 (Ar-C), 160.6 (Ar-C), 169.1 
(C-7) ppm; Minor: 1H NMR (300 MHz, CDCl3): δ 1.01 (3H, t, J = 7.5 Hz, H-9), 2.36 (6H, s, 
H-10), 2.51 (2H, q, J = 7.5 Hz, H-8), 3.86 (3H, s, OMe), 7.32-7.39 (2H, m, Ar-H), 7.91-7.99 
(2H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 11.9 (C-9), 31.4 (C-8), 47.0 (C-10), 55.4 
(OMe), 113.5 (2 x Ar-CH), 128.7 (2 x Ar-CH), 130.2 (Ar-C), 160.6 (Ar-C), 166.7 (C-7) ppm; 
HRMS (ESI) m/z calcd for C12H19N2O [M + H]
+: 207.1497, found 207.1492. 
 
 (E)-1,1-dimethyl-2-(5-methylhexan-3-ylidene)hydrazine 211 
To diisopropylamine (27.5 mmol, 3.88 mL) in anhydrous THF, under N2 
atmosphere, was added n-BuLi (1.5 M, 30 mmol, 25 mL) at 0°C. The 
mixture was allowed to stir at 0°C for 30 min. The reaction mixture was 
cooled to -78°C, (Z)-2-(butan-2-ylidene)-1,1-dimethylhydrazine 208 was 
added dropwise, it was allowed warm to room temperature and allowed to 
stir for 6 h. The 2-iodopropane (5.1 g, 30 mmol) was added dropwise and the reaction was 
allowed warm to room temperature overnight. The reaction was quenched with saturated NH4Cl 
(1.5 mL), Et2O (10 mL) and NH4Cl (10 mL) were added and the mixture was extracted with 
Et2O (3 x 30 mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, 
and concentrated under reduced pressure. The crude product was purified using column 
chromatography (10 : 1, hexane : Et2O, 4% Et3N) on silica gel to give the title compound 211 
as a clear oil (1.42 g, 37%). 
The crude NMR showed a mixture of isomers: 8 : 1. However the compound rapidly 
interconverts over time and a mixture of isomers: 1 : 1 was observed upon purification. 
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Rf = 0.32 (4 : 1, hexane : Et2O). IR (NaCl) ?̅?max: 2957 (C-H stretch, s), 1633 (C=N stretch, s), 
1464 (C-H bending, s) cm-1; Major: 1H NMR (300 MHz, CDCl3): δ 0.92 (6H, d, J = 6.6 Hz, 
H-1), 1.07 (3H, t, J = 7.6 Hz, H-6), 1.85-2.05 (1H, m, H-2), 2.22 (2H, q, J = 7.6 Hz, H-5), 2.34-
2.39 (2H, d, J = 7.6 Hz, H-3), 2.37 (6H, s, H-7) ppm; 13C NMR (75.5 MHz, CDCl3): δ 11.9 (C-
6), 22.6 (C-1), 25.8 (C-2), 29.3 (C-5), 37.9 (C-3), 47.3 (C-7), 173.2 (C-4) ppm; Minor: 1H 
NMR (300 MHz, CDCl3): δ 0.91 (6H, d, J = 6.5 Hz, H-1), 1.07 (3H, t, J = 7.6 Hz, H-6), 1.85-
2.05 (1H, m, H-2), 2.10 (2H, d, J = 7.6 Hz, H-3), 2.38-2.48 (2H, m, H-5), 2.41 (6H, s, H-7) 
ppm; 13C NMR (75.5 MHz, CDCl3): δ 11.2 (C-6), 22.4 (C-1), 23.1 (C-5), 26.2 (C-2), 44.4 (C-
3), 47.6 (C-7), 172.9 (C-4) ppm (Note: Exact structural assignment confirmed using COSY and 
HSQC); HRMS (ESI) m/z calcd for C9H21N2 [M + H]
+: 157.1705, found 157.1698. 
  
Chapter 5    Experimental 
183 
 
5.6 Asymmetric α-Alkylation via Intermolecular Chirality 
Transfer 
5.6.1 Temperature, Solvent and Base Variations 
General Procedure for the Asymmetric Alkylation using Intermolecular Chirality 
Transfer Methodology 
To a schlenk tube, under a N2 atmosphere, were added anhydrous solvent (1 mL/mmol of 
hydrazone) and (-)-sparteine (-)-sp 100 or (+)-sparteine (+)-sp 100 (1.2 equiv.) at room 
temperature. sec-BuLi (1.4 M, 1.1 equiv.) was added at -78°C and allowed to stir for 30 min. 
Hydrazone 203 (1 equiv.) was added dropwise at -78°C, allowed warm to room temperature 
and allowed to stir for 6 h at deprotonation temperature. The reaction was cooled to 
alkylation temperature and electrophile (1.2 equiv.) was added dropwise. The mixture was 
allowed to stir at alkylation temperature for 22 h. 
At alkylation temperature, saturated NH4Cl (0.5 mL) was added and the mixture allowed 
warm to room temperature. Et2O (30 mL) was added and the mixture was washed with NH4Cl 
(3 x 10 mL). The organic layer was dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure to afford the crude hydrazone. The crude hydrazone was used in the 
next step without further purification. 
Hydrazone cleavage 
The resulting oil was hydrolysed by addition of Et2O (5 mL), followed by 4 M HCl (0.5 mL) 
and allowed to stir vigorously, until all starting material had reacted (determined by TLC 
analysis (5 : 1, hexane : Et2O)). Water (5 mL) was added and the mixture extracted with Et2O 
(3 x 30 mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The crude product was purified using column 
chromatography on silica gel to give the pure ketone. 
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aIsolated yield is over two steps. 
Table 5.6.1 Temperature variations. 
 
aIsolated yield is over two steps. 
Table 5.6.2 Solvent Investigations. 
 
   aIsolated yield is over two steps. 
Table 5.6.3 Alkyl lithium reagent. 
  
Ligand Electrophile Deprot. 
Temp. 
Alkyl. 
Temp. 
Solvent Yielda Ketone er R : S % ee 
(-)-sp 100 BnBr RT -78°C to RT Toluene 53% (S)-36 20 : 80 60% 
(-)-sp 100 BnBr RT -70°C Toluene no reaction occurred 
(-)-sp 100 BnBr RT -55°C Toluene 50% (S)-36 28 : 72 44% 
(-)-sp 100 BnBr RT -30°C Toluene 57% (S)-36 24 : 76 52% 
(-)-sp 100 BnBr RT 0°C Toluene 50% (S)-36 27 : 73 46% 
(-)-sp 100 BnBr RT RT Toluene 55% (S)-36 29 : 71 42% 
(-)-sp 100 BnBr RT 70°C Toluene 53% (S)-36 30 : 70 40% 
(-)-sp 100 BnBr 32°C -30°C Toluene 45% (S)-36 23 : 77 54% 
(+)-sp 100 BnBr 40°C -30°C Toluene 32% (R)-36 70 : 30 40% 
(-)-sp 100 BnBr 40°C 40°C Toluene 52% (S)-36 33 : 67 34% 
(-)-sp 100 BnBr 70°C 70°C Toluene 54% (S)-36 36 : 64 28% 
Ligand Electrophile Deprot. 
Temp. 
Alkyl. 
Temp. 
Solvent Yielda Ketone er R : S % ee 
(-)-sp 100 n-PeI RT -30°C Toluene 46% (S)-188 17 : 83 66% 
(+)-sp 100 n-PeI RT -30°C Et2O 43% (R)-188 78 : 22 56% 
(-)-sp 100 n-PeI RT -30°C MTBE 32% (S)-188 33 : 67 34% 
(-)-sp 100 BnBr RT -30°C Toluene 57% (S)-36 24 : 76 52% 
(-)-sp 100 BnBr RT -30°C Cumene 62% (S)-36 25 : 75 50% 
(-)-sp 100 BnBr RT -30°C Benzene 45% (S)-36 31 : 69 38% 
(-)-sp 100 BnBr RT -30°C Cyclohexane 23% (S)-36 31 : 69 38% 
(-)-sp 100 BnBr RT -30°C THF 40% (S)-36 Racemic 
Ligand Electrophile Deprot. 
Temp. 
Alkyl. 
Temp. 
Alkyl Lithium 
Reagent 
Yielda Ketone er R : S % ee 
(-)-sp 100 BnBr RT -30°C PhLi 16% (S)-36 20 : 80 60% 
(-)-sp 100 BnBr RT -30°C n-BuLi 44% (S)-36 28 : 72 44% 
(-)-sp 100 BnBr RT -30°C sec-BuLi 57% (S)-36 24 : 76 52% 
(-)-sp 100 BnBr RT -30°C t-BuLi 35% (S)-36 24 : 76 52% 
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5.6.2 Substrate Investigations 
General Procedure for the Asymmetric Alkylation using Intermolecular Chirality 
Transfer Methodology 
To a schlenk tube, under a N2 atmosphere, were added anhydrous toluene (1 mL/mmol of 
hydrazone) and (-)-sparteine (-)-sp 100 or (+)-sparteine (+)-sp 100 (1.2 equiv.) at room 
temperature. sec-BuLi (1.4 M, 1.1 equiv.) was added at -78°C and allowed to stir for 30 min. 
Hydrazone (1 equiv.) was added dropwise at -78°C, allowed warm to room temperature and 
allowed to stir at room temperature for 6 h. The reaction was cooled to -30°C and electrophile 
(1.2 equiv.) was added dropwise. The mixture was allowed to stir at -30°C for 22 h. 
At -30°C, saturated NH4Cl (0.5 mL) was added and the mixture allowed warm to room 
temperature. Et2O (30 mL) was added and the mixture was washed with NH4Cl (3 x 10 mL). 
The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to afford the crude hydrazone. The crude hydrazone was used in the next step without 
further purification. 
Hydrazone cleavage 
The resulting oil was hydrolysed by addition of Et2O (5 mL), followed by 4 M HCl (0.5 mL) 
and allowed to stir vigorously, until all starting material had reacted (determined by TLC 
analysis (5 : 1, hexane : Et2O)). Water (5 mL) was added and the mixture extracted with Et2O 
(3 x 30 mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The crude product was purified using column 
chromatography on silica gel to give the pure ketone. 
 
(S)-2-methyl-1-phenylpentan-3-one (S)-36 
Prepared following the general procedure outlined above using hydrazone 
203 and benzyl bromide. The crude product was purified using column 
chromatography (10 : 1, hexane : Et2O) on silica gel to give the title 
compound (S)-36 as a clear oil (0.098 g, 57% over two steps, 52% ee). 
[α]23
𝐷
 + 31.7 (c 1.1, CHCl3) (lit.
192 [α]23
𝐷
 + 70.9 (c 1.1, CHCl3, for 99% ee, 
S-enantiomer)). 
Spectroscopic characteristics were consistent with that of 36 shown earlier and with previously 
reported data.192 
Enantioselectivity was determined by GC analysis: 24 : 76 er, tR = 7.4 (R-enantiomer) and 7.8 
min (S-enantiomer) (120°C hold for 10 min, ramp 10°C/min to 140°C, hold for 5 min). 
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(R)-2-methyl-1-(4-(trifluoromethyl)phenyl)pentan-3-one (R)-183 
Prepared following the general procedure outlined above using 
hydrazone 203 and 4-trifluoromethylbenzyl bromide. The crude 
product was purified using column chromatography (15 : 1, hexane 
: Et2O) on silica gel to give the title compound (R)-183 as a clear 
oil (0.112 g, 46% over two steps, 32% ee). 
[α]20
𝐷
 – 17.4 (c 1.11, Et2O).  
*Note: opposite stereochemistry due to the use of (+)-sparteine (+)-sp 100 used as chiral ligand. 
Spectroscopic characteristics were consistent with that of 183 shown earlier and with previously 
reported data.253 
Enantioselectivity was determined by GC analysis: 66 : 34 er, tR = 10.4 (R-enantiomer) and 
12.1 min (S-enantiomer) (120°C hold for 10 min, ramp 5°C/min to 140°C, hold for 5 min). 
 
(S)-(E)-4-methyl-7-phenylhept-6-en-3-one (S)-184 
Prepared following the general procedure outlined above using 
hydrazone 203 and 3-bromo-1-phenyl-1-propene. The crude product 
was purified using column chromatography (15 : 1, hexane : Et2O) on 
silica gel to give the title compound (S)-184 as a clear oil (0.061 g, 
30% over two steps, 58% ee). 
[α]20
𝐷
 + 9.7 (c 0.36, Et2O). 
Spectroscopic characteristics were consistent with that of 184 shown earlier and with previously 
reported data.254 
Enantioselectivity was determined by GC analysis: 21 : 79 er, tR = 25.2 (R-enantiomer) and 
26.5 min (S-enantiomer) (130°C hold for 30 min, ramp 10°C/min to 140°C, hold for 5 min). 
 
(S)-(E)-4-methyloct-6-en-3-one (S)-185 
Prepared following the general procedure outlined above using hydrazone 
203 and crotyl bromide. The crude product was purified using column 
chromatography (50 : 1, hexane : Et2O) on silica gel to give the title 
compound (S)-185 as a clear oil (0.275 g, 20% over two steps, 30% ee). 
[α]20
𝐷
 + 3.6 (c 0.7, CHCl3) (lit.
197 [α]20
𝐷
 + 23.9 (c 1.07, CHCl3, for 98% ee, S-
enantiomer)). 
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Spectroscopic characteristics were consistent with that of 185 shown earlier and with previously 
reported data.197 
Enantioselectivity was determined by GC analysis: 35 : 65 er, tR = 4.0 (R-enantiomer) and 4.4 
min (S-enantiomer) (90°C hold for 5 min, ramp 10°C/min to 140°C, hold for 5 min). 
 
(S)-1-(4-bromophenyl)-2-methylpentan-3-one (S)-186 
Prepared following the general procedure outlined above using 
hydrazone 203 and 4-bromobenzyl bromide. The crude product was 
purified using column chromatography (10 : 1, hexane : Et2O) on 
silica gel to give the title compound (S)-186 as a clear oil (0.070 g, 
28% over two steps, 40% ee). 
[α]20
𝐷
 + 1.2 (c 0.33, Et2O). 
Spectroscopic characteristics were consistent with that of 186 shown earlier and with previously 
reported data.35 
Enantioselectivity was determined by GC analysis: 30 : 70 er, tR = 15.7 (R-enantiomer) and 
16.7 min (S-enantiomer) (140°C hold for 20 min). 
 
(S)-2-methyl-1-p-tolylpentan-3-one (S)-187 
Prepared following the general procedure outlined above using 
hydrazone 203 and 4-methylbenzyl bromide. The crude product was 
purified using column chromatography (20 : 1, hexane : Et2O) on 
silica gel to give the title compound (S)-187 as a clear oil (0.094 g, 
50% over two steps, 46% ee). 
[α]20
𝐷
 + 28.7 (c 0.204, Et2O). 
Spectroscopic characteristics were consistent with that of 187 shown earlier. 
Enantioselectivity was determined by GC analysis: 27 : 73 er, tR = 12.2 (R-enantiomer) and 
12.8 min (S-enantiomer) (120°C hold for 5 min, ramp 10°C/min to 140°C, hold for 5 min). 
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(S)-4-methylnonan-3-one (S)-188 
Prepared following the general procedure outlined above using 
hydrazone 203 and 1-iodopentane. The crude product was purified using 
column chromatography (10 : 1, hexane : Et2O) on silica gel to give the 
title compound (S)-188 as a clear oil (0.07 g, 46% over two steps, 66% 
ee). 
[α]20
𝐷
 + 4.9 (c 0.528, Et2O). 
Spectroscopic characteristics were consistent with that of 188 shown earlier. 
Enantioselectivity was determined by GC analysis: 17 : 83 er, tR = 3.6 (R-enantiomer) and 3.8 
min (S-enantiomer) (105°C hold for 10 min, ramp 10°C/min to 140°C, hold for 5 min). 
 
(S)-1-(4-fluorophenyl)-2-methylpentan-3-one (S)-213 
Prepared following the general procedure outlined above using 
hydrazone 203 and 4-fluorobenzyl bromide. The crude product was 
purified using column chromatography (10 : 1, hexane : Et2O) on 
silica gel to give the title compound (S)-213 as a clear oil (0.049 g, 
26% over two steps, 40% ee). 
Spectroscopic characteristics were consistent with previously reported data.253 
Rf = 0.42 (5 : 1, hexane : Et2O). [α]20
𝐷
 + 7.27 (c 0.22, Et2O). 
1H NMR (300 MHz, CDCl3): δ 0.96 
(3H, t, J = 7.3 Hz, H-1), 1.07 (3H, d, J = 6.9 Hz, H-5), 2.24 (1H, dq, J = 17.9, 7.2 Hz, H-2), 
2.44 (1H, dq, J = 17.9, 7.2 Hz, H-2), 2.54 (1H, dd, J = 7.0, 13.3 Hz, H-6), 2.73-2.87 (1H, m, H-
4), 2.94 (1H, dd, J = 7.4, 13.3 Hz, H-6), 6.89-7.01 (2H, m, Ar-H), 7.03-7.14 (2H, m, Ar-H) 
ppm; 13C NMR (75.5 MHz, CDCl3): δ 7.6 (C-1), 16.7 (C-5), 35.2 (C-2), 38.4 (C-6), 48.0 (C-4), 
115.1 (d, 2JC-F = 21.2 Hz, C-9, C-11), 130.3 (d, 
3JC-F = 7.8 Hz, C-8, C-12), 135.5 (d, 
4JC-F = 3.3 
Hz, C-7), 161.5 (d, JC-F = 244.1 Hz, C-10), 214.6 (C-3) ppm; MS (ESI)
 m/z: 194 [M + H]+. 
Enantioselectivity was determined by GC analysis: 30 : 70 er, tR = 8.8 (R-enantiomer) and 9.8 
min (S-enantiomer) (120°C hold for 10 min, ramp 10°C/min to 140°C, hold for 5 min). 
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(R)-2-methyl-1-(o-tolyl)pentan-3-one (S)-216 
Prepared following the general procedure outlined above using 
hydrazone 203 and 2-methylbenzyl bromide, on 5 mmol scale. The 
crude product was purified using column chromatography (10 : 1, 
hexane : Et2O) on silica gel to give the title compound (S)-216 as a clear 
oil (0.52 g, 55% over two steps, 52% ee). *Note: opposite 
stereochemistry due to the use of (+)-sparteine (+)-sp 100 used as chiral ligand. 
Spectroscopic characteristics were consistent with previously reported data.253 
Rf = 0.55 (5 : 1, hexane : Et2O). [α]20
𝐷
 – 45.9 (c 1, Et2O). 1H NMR (300 MHz, CDCl3): δ 0.97 
(3H, t, J = 7.3 Hz, H-1), 1.09 (3H, d, J = 6.9 Hz, H-5), 2.23 (1H, dq, J = 17.9, 7.3 Hz, H-2), 
2.31 (3H, s, H-13), 2.42 (1H, dq, J = 17.9, 7.3 Hz, H-2), 2.57 (1H, dd, J = 6.9, 13.4 Hz, H-6), 
2.77-2.90 (1H, m, H-4), 2.97 (1H, dd, J = 6.9, 13.4 Hz, H-6), 6.97-7.19 (4H, m, Ar-H) ppm; 
13C NMR (75.5 MHz, CDCl3): δ 7.6 (C-1), 16.6 (C-5), 19.4 (C-13), 35.2 (C-2), 36.5 (C-6), 46.4 
(C-4), 125.9 (Ar-CH), 126.4 (Ar-CH), 129.7 (Ar-CH), 130.4 (Ar-CH), 136.0 (Ar-C), 138.0 (Ar-
C), 214.8 (C-3) ppm (Note: Exact structural assignment confirmed using COSY and HSQC); 
MS (ESI) m/z: 191 [M + H]+. 
Enantioselectivity was determined by GC analysis: 76 : 24 er, tR = 11.4 (R-enantiomer) and 
11.9 min (S-enantiomer) (120°C hold for 20 min, ramp 10°C/min to 140°C, hold for 5 min). 
 
(S)-1-(4-methoxyphenyl)-2-methylpentan-3-one (S)-215 
Prepared following the general procedure outlined above using 
hydrazone 203 and 4-methoxybenzyl bromide. The crude product 
was purified using column chromatography (10 : 1, hexane : Et2O) 
on silica gel to give the title compound (S)-215 as a clear oil (0.067 
g, 33% over two steps, 34% ee). 
Spectroscopic characteristics were consistent with previously reported data.253 
Rf = 0.41 (4 : 1, hexane : Et2O). [α]20
𝐷
 + 17.1 (c 0.88, CH2Cl2) (lit.
260 [α]20
𝐷
 + 61.1 (c 2, CH2Cl2, 
for 97.5% ee, configuration not specified)). 1H NMR (300 MHz, CDCl3): δ 0.96 (3H, t, J = 7.3 
Hz, H-1), 1.07 (3H, d, J = 7.1 Hz, H-5), 2.25 (1H, dq, J = 17.9, 7.3 Hz, H-2), 2.42 (1H, dq, J = 
17.9, 7.3 Hz, H-2), 2.51 (1H, dd, J = 6.9, 13.1 Hz, H-6), 2.71-2.86 (1H, m, H-4), 2.90 (1H, dd, 
J = 7.2, 13.1 Hz, H-6), 3.78 (3H, s, OMe), 6.74-6.85 (2H, m, Ar-H), 7.00-7.10 (2H, m, Ar-H) 
ppm; 13C NMR (75.5 MHz, CDCl3): δ 7.6 (C-1), 16.6 (C-5), 35.2 (C-2), 38.5 (C-6), 48.1 (C-4), 
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55.2 (OMe), 113.8 (2 x Ar-CH), 129.9 (2 x Ar-CH), 131.9 (Ar-C), 158.0 (Ar-C), 214.9 (C-3) 
ppm; MS (ESI) m/z: 207 [M + H]+. 
Enantioselectivity was determined by GC analysis: 33 : 67 er, tR = 23.2 (R-enantiomer) and 
23.6 min (S-enantiomer) (120°C hold for 25 min, ramp 10°C/min to 140°C, hold for 5 min). 
 
(R)-1-(4-(tert-butyl)phenyl)-2-methylpentan-3-one (S)-214 
Prepared following the general procedure outlined above using 
hydrazone 203 and 4-tert-butylbenzyl bromide. The crude product 
was purified using column chromatography (10 : 1, hexane : Et2O) 
on silica gel to give the title compound (S)-214 as a clear oil (0.143 
g, 62% over two steps, 42% ee). 
*Note: opposite stereochemistry due to the use of (+)-sparteine (+)-sp 100 used as chiral ligand. 
Spectroscopic characteristics were consistent with previously reported data.253 
Rf = 0.45 (5 : 1, hexane : Et2O). [α]20
𝐷
 – 25.1 (c 1, Et2O). 1H NMR (300 MHz, CDCl3): δ 0.98 
(3H, t, J = 7.3 Hz, H-1), 1.07 (3H, d, J = 6.9 Hz, H-5), 1.29 (9H, s, H-14), 2.28 (1H, dq, J = 
17.9, 7.3 Hz, H-2), 2.43 (1H, dq, J = 17.9, 7.3 Hz, H-2), 2.52 (1H, dd, J = 6.9, 13.4 Hz, H-6), 
2.74-2.89 (1H, m, H-4), 2.95 (1H, dd, J = 6.9, 13.4 Hz, H-6), 7.06 (2H, d, J = 8.2 Hz, Ar-H), 
7.28 (2H, d, J = 8.2 Hz, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 7.6 (C-1), 16.6 (C-5), 
31.4 (C-14), 34.4 (C-13), 34.9 (C-2) 38.7 (C-6), 47.9 (C-4), 125.3 (2 x Ar-CH), 128.6 (2 x Ar-
CH), 136.7 (Ar-C), 149.0 (Ar-C), 214.8 (C-3) ppm (Note: Exact structural assignment 
confirmed using COSY and HSQC); MS (ESI) m/z: 233 [M + H]+. 
Enantioselectivity was determined by GC analysis: 71 : 29 er, tR = 12.9 (R-enantiomer) and 
13.2 min (S-enantiomer) (140°C hold for 20 min). 
 
(S)-2-methyl-1-(4-nitrophenyl)pentan-3-one (S)-212 
Prepared following the general procedure outlined above using 
hydrazone 203 and 4-nitrobenzyl bromide. The crude product was 
purified using column chromatography (10 : 1, hexane : Et2O) on 
silica gel to give the title compound (S)-212 as a clear oil (0.048 g, 
22% over two steps, 20% ee).  
Rf = 0.32 (4 : 1, hexane : Et2O). [α]20
𝐷
 + 0.658 (c 0.38, Et2O). IR (NaCl) ?̅?max: 2966-2930 (C-H 
stretch, s), 1712 (C=O stretch, s), 1518 (Aromatic C=C stretch, s), 1345 (N-O stretch, s) cm-1; 
1H NMR (300 MHz, CDCl3): δ 0.91 (3H, t, J = 7.2 Hz, H-1), 1.06 (3H, d, J = 7.0 Hz, H-5), 2.19 
Chapter 5    Experimental 
191 
 
(1H, dq, J = 17.9, 7.2 Hz, H-2), 2.43 (1H, dq, J = 17.9, 7.2 Hz, H-2), 2.60 (1H, dd, J = 7.0, 13.4 
Hz, H-6), 2.74-2.87 (1H, m, H-4), 3.03 (1H, dd, J = 7.0, 13.3 Hz, H-6), 7.02-7.28 (2H, m, Ar-
H), 8.02-8.12 (2H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 6.5 (C-1), 15.7 (C-5), 34.0 
(C-2), 37.6 (C-6), 46.4 (C-4), 122.7 (2 x Ar-CH), 128.8 (2 x Ar-CH), 145.6 (Ar-C), 145.9 (Ar-
C), 212.5 (C-3) ppm; HRMS (ESI) m/z calcd for C12H14NO3 [M - H]
-: 220.0974, found 
220.0972. 
Enantioselectivity was determined by GC analysis: 40 : 60 er, tR = 79.0 (R-enantiomer) and 
93.1 min (S-enantiomer) (140°C hold for 100 min). 
 
(R)-2,4-dimethyl-1-phenylpentan-3-one (R)-189 
Prepared following the general procedure outlined above using 
hydrazone 207 and benzyl bromide. The crude product was purified 
using column chromatography (10 : 1, hexane : Et2O) on silica gel to 
give the title compound (R)-189 as a clear oil (0.089 g, 47% over two 
steps, 8% ee). *Note: opposite stereochemistry due to the use of (+)-
sparteine (+)-sp 100 used as chiral ligand. 
 [α]20
𝐷
 – 6.2 (c 0.86, CHCl3) (lit.255 [α]20
𝐷
 – 83.8 (c 1.07, CHCl3 for > 99% ee, R-enantiomer)).  
Spectroscopic characteristics were consistent with that of 189 shown earlier and with previously 
reported data.255 
Enantioselectivity was determined by GC analysis: 54:46 er, tR = 10.8 (R-enantiomer) and 11.1 
min (S-enantiomer) (110°C hold for 20 min, ramp 10°C/min to 140°C, hold for 5 min). 
 
2-methyl-1-phenylbutan-1-one 190 
Prepared following the general procedure outlined above using 
hydrazone 209 and ethyl iodide. The crude product was purified using 
column chromatography (10 : 1, hexane : Et2O) on silica gel to give the 
title compound 190 as a clear oil (0.090 g, 56% over two steps, racemic).  
Spectroscopic characteristics were consistent with that of 190 shown earlier and with previously 
reported data.256 
Enantioselectivity was determined by GC analysis: 50:50 er, tR = 14.0 and 14.9 min (100°C 
hold for 20 min, ramp 5°C/min to 140°C, hold for 5 min). 
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2-methyl-1,3-diphenylpropan-1-one 191 
Prepared following the general procedure outlined above using 
hydrazone 209 and benzyl bromide. The crude product was purified 
using column chromatography (10 : 1, hexane : Et2O) on silica gel 
to give the title compound 191 as a clear oil (0.139 g, 62% over two 
steps, racemic). 
Spectroscopic characteristics were consistent with that of 191 shown earlier and with previously 
reported data.256 
Enantioselectivity was determined by GC analysis: 50:50 er, tR = 53.2 and 57.2 min (90°C hold 
for 5 min, ramp 10°C/min to 140°C, hold for 5 min). 
 
1-(4-methoxyphenyl)-2-methyl-3-phenylpropan-1-one 218 
Prepared following the general procedure outlined above using 
hydrazone 210 and benzyl bromide. The crude product was 
purified using column chromatography (10 : 1, hexane : Et2O) 
on silica gel to give the title compound 218 as a clear oil (0.129 
g, 51% over two steps, racemic). 
Spectroscopic characteristics were consistent with previously reported data.256 
Rf = 0.41 (4 : 1, hexane : Et2O). 
1H NMR (300 MHz, CDCl3): δ 1.18 (3H, d, J = 6.8 Hz, H-9), 
2.67 (1H, dd, J = 7.8, 13.7 Hz, H-10), 3.14 (1H, dd, J = 6.3, 13.7 Hz, H-10), 3.69 (1H, m, H-
8), 3.86 (3H, s, OMe), 6.86-6.99 (2H, m, Ar-H), 7.09-7.34 (5H, m, Ar-H), 7.87-7.97 (2H, m, 
Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 17.6 (C-9), 39.5 (C-10), 42.3 (C-8), 55.5 (OMe), 
113.8 (2 x Ar-CH), 126.1 (Ar-CH), 128.3 (2 x Ar-CH), 129.1 (2 x Ar-CH), 129.5 (Ar-C), 130.6 
(2 x Ar-CH), 140.1 (Ar-C), 163.4 (Ar-C), 202.3 (C-7) ppm; MS (ESI) m/z: 255 [M + H]+. 
Enantioselectivity was determined by GC analysis: 50:50 er, tR = 200.3 and 202.6 min (140°C 
hold for 240 min). 
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(R)-2,5,8-trimethylnon-7-en-4-one (R)-219 
Prepared following the general procedure outlined above using 
hydrazone 211 and 3,3-dimethylallyl bromide. The crude product was 
purified using column chromatography (10 : 1, hexane : Et2O) on silica 
gel to give the title compound (R)-219 as a clear oil (0.050 g, 28% 
over two steps, 30% ee). *Note: opposite stereochemistry due to the 
use of (+)-sparteine (+)-sp 100 used as chiral ligand. 
Spectroscopic characteristics were consistent with previously reported data.181 
Rf = 0.58 (5 : 1, hexane : Et2O). [α]25
𝐷
 – 3.3 (c 1.3, CHCl3) (lit.181 [α]25
𝐷
 – 26.9 (c 1.3, CHCl3, for 
92% ee, R-enantiomer)). 1H NMR (300 MHz, CDCl3): δ 0.90 (6H, d, J = 6.6 Hz, H-1), 1.03 
(3H, d, J = 6.9 Hz, H-6), 1.64 (3H, s, H-10), 1.68 (3H, s, H-11), 1.95-2.08 (1H, m, H-7), 2.09-
2.22 (1H, m, H-2), 2.22-2.37 (3H, m, H-7, H-3), 2.43-2.58 (1H, m, H-5), 5.03 (1H, t, J = 7.4 
Hz, H-8) ppm; 13C NMR (75.5 MHz, CDCl3): δ 15.9 (C-6), 17.8 (C-10), 22.5, 22.6 (C-1), 24.2 
(C-2), 25.7 (C-11), 31.4 (C-7), 46.8 (C-5), 50.5 (C-3), 121.6 (C-8), 133.4 (C-9), 214.3 (C-4) 
ppm (Note: Exact structural assignment confirmed using COSY and HSQC); MS (ESI) m/z: 
183 [M + H]+. 
GC analysis: 65:35 er, tR = 27.1 (R-enantiomer) and 27.5 min (S-enantiomer) (75°C hold for 30 
min, ramp 10°C/min to 140°C, hold for 5 min). 
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aIsolated yield is over two steps. bAbsolute configuration assigned based on the optical rotation data of (S)-36 and inferred for the others 
Table 5.6.4 Summary of Substrate Scope. 
 
  
Ligand Hydrazone Electrophile Yielda Ketone er R : Sb % ee 
(-)-sp 100 203 benzyl bromide 57% (S)-36 24 : 76 52% 
(+)-sp 100 203 4-trifluoromethyl benzyl bromide 46% (R)-183 66 : 34 32% 
(-)-sp 100 203 3-bromo-1-phenyl-1-propene 30% (S)-184 21 : 79 58% 
(-)-sp 100 203 crotyl bromide 20% (S)-185 35 : 65 30% 
(-)-sp 100 203 4-bromobenzyl bromide 28% (S)-186 30 : 70 40% 
(-)-sp 100 203 4-methylbenzyl bromide 50% (S)-187 27 : 73 46% 
(-)-sp 100 203 1-iodopentane 46% (S)-188 17 : 83 66% 
(-)-sp 100 203 4-fluorobenzyl bromide 26% (S)-213 30 : 70 40% 
(+)-sp 100 203 2-methylbenzyl bromide 54% (R)-216 76 : 24 52% 
(-)-sp 100 203 4-methoxybenzyl bromide 33% (S)-215 33 : 67 34% 
(+)-sp 100 203 4-tert-butylbenzyl bromide 62% (R)-214 71 : 29 42% 
(-)-sp 100 203 4-nitrobenzyl bromide 22% (S)-212 40 : 60 20% 
(+)-sp 100 207 benzyl bromide 48% (R)-189 54 : 46 8% 
(-)-sp 100 209 ethyl iodide 56% 190 Racemic 
(-)-sp 100 209 benzyl bromide 62% 191 Racemic 
(-)-sp 100 210 benzyl bromide 51% 218 Racemic 
(+)-sp 100 211 3,3-dimethylallyl bromide 28% (R)-219   65 : 35 30% 
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5.6.3 Procedures for Work-up Investigations 
(R)-1-(4-(tert-butyl)phenyl)-2-methylpentan-3-one (R)-214 
To a schlenk tube, under a N2 atmosphere, were added anhydrous 
toluene (5 mL) and (+)-sparteine (+)-sp 100 (0.28 g, 1.2 mmol) at 
room temperature. sec-BuLi (1.4 M, 1.1 mmol, 0.78 mL) was 
added at -78°C and allowed to stir for 30 min. Hydrazone 203 
(0.128 g, 1 mmol) was added dropwise at -78°C, allowed warm to 
room temperature and allowed to stir at room temperature for 6 h. The reaction was cooled to -
30°C and 4-tert-butylbenzyl bromide (0.27 g, 1.2 mmol) was added dropwise. The mixture was 
allowed to stir at -30°C for 22 h. 
Work-up: The reaction was worked up using one of the methods detailed below. 
 
Work-up A 
At -30°C, saturated NH4Cl (0.5 mL) was added and the mixture allowed warm to room 
temperature. Et2O (30 mL) was added and the mixture was washed with NH4Cl (3 x 10 mL). 
The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure. The crude hydrazone was subjected to the HCl hydrolysis method (see method A in 
section 5.6.4). The crude product was purified using column chromatography (10 : 1, hexane : 
Et2O) on silica gel to give the title compound (R)-214 as a clear oil (0.243 g, 62% over two 
steps, 42% ee). 
Spectroscopic characteristics were consistent with that of (R)-214 shown earlier and with 
previously reported data.253 
Enantioselectivity was determined by GC analysis: 71 : 29 er, tR = 12.9 (R-enantiomer) and 
13.2 min (S-enantiomer) (140°C hold for 20 min). 
 
Work-up B 
At -30°C, MeOH (0.5 mL) was added and the mixture allowed warm to room temperature. The 
reaction mixture was concentrated under reduced pressure. Et2O (10 mL) was added and the 
mixture extracted with Et2O (3 x 10 mL). The organic layers were combined and dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure. The crude hydrazone 
purified using column chromatography (10 : 1, hexane : Et2O, 4% Et3N) on silica gel to give 
the pure hydrazone which was immediately subjected to the HCl hydrolysis method (see 
method A in section 5.6.4). The crude ketone was purified using column chromatography (10 : 
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1, hexane : Et2O) on silica gel to give the title compound (R)-214 as a clear oil (0.123 g, 53% 
over two steps, 42% ee). 
Spectroscopic characteristics were consistent with that of (R)-214 shown earlier and with 
previously reported data.253 
Enantioselectivity was determined by GC analysis: 71 : 29 er, tR = 12.9 (R-enantiomer) and 
13.2 min (S-enantiomer) (140°C hold for 20 min). 
 
Work-up C 
At -30°C, pH 7 buffer solution (0.5 mL) was added and the mixture allowed warm to room 
temperature. Et2O (10 mL) was added and the mixture extracted with Et2O (3 x 20 mL). The 
organic layers were combined and dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure. The crude hydrazone was purified using column chromatography (10 
: 1, hexane : Et2O, 4% Et3N) on silica gel to give the pure hydrazone which was immediately 
subjected to the HCl hydrolysis method (see method A in section 5.6.4). The crude ketone was 
purified using column chromatography (10 : 1, hexane : Et2O) on silica gel to give the title 
compound (R)-214 as a clear oil (0.120 g, 52% over two steps, 42% ee). 
Spectroscopic characteristics were consistent with that of (R)-214 shown earlier and with 
previously reported data.253 
Enantioselectivity was determined by GC analysis: 71 : 29 er, tR = 12.9 (R-enantiomer) and 
13.2 min (S-enantiomer) (140°C hold for 20 min). 
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5.6.4 Hydrazone Cleavage Methods 
(R)-2-methyl-1-(o-tolyl)pentan-3-one (R)-216 
To a schlenk tube, under a N2 atmosphere, were added anhydrous 
toluene (5 mL) and (+)-sparteine (+)-sp 100 (1.686 g, 6 mmol) at room 
temperature. sec-BuLi (1.4 M, 5.5 mmol, 3.9 mL) was added at -78°C 
and allowed to stir for 30 min. Hydrazone 203 (0.64 g, 5 mmol) was 
added dropwise at -78°C, allowed warm to room temperature and 
allowed to stir at room temperature for 6 h. The reaction was cooled to -30°C and 2-
methylbenzyl bromide (1.11 g, 6 mmol) was added dropwise. The mixture was allowed to stir 
at -30°C for 22 h. 
At -30°C, saturated NH4Cl (0.5 mL) was added and the mixture allowed warm to room 
temperature. Et2O (30 mL) was added and the mixture was washed with NH4Cl (3 x 10 mL). 
The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure.  
The crude product was then subjected to one of the following hydrazone cleavage methods. 
 
Hydrazone cleavage method A 
The hydrazone (max. 5 mmol) was cleaved by addition of Et2O (10 mL), followed by 4 M HCl 
(2.5 mL) and allowed to stir vigorously, until all starting material had reacted (determined by 
TLC analysis (5 : 1, hexane : Et2O)). Water (10 mL) was added and the mixture extracted with 
Et2O (3 x 30 mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, 
and concentrated under reduced pressure. The crude product was purified using column 
chromatography (10 : 1, hexane : Et2O) on silica gel to give the title compound (R)-216 as a 
clear oil (0.52 g, 55% over two steps, 52% ee). 
Spectroscopic characteristics were consistent with that of (R)-216 shown earlier and with 
previously reported data.253 
Enantioselectivity was determined by GC analysis: 76 : 24 er, tR = 11.4 (R-enantiomer) and 
11.9 min (S-enantiomer) (120°C hold for 20 min, ramp 10°C/min to 140°C, hold for 5 min). 
 
Hydrazone cleavage method B 
The hydrazone (max. 2.5 mmol) was cleaved by adding SeO2 (0.416 g, 3.75 mmol) and MeOH 
(37.5 mL) followed by pH 7 phosphate buffer (12.5 mL) and H2O2 (30%, 1.25 mL). After 
completion, saturated NaHCO3 (20 mL) was added to the mixture and the aqueous layers were 
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extracted with Et2O (3 x 50 mL). The organic layers were combined and dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure. The crude product was purified 
using column chromatography (10 : 1, hexane : Et2O) on silica gel to give the title compound 
(R)-216 as a clear oil (0.254 g, 54% over two steps, 52% ee). 
Spectroscopic characteristics were consistent with that of (R)-216 shown earlier and with 
previously reported data.253 
Enantioselectivity was determined by GC analysis: 76 : 24 er, tR = 11.4 (R-enantiomer) and 
11.9 min (S-enantiomer) (120°C hold for 20 min, ramp 10°C/min to 140°C, hold for 5 min). 
 
Hydrazone cleavage method C 
The hydrazone (max. 2.5 mmol) was cleaved by adding acetone (25 mL) and water (2.5 mL), 
followed by Amberlyst® 15 hydrogen form beads (500 mg, 200 mg per mmol of hydrazone). 
The reaction mixture was heated at reflux, until all starting material had reacted (determined by 
TLC analysis (5 : 1, hexane : Et2O)). The reaction mixture was cooled and the Amberlyst® 
beads were removed by filtration and washed with acetone (10 mL). The filtrate was 
concentrated under reduced pressure. To the resulting residue, water (10 mL) and Et2O (10 mL) 
were added and the mixture was extracted with Et2O (3 x 20 mL). The organic layers were 
combined and dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure. 
The crude product was purified using column chromatography (10 : 1, hexane : Et2O) on silica 
gel to give the title compound (R)-216 as a clear oil (0.219 g, 46% over two steps, 52% ee). 
Spectroscopic characteristics were consistent with that of (R)-216 shown earlier and with 
previously reported data.253 
Enantioselectivity was determined by GC analysis: 76 : 24 er, tR = 11.4 (R-enantiomer) and 
11.9 min (S-enantiomer) (120°C hold for 20 min, ramp 10°C/min to 140°C, hold for 5 min). 
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5.6.5 Addition of Lithium Salts 
(R)-1-(4-(tert-butyl)phenyl)-2-methylpentan-3-one (R)-214 
To a schlenk tube, under a N2 atmosphere, were added lithium salt 
(1.1 mmol), anhydrous toluene (2 mL) and (+)-sparteine (+)-sp 100 
(0.28 g, 1.2 mmol) at room temperature. sec-BuLi (1.4 M, 1.1 
mmol, 0.78 mL) was added at -78°C and allowed to stir for 30 min. 
Hydrazone 203 (0.128 g, 1 mmol) was added dropwise at -78°C, 
allowed warm to room temperature and allowed to stir at room temperature for 6 h. The reaction 
was cooled to -30°C and 4-tert-butylbenzyl bromide (0.27 g, 1.2 mmol) was added dropwise. 
The mixture was allowed to stir at -30°C for 22 h. 
At -30°C, saturated NH4Cl (0.5 mL) was added and the mixture allowed warm to room 
temperature. Et2O (30 mL) was added and the mixture was washed with NH4Cl (3 x 10 mL). 
The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to afford the crude hydrazone. 
Hydrazone cleavage 
The resulting oil was hydrolysed by addition of Et2O (5 mL), followed by 4 M HCl (0.5 mL) 
and allowed to stir vigorously, until all starting material had reacted (determined by TLC 
analysis (5 : 1, hexane : Et2O)). Water (5 mL) was added and the mixture extracted with Et2O 
(3 x 30 mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The crude product was purified using column 
chromatography (10 : 1, hexane : Et2O) on silica gel to give the pure ketone (R)-214. 
Spectroscopic characteristics were consistent with that of (R)-214 shown earlier and with 
previously reported data.253 
Enantioselectivity was determined by GC analysis: tR = 12.9 (R-enantiomer) and 13.2 min (S-
enantiomer) (140°C hold for 20 min). 
aYield determined using NMR and 1,3,5-trimethoxybenzene as internal standard. b2 equiv. lithium bromide were added after the 
deprotonation and allowed to stir for 45 min at room temperature, before cooling to -30°C for alkylation. 
Table 5.6.5 Addition of Lithium Salts. 
  
Ligand Hydrazone Lithium Salt Yielda Ketone er R : S % ee 
(+)-sp 100 203 Lithium chloride 35% (R)-214 69 : 31 38% 
(+)-sp 100 203 Lithium bromide 9% (R)-214 59 : 41 18% 
(+)-sp 100 203 Lithium iodide 7% (R)-214 61 : 39 22% 
(+)-sp 100 203 Lithium bromide 59% (R)-214 71 : 29 42%b 
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5.6.6 Procedures for Mechanistic Investigations 
Using the general procedure as detailed in section 5.6.2 the following variations were also 
investigated and are summarised in Table 5.6.6, Table 5.6.7 and Table 5.6.8. 
 
aIsolated yield over two steps. bYield determined using NMR and 1,3,5-trimethoxybenzene as internal standard. cLigand was added after the 
deprotonation and allowed to stir for 45 min, before alkylation @ -30°C. 
Table 5.6.6 Mechanistic Investigations. 
 
Ligand Variation from standard 
conditions 
Electrophile Yield Ketone er R : S % ee 
(+)-sp 100 0.4 equiv. (+)-sp 100 4-tert-butylbenzyl bromide 38%a (R)-214 68 : 32 36% 
(+)-sp 100 0.4 equiv. (+)-sp 100 in 
ether 
4-tert-butylbenzyl bromide 34%a (R)-214 59 : 41 18% 
aYield determined using NMR and 1,3,5-trimethoxybenzene as internal standard. bLigand was added after the deprotonation and allowed to 
stir for 45 min at room temperature, before cooling to -30°C for alkylation. 
Table 5.6.7 Catalytic Use of Chiral Ligand. 
 
Ligand Variation from 
standard conditions 
Electrophile Yielda Ketone er R : S % ee 
(+)-sp 100 1.5 h alkylation 
(+)-sp/secBuLi 
4-tert-butylbenzyl bromide 20% (R)-214 68 : 32 36% 
No ligand 1.5 h alkylation  
Only secBuLi 
4-tert-butylbenzyl bromide 10% (R)-214 n/a n/a 
aYield determined using NMR and 1,3,5-trimethoxybenzene as internal standard. 
Table 5.6.8 Sparteine/sec-BuLi versus sec-BuLi Rate Experiments. 
  
Ligand Variation from 
standard conditions 
Electrophile Yield Ketone er R : S % ee 
(-)-sp 100 (-)-sp 100 added  
@ RT after deprot. 
benzyl bromide 25%a (S)-10 
 
23 : 77 54%c 
(+)-sp 100 2 h alkylation 4-tert-butylbenzyl bromide 43%b (R)-214 71 : 29 42% 
(+)-sp 100 0.2 equiv. electrophile 2-methylbenzyl bromide 18%b (R)-216 76 : 24 52% 
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5.7 Preparation of Chiral Ligands and their use in the 
Asymmetric Synthesis of α-Alkylated Ketones 
5.7.1 Preparation of 2,2'-isopropylidenebis[(4S)-4-phenyl-4,5-dihydro-1,3-oxazole] 
Synthetic route A 
(S)-(+)-phenylglycinol (S)-232 
To sodium borohydride (4.5 g, 0.118 mol) under a N2 atmosphere was 
added anhydrous THF (80 mL), followed by the dropwise addition of 
boron trifluoride diethyl etherate (0.237 mol, 29 mL). The suspension was 
allowed to stir for 15 min, followed by portion-wise addition of (S)-(+)-
2-phenylglycine (8.9 g, 0.059 mol) over 10 min. The resulting suspension was allowed to stir 
at room temperature overnight, and heated at reflux for 12 h, allowed to cool to room 
temperature and allowed to stir overnight again. The reaction mixture was quenched with 
methanol until gas evolution ceased. The reaction mixture was concentrated under reduced 
pressure to yield a white solid. 20% aqueous sodium hydroxide solution (400 mL) was added 
and the basic solution was extracted with CH2Cl2 (3 x 200 mL). The organic layers were 
combined and dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure 
to afford (S)-232 as a white solid (7.01 g, 97%). Mp 70-72°C (lit.261 72-74°C). 
Spectroscopic characteristics were consistent with previously reported data.261,262 
[α]22
𝐷
 + 27.4 (c 1.07, MeOH) (lit.262 [α]22
𝐷
 – 28.5 (c 1, MeOH, for R-enantiomer)). 1H NMR (300 
MHz, CDCl3): δ 2.01 (1H, bs, O-H), 3.55 (1H, dd, J = 8.5, 10.6 Hz, H-7), 3.74 (1H, dd, J = 4.2, 
10.6 Hz, H-8), 4.05 (1H, dd, J = 4.2, 8.5 Hz, H-8), 7.21-7.41 (5H, m, Ar-H) ppm; 13C NMR 
(75.5 MHz, CDCl3): δ 57.3 (C-7), 68.1 (C-8), 126.4 (2 x Ar-CH), 127.6 (Ar-CH), 128.6 (2 x 
Ar-CH), 142.8 (C-6) ppm; MS (ESI) m/z: 138 [M + H]+. 
  
2,2-dimethyl malonyl dichloride 233 
To thionyl chloride (54.0 g, 454 mmol) at 0°C was added malonic acid (12.0 
g, 90.8 mmol). The reaction mixture was heated at reflux for 6 h. The excess 
thionyl chloride was removed under reduced pressure. The crude acid 
chloride was purified by kugelrohr distillation to give the pure acid chloride 
233 as a yellow oil (8.48 g, 55%). 
Spectroscopic characteristics were consistent with previously reported data.213 
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1H NMR (300 MHz, CDCl3): δ 1.68 (6H, s, H-4, H-5) ppm; 13C NMR (75.5 MHz, CDCl3): δ 
23.0 (C-4, C-5), 69.1 (C-2), 172.0 (C-1, C-3) ppm; MS (ESI) m/z: 167 [M + H]+. 
 
N,N'-bis((S)-2-hydroxy-1-phenylethyl)-2,2-dimethylmalonamide (S,S)-234 
To a stirred solution of the amino alcohol (S)-232 (13.6 g, 99.4 
mmol) and Et3N (248 mmol, 34.7 mL) in CH2Cl2 (150 mL) was 
added dropwise, a solution of the acid chloride 233 (8.4 g, 49.7 
mmol) in CH2Cl2 (35 mL) at 0°C, and the mixture was allowed 
to stir overnight at room temperature. The formed solid was 
removed by filtration and was washed with CH2Cl2 (20 mL). For a second crop of product, the 
mother liquor was extracted with 10% HCl solution (250 mL), the aqueous layer was extracted 
with CH2Cl2 (50 mL). The combined organic extracts were washed with saturated aqueous 
NaHCO3, water, and brine. The organic layer was dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure to afford the crude product, this was crystallised from 1 : 
1, CH2Cl2 : hexane to give the pure bisamide (S,S)-234 as a white solid (13.01 g, 71%). Mp 60-
62°C. 
[α]22
𝐷
 + 55.1 (c 1, MeOH). 1H NMR (300 MHz, MeOD): δ 1.49 (6H, s, H-8, H-9), 3.72 (2H, dd, 
J = 7.8, 11.3 Hz, H-2, H-6), 3.79 (2H, dd, J = 5.0, 11.3 Hz, H-1, H-7), 5.04 (2H, dd, J = 5.0, 
7.8 Hz, H-1, H-7), 7.15-7.36 (10H, m, Ar-H) ppm; 13C NMR (75.5 MHz, MeOD): δ 24.3 (C-8, 
C-9), 51.5 (C-4), 57.3 (C-2, C-6), 66.0 (C-1, C-7), 127.8 (4 x Ar-CH), 128.4 (2 x Ar-CH), 129.5 
(4 x Ar-CH), 140.9 (C-10, C-16), 175.8 (C-3, C-5) ppm; MS (ESI) m/z: 371 [M + H]+. 
Crystallographic data was also obtained for this compound (see Appendix). 
 
2,2'-isopropylidenebis[(4S)-4-phenyl-4,5-dihydro-1,3-oxazole] (S,S)-227 
To a stirred solution of the bisamide (S,S)-234 (8.0 g, 21.6 
mmol), DMAP (0.26 g, 2.16 mmol) and Et3N (94.9 mmol, 13.2 
mL) in CH2Cl2 (100 mL) at 0°C was added a solution of p-
toluenesulfonyl chloride (8.22 g, 43.14 mmol) in CH2Cl2 (20 
mL) over a period of 10 min. The reaction mixture was allowed 
to stir at room temperature for 48 h. Saturated NH4Cl (50 mL) 
was added to the reaction and the biphasic mixture was allowed to stir for 15 min. The layers 
were separated and the aqueous layer was extracted with CH2Cl2 (3 x 100 mL). The organic 
layers were combined and washed with saturated aqueous NaHCO3 (100 mL). The aqueous 
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layer was extracted with CH2Cl2 (3 x 100 mL). The organic layers were combined and washed 
with brine (2 x 100 mL).  The organic layer was dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure to afford the crude product. The crude product was 
purified using column chromatography (4 : 1, hexane : EtOAc, with 0.4% Et3N) on silica gel to 
give the title compound (S,S)-227 (0.74 g, 10%). 
Spectroscopic characteristics were consistent with previously reported data.216  
Rf = 0.55 (4 : 1, hexane : EtOAc, with 0.4% Et3N). [α]20
𝐷
 – 141.3 (c 1, EtOH) (lit.216 [α]20
𝐷
 + 153 
(c 1, EtOH, for S,S-enantiomer)). 1H NMR (300 MHz, CDCl3): δ 1.69 (6H, s, H-8, H-9), 4.17 
(2H, dd, J = 7.7, 8.3 Hz, H-1, H-7), 4.68 (2H, dd, J = 8.3, 10.1 Hz, H-2, H-6), 5.23 (2H, dd, J 
= 7.7, 10.1 Hz, H-1, H-7), 7.12-7.42 (10H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 
24.5 (C-8, C-9) 39.0 (C-4), 69.5 (C-2, C-6), 75.5 (C-1, C-7), 126.7 (4 x Ar-CH), 127.6 (2 x Ar-
CH), 128.7 (4 x Ar-CH), 142.4 (C-10, C-16), 170.4 (C-3, C-5) ppm; MS (ESI) m/z: 335 [M + 
H]+. 
 
Synthetic route B215,216 
2,2'-isopropylidenebis[(4S)-4-phenyl-4,5-dihydro-1,3-oxazole] (S,S)-227 
To a stirred solution of 2,2-dimethyl malononitrile (1.47 g, 15.6 
mmol) and zinc triflate (5.73 g, 15.7 mmol) in anhydrous 
toluene (120 mL), was added a solution of the amino alcohol 
(S,S)-232 (4.33 g, 31.4 mmol) in anhydrous toluene (60 mL). 
The solution was heated at reflux for 7 days. The reaction 
mixture was allowed to cool to room temperature. The reaction 
mixture was washed with brine (3 x 100 mL) and saturated aqueous NaHCO3 (3 x 100 mL). 
The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to afford the crude product. The crude product was purified using column 
chromatography (4 : 1, hexane : EtOAc, with 0.4% Et3N) on silica gel to give the title compound 
(S,S)-227 (2.15 g, 41%). 
Spectroscopic characteristics were consistent with that of (S,S)-227 shown earlier and with 
previously reported data.216 
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5.7.2 Preparation of (1S,2S)-N1,N1,N2,N2-tetramethyl-1,2-diphenylethane-1,2-diamine 
 (1S,2S)-N1,N1,N2,N2-tetramethyl-1,2-diphenylethane-1,2-diamine (S,S)-228 
To a solution of (1S,2S)-1,2-diphenylethylenediamine (0.5 g, 2.34 
mmol) in formic acid (90%, 56.3 mmol, 1.1 mL) was added formalin 
(37%, 37.2 mmol, 1.4 mL) dropwise. The reaction mixture was 
heated at reflux for 3 days. Formic acid (5.5 mL) and formalin (7 
mL) were added and reflux was continued for 4 days. Again formic acid (5.5 mL) and formalin 
(7 mL) were added and reflux was continued for another 3 days. Once again formic acid (5.5 
mL) and formalin (7 mL) were added and reflux was continued for another 7 days. The reaction 
mixture was allowed cool, and 10% HCl solution (40 mL) as added and the aqueous layer was 
washed with Et2O (15 mL). After the addition of 50% NaOH solution (pH 11), the aqueous 
layer was extracted with EtOAc (50 mL) and the organic layer was washed with brine (15 mL). 
The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to afford the crude product. The crude product was purified using column 
chromatography (4 : 1, hexane : EtOAc, with 0.4% Et3N) on silica gel to give the title compound 
(S,S)-228 (0.36 g, 45%). Mp 82-85°C (lit.156 88-90°C). 
Spectroscopic characteristics were consistent with previously reported data.156  
Rf = 0.33 (4 : 1, hexane : EtOAc, with 0.4% Et3N). [α]20
𝐷
 + 53.8 (c 1.09, CHCl3) (lit.
156 [α]20
𝐷
 + 
57.2 (c 1, CHCl3, for S,S-enantiomer)). 
1H NMR (300 MHz, CHCl3): δ 2.25 (12H, s, H-15, H-
16), 4.24 (2H, s, H-1, H-2), 6.95-7.18 (10H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CHCl3): δ 
40.8 (C-15, C-16), 67.9 (C-1, C-2), 126.6 (2 x Ar-CH), 127.2 (4 x Ar-CH), 129.9 (4 x Ar-CH), 
133.8 (C-3, C-9) ppm; MS (ESI) m/z: 269 [M + H]+. 
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5.7.3 Preparation of (1R,2R)-1,2-dimethoxy-1,2-diphenylethane 
(1R,2R)-1,2-dimethoxy-1,2-diphenylethane (R,R)-229 
To a stirred suspension of NaH (1.2 g, 30.1 mmol, 60 % in oil, 
washed with anhydrous hexane (3 x 10 mL) in anhydrous THF (25 
mL) was added a solution of (+)-hydrobenzoin (2.5 g, 11.7 mmol) in 
anhydrous THF (12 mL) at room temperature under a N2 atmosphere. 
The reaction mixture was heated at reflux for 30 min. The reaction mixture was cooled to 0°C, 
dimethyl sulfate (3.1 g, 24.5 mmol, 2.33 mL) was added. The hard viscous mass was allowed 
to stir for 15 h at room temperature. NH4Cl (5 mL) was added to quench the reaction. The 
mixture was extracted with Et2O (2 x 25mL). The combined organic layers were washed with 
saturated NaHCO3 (10 mL) and brine (10 mL). The organic layer was dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure to afford the crude product. The 
crude product was crystallized from hexane to give the title compound (R,R)-229 as a colourless 
solid (1.93 g, 68%). Mp 94-96°C (lit.156 99-100°C). 
Spectroscopic characteristics were consistent with previously reported data.156 
[α]25
𝐷
 – 13.4 (c 1.22, CHCl3) (lit.156 [α]25
𝐷
 – 15.2 (c 1.22, CHCl3, for R,R-enantiomer)). 1H NMR 
(300 MHz, CDCl3): δ 3.27 (6H, s, H-15, H-16), 4.31 (2H, s, H-1, H-2), 6.95-7.04 (4H, m, Ar-
H), 7.12-7.20 (6H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 57.2 (C-15, C-16), 87.7 (C-
1, C-2), 127.6 (2 x Ar-CH), 127.8 (4 x Ar-CH), 127.9 (4 x Ar-CH), 138.2 (C-3, C-9) ppm; MS 
(ESI) m/z: 243 [M + H]+. 
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5.7.4 Preparation of (S)-1-methyl-2-(pyrrolidin-1-ylmethyl)pyrrolidine  
Synthetic route A 
(S)-1-methyl-2-(pyrrolidin-1-ylmethyl)pyrrolidine (S)-230 
To a solution of (S)-(1-pyrrolidinylmethyl)-pyrrolidine (S)-193 (1.5 g, 
9.72 mmol) in water (10 mL) was added formic acid (90%, 215 mmol, 8.1 
mL) and formalin (37%, 108 mmol, 8.1 mL) dropwise. The reaction 
mixture was heated at reflux for 24 h. The reaction mixture was allowed 
cool, 15% NaOH solution was added, until pH 11 was reached. The aqueous layer was extracted 
with EtOAc (3 x 20 mL). The organic layers were combined and dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure to afford the crude product. The product was 
further purified by kugelrohr distillation to give the title compound (S)-230, as a colourless oil 
(0.6 g, 38%). 
Spectroscopic characteristics were consistent with previously reported data.219,263 
[α]21
𝐷
 – 83.5 (c 0.53, EtOH) (lit.263 [α]21
𝐷
 – 84.5 (c 0.53, EtOH, for S-enantiomer)). 1H NMR (300 
MHz, CDCl3): δ 1.45-1.79 (7H, m, H-2, H-3, H-7, H-8), 1.87-2.02 (1H, m, H-3), 2.03-2.29 (3H, 
m, H-4, H-5),  2.32 (3H, s, H-10), 2.38-2.51 (4H, m, H-6, H-9), 2.58 (1H, dd, J = 4.0, 11.5 Hz, 
H-5), 2.97 (1H, m, H-1) ppm; 13C NMR (75.5 MHz, CDCl3): δ 21.6 (C-2), 22.5 (C-7, C-8), 
30.1 (C-3), 40.4 (C-10), 53.9 (C-6, C-9), 56.6 (C-4), 60.6 (C-5), 63.9 (C-1) ppm; MS (ESI) m/z: 
169 [M + H]+. 
 
Synthetic route B219 
 (S)-(1-methylpyrrolidin-2-yl)(pyrrolidin-1-yl)methanone (S)-250 
To a suspension of the (S)-boc-proline (21.5 g, 100 mmol) in CH2Cl2 (30 
mL) was added a solution of DCC (20.6 g, 100 mmol) in CH2Cl2 (60 
mL) at 0°C under a N2 atmosphere. The reaction mixture was allowed to 
stir for 30 min at room temperature. To the reaction mixture was added 
a solution of pyrrolidine (100 mmol, 8.35 mL) in CH2Cl2 (60 mL) slowly 
at 0°C and the reaction temperature was increased to room temperature 
for 15 min. After 12 h, the reaction mixture was concentrated under reduced pressure. EtOAc 
(100 mL) was added to the residue. After insoluble materials were removed by filtration, the 
filtrate was washed with 1M HCl solution (20 mL), saturated NaHCO3 (20 mL) and brine (2 x 
100 mL).  The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure to afford the crude product. The crude product was purified using column 
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chromatography (10 : 1, CHCl3 : EtOAc) on silica gel to give the title compound (S)-250 (9.3 
g, 35%). Mp 69-72°C (lit.264 85°C). 
Spectroscopic characteristics were consistent with previously reported data.265  
The N-amide moiety has energetically similar cis and trans isomers (rotamers). These rotamers 
have slightly different chemical shifts, both are reported here. 
Rf = 0.15 (5 : 1, CHCl3 : EtOAc, with 0.4% Et3N). [α]23
𝐷
 – 32.9 (c 1, MeOH) (lit.265 [α]23
𝐷
 – 36.4 
(c 1, MeOH, for S-enantiomer)). 1H NMR (300 MHz, CDCl3): δ 1.40 (9H, s, H-12), 1.46 (9H, 
s, H-12), 1.74-2.24 (16H, m, H-2, H-3, H-7, H-8), 3.32-3.80 (12H, m, H-4, H-6, H-9), 4.35 (1H, 
dd, J = 5.0, 7.9 Hz, H-1), 4.48 (1H, dd, J = 3.1, 7.7 Hz, H-1) ppm; 13C NMR (75.5 MHz, CDCl3): 
δ 23.8, 24.0, 24.1, 24.2, 26.2, 26.3, 29.5, 30.4, 45.9, 46.0, 46.1, 46.7, 46.8 (C-2, C-3, C-4, C-6, 
C-7, C-8, C-9), 28.4, 28.5 (C-12), 57.8, 58.0 (C-1), 79.3, 79.4 (C-11), 153.8, 154.5 (C-10), 
171.0, 171.3 (C-5) ppm; MS (ESI) m/z: 269 [M+H]+. 
 
(S)-1-methyl-2-(pyrrolidin-1-ylmethyl)pyrrolidine (S)-230 
To LiAlH4 (3.16 g, 83.4 mmol) in anhydrous THF (35 mL), under a N2 
atmosphere at 0°C, was added (S)-(1-methylpyrrolidin-2-yl)(pyrrolidin-1-
yl)methanone (S)-250 (9.0 g, 33.4 mmol) in anhydrous THF (35 mL). The 
reaction mixture was brought to room temperature and allowed to stir 
overnight. It was then heated at reflux for 4 h. The reaction mixture was allowed cool to room 
temperature and quenched by addition of water (4 mL), 15% NaOH solution (4 mL) and water 
(12 mL) and allowed to stir for 1 h, until a white precipitate had formed. The mixture was 
filtered through a pad of Celite® to remove the inorganic salts and washed with EtOAc (100 
mL). The filtrate was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product. The product was further purified by kugelrohr distillation to 
give the title compound (S)-230, as a colourless oil (2.85 g, 51%). 
Spectroscopic characteristics were consistent with that of (S)-230 shown earlier and with 
previously reported data.219,263 
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5.7.5 Preparation of (1S,2S)-N1,N2-bis(3,3-dimethylbutyl)-N1,N2-dimethylcyclohexane-
1,2-diamine 
(1S,2S)-(+)-1,2-diaminocyclohexane D-tartrate (S,S)-251 
 Trans-(±)-1,2-diaminocyclohexane (100 mmol, 20 mL) was 
added dropwise to a stirred solution of D-tartaric acid (12.5 g, 50 
mmol) in water (45 mL), such that the internal temperature did 
not exceed 70°C (during this time a white precipitate forms, but 
this disappears by the point of complete addition). AcOH (5 mL) was added dropwise such that 
the internal temperature did not exceed 90°C. The resulting solution was allowed to cool in an 
ice bath and left in the refrigerator for 6 h. The solids were removed by filtration and the filter-
cake was washed with cold water (20 mL) and MeOH (5 x 10 mL) (washings kept separate). 
The resulting white solid was dried to give the (1S,2S)-cyclohexane diamine D-tartaric acid salt 
(S,S)-251 (13.1 g, 99%). Mp 265-268°C (lit.97 283-284°C). 
Spectroscopic characteristics were consistent with previously reported data.97 
[α]20
𝐷
 – 12.05 (c 4, H2O) (lit.266 [α]20
𝐷
 – 12.5 (c 4, H2O, for S,S-enantiomer)). 1H NMR (300 MHz, 
CDCl3): δ 1.21-1.37 (2H, m, H-4, H-5), 1.37-1.56 (2H, m, H-4, H-5), 1.67-1.86 (2H, m, H-3, 
H-6), 2.01-2.17 (2H, m, H-3, H-6), 3.22-3.38 (2H, m, H-1, H-2), 4.26 (2H, s, H-7, H-8) ppm; 
13C NMR (75.5 MHz, CDCl3): δ 22.8 (C-4, C-5) 29.4 (C-3, C-6), 52.2 (C-1, C-2), 73.8 (C-7, 
C-8), 178.5 (C-9, C-10) ppm; MS (ESI) m/z: 115 [M + H]+ (1,2-diaminocyclohexane), 149 [M 
- H]- (D-tartaric acid). 
 
(1R,2R)-(+)-1,2-diaminocyclohexane L-tartrate (R,R)-251 
The aqueous filtrate was combined with the aqueous washings 
from the preparation of (1S,2S)-(+)-1,2-diaminocyclohexane D-
tartrate (S,S)-251 and cooled to 0°C. L-tartaric acid (12.5 g, 50 
mmol) was added portion wise to the solution over 5 min. The 
resulting solution was allowed to stir at 0°C for 4 h. The solids were removed by filtration and 
the filter-cake was washed with cold water (20 mL) and MeOH (5 x 10 mL). The resulting 
white solid was dried to give the (1R,2R)-cyclohexane diamine L-tartaric acid salt (R,R)-251 
(10.1 g, 76%). Mp 260-262°C (lit.97 275-276°C). 
Spectroscopic characteristics were consistent with that of (S,S)-251 shown earlier and with 
previously reported data.97 
[α]20
𝐷
 + 11.7 (c 4, H2O) (lit.
266 [α]20
𝐷
 + 12.5 (c 4, H2O, for R,R-enantiomer)). 
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dimethyl-(1S,2S)-cyclohexane-1,2-diyldicarbamate (S,S)-280 
A solution of NaOH (12.2 g, 306 mmol) in water (20 mL) and 
methylchloroformate (6.20 mL, 80.3 mmol) were simultaneously added 
to a stirred suspension of (1S,2S)-cyclohexane diamine D-tartaric acid salt 
(S,S)-251 (10.01 g, 37.9 mmol) in toluene (50 mL) at 0°C. This led to the 
formation of a gel-like precipitate. The resulting mixture was allowed to 
stir at room temperature for 48 h. CHCl3 (50 mL) was added and the solids 
were removed by filtration and washed with CHCl3 (2 x 25 mL). The filtrate was washed with 
water (25 mL). The aqueous layer was extracted with CHCl3 (2 x 50 mL). The organic layers 
were combined and dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as a white solid (7.27 g, 83%). 
The crude product (S,S)-280 was used in the next step without further purification. 
Spectroscopic characteristics were consistent with previously reported data.97 
1H NMR (300 MHz, CDCl3): δ 1.08-1.40 (4H, m, H-4, H-5), 1.65-1.83 (2H, m, H-3, H-6), 1.96-
2.16 (2H, m, H-3, H-6), 3.14-3.44 (2H, m, H-1, H-2), 3.65 (6H, s, 2 x OMe), 4.95 (2H, bs, 2 x 
N-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 24.7 (C-4, C-5) 32.9 (C-3, C-6), 52.1 (2 x OMe), 
55.5 (C-1, C-2), 157.5 (C-7, C-8) ppm; MS (ESI) m/z: 231 [M + H]+. 
 
(1S,2S)-N1,N2-dimethylcyclohexane-1,2-diamine (S,S)-252 
To a stirred suspension of LiAlH4 (7.20 g, 189.6 mmol) in anhydrous THF 
(60 mL) at 0°C under a N2 atmosphere, was added a solution of the crude 
carbamate (S,S)-280 (max. 37.9 mmol) in anhydrous THF (60 mL), 
dropwise. The resulting solution was heated at reflux for 40 h. The solution 
was cooled to 0°C and Et2O (50 mL) was added. The mixture was quenched by the slow 
addition of water (7 mL), 15% NaOH solution and water (21 mL) and allowed to stir for 1 h, a 
white precipitate formed. The mixture was filtered through a pad of Celite® to remove the 
inorganic salts and washed with 24 : 1, CH2Cl2  : MeOH (2 x 50 mL). The filtrate was dried 
over anhydrous MgSO4, filtered, and concentrated under reduced pressure to give the crude 
product as a yellow oil (4.25 g, 79%). 
The crude product (S,S)-252 was used in the next step without further purification. 
Spectroscopic characteristics were consistent with previously reported data.97 
1H NMR (300 MHz, CDCl3): δ 0.85-1.07 (2H, m, H-4, H-5), 1.17-1.34 (2H, m, H-4, H-5), 1.69-
1.82 (2H, m, H-3, H-6), 1.96-2.06 (2H, m, H-3, H-6), 2.06-2.15 (2H, m, H-1, H-2), 2.39 (6H, 
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s, H-7, H-8) ppm; 13C NMR (75.5 MHz, CDCl3): δ 25.0 (C-4, C-5) 30.7 (C-3, C-6), 33.5 (C-7, 
C-8), 55.5 (C-1, C-2) ppm; MS (ESI) m/z: 143 [M + H]+. 
 
(1S,2S)-N1,N2-(cyclohexane-1,2-diyl)bis(N,3,3-trimethylbutanamide) (S,S)-281 
A solution of tert-butylacetylchloride (10.8 mL, 77.5 mmol) in 
CH2Cl2 (20 mL) was added dropwise to a stirred biphasic mixture of 
crude diamine (S,S)-252 (max. 37.9 mmol) in CH2Cl2 (50 mL) and 
NaOH (7.06 g, 176 mmol) in water (25 mL) at 0°C. The resulting 
mixture was allowed to stir at room temperature for 40 h. The two 
layers were separated and the aqueous layer was extracted with CH2Cl2 (5 x 100 mL). The 
organic layers were combined and dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure to give the crude bis-amide as a white solid (10.2 g, 80%). 
The crude product (S,S)-281 was used in the next step without further purification. 
Spectroscopic characteristics were consistent with previously reported data.97 
1H NMR (300 MHz, CDCl3): δ 1.03 (18H, s, H-15, H-16), 1.25-1.85 (8H, m, H-3, H-4, H-5, H-
6), 2.18 (2 x 2H, d, J = 14.0 Hz, H-11, H-12), 2.83 (6H, s, H-7, H-8), 4.66-4.79 (2H, m, H-1, 
H-2) ppm; 13C NMR (75.5 MHz, CDCl3): δ 25.1 (C-4, C-5) 29.5 (C-3, C-6), 29.9 (C-15, C-16), 
30.9 (C-7, C-8), 31.5 (C-13, C-14), 45.4 (C-11, C-12), 51.6 (C-1, C-2), 171.9 (C-9, C-10) ppm; 
MS (ESI) m/z: 339 [M + H]+. 
 
(1S,2S)-N1,N2-dimethyl- N1,N2-bis(3,3-dimethylbutyl)cyclohexane-1,2-diamine (S,S)-113 
To a stirred suspension of LiAlH4 (7.20 g, 189.6 mmol) in anhydrous 
THF (60 mL) at 0°C under a N2 atmosphere, was added a solution 
of the bisamide (S,S)-281 (max. 37.9 mmol) in anhydrous THF (60 
mL), dropwise. The resulting solution was heated at reflux for 40 h. 
The solution was cooled to 0°C and Et2O (50 mL) was added. The 
mixture was quenched by the slow addition of water (7 mL), 15% NaOH solution and water 
(21 mL) and allowed to stir for 1 h, a white precipitate formed. The mixture was filtered through 
a pad of Celite® to remove the inorganic salts and washed with 24 : 1, CH2Cl2 : MeOH (2 x 50 
mL). The filtrate was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to give the crude product as a yellow oil. The product was further purified by kugelrohr 
distillation to give the title compound (S,S)-113, as a colourless oil (4.84 g, 41% over four 
steps). 
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Spectroscopic characteristics were consistent with previously reported data.97 
[α]20
𝐷
 + 27.1 (c 1, CHCl3) (lit.
220 [α]20
𝐷
 – 31.1 (c 1.02, CHCl3, for R,R-enantiomer)). 1H NMR 
(300 MHz, CDCl3): δ 0.89 (18H, s, H-15, H-16), 1.04-1.24 (4H, m, H-4, H-5), 1.32-1.44 (4H, 
t, J = 8.4 Hz,  H-11, H-12), 1.62-1.84 (4H, m, H-3, H-6), 2.24 (6H, s, H-7, H-8), 2.37-2.59 (6H, 
m, H-1, H-2, H-9, H-10) ppm; 13C NMR (75.5 MHz, CDCl3): δ 25.1 (C-4, C-5), 25.9 (C-3, C-
6), 29.6 (C-15, C-16), 29.8 (C-13, C-14), 37.0 (C-7, C-8), 42.2 (C-11, C-12), 50.1 (C-9, C-10), 
62.6 (C-1, C-2) ppm; MS (ESI) m/z: 311 [M + H]+. 
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5.7.6 Preparation of N1,N1,N2,N2-tetramethylcyclohexane-1,2-diamine 
(1S,2S)-N1,N1,N2,N2-tetramethylcyclohexane-1,2-diamine (S,S)-231 
(1S,2S)-(+)-1,2-diaminocyclohexane D-tartrate (S,S)-251 (4 g, 15.17 mmol) 
was dissolved in formic acid (90%, 159 mmol, 6 mL) and formalin (37%, 
97.6 mmol, 8 mL) was added slowly at room temperature. The reaction 
mixture was heated at reflux for 2 h. The reaction mixture was allowed cool 
and made basic, until pH 14 was reached. The aqueous layer was extracted with Et2O (3 x 20 
mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure to afford the crude product. The product was further 
purified by kugelrohr distillation to give the title compound (S,S)-231 as a colourless oil (1.82 
g, 71%). 
Spectroscopic characteristics were consistent with previously reported data.220  
[α]20
𝐷
 + 58.3 (c 1.05, CHCl3) (lit.
220 [α]20
𝐷
 – 62.9 (c 1.05, CHCl3, for R,R-enantiomer)). 1H NMR 
(300 MHz, CDCl3): δ 1.00-1.23 (4H, m, H-4, H-5), 1.63-1.78 (2H, m, H-3, H-6), 1.78-1.91 (2H, 
m, H-3, H-6), 2.28 (12H, s, H-7, H-8, H-9, H-10), 2.35-2.42 (2H, m, H-1, H-2) ppm; 13C NMR 
(75.5 MHz, CDCl3): δ 22.9 (C-4, C-5), 25.6 (C-3, C-6), 40.1 (C-7, C-8, C-9, C-10), 63.9 (C-1, 
C-2) ppm; MS (ESI) m/z: 171 [M + H]+. 
 
 
(1R,2R)-N1,N1,N2,N2-tetramethylcyclohexane-1,2-diamine (R,R)-231 
Prepared following the procedure outlined above for (1S,2S)-N1,N1,N2,N2-
tetramethylcyclohexane-1,2-diamine (S,S)-231, using (1R,2R)-(+)-1,2-
diaminocyclohexane L-tartrate (R,R)-251 as starting material. The crude 
product was purified by kugelrohr distillation to give the title compound 
(R,R)-231 as a colourless oil (1.4 g, 55%). 
Spectroscopic characteristics were consistent with that of (S,S)-231 shown earlier and with 
previously reported data.220  
[α]20
𝐷
 – 59.9 (c 1.05, CHCl3) (lit.220 [α]20
𝐷
 – 62.9 (c 1.05, CHCl3, for R-enantiomer)).  
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5.7.7 Chiral Ligand Screen in the Asymmetric Synthesis of α-Alkylated Ketones 
General Procedure 
To a schlenk tube, under a N2 atmosphere, were added anhydrous toluene (1 mL) and ligand 
(1.2 mmol) at room temperature. sec-BuLi (1.4 M, 1.1 mmol, 0.78 mL) was added at -78°C and 
allowed to stir for 30 min. Hydrazone 203 (0.128 g, 1 mmol) was added dropwise at -78°C, 
allowed warm to room temperature and allowed to stir at room temperature for 6 h. The reaction 
was cooled to -30°C and electrophile (1.2 mmol) was added dropwise. The mixture was 
allowed to stir at -30°C for 22 h. 
At -30°C, saturated NH4Cl (0.5 mL) was added and the mixture allowed warm to room 
temperature. Et2O (30 mL) was added and the mixture was washed with NH4Cl (3 x 10 mL). 
The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure. The crude product was purified using column chromatography (10 : 1, hexane : Et2O) 
on silica gel to give a clear oil. 
Hydrazone cleavage 
The resulting oil was hydrolysed by addition of Et2O (5 mL), followed by 4 M HCl (0.5 mL) 
and allowed to stir vigorously, until all starting material had reacted (determined by TLC 
analysis (5 : 1, hexane : Et2O)). Water (5 mL) was added and the mixture extracted with Et2O 
(3 x 30 mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The crude product was purified using column 
chromatography (10 : 1, hexane : Et2O) on silica gel to give the pure ketone. 
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aIsolated yield over two steps 
Table 5.7.1 Chiral ligand screen in the asymmetric synthesis of α-alkylated ketones. 
 
 
   (-)-sp 100            (S,S)-227          (S,S)-228 
       
 
                (R,R)-229            (S)-230            (S,S)-113         (S,S)-231 
 
Figure 5.7.1   
Ligand Electrophile Deprot. Temp. Alkyl. Temp. Yielda Product er R : S % ee 
(-)-sp 100  n-PeI RT -30°C 34% (S)-188 17 : 83 66% 
(S,S)-227 n-PeI RT -30°C No reaction occurred 
(S,S)-228 BnBr RT -30°C 31% (S)-36 45 : 55 10% 
(R,R)-229 BnBr RT -30°C 27% (R)-36 57 : 43 14% 
(S)-230 n-PeI RT -30°C 16% 188 50 : 50 Racemic 
(S,S)-113 n-PeI RT -30°C 53% (S)-188 29 : 71 42% 
(S,S)-231 n-PeI RT -30°C 23% (R)-188 58 : 42 16% 
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5.8 Aldol & Michael Reactions using (-)- and (+)-Sparteine 
1-hydroxy-2-methyl-1-phenylpentan-3-one 254 
To a schlenk tube, under a N2 atmosphere, were added anhydrous 
toluene (1 mL) and (-)-sparteine (-)-sp 100 (0.281 g, 1.2 mmol) at 
room temperature. sec-BuLi (1.4 M, 1.1 mmol, 0.78 mL) was added 
at -78°C and allowed to stir for 30 min. Hydrazone 203 (0.128 g, 1 
mmol) was added dropwise at -78°C, allowed warm to room temperature and allowed to stir at 
room temperature for 6 h. The reaction was cooled to -30°C and benzaldehyde (0.127 g, 1.2 
mmol) was added dropwise. The mixture was allowed to stir at -30°C for 22 h. 
At -30°C, saturated NH4Cl (0.5 mL) was added and the mixture allowed warm to room 
temperature. Et2O (30 mL) was added and the mixture was washed with NH4Cl (3 x 10 mL). 
The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to afford the crude hydrazone. The crude hydrazone was used in the next step without 
further purification. 
Hydrazone Cleavage 
The hydrazone was cleaved by adding acetone (10 mL) and water (1 mL), followed by 
Amberlyst® 15 hydrogen form beads (200 mg). The mixture was heated at reflux, until all 
starting material had reacted (determined by TLC analysis (1 : 1, hexane : Et2O)). The reaction 
mixture was cooled and the Amberlyst® beads were removed by filtration and washed with 
acetone (10 mL). The filtrate was concentrated under reduced pressure. To the resulting residue, 
water (10 mL) and Et2O (10 mL) were added and the mixture was extracted with Et2O (3 x 20 
mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The crude product was purified using column 
chromatography (5 : 1, hexane : Et2O) on silica gel to give the title compound 254 as a clear 
oil, isolated as a mixture of diastereomers, 0.125 g, 65% over two steps, 60 : 40 dr, syn 52% ee, 
anti 30% ee. 
Spectroscopic characteristics were consistent with previously reported data.267 
Rf = 0.6 (1 : 1, hexane : Et2O). Syn diastereomer: 
1H NMR (400 MHz, CDCl3): δ 1.00 (3H, t, 
J = 7.3 Hz, H-1), 1.08 (3H, d, J = 7.2 Hz, H-5), 2.33 (1H, dq, J = 18.1, 7.3 Hz, H-2), 2.50 (1H, 
dq, J = 17.9, 7.3 Hz, H-2), 2.84 (1H, dq, J = 4.0, 7.2 Hz, H-4), 3.11 (1H, bs, O-H), 5.05 (1H, 
bd, J = 4.0 Hz, H-6), 7.20-7.39 (5H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 7.5 (C-1), 
10.5 (C-5), 35.4 (C-2), 52.2 (C-4), 73.3 (C-6), 125.9 (2 x Ar-CH), 127.4 (Ar-CH), 128.3 (2 x 
Ar-CH), 141.8 (C-7), 216.2 (C-3) ppm; Anti diastereomer: 1H NMR (400 MHz, CDCl3): δ 
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0.94 (3H, d, J = 7.2 Hz, H-5), 1.04 (3H, t, J = 7.3 Hz, H-1), 2.43 (1H, dq, J = 18.1, 7.3 Hz, H-
2), 2.56 (1H, dq, J = 18.1, 7.3 Hz, H-2), 2.87-2.99 (1H, m, H-4), 4.69 (1H, bd, J = 5.0 Hz, O-
H), 4.75 (1H, dd, J = 5.0, 8.2 Hz, H-6), 7.20-7.39 (5H, m, Ar-H) ppm; 13C NMR (75.5 MHz, 
CDCl3): δ 7.4 (C-1), 14.5 (C-5), 36.5 (C-2), 52.6 (C-4), 76.7 (C-6), 126.5 (2 x Ar-CH), 127.9 
(Ar-CH), 128.5 (2 x Ar-CH), 142.2 (C-7), 216.0 (C-3) ppm; MS (ESI) m/z: 193 [M + H]+. 
Diastereoselectivity and enantioselectivity were determined by GC analysis: 60 : 40 dr, syn 23 
: 77 er, anti 35 : 65 er, tR = 17.3 (syn, major enantiomer), 19.5 min (anti, major enantiomer), 
21.7 min (anti, minor enantiomer) and 22.6 min (syn, minor enantiomer) (130°C hold for 30 
min). 
 
4-methyl-6-nitro-5-phenylhexan-3-one 256 
To a schlenk tube, under a N2 atmosphere, were added anhydrous 
toluene (1 mL) and (+)-sparteine (+)-sp 100 (0.281 g, 1.2 mmol) at 
room temperature. sec-BuLi (1.4 M, 1.1 mmol, 0.78 mL) was added 
at -78°C and allowed to stir for 30 min. Hydrazone 203 (0.128 g, 1 
mmol) was added dropwise at -78°C, allowed warm to room temperature and allowed to stir at 
room temperature for 6 h. The reaction was cooled to -38°C and β-nitrostyrene (0.179 g, 1.2 
mmol, in toluene (1 mL)) was added dropwise. The mixture was allowed to stir at -70°C for 22 
h. 
At -70°C, saturated NH4Cl (0.5 mL) was added and the mixture allowed warm to room 
temperature. Et2O (30 mL) was added and the mixture was washed with NH4Cl (3 x 10 mL). 
The organic layer was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure to afford the crude hydrazone. The crude hydrazone was used in the next step without 
further purification. 
Hydrazone Cleavage 
The resulting oil was hydrolysed by addition of Et2O (5 mL), followed by 4 M HCl (0.5 mL) 
and allowed to stir vigorously, until all starting material had reacted (determined by TLC 
analysis (1 : 1, hexane : Et2O)). Water (5 mL) was added and the mixture extracted with Et2O 
(3 x 30 mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The crude product was purified using column 
chromatography (10 : 1, hexane : Et2O) on silica gel to give the title compound 256 as a brown 
oil, 0.123 g, 53% over two steps, mixture of diastereomers, 88 : 12 dr, syn 2% ee, anti 2% ee. 
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Spectroscopic characteristics were consistent with previously reported data for both the syn and 
the anti.268 
Syn diastereomer: The syn diastereomer was isolated using column chromatography (10 : 1, 
hexane : Et2O) on silica gel to give the title compound 256 as a brown oil, 0.105 g, 45% over 
two steps, syn 2% ee. 
Rf = 0.52 (1 : 1, hexane : Et2O). [α]23
𝐷
 – 0.278 (c 0.36, CHCl3) (lit.268 [α]23
𝐷
 – 185 (c 0.36, CHCl3, 
for 96% ee, S,R-diastereomer)). 1H NMR (300 MHz, CDCl3): δ 0.97 (3H, d, J = 7.3 Hz, H-5), 
1.07 (3H, t, J = 7.3 Hz, H-1), 2.41 (1H, dq, J = 18.0, 7.3 Hz, H-2), 2.61 (1H, dq, J = 18.0, 7.3 
Hz, H-2), 2.99 (1H, dq, J = 9.6, 7.3 Hz, H-4), 3.62-3.76 (1H, m, H-6), 4.55-4.73 (2H, m, H-13), 
7.13-7.20 (2H, m, Ar-H), 7.22-7.23 (3H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 7.6 
(C-1), 16.3 (C-5), 35.4 (C-2), 46.1 (C-4), 48.3 (C-6), 78.3 (C-13), 127.9 (2 x Ar-CH), 128.0 
(Ar-CH), 129.0 (2 x Ar-CH), 137.6 (C-7), 213.5 (C-3) ppm; MS (ESI) m/z: 236 [M + H]+. 
Anti diastereomer: The anti diastereomer was isolated using column chromatography (10 : 1, 
hexane : Et2O) on silica gel to give the title compound 256 as a clear oil, (0.018 g, 8% over two 
steps, anti 2% ee). 
Rf = 0.41 (1 : 1, hexane : Et2O). [α]23
𝐷
 + 2.5 (c 0.26, CHCl3) (lit.
268 [α]23
𝐷
 – 23 (c 0.26, CHCl3, 
for 85% ee, R,R-diastereomer)). 1H NMR (300 MHz, CDCl3): δ 0.83 (3H, t, J = 7.3 Hz, H-1), 
1.19 (3H, d, J = 6.9 Hz, H-5), 2.05 (1H, dq, J = 18.0, 7.3 Hz, H-2), 2.31 (1H, dq, J = 18.0, 7.3 
Hz, H-2), 2.91-3.05 (1H, m, H-4), 3.72-3.84 (1H, m, H-6), 4.65-4.85 (2H, m, H-13), 7.11-7.47 
(5H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 7.3 (C-1), 14.5 (C-5), 35.8 (C-2), 45.9 
(C-4), 49.1 (C-6), 77.6 (C-13), 127.7 (2 x Ar-CH), 127.8 (Ar-CH), 128.9 (2 x Ar-CH), 138.0 
(C-7), 212.5 (C-3) ppm; MS (ESI) m/z: 236 [M + H]+. 
Diastereoselectivity and enantioselectivity were determined by GC analysis: 88 : 12 dr, syn 51 
: 49 er, anti 51 : 49 er, tR = 49.2 (syn, major enantiomer), 54.9 min (anti, major enantiomer), 
56.5 min (syn, minor enantiomer) and 60.1 min (anti, minor enantiomer) (140°C hold for 80 
min). 
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5.9 Procedures for NMR Investigations of Asymmetric Alkylation 
with (+)-Sparteine 
Procedure for reaction to be analysed by NMR 
(R)-1-(4-(tert-butyl)phenyl)-2-methylpentan-3-one (R)-214 
To a schlenk tube, under a N2 atmosphere, were added anhydrous 
deuterated toluene (2 mL) and (+)-sparteine (+)-sp 100 (0.28 g, 1.2 
mmol) at room temperature. sec-BuLi (1.4 M, 1.1 mmol, 0.78 mL) 
was added at -78°C and allowed to stir for 30 min. Hydrazone 203 
(0.128 g, 1 mmol) was added dropwise at -78°C, allowed warm to 
room temperature. After 30 min a sample was removed using a glass syringe (Figure 5.9.1), 
under a N2 atmosphere, and transferred to the sealed NMR tube (Figure 5.9.2) and analysed via 
NMR. The reaction continued to stir at room temperature for a further 5.5 h. At room 
temperature, 4-tert-butylbenzyl bromide (0.27 g, 1.2 mmol) was added dropwise. After 30 min 
a sample was removed using a glass syringe (Figure 5.9.1), under a N2 atmosphere, and 
transferred to the sealed NMR tube (Figure 5.9.2) and analysed via NMR. The mixture was 
allowed to stir at room temperature for 22 h. 
Saturated NH4Cl (0.5 mL) was added at room temperature. Et2O (30 mL) was added and the 
mixture washed with NH4Cl (3 x 10 mL). The organic layer was dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure to afford the crude hydrazone. Another 
sample was taken of the crude hydrazone after work-up and analysed via NMR. 
Hydrazone cleavage  
The resulting oil was hydrolysed by addition of Et2O (5 mL), followed by 4 M HCl (0.5 mL) 
and allowed to stir vigorously, until all starting material had reacted (determined by TLC 
analysis (1 : 1, hexane : Et2O)). Water (5 mL) was added and the mixture extracted with Et2O 
(3 x 30 mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The crude product was purified using column 
chromatography (10 : 1, hexane : Et2O) on silica gel to give the pure ketone (44%, yield 
determined using NMR and 1,3,5-trimethoxybenzene as internal standard, 28% ee). 
Spectroscopic characteristics were consistent with that of (R)-214 shown earlier and with 
previously reported data.253 
Enantioselectivity was determined by GC analysis: 64 : 36 er, tR = 12.9 (R-enantiomer) and 
13.2 min (S-enantiomer) (140°C hold for 20 min). 
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Procedure for preparing NMR samples under inert atmosphere 
An NMR tube, fitted with a rubber septum and wrapped in parafilm, was put under vacuum via 
a needle connected to a schlenk line (Figure 5.9.2).  The tube was heated gently and filled with 
N2, the NMR tube was allowed to cool under N2 atmosphere. Using a glass syringe 0.6 mL of 
the reaction mixture was removed under inert atmosphere (Figure 5.9.1) and transferred to the 
NMR tube (Figure 5.9.2). The samples were analysed at 600 MHz on a Bruker AVANCE 600 
instrument. 
 
 
 
 
 
 
 
 
 
 
       Figure 5.9.1          Figure 5.9.2 
 
  
To schlenk line 
To schlenk line 
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5.10 Asymmetric α-Alkylation and Synthesis of a 1,3-Amino 
Alcohol Precursors using Chiral Sulfinimines 
5.10.1 Synthesis of N-tert-butanesulfinyl imines 
General procedure for the synthesis of N-tert-butanesulfinyl imines 
To a mixture of (S)-(-)-2-methyl-2-propanesulfinamide (1 equiv.) and the corresponding ketone 
(1 equiv.) in THF (4 mL per mmol of ketone), was added Ti(OEt)4 (2 equiv.). The resulting 
mixture was heated at reflux overnight. The reaction mixture was allowed to cool to room 
temperature and brine (4 mL per mmol of ketone) and allowed to stir for 30 min before filtration 
through a pad of Celite®. The filtrate was dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure, to afford the crude N-tert-butanesulfinyl imine. 
 
(S,E)-2-methyl-N-(1-phenylethylidene)propane-2-sulfinamide (S)-259 
Prepared following the general procedure outlined above using 
acetophenone. The crude product was purified using column 
chromatography (10 : 1, hexane : EtOAc) on silica gel to give the title 
compound (S)-259 as a yellow/green solid (0.802 g, 72%). Mp 36-40°C 
(lit.269 Mp 36-40°C). 
Spectroscopic characteristics were consistent with previously reported 
data.269 
Rf = 0.2 (4 : 1, hexane : EtOAc). [α]20
𝐷
 + 14.0 (c 1.03, CH2Cl2) (lit.
269 [α]20
𝐷
 + 13.0 (c 1.03, 
CH2Cl2, for S-enantiomer)). 
1H NMR (300 MHz, CDCl3): δ 1.22 (9H, s, H-10), 2.64 (3H, s, H-
8), 7.23-7.42 (3H, m, Ar-H), 7.77 (2H, m, Ar-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 19.7 
(C-8), 22.5 (C-10), 57.4 (C-9), 127.2 (2 x Ar-CH), 128.5 (2 x Ar-CH), 131.6 (Ar-CH), 138.6 
(C-6), 176.4 (C-7) ppm; MS (ESI) m/z: 224 [M + H]+. 
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(S,E)-2-methyl-N-(1-phenylpropylidene)propane-2-sulfinamide (S)-260 
Prepared following the general procedure outlined above using 
propiophenone. The crude product was purified using column 
chromatography (10 : 1, hexane : EtOAc) on silica gel to give the title 
compound (S)-260 as a yellow oil (0.691 g, 58%). 
Spectroscopic characteristics were consistent with previously reported 
data.269 
Rf = 0.35 (4 : 1, hexane : EtOAc). [α]20
𝐷
 + 7.9 (c 1.06, CH2Cl2) (lit.
269 [α]20
𝐷
 + 9 (c 1.06, CH2Cl2, 
for S-enantiomer)). 1H NMR (300 MHz, CDCl3): δ 1.28 (3H, t, J = 7.6 Hz, H-9), 1.33 (9H, s, 
H-11), 3.06-3.42 (2H, m, H-8), 7.34-7.6 (3H, m, Ar-H), 7.73-7.98 (2H, m, Ar-H) ppm; 13C 
NMR (75.5 MHz, CDCl3): δ 13.2 (C-9), 22.7 (C-11), 25.9 (C-8), 57.3 (C-10), 127.5 (Ar-CH), 
128.6 (3 x Ar-CH), 131.5 (Ar-CH), 137.6 (C-6), 181.3 (C-7) ppm; MS (ESI) m/z: 238 [M + H]+. 
 
(S)-2-methyl-N-(pentan-3-ylidene)propane-2-sulfinamide (S)-261 
Prepared following the general procedure outlined above using 3-
pentanone. The crude product was purified using column chromatography 
(10 : 1, hexane : EtOAc) on silica gel to give the title compound (S)-261 as 
a yellow oil (1.194 g, 32%). 
Spectroscopic characteristics were consistent with previously reported 
data.270  
Rf = 0.3 (4 : 1, hexane : EtOAc). [α]20
𝐷
 + 156.8 (c 1, CH2Cl2). 
1H NMR (300 MHz, CDCl3): δ 
1.10 (3H, t, J = 7.2 Hz, H-1), 1.20 (3H, t, J = 7.6 Hz, H-5), 1.24 (9H, s, H-7), 2.37-2.54 (2H, 
m, H-2), 2.63-2.78 (2H, m, H-4) ppm; 13C NMR (75.5 MHz, CDCl3): δ 9.9 (C-1), 11.8 (C-5), 
22.2 (C-7), 29.5 (C-2), 33.4 (C-4), 56.2 (C-6), 190.2 (C-3) ppm; MS (ESI) m/z: 190 [M + H]+. 
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5.10.2 Asymmetric α-Alkylation using Chiral Sulfinimines 
(S)-2-methyl-N-((Z)-2-methyl-1,3-diphenylpropylidene)propane-2-sulfinamide (S)-282 
To a schlenk tube under N2 atmosphere, containing 
diisopropylamine (1.2 mmol, 0.17 mL) in anhydrous THF (5 mL), 
was added n-BuLi (1.1 mmol, 1.6 M, 0.69 mL) at 0°C. The mixture 
was allowed to stir at 0°C for 30 min. The solution was cooled to -
78°C and tert-butanesulfinyl imine (S)-260 (0.237 g, 1 mmol, 0.22 
mL) was added dropwise. After the reaction mixture was allowed to 
stir for 1 h at -78°C, benzyl bromide (0.222 g, 1.3 mmol) was added 
slowly. The reaction mixture was kept at -78°C for 3 h and was allowed warm to room 
temperature overnight. The reaction was quenched with saturated NH4Cl (1.5 mL). NH4Cl (10 
mL) was added and the mixture was extracted with EtOAc (3 x 20 mL). The organic layers 
were combined and dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure. 
1H NMR analysis showed a complex mixture of products had formed. 
This complex mixture of products were inseparable by column chromatography (10 : 1, hexane 
: EtOAc) on silica gel. 
 
(S)-2-methyl-N-((E)-2-methyl-1-phenylpentan-3-ylidene)propane-2-sulfinamide (S)-283 
To a schlenk tube under N2 atmosphere, containing diisopropylamine 
(1.2 mmol, 0.17 mL) in anhydrous THF (5 mL), was added n-BuLi 
(1.1 mmol, 1.6 M, 0.69 mL) at 0°C. The mixture was allowed to stir 
at 0°C for 30 min. The solution was cooled to -78°C and tert-
butanesulfinyl imine (S)-261 (0.189 g, 1 mmol, 0.22 mL) was added 
dropwise. After the reaction mixture was allowed to stir for 1 h at -
78°C, benzyl bromide (0.222 g, 1.3 mmol) was added slowly. The 
reaction mixture was kept at -78°C for 3 h and was allowed warm to room temperature 
overnight. The reaction was quenched with saturated NH4Cl (1.5 mL). NH4Cl (10 mL) was 
added and the mixture was extracted with EtOAc (3 x 20 mL). The organic layers were 
combined and dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure. 
1H NMR analysis showed a complex mixture of products had formed. 
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5.10.3 Synthesis of 1,3-Amino Alcohol Precursors 
(1S,3S)-1-(((S)-tert-butylsulfinyl)amino)-4,4-dimethyl-1-phenylpentan-3-yl pivalate 
(S,S,S)-270 
 
 
 
 
 
 
Method A 
To a schlenk tube under N2 atmosphere, containing diisopropylamine (1.2 mmol, 0.17 mL) in 
anhydrous THF (5 mL), was added n-BuLi (1.1 mmol, 1.5 M, 0.73 mL) at 0°C. The mixture 
was allowed to stir at 0°C for 30 min. The solution was cooled to -78°C and tert-butanesulfinyl 
imine (S)-259 (0.223 g, 1 mmol) was added in one portion. After the reaction mixture was 
allowed to stir for 1 h at -78°C, pivaldehyde (0.189 g, 2.2 mmol) was added slowly. The reaction 
mixture was kept at -78°C for 3 h and was allowed warm to room temperature overnight. The 
reaction was quenched with saturated NH4Cl (1.5 mL). NH4Cl (10 mL) was added and the 
mixture was extracted with EtOAc (3 x 20 mL). The organic layers were combined and dried 
over anhydrous MgSO4, filtered, and concentrated under reduced pressure. The crude product 
was purified using column chromatography (10 : 1, hexane : EtOAc) on silica gel to give the 
title compound (S,S,S)-270 as a pale yellow solid (0.253 g, 64%, mixture of diastereomers, 90 
: 10 dr). 
Major diastereomer (S,S,S): The major diastereomer was isolated using column 
chromatography (10 : 1, hexane : EtOAc) on silica gel to give the title compound (S,S,S)-270 
as a pale yellow solid (0.232 g, 59%). Mp 162-168°C.  
Rf = 0.15 (4 : 1, hexane : EtOAc). [α]23
𝐷
 + 37.9 (c 1, CHCl3). IR (NaCl) ?̅?max: 3244 (N-H stretch, 
m), 2969 (C-H stretch, s), 1725 (C=O stretch, s), 1470 (C-H bending, s), 1163 (C-O stretch, s), 
1039 (C-N stretch, s) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.95 (9H, s, H-11), 1.19 (9H, s, H-
16), 1.23 (9H, s, H-14), 1.92 (1H, ddd, J = 3.0, 10.9, 14.1 Hz, H-8), 2.33 (1H, ddd, J = 1.5, 
10.9, 14.1 Hz, H-8), 4.10 (1H, ddd, J = 3.0, 6.2, 10.9 Hz, H-7), 4.19 (1H, d, J = 6.2 Hz N-H), 
5.07 (1H, dd, J = 1.5, 10.9 Hz, H-9), 7.22-7.41 (5H, m, Ar-H) ppm; 13C NMR (75.5 MHz, 
CDCl3): δ 22.6 (C-16), 26.1 (C-11), 27.4 (C-14), 34.9 (C-10), 37.2 (C-8), 39.1 (C-13), 56.2 (C-
15), 57.3 (C-7), 77.3 (C-9), 127.4 (2 x Ar-CH), 127.6 (Ar-CH), 128.6 (2 x Ar-CH), 142.1 (C-
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6), 178.6 (C-12) ppm (Note: Exact structural assignment confirmed using COSY, HSQC and 
HMBC); HRMS (ESI) m/z calcd for C22H38NO3S [M + H]
+: 396.2572, found 396.2559. 
Crystallographic data was also obtained for this compound (see Appendix). 
 
Minor diastereomer: The absolute configuration was not determined. 
The minor diastereomer was isolated using column chromatography (10 : 1, hexane : EtOAc) 
on silica gel to give the minor diastereomer of 270 as a yellow oil (0.021 g, 5%).  
Rf = 0.22 (4 : 1, hexane : EtOAc). [α]23
𝐷
 + 57.5 (c 1, CHCl3). IR (NaCl) ?̅?max: 3244 (N-H stretch, 
m), 2970 (C-H stretch, s), 1725 (C=O stretch, s), 1471 (C-H bending, s), 1164 (C-O stretch, s), 
1039 (C-N stretch, s) cm-1; 1H NMR (300 MHz, CDCl3): δ 0.89 (9H, s, H-11), 1.21 (9H, s, H-
16), 1.27 (9H, s, H-14), 1.92 (1H, ddd, J = 3.0, 11.0, 14.4 Hz, H-8), 2.05 (1H, ddd, J = 3.0, 9.9, 
14.4 Hz, H-8), 4.13-4.19 (1H, d, J = 2.7 Hz,  N-H), 4.24 (1H, ddd, J = 2.7, 3.0, 9.9 Hz, H-7), 
4.94 (1H, dd, J = 3.0, 11.0 Hz, H-9), 7.27-7.38 (5H, m, Ar-H) ppm; 13C NMR (75.5 MHz, 
CDCl3): δ 22.8 (C-16), 25.8 (C-11), 27.3 (C-14), 34.8 (C-10), 38.9 (C-8), 39.2 (C-13), 55.3 (C-
7, C-15), 75.5 (C-9), 127.8 (Ar-CH), 127.9 (2 x Ar-CH), 128.5 (2 x Ar-CH), 141.7 (C-6), 178.6 
(C-12) ppm (Note: Exact structural assignment confirmed using COSY, HSQC and HMBC); 
HRMS (ESI) m/z calcd for C22H38NO3S [M + H]
+: 396.2572, found 396.2559. 
 
Isolated by-product from Aldol-Tishchenko Reaction 
(S)-N-(3-hydroxy-4,4-dimethyl-1-phenylpentyl)-2-methylpropane-2-sulfinamide (S)-273 
Yield: 0.078 g, 25%. Mp 82-85°C. Rf = 0.34 (4 : 1, hexane : EtOAc). 
[α]23
𝐷
 – 16.3 (c 0.43, CHCl3). IR (NaCl) ?̅?max: 3583 (N-H stretch, m), 
2962 (C-H stretch, s), 1558 (C=O stretch, s), 1081 (C-N stretch, s) 
cm-1; 1H NMR (300 MHz, CDCl3): δ 1.19 (9H, s, H-11), 1.33 (9H, 
s, H-13), 5.69 (1H, s, H-8), 7.40-7.56 (5H, m, Ar-H), 12.07 (1H, bs, 
N-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 22.6 (C-13), 27.2 (C-
11), 43.0 (C-10), 57.3 (C-12), 99.5 (C-8), 128.6 (2 x Ar-CH), 128.7 (2 x Ar-CH), 130.3 (Ar-
CH), 135.0 (C-6), 160.9 (C-7), 207.7 (C-9) ppm; HRMS (ESI) m/z calcd for C17H26NO2S [M + 
H]+: 308.1688, found 308.1684. 
Crystallographic data was also obtained for this compound (see Appendix). 
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Method B 
To a schlenk tube under N2 atmosphere, containing diisopropylamine (1.2 mmol, 0.17 mL) in 
anhydrous THF (5 mL), was added n-BuLi (1.1 mmol, 1.5 M, 0.73 mL) at 0°C. The mixture 
was allowed to stir at 0°C for 30 min. The solution was cooled to -78°C and tert-butanesulfinyl 
imine (S)-259 (0.223 g, 1 mmol) was added in one portion. After the reaction mixture was 
allowed to stir for 1 h at -78°C, MgBr2 (0.368 g, 2 mmol) was added in one portion. The reaction 
mixture was allowed to stir for a further 45 min at -78°C. Pivaldehyde (0.189 g, 2.2 mmol) was 
added dropwise. The reaction mixture was kept at -78°C for 3 h and was allowed warm to room 
temperature overnight. The reaction was quenched with saturated NH4Cl (1.5 mL), EtOAc (10 
mL) and NH4Cl (10 mL) were added and the mixture was extracted with EtOAc (3 x 20 mL). 
The organic layers were combined and dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure. The crude product was purified using column chromatography (10 : 1, 
hexane : EtOAc) on silica gel to give 270 as a clear oil (0.059 g, 15%, mixture of diastereomers, 
79 : 21 dr). 
Spectroscopic characteristics were consistent with that of 270 shown earlier. 
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(S)-N-((1S,3S)-3-hydroxy-4,4-dimethyl-1-phenylpentyl)-2-methylpropane-2-sulfinamide 
(S,S,S)-278  
 
 
 
 
 
Method A 
To potassium hydroxide (0.007 g, 0.126 mmol) in 1:1, EtOH : water, was added  (1S,3S)-1-
(((S)-tert-butylsulfinyl)amino)-4,4-dimethyl-1-phenylpentan-3-yl pivalate (S,S,S)-270 (0.05 g, 
0.126 mmol) at room temperature. This mixture was allowed to stir for 24 h. The reaction 
mixture was concentrated under reduced pressure to remove the EtOH. Water (1 mL) was added 
and the mixture was extracted with EtOAc (3 x 10 mL). The organic layers were combined and 
dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to give a pale 
yellow solid. 
1H NMR analysis and TLC analysis showed the reaction was unsuccessful and that only starting 
material remained. 
 
Method B 
To (1S,3S)-1-(((S)-tert-butylsulfinyl)amino)-4,4-dimethyl-1-phenylpentan-3-yl pivalate 
(S,S,S)-270 (0.091 g, 0.23 mmol)  in MeOH (5 mL) was added potassium carbonate (0.079 g, 
0.575 mmol) in one portion. The reaction mixture was heated at reflux overnight. The reaction 
mixture was cooled to room temperature. EtOAc (5 mL), water (2 mL), and a solution of 
saturated NH4Cl (2 mL) were added. The resulting biphasic mixture was extracted with EtOAc 
(3 x 10 mL). The organic layers were combined and dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure to give a pale yellow solid. 
1H NMR analysis and TLC analysis showed the reaction was unsuccessful and that only starting 
material remained. 
 
Method C 
To a schlenk tube under N2 atmosphere, containing DIBAL-H (0.315 mmol, 1 M, 0.315 mL) in 
anhydrous CH2Cl2 (2 mL), was added the (1S,3S)-1-(((S)-tert-butylsulfinyl)amino)-4,4-
dimethyl-1-phenylpentan-3-yl pivalate (S,S,S)-270 (0.05 g, 0.126 mmol, major diastereomer) 
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at -78°C. The mixture was allowed warm to room temperature and allowed to stir for 1 h at this 
temperature. The reaction was cooled to 0°C and MeOH (1 mL) was added slowly to quench 
the excess DIBAL-H. The reaction was allowed warm to room temperature. Aqueous 10% HCl 
was slowly added to hydrolyse the aluminium salts. The layers were separated and the organic 
layer was washed with aqueous NaHCO3 and brine. The organic layer was dried over anhydrous 
MgSO4, filtered, and concentrated under reduced pressure. The crude product was purified 
using column chromatography (4 : 1, hexane : EtOAc) on silica gel to give the title compound 
(S,S,S)- 278 as a white solid (0.020 g, 51%, >98 : 2 dr). Mp 142-147°C. 
Rf = 0.3 (1 : 1, hexane : EtOAc). [α]23
𝐷
 – 24.6 (c 1, CHCl3) for S,S,S diastereomer. IR (NaCl) 
?̅?max: 3263 (O-H stretch, s), 2957 (C-H stretch, s), 1479 (C-H bending, s), 1164 (C-O stretch, 
s), 1028 (C-N stretch, s) cm-1, 1H NMR (300 MHz, CDCl3): δ 0.89 (9H, s, H-11), 1.16 (9H, s, 
H-13), 1.70-1.89 (2H, m, H-8), 2.77 (1H, bs, OH), 3.43 (1H, dd, J = 2.2, 10.1 Hz, H-9), 3.94 
(1H, d, J = 7.2 Hz, N-H), 4.71 (1H, ddd, J = 3.9, 7.2, 11.1 Hz, H-7), 7.20-7.42 (5H, m, Ar-H) 
ppm; 13C NMR (75.5 MHz, CDCl3): δ 22.8 (C-13), 25.8 (C-11), 34.6 (C-10), 40.8 (C-8), 54.3 
(C-7), 56.7 (C-12), 75.2 (C-9), 126.7 (2 x Ar-CH), 127.3 (Ar-CH), 128.7 (2 x Ar-CH), 143.5 
(C-6) ppm (Note: Exact structural assignment confirmed using COSY, HSQC and HMBC); 
HRMS (ESI) m/z calcd for C18H30NO2 [M + H]
+: 312.1997, found 312.2001. 
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(1S,3S)-1-amino-4,4-dimethyl-1-phenylpentan-3-yl pivalate.HCl (S,S,S)-279  
To tert-butylsulfinyl-amino-pivalate (S,S,S)-270 (0.062 g, 0.16 
mmol, major diastereomer) were added 1,4-dioxane (1.9 mL) and 4 
M HCl (2.88 mL). The reaction mixture was heated at reflux 
overnight. The reaction mixture was cooled to room temperature and 
concentrated under reduced pressure. EtOAc (10 mL) was added at 
which point the product crashed out of solution. The solid was 
filtered and dried to afford the title compound (S,S,S)-279 as a white solid (0.039g, 85%, >98 : 
2 dr). Mp 218-220°C. 
[α]23
𝐷
 + 7.7 (c 1, CH2Cl2). IR (NaCl) ?̅?max: 2959 (C-H stretch, s), 1716 (C=O stretch, s), 1458 
(C-H bending, s), 1162 (C-O stretch, s), 1042 (C-N stretch, s) cm-1; 1H NMR (300 MHz, 
CDCl3): δ 0.91 (9H, s, H-11), 1.11 (9H, s, H-14), 1.96 (1H, ddd, J = 4.8, 10.5, 15.0 Hz, H-8), 
2.63 (1H, dd, J = 8.4, 15.0 Hz, H-8), 3.91-4.13 (1H, m, H-7), 4.79-5.03 (1H, m, H-9), 7.27-7.41 
(3H, m, Ar-H), 7.41-7.55 (2H, m, Ar-H), 8.75 (3H, bs, N-H) ppm; 13C NMR (75.5 MHz, 
CDCl3): δ 25.9 (C-11), 27.2 (C-14), 34.9 (C-10), 35.9 (C-8), 39.1 (C-13), 54.5 (C-7), 77.6 (C-
9), 127.6 (2 x Ar-CH), 129.0 (Ar-CH), 129.1 (2 x Ar-CH), 136.1 (C-6), 179.1 (C-12) ppm 
(Note: Exact structural assignment confirmed using COSY, HSQC and HMBC); HRMS (ESI) 
m/z calcd for C18H30NO2 [M + H]
+: 292.2277, found 292.2276. 
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1.1 Introduction 
1.1.1 Background 
Currently, we are confronted with a worrying situation with respect to the lack of effective 
therapies against antibiotic-resistant bacterial infections. This predicament is attributed to the 
mode of action of marketed antibiotics, which is based on interference with bacterial growth. 
This therapeutic treatment inevitably results in the development of resistant strains.1  
A promising strategy to overcome the growing and challenging resistance problem is to 
selectively target non-vital functions that are associated with the pathogenicity of a bacteria, 
such as the production of virulence factors.2-5 The human opportunistic pathogen Pseudomonas 
aeruginosa is a Gram-negative bacterium and opportunistic pathogen that causes diseases in 
patients with impaired host defences and is often responsible for life-threatening nosocomial 
infections among immunocompromised individuals.6,7 It is also the main morbidity- and 
mortality-causing agent in people suffering from cystic fibrosis. Aside from an extensive 
inflammatory response that is dominated by polymorphonuclear neutrophils,8 virulence factors 
play a critical role in progressive lung deterioration during infection. Their production is 
controlled by a cell density-dependent extraordinary cell-to-cell communication system, which 
is known as quorum sensing.9,10 Quorum sensing in P. aeruginosa is controlled by small organic 
molecules. With a focus on developing anti-infectives with novel modes of action, recent 
publications highlight quorum sensing inhibitors (QSIs) as potential powerful agents for anti-
virulence therapy.11-14 
P. aeruginosa uses quorum sensing to modulate gene expression in phenotypes such as 
swarming motility and the production of an arsenal of extracellular virulence factors that are 
capable of causing extensive tissue damage, bloodstream invasion, and consequently the 
promotion of systemic dissemination.15 A key phenotype modulated by P. aeruginosa involves 
the formation of a protective biofilm which play a key role in its defence against antibiotics. 
Quorum sensing allows bacteria to regulate the gene expression of a large array of target genes 
in a cell population density-dependent manner via the exchange of small signalling molecules 
referred to as an autoinducers.16,17  
There are two classes of quorum-sensing molecules produced by P. aeruginosa, the N-
acylhomoserine lactone family including N-(3-oxo-dodecanoyl)-l-homoserine lactone 1 and N-
butanoyl-homoserine lactone 2 (C4-HSL) and the 2-alkylquinolones, including 2-heptyl-4-
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quinolone 3 (HHQ) and the corresponding dihydroxylated derivative, 2-heptyl-3-hydroxy-4-
quinolone or as it is better known Pseudomonas quinolone signal 4 (PQS) (Figure 1.1.1).18-20 
 
 
 
 
 
      1               2  
 
 
 
 
 
 
 
 
   HHQ 3            PQS 4 
Figure 1.1.1 
Acyl-homoserine lactone signalling can occur in vivo in the mouse lung, and acyl-homoserine 
lactone signals are produced by P. aeruginosa growing ex vivo within sputum samples from 
infected cystic fibrosis patients.21 PQS-mediated cell-to-cell signalling occurs within the 
infected cystic fibrosis lung and therefore PQS has been recognised as a unique drug target for 
the development of new therapies for treating P. aeruginosa infections.22 
 
  
Appendix 1   Introduction 
5 
 
1.1.2 The Biosynthesis of PQS 
Studies on the biosynthesis of 4-quinolones have shown that they are derived from the 
condensation of anthranilic acid 5 and a β-keto-fatty acid 6.  Because PQS has a similar 4-
quinolone base structure, it was predicted to have a similar metabolic route (Scheme 1.1.1).  
Calfee et al. confirmed that anthranilate was a precursor for PQS and also showed that an 
anthranilate analogue, methyl anthranilate, competes with anthranilate in this process, thereby 
decreasing the production of PQS.23 Cells grown in the presence of methyl anthranilate were 
shown to have reduced elastase activity (a key feature of biofilm formation), suggesting that 
interfering with the PQS biosynthetic pathway may be a potential target to reduce the virulence 
of P. aeruginosa.23 The primary metabolite anthranilate was shown to undergo a head-to-head 
condensation with β-keto-decanoic or β-keto-dodecanoic acid involving the release of the 
carboxlylate of the fatty acid as CO2 (Scheme 1.1.1) This study also verified this mechanism 
for the synthesis of PQS using labelling studies, since it showed that C-4 of PQS derives from 
anthranilic acid 5 and C-2 derives from the acetate 6.24 
 
 
 
 
 
          Anthranilic Acid 5        6 
 
 
 
 
 
 
 
 
 
 
 
PQS 4 
Scheme 1.1.1 
In P. aeruginosa, anthranilate is synthesised by either the conversion of chorismate 7 via one 
of the two anthranilate synthases TrpEG and PhnAB, or by the breakdown of tryptophan 8 
through the kynurenine pathway. The kynurenine pathway and the secondary anthranilate 
synthase PhnAB have been shown to provide anthranilate for the production of PQS (Scheme 
1.1.2).25  
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Chorismate 7           Formyl kynurenine 9 
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            Anthranilic Acid 5 
 
 
 
 
 
 
 
 
 
      HHQ 3 
 
 
 
 
 
 
 
 
 
      PQS 4 
Scheme 1.1.2 
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In the kynurenine pathway, three genes (kynA, kynB and kynU) of the anthranilate branch are 
responsible for converting tryptophan 8 to anthranilate, and these are present in P. aeruginosa.26 
This proposal was verified since a strain fed with radiolabelled tryptophan 8 produced 
radiolabelled PQS.26 Experiments with mutant strains showed that kynA and kynU mutants did 
not produce PQS and a kynB mutant did produce PQS but at a level which was much lower 
than wild-type.26 Interestingly, none of the PQS detected from any of the mutant strains showed 
any radioactivity, indicating that a major source of the anthranilic acid 5 used in the synthesis 
of PQS via the kynurenine pathway.26 The pathway is proposed to function via three enzymes: 
KynA, (a tryptophan 2,3-dioxygenase) converts tryptophan 8 to formyl kynurenine 9, which is 
then converted to kynurenine 10 via KynB (kynurenine formidase), which is in turn converted 
to anthranilic acid 5 via a kynureninase, KynU.26  
The fact that there are two separate pathways (Kyn and PhnAB) to anthranilate, which is a 
precursor to 4-quinolones, highlights the fact that this metabolite is important for the 
pathogenesis of P. aeruginosa.26 Experiments to determine the relative importance of the two 
pathways show that in the kyn pathway mutants grown in minimal medium, PQS was still 
produced, however a phnA mutant did not produce PQS unless supplemented with anthranilate 
or phnAB genes.26 In strains grown in rich medium it was determined that the kyn pathway was 
the main source of anthranilate.26 It was therefore concluded that PhnAB is used to produce 
PQS when tryptophan 8 is unavailable, but when tryptophan 8 is present, the kyn pathway is 
the major route to anthranilic acid 5.26 
It is also interesting that sputum from the lungs of cystic fibrosis patients has been shown to 
contain a large proportion of amino acids.27  It is suggested that these amino acids, and 
particularly aromatic amino acids provide the sole carbon source to support growth of P. 
aeruginosa in cystic fibrosis sputum and contribute to the induction of PQS.27 In experiments, 
a P. aeruginosa strain grown in minimal medium produced three times more PQS when 
supplemented with tryptophan 8.27 Furthermore the strain produced five times more PQS when 
grown in cystic fibrosis sputum than when grown in a glucose medium.27 This implies that the 
cystic fibrosis lung may provide an amino acid-rich environment which promotes the 
production of PQS.26 
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1.1.3 Cell-to-Cell Communication 
P. aeruginosa’s virulence depends on a large number of cell-associated and extracellular 
factors. Cell-to-cell signalling systems control the expression and allow a coordinated, cell-
density-dependent production of many virulence factors. 
Cell-to-cell signaling systems enable P. aeruginosa to overcome host defense mechanisms. 
Isolated production of extracellular virulence factors by a small number of bacteria lead to an 
efficient host response neutralizing these compounds. However, the coordinated expression of 
virulence genes by an entire bacterial population allow P. aeruginosa to secrete extracellular 
factors but only when they can be produced at high enough levels to overcome host defenses. 
These factors alter the precarious balance between host defenses and production of bacterial 
toxins, leading to invasion of blood vessels, dissemination, systemic inflammatory-response 
syndrome, and finally death. Even appropriate antibiotic therapies are often unable to stop this 
course; therefore, the process must be blocked early.28 
The pathogenesis of P. aeruginosa is clearly multifactorial as underlined by the large number 
of virulence factors and the broad spectrum of diseases the bacterium causes. Many of the 
extracellular virulence factors required for tissue invasion and dissemination are controlled by 
cell-to-cell signaling systems involving homoserine lactone-based signal molecules and 
specific transcriptional activator proteins.29-32 These regulatory systems enable P. aeruginosa to 
produce virulence factors in a coordinated, cell-density-dependent manner that could allow the 
bacteria to overwhelm the host defense mechanisms. Interference with cell-to-cell signaling 
dependent virulence factor production is a promising therapeutic approach for reducing illness 
and death associated with P. aeruginosa colonization and infection. The growing number of 
human pathogens found to contain cell-to-cell signaling systems highlights the importance of 
exploring interference with bacterial cell-to-cell signaling for new therapeutic interventions.28  
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1.1.4 Biological Functions and Applications 
The quinolone PQS has a vast and varied array of biological functions, influencing iron 
homeostasis,20,33 vesicle formation,34 secondary metabolite production and biofilm formation.35 
P. aeruginosa PQS signalling is highly responsive to environmental and host-specific cues, 
including Mg2+ concentration and the cystic fibrosis therapeutic colistin.36 Recent evidence has 
revealed that PQS is capable of modulating immune responses and human T-cell 
proliferation.37,38 However, relatively little is known about their role within a host.39  
P. aeruginosa infects the airways of almost 100% of cystic fibrosis patients. These patients 
have a defective immune system which is unable to clear the bacteria, leading to chronic lung 
infections which are notoriously difficult to treat, due to the development of resistance to 
antimicrobial therapy.36 PQS production is altered in the lungs of the cystic fibrosis patient.36 
It has been demonstrated that PQS levels produced are 7 to 15 fold higher in cystic fibrosis 
patients aged 24-36 months than in a laboratory strain.36 However in older patients there is a 
significant reduction in PQS production.36 This suggests that PQS production varies during 
adaptation to the environment of the cystic fibrosis lung and therefore may be a target to exploit 
in attempts to alter early colonization.36 
In the environment of the cystic fibrosis lung, P. aeruginosa forms a biofilm which protects the 
bacteria from attack from the host immune system and antibacterial agents, therefore rendering 
these infections very difficult to treat.40 Bacterial biofilms are organised groups of cells existing 
in a polymer matrix which is generally self-produced and adhered to an inert or living surface.  
Extracellular DNA, polysaccharides and proteins can all function as components of the biofilm 
matrix.  PQS has been indicated as being important in the formation of biofilms.35 Growth of a 
P. aeruginosa biofilm on a stainless-steel coupon was increased on addition of PQS.35 The 
molecular mechanism for this is not fully defined, however it was observed that lectin, which 
is under the control of PQS, may be involved, since lecA mutants formed poor biofilms35 and 
further observations suggest that lectin plays a role in the maturation of biofilms. 
The virulence of P. aeruginosa is also likely to be affected by the amount of PQS produced, 
since many virulence factors including elastase, rhamnolipids, the galactophilic lectin, LecA 
and pyocyanin are regulated by PQS.  Gallagher et al. showed that P. aeruginosa strains which 
were unable to produce PQS had a reduced ability to kill nematodes, a group of cylindrically 
shaped worms.41 Modern 4-quinolone antibiotics target DNA gyrase of bacteria, but this is often 
naturally mutated, especially in P. aeruginosa, to give resistant strains.42 In spite of the growth 
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of these resistant strains, some 4-quinolones are shown to have an inhibitory effect, possibly 
because the quinolone reduces the synthesis of various virulence factors controlled by quorum 
sensing. 
There is increasing evidence to suggest that environmental factors other than cell density play 
a role in signalling via quorum sensing systems.39 Addition of exogenous PQS to P. aeruginosa 
depletes free iron from the growth medium, and probably functions as an iron trap, taking in 
iron from the growth medium and retaining it in association with the bacterial cell surface.20 In 
this way PQS may promote trapping and storing of iron for future use, since iron is an essential 
nutrient for P. aeruginosa.20,39 In addition, by using up available sources of iron, it may also 
starve competing bacterial species of free iron, promoting its chances of survival.39 
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1.2 Results and Discussion 
1.2.1 Introduction 
The anti-virulence therapy using QS inhibitors (QSIs) selectively intervening with 
pathogenicity, e.g. by repressing the production of virulence factors, without impairing bacterial 
viability has been proposed as an alternative approach to conventional anti-bacterial therapy. It 
is supposed that in this anti-virulence therapy the selection pressure is reduced. This treatment 
option is therefore regarded as a promising strategy to overcome the rising and challenging 
resistance problem. This approach is not bactericidal therefore resistance is not a problem.23 
PQS and HHQ have emerged as key regulators of bacterial cooperative behaviour in the 
antibiotic resistant human pathogen P. aeruginosa (as discussed in section 1.1) and would 
therefore become the targets of our investigations. 
Our objective during this research project was twofold: Firstly, to synthesise 3-haloquinolin-4-
ones as analogues of PQS. These substrates would facilitate mechanistic studies into PQS 
signalling in virulent Pseudomonas populations with important clinical applications. We would 
hope to interrupt PQS biosynthesis by inhibiting conversion of HHQ to PQS, and in turn disrupt 
the production of virulence factors of P. aeruginosa using C-3 analogues by functionalising the 
C-3 position. With these analogues hydrogen bonding would also not be possible, however an 
electron-withdrawing group would still be present, and the impact of this would be investigated.  
Secondly, we wanted to explore if a new N-methyl version could be used in palladium cross-
coupling reactions, thus providing access to an array of new biologically important quinolones. 
Importantly, the 2-heptyl chain is essential for certain biological functions such as the 
stimulation of outer vesicle formation in P. aeruginosa and thus synthetic procedures on 
compounds bearing this bulky and hydrophobic substituent are important. There are no reports 
of halogenation or subsequent cross-coupling of HHQ at the C-3 position. From a synthetic 
viewpoint, the presence of the long hydrophobic chain represents a challenge due to low 
solubility and the obvious steric hindrance.  
The literature on the chemical synthesis of HHQ and PQS was scant at the onset of this project. 
The Somanathan et al. synthesis of HHQ involved condensation of  the long chain acid chloride 
with the carbanion derived from ethyl acetoacetate 11 to give 12, followed by deacetylation 
using sodium ethoxide to  afford  the  corresponding β-keto-ester 13. This β-keto-ester 13 was 
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condensed with aniline in the presence of p-toluene sulfonic acid and a Conrad–Limpach 
cyclisation gave HHQ 3 (Scheme 1.2.1).43 
 
 
 
 
           11 
          12 
           
 
 
 
 
 
 
            
          13 
   HHQ 3 
Scheme 1.2.1 
In Woschek’s synthesis of HHQ,44 the β-keto-ester 13 was prepared using a procedure described 
by Epstein (Scheme 1.2.2).45  
 
 
 
      14        13 
 
 
 
 
 
 
 
 
 
 
 
 
 
   HHQ 3 
Scheme 1.2.2 
Ethyl acetate 14 was deprotonated using lithium hexamethyldisilazide followed by reaction 
with octanoyl chloride. The β-keto-ester 13 was condensed with aniline and cyclised using 
diphenyl ether as described in Somanathan’s synthesis above. An alternative method for the 
cyclisation step involves the use of sulphuric acid and acetic anhydride, also yielding HHQ.46 
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The conversion of HHQ to PQS via the formyl intermediate, which is oxidised with hydrogen 
peroxide in basic medium, has been described by Pesci et al.42 
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1.2.2 Synthesis of 2-heptylquinolin-4(1H)-one 
For our synthesis of HHQ, we decided to employ a procedure from Oikawa et al. for the 
preparation of the β-keto-ester,47 which takes advantage of the reactivity of Meldrum’s acid 15. 
Meldrum’s acid 15 readily reacts with electrophiles, even in the absence of a strong base 
because of its high acidity (pKa of 4.97).
47,47 Therefore, acylation of 15 is also expected to occur 
under similar conditions.47 
Meldrum’s acid 15 was reacted with octanoyl chloride in the presence of pyridine. The reaction 
was monitored by NMR analysis until all starting material had reacted. The mixture was then 
washed with 5% HCl solution several times and water. The organic layer was dried, filtered, 
and concentrated under reduced pressure, to afford the acylated Meldrum’s acid 16 as a brown 
oil. This residue was used in the next step without further purification (Scheme 1.2.3). The 
spectroscopic data obtained for 16 was consistent with that previously reported.48 
 
 
 
 
        15      16 
Scheme 1.2.3 
Newly formed 16 was then subjected to methanolysis, instead of ethanolysis because of the 
excellent yields obtained by Oikawa, to afford the methyl β-keto-ester 17 in 66% yield over 
two steps (Scheme 1.2.4). The spectroscopic data corresponded to that previously reported in 
the literature.48 
 
 
 
    
  
       16                              17, 66% over two steps  
Scheme 1.2.4 
For the remaining steps, we employed Somanathan’s conditions.43 β-keto-ester 17 was 
condensed with aniline in the presence of p-toluene sulfonic acid at reflux, using a Dean-Stark 
apparatus. The crude enamine 18 was used in the next step without further purification (Scheme 
1.2.5). To the best of our knowledge there has been no previous report of compound 18 in the 
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literature. The 1H NMR spectrum was distinctly different from that of the β-keto-ester 17. A 
distinctive peak was observed at 4.73 ppm for the enamine hydrogen at C-2. A broad singlet 
was observed at 10.30 ppm for the NH signal, confirming incorporation of the aniline moiety 
into the target compound. A dramatic shift is also observed for C-2 in the 13C NMR. The signal 
for the CH2 at C-2 for the β-keto-ester 17 had been observed at 49.0 ppm, but was now present 
much further downfield at 84.5 ppm for the enamine. DEPT spectra confirmed this was a CH 
signal. A mass spectrum in the positive mode confirmed the presence of the protonated 
molecular ion at m/z = 276. 
Enamine 18 was subjected to Conrad–Limpach cyclisation by refluxing in diphenyl ether. The 
formed MeOH was removed under reduced pressure. To the isolated residue, diethyl ether and 
2 M hydrochloric acid solution were added. The mixture was allowed to stir vigorously for 5 
min, then allowed stand at room temperature for 18 h. The crystalline solid which formed was 
filtered and washed with diethyl ether to afford a yellow solid. The crude product was 
crystallised from ethyl acetate and the pure 19 isolated as a cream solid in a 40% yield over two 
steps (Scheme 1.2.5). 
 
  
 
 
 
   17                18 
 
 
 
 
 
 
 
 
 
 
 
 
            HHQ.HCl 19, 40% over two steps 
Scheme 1.2.5 
Initially we were concerned that the 1H NMR and 13C NMR spectra did not correspond to 
previous data obtained for HHQ. The carbon at C-4 was observed much further upfield (169.7 
ppm) then one would expect for a carbonyl in this system. We concluded this signal was more 
indicative of the C=C-OH and that HHQ must be present as the hydroxy-quinoline tautomer. 
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This was further supported by crystal structure analysis (Figure 1.2.1), which confirmed HHQ 
was isolated as the hydrochloride salt HHQ.HCl 19.  
 
 
HHQ.HCl 19 
Figure 1.2.1 
The free base, HHQ (Figure 1.2.2) was easily obtained by stirring the hydrochloride salt 
HHQ.HCl 19 in chloroform (due to poor solubility in other solvents) and adding 15% sodium 
hydroxide solution until the aqueous layer reached neutral pH. The mixture was separated and 
extracted with chloroform. The combined organic layers were dried, filtered and concentrated 
to afford HHQ 3 in a 95% yield. 
 
HHQ 3 
Figure 1.2.2 
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1.2.3 Synthesis of 3-halo-analogues of 2-heptylquinolin-4(1H)-one  
At the onset of the project, structure–function analysis on HHQ and PQS had centred on the 
alkyl chain length49,50 and substitution of the anthranilate ring.49 The crucial C-3 position had 
not been investigated. Subsequent to our published investigations,51,52 Hartmann and co-
workers have reported ‘blocking’ the C-3 position of HHQ and repressing PQS biosynthesis 
using 20 (Figure 1.2.3).14,53 
 
20 
Figure 1.2.3 
Therefore, the structure–function analysis in this project study was designed to provide key 
insights into the activity of the HHQ and PQS compounds both within P. aeruginosa and also 
towards non-pseudomonal bacterial and fungal species. To date there have been no reports of 
halogenation or cross-coupling of HHQ or its derivatives. 
HHQ was subjected to chlorination using sodium dichloroisocyanurate 21 following a 
chlorination-procedure by Staskun.54 Crystallisation from MeOH afforded the product 22 as 
colourless crystals in a 58% yield (Scheme 1.2.6). Successful chlorination was confirmed by 
the absence of the C-3 proton signal at 6.21 ppm in the 1H NMR spectrum. A high resolution 
mass spectrum in the positive mode confirmed the presence of the protonated molecular ion at 
m/z = 278.1306. 
 
 
 
 
 
 
         21  
 
 
        HHQ 3                  22, 58% 
Scheme 1.2.6 
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Bromination of HHQ was achieved using pyridinium tribromide 23 and acetic acid. Aqueous 
sodium thiosulfate was added to quench the reaction and the formed precipitate was filtered and 
washed with ice-cold EtOH (15 ml). The crude solid was crystallised from EtOH to give 24 as 
pale yellow cystals in a 50% yield (Scheme 1.2.7). The successful incorporation of the bromine 
was evident in the 13C NMR where a shift in the C-3 peak was observed from 108.5 ppm (for 
HHQ) to 105.1 ppm for 24. Again the C-3 proton signal at 6.21 ppm, for HHQ was absent from 
the 1H NMR spectrum. A high resolution mass spectrum in the positive mode confirmed the 
presence of the protonated molecular ion at m/z = 322.0812. 
 
 
 
 
 
      23 
    
 
                HHQ 3       24, 50% 
Scheme 1.2.7 
Iodination was successful using iodine and sodium carbonate in THF. Sodium thiosulfate was 
used to quench the reaction and the precipitate which formed was collected by filtration and 
washed with ice cold water. The product 25 did not require further purification and was isolated 
in 48% yield (Scheme 1.2.8). 
 
 
 
  
 
 
         HHQ 3             25, 40% 
Scheme 1.2.8 
Iodination was also evident in the 13C NMR where a shift in the C-3 peak was observed from 
108.5 ppm (for HHQ) to 85.7 ppm for 25. Again the C-3 proton signal at 6.21 ppm, for HHQ 
was absent from the 1H NMR spectrum. A high resolution mass spectrum in the positive mode 
confirmed the presence of the protonated molecular ion at m/z = 370.0656. 
The anticipated low reactivity associated with the sterically demanding neighbouring alkyl 
chains never materialised in these reactions and moderate to good yields were achieved for all 
halogenations.  
Appendix 1   Results and Discussion 
19 
 
Furthermore, iodide 25 was easily methylated by deprotonation with sodium hydride, at 40°C 
for 5 h, followed by alkylation with methyl iodide, for 12 h at 40°C, affording 26 in 67% yield 
(Scheme 1.2.9).55 
 
  
 
 
 
 
         25       26, 67% 
Scheme 1.2.9 
We were aware that the structural isomer 27 (Figure 1.2.4) could also be formed from this 
reaction. 
 
27 
Figure 1.2.4 
The spectroscopic data showed that one product had been formed. On comparison of the 13C 
NMR spectra with the signals of similar compounds, 2856 and 29,53 in the literature (Figure 
1.2.5), we elucidated, 26 had been prepared in preference to the structural isomer 27. 
 
           28     29 
Figure 1.2.5 
On analysis of the 13C NMR spectra, the data clearly showed a distinct similarity to that of N-
methylated 28. In our 13C NMR spectrum a signal at 173.8 ppm was observed which was 
indicative of a carbonyl moiety. Also a signal at 40.1 ppm supported our claims for the 
preferential formation of the N-methylated isomer, 26. 
 
177.7 ppm 
34.3 ppm 
55.5 ppm 
164.3 ppm 
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Oxidative addition of HHQ to the palladium complex would be expected to be slow due to the 
large steric bulk of the seven carbon alkyl chain. However we were encouraged by reports 
previously in the literature, where a similar substrate successfully underwent Suzuki-Miyaura 
coupling at the C-3 position with the presence of a phenyl group at C-2.55 
To our delight, we were able to successfully perform a Suzuki-Miyaura coupling reaction at C-
3 using phenylboronic acid and palladium-tetrakis(triphenylphosphine) as precatalyst (Scheme 
1.2.10).  
 
 
 
 
 
 
         26       30, 50% 
Scheme 1.2.10 
After heating at 130°C for 30 min, palladium black was seen to precipitate and the reaction was 
stopped. The coupled product was purified using column chromatography (1:1, hexane:EtOAc) 
and 30 was isolated in 50% yield.  
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This reaction follows the general Suzuki-Miyaura coupling reaction mechanism57,58 (Scheme 
1.2.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
  
 
 
 
Scheme 1.2.11  
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1.2.4 Biological Results and Discussion 
Biological studies were carried out by our collaborators Dr. Jerry Reen and Prof. Fergal O’Gara 
at the Microbiology Department, University College Cork. 
The PQS signalling system, a key component of quorum sensing in P. aeruginosa, is known to 
control production of a range of virulence factors, including biofilm formation, elastase, 
rhamnolipid and the phenazine redox compound pyocyanin.35,41 The synthesis of PQS itself 
was not completed as part of this PhD project but was prepared by another member of the group. 
It was hoped functionalisation at the C-3 position would identify either a potential antagonist 
in the biosynthesis of PQS or an antivirluence agent to interfere with the pathogency of P. 
aeruginosa. 
Phenazine is important in P. aeruginosa for the production of pyocyanin. It is this compound 
which contributes to the ability of P. aeruginosa to colonise the lungs of cystic fibrosis patients. 
Phenazine natural products have been implicated in the virulence and competitive fitness of 
producing organisms. Phenazines can benefit P. aeruginosa by serving as signalling molecules, 
regulating persister cell formation, influencing colony morphology, and promoting iron 
acquisition and biofilm development.59 By interfering with phenazine restoration we would be 
impeding a key virulence factor of P. aeruginosa. 
Halo-analogues, 22, 24 and 25 were first assessed for restoration of phenazine production in a 
pqsA mutant, in which the biosynthetic steps required for 2-alkylquinolone production have 
been disrupted. 
While both HHQ 3 and PQS restored phenazine production in the pqsA mutant strain, the halo-
analogues, 22, 24 and 25, were significantly less effective in triggering production of the 
phenazine (Figure 1.2.6), suggesting that the C-3 position is crucial for control of phenazine 
production in P. aeruginosa and identifying 22, 24 and 25 as potential anti-virulence agents. 
 
Appendix 1   Results and Discussion 
23 
 
 
 
Figure 1.2.6 
P. aeruginosa is notorious for its ability to cause chronic infections by its high level of drug 
resistance involving the formation of biofilms as previously mentioned. Biofilm formation20,39 
is a structured community of bacterial cells enclosed in a self-produced polymeric matrix 
adhering to an inert or living surface.60 This mode of growth is particularly resistant to 
antibodies and antibiotics. In multi-drug resistant bacteria, biofilms play a key role in allowing 
the pathogen to overcome host defences and contribute to its virulence. PQS has been shown to 
mediate the formation of biofilm in P. aeruginosa.35 Bacillus substilis is a Gram positive 
bacteria which co-inhabits the soil environment with P. aeruginosa.61 B. substilis species are 
an excellent and well-utilised model system for Gram positive bacteria, and a cross-species 
influence with P. aeruginosa has been shown.62 In light of this co-existance of B. substilis and 
P. aeruginosa in soil, it is perhaps unsurprising that communication mechanisms between both 
organisms would exist. 
Given that both the quinolone (HHQ) and the HCl salt of its tautomer hydroxy-quinoline 
(HHQ.HCl 19) were accessible, we felt it would be valuable to confirm that both exhibited 
identical activities for biofilm formation. Biofilm formation were similarly influenced in B. 
subtilis in the presence of HHQ 3 and HHQ.HCl 19 (Figure 1.2.7). This was determined using 
optical density measurments at 595 nm. Optical density, measured in a spectrophotometer, can 
be used to measure biofilm thickness. As visible light passes through a cell suspension the light 
is scattered. Greater scatter indicates thicker biofilm formation. 
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Figure 1.2.7 
However, in contrast to HHQ and HHQ.HCl 19, antibiofilm activity towards B. subtilis was 
abolished upon substitution at the C-3 position, i.e. halo-analogue 24 (Figure 1.2.7), 
highlighting the importance of the C-3 position in the biological role of these compounds. 
Although PQS has been found in sputum of patients suffering from cystic fibrosis,22 the impact 
and potential cytotoxic effects of these compounds on airway epithelial cells has not been 
investigated. Therefore, HHQ, PQS and compounds 22, 24 and 25  were tested for cytotoxicity 
towards a human airway epithelial cell line (Figure 1.2.8).  
B. subtilis biofilm formation 
H
H
Q
.H
C
l 
3
0
2
 
H
H
Q
 2
8
6
 
C
o
n
tr
o
l 
P
Q
S
 2
8
7
 
B
r 
3
0
7
 
Appendix 1   Results and Discussion 
25 
 
 
 
  
Figure 1.2.8 
Interestingly, HHQ was found to be cytotoxic towards IB3-1 cells while PQS did not exhibit 
any cytotoxic activity. The cytotoxicity of both the quinolone (HHQ) and hydroxy-quinoline 
hydrochloride (HHQ.HCl 19), towards IB3-1 cells were comparable (∼60%). The halo-
analogues 22, 24 and 25 did not exhibit cytotoxicity towards IB3-1 cells. This is further 
evidence to support the importance of the C-3 position in the biological functionality of the 
HHQ and PQS molecules. 
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1.3 Conclusions and Future Work 
In conclusion the synthesis of multigram quantities of HHQ has been achieved.  
For the first time, halo-analouges of HHQ have been prepared which showed potential as 
antivirulence agents in impeding the restoration of phenazine production. Disappointingly, 
halo-analogue 24 did not show any antibiofilm activity. However, these biological 
investigations highlight the strict structural requirements at the C-3 position for the biological 
activity of HHQ and PQS.  
Also the first successful palladium-catalysed cross coupling reaction has been performed on N-
methylated HHQ opening up the possibility of synthesising other novel alkylquinolones bearing 
aryl, heteroaryl and alkyl groups at the C-3 position. These would be useful for further structure 
function analysis of PQS analogues. 
The future work of this project will expand the palladium-catalysed cross coupling to other 
reactions such as the Mizoroki-Heck reaction. Initial thoughts that oxidative addition would be 
problematic due to steric hindrance of the bulky alkyl chain at C-2 did not materialise.  
Future structural studies will involve continued functionalisation of the 3-position (e.g. 
introduction of fluorine) with a view towards attaining a deeper understanding of the complex 
roles of these molecules in bacterial and fungal species. 
Publications on this work to date are included in the Appendix. 
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1.4 Experimental 
*Note: An arbitrary numbering system was employed to assist in the clear assignment of the 
spectroscopic data and does not correspond to the IUPAC number system for these compounds. 
Only carbon atoms were numbered in the experimental. 
1.4.1 Synthesis of 2-heptylquinolin-4(1H)-one 
5-(1-hydroxyoctylidiene)-2,2-dimethyl-1,3-dioxane-4,6-dione 16 
To a solution of 2,2-dimethyl-1,3-dioxane-4,6-dione 15 
(Meldrum’s Acid) (40 g, 0.278 mol), in distilled CH2Cl2 
(400 mL) at 0°C under a N2 atmosphere, was added 
pyridine (45 mL, 0.556 mol), followed by the dropwise 
addition of octanoyl chloride 31 (52.5 mL, 0.306 mol) over 5 min.  After allowing the resulting 
orange liquid to stir at 0°C for 1 h, the reaction mixture was allowed warm to room temperature 
for 20 h. The reaction was monitored by NMR analysis until all starting material had reacted. 
The mixture was then washed with 5% HCl solution (6 x 200 mL) and water (200 mL). The 
organic layer was dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure, to afford the title compound 16 as a brown oil (73.9 g). This residue was used in the 
next step without further purification. 
Spectroscopic characteristics were consistent with previously reported data.48 
1H NMR (300 MHz, CDCl3): δ 0.88 (3H, t, J = 6.9 Hz, H-12), 1.20-1.45 (10H, m, H-11, H-10, 
H-9, H-8, H-7), 1.79 (6H, s, H-13, H-14), 3.04 (2H, t, J = 7.6 Hz, H-6), 15.30 (1H, br s, O-H) 
ppm; 13C NMR (75.5 MHz, CDCl3): δ 14.1 (C-12), 26.8 (2 x CH3, C-13, C-14), 22.6, 26.2, 
28.9, 29.0, 31.6, 35.8 (6 x CH2, C-11, C-10, C-9, C-8, C-7, C-6), 91.7 (C-4), 104.8 (C-2), 160.2 
(C-1), 170.6 (C-3), 198.4 (C-5) ppm; MS (ESI) m/z: 269 [M - H]-. 
 
methyl-3-oxo-decanoate 17 
To MeOH (300 mL) was added 5-(1-hydroxyoctylidiene)-
2,2-dimethyl-1,3-dioxane-4,6-dione 16 (max. 0.278 mol) 
from the previous step and the mixture was heated at reflux 
for 2.5 h. The reaction mixture was allowed to cool to room temperature and concentrated under 
reduced pressure, yielding an orange liquid.  This crude product was purified by fractional 
distillation to afford the β- keto ester 17 as a clear oil (36.5 g, 66% over two steps). 
Spectroscopic characteristics were consistent with previously reported data.48 
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1H NMR (300 MHz, CDCl3): δ 0.88 (3H, t, J = 6.7 Hz, H-10), 1.20-1.40 (8H, m, H-9, H-8, H-
7, H-6), 1.52-1.66 (2H, m, H-5), 2.52 (2H, t, J = 7.4 Hz, H-4), 3.45 (2H, s, H-2), 3.74 (3H, s, 
OMe) ppm; 13C NMR (75.5 MHz, CDCl3): δ 14.1 (C-10), 22.6, 23.4, 28.9, 29.0, 31.6, 43.1 (6 
x CH2, C-9, C-8, C-7, C-6, C-5, C-4), 49.0 (C-2), 52.3 (OMe), 167.7 (C-1),  202.9 (C-3) ppm; 
MS (ESI) m/z: 201 [M + H]+. 
 
(Z)-methyl 3-(phenylamino)dec-2-enoate 18 
To methyl-3-oxo-decanoate 17 (36.5 g, 0.184 mol) was 
added aniline (17.6 g, 0.189 mol), hexane (300 mL) and p-
toluene sulfonic acid (0.519 g, 0.003 mol) were added, at 
which point cloudiness was observed. The mixture was 
heated at reflux under a N2 atmosphere for 5 h using a Dean-Stark apparatus and allowed to stir 
overnight at room temperature. The crude reaction mixture was dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure yielding 18 as a dark orange oil (51.4 g). This 
crude product was used in the next step without further purification. 
1H NMR (300 MHz, CDCl3): δ 0.84 (3H, t, J = 6.8 Hz, H-10), 1.10-1.35 (8H, m, H-9, H-8, H-
7, H-6), 1.35-1.47 (2H, m, H-5), 2.28 (2H, t, J = 7.8 Hz, H-4), 3.69 (3H, s, OMe), 4.73 (1H, s, 
H-2), 7.09 (2H, d, J = 7.5 Hz, H-12), 7.17 (1H, t, J = 7.3 Hz, H-14), 7.33 (2H, t, J = 7.5 Hz, H-
13), 10.30 (1H, br s, N-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 14.2 (C-10), 22.6, 27.9, 28.8, 
28.9, 31.6, 32.2 (6 x CH2, C-9, C-8, C-7, C-6, C-5, C-4), 50.3 (OMe), 84.5 (C-2), 125.1 (2 x 
Ar-CH), 125.3 (Ar-CH), 129.1 (2 x Ar-CH), 139.2 (C-11), 163.8 (C-3), 171.0 (C-1) ppm; MS 
(ESI) m/z: 276 [M + H]+. 
 
2-heptylquinolin-4(1H)-one.HCl 19 
To diphenyl ether (45 mL, 0.264 mol) heated at reflux was 
added 18 (max. 0.184 mol), dropwise over 1.5 h, ensuring 
vigorous reflux was maintained. Heating was continued 
for 1 h. The reaction mixture was then cooled to room 
temperature.  The formed MeOH was removed under 
reduced pressure.  To the isolated residue, Et2O (120 mL) and 2 M HCl solution (160 mL) were 
added. This mixture was allowed to stir vigorously for 5 min, then allowed stand at room 
temperature for 18 h.  The crystalline solid which formed, was filtered and washed with Et2O 
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to afford a yellow solid. The crude product was crystallised from EtOAc and the pure 19 isolated 
as a cream solid (19.9 g, 40% over two steps). Mp 111-114°C. 
IR (KBr) ?̅?max: 3103 (O-H stretch, m), 2930-2728 (C-H stretch, s), 2442 (N-H stretch, s) 1639 
(C=N stretch, s), 1594 (aromatic C=C, s), 1488 (C-H bending, m) cm-1; 1H NMR (300 MHz, 
CDCl3): δ 0.77 (3H, t, J = 6.7 Hz, H-16), 1.05-1.30 (6H, m, H-15, H-14, H-13), 1.30-1.41 (2H, 
m, H-12), 1.75-1.91 (2H, m, H-11), 3.12 (2H, t, J = 7.8 Hz, H-10), 7.63 (1H, m, H-5), 7.63 (1H, 
s, H-1), 7.84 (1H, ddd, J = 1.2, 7.0, 8.4 Hz, H-6), 8.34 (1H, dd, J = 1.2, 8.4 Hz, H-4), 8.53 (1H, 
d, J = 8.4 Hz, H-7), 14.95 (1H, br s, O-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 14.0 (C-16), 
22.5, 28.9, 29.3, 29.8, 31.6 (5 x CH2, C-15, C-14, C-13, C-12, C-11), 34.3 (C-10), 105.4 (C-1), 
119.5 (C-3), 119.9 (C-7), 123.8 (C-4), 127.2 (C-5), 133.9 (C-6), 139.7 (C-8), 160.9 (C-9), 169.7 
(C-2) ppm (Note: Structural assignment confirmed using COSY, HSQC and HMBC); HRMS 
(ESI) m/z calcd for C16H22NO [M + H]
+: 244.1701, found 244.1696 (HHQ). Anal. Calcd for 
C16H22ClNO: C, 68.68; H, 7.93; N, 5.01. Found: C, 68.99; H, 7.91; N, 5.02. 
Crystallographic data was also obtained for this compound (see Appendix). 
 
2-heptylquinolin-4(1H)-one 3 
To a solution of 2-heptylquinolin-4(1H)-one.HCl 19 
(0.050 g, 0.179 mmol) in CHCl3 (2 mL) was added 15% 
NaOH solution, until neutral pH was achieved. The 
mixture was extracted with CHCl3 (3 x 20 mL). The 
combined organic fractions were dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure, to afford 3 as a cream solid (0.041 g, 95% yield). Mp 143-146°C (Lit.44 Mp 
146-147°C). 
Spectroscopic characteristics were consistent with previously reported data.44 
1H NMR (400 MHz, CDCl3): δ 0.86 (3H, t, J = 7.0 Hz, H-16), 1.15-1.36 (8H, m, H-15, H-14, 
H-13, H-12), 1.68-1.76 (2H, m, H-11), 2.65 (2H, t, J = 7.7 Hz, H-10), 6.21 (1H, s, H-1), 7.32 
(1H, ddd, J = 1.8, 6.4, 8.1 Hz, H-5), 7.51-7.61 (2H, m, H-6, H-7), 8.35 (1H, dd, J = 1.4, 8.1 Hz 
H-4), 10.37 (1H, br s, N-H) ppm; 13C NMR (75.5 MHz, CDCl3): δ 14.0 (C-16), 22.5, 28.7, 28.9, 
29.1, 31.6 (5 x CH2, C-15, C-14, C-13, C-12, C-11), 34.3 (C-10), 108.5 (C-1), 117.8 (C-7), 
123.5 (C-5), 125.1 (C-3), 125.7 (C-4), 131.8 (C-6), 140.2 (C-8), 154.1 (C-9), 178.9 (C-2) ppm 
(Note: Structural assignment confirmed using COSY, HSQC and HMBC); MS (ESI) m/z: 244 
[M + H]+. 
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1.4.2 Synthesis of 3-halo-analogues of 2-heptylquinolin-4(1H)-one 
3-chloro-2-heptylquinolin-4-ol 22 
To a stirred solution of 2-heptylquinolin-4(1H)-one 3 
(0.106 g, 0.435 mmol) in a mixture of MeOH (5 mL), 2 M 
NaOH (1.4 mL), and water (1.4 mL) at room temperature 
was added sodium dichloroisocyanurate (0.146 g, 0.79 
mmol). After 40 min, the reaction mixture was filtered, and the combined filtrate and MeOH 
washings were acidified to pH 4 (2 M HCl) and cooled to 4°C in the refrigerator. The solid 
product 22 was collected by filtration and crystallised from MeOH to afford colourless crystals 
(0.070 g, 58%). Mp 269-272°C. 
IR (KBr) ?̅?max: 3348 (N-H stretch, m), 2924 (C-H stretch, s), 1633 (C=O stretch, m), 1562 
(aromatic C=C, s), 1031 (C-N, stretch, s) cm-1; 1H NMR (400 MHz, CD3SOCD3): δ 0.85 (3H, 
t, J = 6.9 Hz, H-16), 1.32 (8H, m, H-15, H-14, H-13, H-12), 1.69 (2H, m, H-11), 2.83 (2H, t, J 
= 7.8 Hz, H-10), 7.34 (1H, ddd, J = 1.3, 7.0, 8.0 Hz, Ar-H), 7.57 (1H, d, J = 8.4 Hz, Ar-H), 7.67 
(1H, ddd, J = 1.3, 7.0, 8.4 Hz, Ar-H), 8.09 (1H, dd, J = 1.3, 8.0 Hz, Ar-H), 12.07 (1H, br s, N-
H) ppm; 13C NMR (125.8 MHz, CD3SOCD3): δ 13.9 (C-16), 21.9, 27.5, 28.3, 28.6, 31.1, 32.1 
(6 x CH2, C-15, C-14, C-13, C-12, C-11, C-10), 113.3 (C-1), 118.0 (Ar-CH), 123.4 (C-3), 123.5 
(Ar-CH), 125.1 (Ar-CH), 131.8 (Ar-CH), 138.5 (C-8), 150.6 (C-9), 170.8 (C-2) ppm; HRMS 
(ESI) m/z calcd for C16H21
35ClNO [M + H]+: 278.1312, found 278.1306. 
 
3-bromo-2-heptylquinolin-4-ol 24 
To a solution of 2-heptylquinolin-4(1H)-one 3 (0.038 g, 
0.156 mmol) in acetic acid (0.78 mL, 5 mL per mmol of  
HHQ) was added pyridinium tribromide (0.100 g, 0.313 
mmol). The reaction mixture was allowed to stir at room 
temperature for 3 h. Aqueous Na2S2O3 was added to quench the reaction and the formed 
precipitate was filtered and washed with ice-cold EtOH (15 ml). The crude solid was 
crystallised from EtOH to give pale yellow crystals 24 (0.025 g, 50%). Mp 245-248°C. 
IR (KBr) ?̅?max: 3432 (N-H stretch, m), 2926 (C-H stretch, s), 1631 (C=O stretch, m), 1581 
(aromatic C=C, s), 1141 (C-N stretch, s) cm-1; 1H NMR (400 MHz, CD3SOCD3): δ 0.85 (3H, t, 
J = 6.8 Hz, H-16), 1.30 (8H, m, H-15, H-14, H-13, H-12), 1.70 (2H, m, H-11), 2.86 (2H, t, J = 
7.8 Hz, H-10), 7.35 (1H, ddd, J = 1.4, 6.8, 8.1 Hz, Ar-H), 7.58 (1H, d, J = 8.3 Hz, Ar-H), 7.68 
(1H, ddd, J = 1.4, 6.8, 8.3 Hz, Ar-H), 8.09 (1H, dd, J = 1.4, 8.1 Hz, Ar-H), 12.07 (1H, br s, N-
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H) ppm; 13C NMR (125.8 MHz, CD3SOCD3): δ 13.9 (C-16), 21.9, 27.6, 28.3, 28.6, 31.1, 34.5 
(6 x CH2, C-15, C-14, C-13, C-12, C-11, C-10), 105.5 (C-1), 117.9 (Ar-CH), 122.7 (C-3), 123.6 
(Ar-CH), 125.2 (Ar-CH), 131.8 (Ar-CH), 138.7 (C-8), 152.1 (C-9), 171.2 (C-2) ppm; HRMS 
(ESI) m/z calcd for C16H21
79BrNO [M + H]+: 322.0807, found 322.0812. 
 
3-heptyl-2-iodoquinolin-4(1H)-ol 25 
A mixture of 2-heptylquinolin-4(1H)-one 3 (0.2 g, 0.823 
mmol), iodine (0.418 g, 1.65 mmol) and Na2CO3 (0.131 
g, 1.235 mmol) in THF (4 mL) was allowed to stir at room 
temperature for 18 h. The mixture was quenched with 
Na2S2O3 (0.613 g, 3.88 mmol) and the precipitate was collected by filtration before washing 
with ice cold water (50 mL). The product 25 did not require further purification (0.146 g, 48%). 
Mp 221-225°C. 
IR (KBr) ?̅?max: 3419 (N-H stretch, s), 2920 (C-H stretch, m), 1627 (C=O stretch, m), 1556 
(aromatic C=C, s), 1134 (C-N stretch, s) cm-1; 1H NMR (500 MHz, CD3SOCD3): δ 0.86 (3H, t, 
J = 7.0 Hz, H-16), 1.27-1.42 (8H, m, H-15, H-14, H-13, H-12), 1.68 (2H, m, H-11), 2.91 (2H, 
t, J = 7.9 Hz, H-10), 7.35 (1H, ddd, J = 1.2, 7.0, 8.3, Hz, Ar-H), 7.58 (1H, d, J = 8.3 Hz, Ar-H), 
7.68 (1H, ddd, J = 1.2, 7.0, 8.3 Hz, Ar-H), 8.07 (1H, dd, J = 1.2, 8.3 Hz, Ar-H), 12.08 (1H, br 
s, O-H) ppm; 13C NMR (125.8 MHz, CD3SOCD3): δ 13.9 (C-16), 21.9, 27.9, 28.3, 28.6, 31.1, 
38.7 (6 x CH2, C-15, C-14, C-13, C-12, C-11, C-10), 85.7 (C-1), 117.7 (Ar-CH), 120.6 (C-3), 
123.8 (Ar-CH), 125.5 (Ar-CH), 131.9 (Ar-CH), 139.0 (C-8), 154.5 (C-9), 173.2 (C-2) ppm; 
HRMS (ESI) m/z calcd for C16H21INO [M + H]
+: 370.0668, found 370.0656.  
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1.4.3 N-methylation and the Suzuki-Miyaura reaction 
2-heptyl-3-iodo-1-methylquinolin-4(1H)-one 26 
To stirred suspension of NaH (0.016 g, 0.669 mmol, 50% 
in oil, washed with anhydrous hexane (3 x 10 mL)) in dry 
THF (3 mL) was added 3-heptyl-2-iodoquinolin-4(1H)-
one 25 (0.165 g, 0.446 mmol) at room temperature under 
a N2 atmosphere. The reaction mixture was allowed to stir at 40°C for 5 h. The reaction mixture 
was treated with iodomethane (0.095 g, 0.669 mmol) and allowed to stir for 12 h at 40°C. Water 
(1 mL) was added to quench the reaction. The mixture was extracted with CHCl3 (2 x 20 mL). 
The combined organic fractions were then washed with brine (10 mL). The organic layer was 
dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure. The product 
was puriﬁed using column chromatography (1:1, hexane : EtOAc) to afford 26 as a crystalline 
solid (0.082 g, 48%). Mp 66-69°C.  
IR (KBr) ?̅?max: 2926-2854 (C-H stretch, s), 1617 (C=O stretch, s), 1592 (C=C stretch, s), 1519 
(aromatic C=C, s) cm-1; 1H NMR (400 MHz, CDCl3): δ 0.91 (3H, t, J = 6.8 Hz, H-16), 1.34-
1.53 (8H, m, H-15, H-14, H-13, H-12), 1.55-1.70 (2H, m, H-11), 3.22 (2H, t, J = 8.3, H-10), 
3.89 (3H, s, N-CH3), 7.36 (1H, ddd, J = 1.3, 7.0, 8.1 Hz, Ar-H), 7.52 (1H, d, J = 8.6 Hz, Ar-H), 
7.65 (1H, ddd, J = 1.3, 7.0, 8.6 Hz, Ar-H), 8.43 (1H, dd, J = 1.3, 8.1 Hz, Ar-H) ppm; 13C NMR 
(100.6 MHz, CDCl3): δ 14.1 (C-16), 22.6, 27.5, 28.8, 29.5, 31.7, 36.6 (6 x CH2, C-15, C-14, C-
13, C-12, C-11, C-10), 40.1 (N-CH3), 90.4 (C-1), 115.3 (Ar-CH), 122.5 (C-3), 124.2 (Ar-CH), 
127.8 (Ar-CH), 132.3 (Ar-CH), 140.8 (C-8), 155.1 (C-9), 173.8 (C-2) ppm; HRMS (ESI) m/z 
calcd for C17H23INO [M + H]
+: 384.0824, found 384.0806. 
 
2-heptyl-1-methyl-3-phenylquinolin-4(1H)-one 30 
A mixture of 2-heptyl-3-iodo-1-methylquinolin-4(1H)-one 
26 (0.055 g, 0.143 mmol), phenylboronic acid (0.035 g, 
0.286 mmol) and Pd(PPh3)4 (0.008 g, 5 mol%) in DMF (1.5 
mL) and aqueous 2 M Na2CO3 (1.5 mL) was heated at 
reflux for 2 h and then cooled to room temperature. The 
mixture was poured into ice-cold water and the precipitate was taken-up into CHCl3 (10 mL), 
washed with brine (10 mL). The organic layer was dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The product was puriﬁed using column chromatography 
(1:1, hexane : EtOAc) affording the pure product 30 as a solid (0.024 g, 50%). Mp 213-215°C.  
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IR (KBr) ?̅?max: 2926-2854 (C-H stretch, s), 1618 (C=O stretch, s), 1592 (C=C stretch, s), 1538 
(aromatic C=C, s) cm-1; 1H NMR (400 MHz, CDCl3): δ 0.84 (3H, t, J = 7.1 Hz, H-16), 1.08-
1.36 (8H, m, H-15, H-14, H-13, H-12), 1.49-1.62 (2H, m, H-11), 2.63 (2H, t, J = 8.2 Hz, H-
10), 3.83 (3H, s, N-CH3), 7.21-7.25 (2H, m, Ar-H), 7.35 (4H, m, Ar-H), 7.56 (1H, d, J = 8.6 
Hz, Ar-H), 7.67 (1H, ddd, J = 1.6, 7.1, 8.6 Hz, Ar-H), 8.45 (1H, dd, J = 1.6, 8.0 Hz, Ar-H) ppm; 
13C NMR (100.6 MHz, CDCl3): δ 14.0 (C-16), 22.5, 28.5, 28.9, 29.3, 31.5, 31.8 (6 x CH2, C-
15, C-14, C-13, C-12, C-11, C-10), 35.0 (N-CH3), 115.2 (Ar-CH), 123.2 (Ar-CH), 124.3 (C-3), 
126.2 (C-1), 127.0 (Ar-CH), 127.3 (Ar-CH), 128.4 (2 x Ar-CH), 130.6 (2 x Ar-CH), 131.9 (Ar-
CH), 137.1 (C-17), 141.5 (C-8), 152.3 (C-9), 176.3 (C-2) ppm; HRMS (ESI) m/z calcd for 
C23H27NO [M + H]
+: 334.2171, found 334.2164. 
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II. Single Crystal Analysis Reports 
 
*Note: All single crystal analysis was carried out by members of the Dr. Simon Lawrence 
research group in University College Cork. 
  
  
 
  
  
 
Crystallographic data for N,N'-bis((S)-2-hydroxy-1-phenylethyl)-2,2-dimethylmalonamide 
(S,S)-240 
  
 
 
 
  
  
 
  
checkCIF/PLATON report 
You have not supplied any structure factors. As a result the full set of tests cannot be run.
No syntax errors found.        CIF dictionary        Interpreting this report
Datablock: I 
Bond precision: C-C = 0.0045 A Wavelength=0.71073
Cell: a=8.423(3) b=11.261(3) c=11.347(4)
alpha=90 beta=91.054(12) gamma=90
Temperature: 300 K
Calculated Reported
Volume 1076.1(6) 1076.1(7)
Space group P 21 P 1 21 1 
Hall group P 2yb P 2yb 
Moiety formula C21 H26 N2 O4, 2(H2 O) C21 H26 N2 O4, 2(H2 O)
Sum formula C21 H30 N2 O6 C21 H30 N2 O6
Mr 406.47 406.47
Dx,g cm-3 1.255 1.254
Z 2 2
Mu (mm-1) 0.092 0.092
F000 436.0 436.0
F000’ 436.22
h,k,lmax 9,13,13 9,13,13
Nref 1981[ 3754] 3505 
Tmin,Tmax 0.985,0.995 0.960,1.000
Tmin’ 0.965
Correction method= MULTI-SCAN
Data completeness= 1.77/0.93 Theta(max)= 24.920
R(reflections)= 0.0411( 2599) wR2(reflections)= 0.0944( 3505)
S = 1.016 Npar= 290
The following ALERTS were generated. Each ALERT has the format
       test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.
 Alert level C
STRVA01_ALERT_4_C           Flack parameter is too small
           From the CIF: _refine_ls_abs_structure_Flack   -0.800
           From the CIF: _refine_ls_abs_structure_Flack_su    1.300
PLAT033_ALERT_4_C Flack x Parameter Value Deviates from Zero .....     -0.800      
PLAT340_ALERT_3_C Low Bond Precision on  C-C Bonds ...............     0.0045 Ang  
PLAT420_ALERT_2_C D-H Without Acceptor       N10    -   H10    ...          ?      
 Alert level G
REFLT03_ALERT_4_G  ALERT: MoKa measured Friedel data cannot be used to
                   determine absolute structure in a light-atom
                   study EXCEPT under VERY special conditions.
                   It is preferred that Friedel data is merged in such cases.
           From the CIF: _diffrn_reflns_theta_max           24.92
           From the CIF: _reflns_number_total               3505
           Count of symmetry unique reflns         1981
           Completeness (_total/calc)            176.93%
           TEST3: Check Friedels for noncentro structure
           Estimate of Friedel pairs measured      1524
           Fraction of Friedel pairs measured     0.769
           Are heavy atom types Z>Si present         no
PLAT002_ALERT_2_G Number of Distance or Angle Restraints on AtSite          6      
PLAT005_ALERT_5_G No _iucr_refine_instructions_details in CIF ....          ?
PLAT032_ALERT_4_G Std. Uncertainty on Flack Parameter Value High .      1.300      
PLAT791_ALERT_4_G Note: The Model has Chirality at C7     (Verify)          S      
PLAT791_ALERT_4_G Note: The Model has Chirality at C19    (Verify)          S      
PLAT860_ALERT_3_G Note: Number of Least-Squares Restraints .......          5      
   0 ALERT level A = Most likely a serious problem - resolve or explain
   0 ALERT level B = A potentially serious problem, consider carefully
   4 ALERT level C = Check. Ensure it is not caused by an omission or oversight
   7 ALERT level G = General information/check it is not something unexpected
   0 ALERT type 1 CIF construction/syntax error, inconsistent or missing data
   2 ALERT type 2 Indicator that the structure model may be wrong or deficient
   2 ALERT type 3 Indicator that the structure quality may be low
   6 ALERT type 4 Improvement, methodology, query or suggestion
   1 ALERT type 5 Informative message, check
It is advisable to attempt to resolve as many as possible of the alerts in all categories. Often the
minor alerts point to easily fixed oversights, errors and omissions in your CIF or refinement
strategy, so attention to these fine details can be worthwhile. In order to resolve some of the more
serious problems it may be necessary to carry out additional measurements or structure
refinements. However, the purpose of your study may justify the reported deviations and the more
serious of these should normally be commented upon in the discussion or experimental section of a
paper or in the "special_details" fields of the CIF. checkCIF was carefully designed to identify
outliers and unusual parameters, but every test has its limitations and alerts that are not important
in a particular case may appear. Conversely, the absence of alerts does not guarantee there are no
aspects of the results needing attention. It is up to the individual to critically assess their own
results and, if necessary, seek expert advice.
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic checks will be run on all CIFs
submitted for publication in IUCr journals (Acta Crystallographica, Journal of Applied 
Crystallography, Journal of Synchrotron Radiation); however, if you intend to submit to Acta
Crystallographica Section C or E, you should make sure that full publication checks are run on the
final version of your CIF prior to submission.
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any special instructions relating to
CIF submission.
PLATON version of 18/07/2011; check.def file version of 04/07/2011 
Datablock I - ellipsoid plot
  
 
Crystallographic data for (1S,3S)-1-(((S)-tert-butylsulfinyl)amino)-4,4-dimethyl-1-
phenylpentan-3-yl pivalate (S,S,S)-275  
 
 
  
  
 
  
checkCIF/PLATON report 
You have not supplied any structure factors. As a result the full set of tests cannot be run.
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW PROCEDURE
FOR PUBLICATION, IT SHOULD NOT REPLACE THE EXPERTISE OF AN EXPERIENCED
CRYSTALLOGRAPHIC REFEREE.
No syntax errors found.        CIF dictionary        Interpreting this report
Datablock: I 
Bond precision: C-C = 0.0048 A Wavelength=0.71073
Cell: a=9.6296(11) b=10.9154(19) c=23.692(4)
alpha=90 beta=90 gamma=90
Temperature: 296 K
Calculated Reported
Volume 2490.3(7) 2490.3(6)
Space group P 21 21 21 P 21 21 21 
Hall group P 2ac 2ab P 2ac 2ab 
Moiety formula C22 H37 N O3 S ?
Sum formula C22 H37 N O3 S C22 H37 N O3 S
Mr 395.60 395.59
Dx,g cm-3 1.055 1.055
Z 4 4
Mu (mm-1) 0.149 0.149
F000 864.0 864.0
F000’ 864.83
h,k,lmax 12,13,29 12,13,29
Nref 5133[ 2918] 5094 
Tmin,Tmax 0.968,0.987 0.870,0.990
Tmin’ 0.927
Correction method= MULTI-SCAN
Data completeness= 1.75/0.99 Theta(max)= 26.470
R(reflections)= 0.0494( 3286) wR2(reflections)= 0.1164( 5094)
S = 1.007 Npar= Npar = 257
The following ALERTS were generated. Each ALERT has the format
       test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.
 Alert level B
PLAT035_ALERT_1_B No _chemical_absolute_configuration info given .     Please Do ! 
PLAT242_ALERT_2_B Low       Ueq as Compared to Neighbors for .....        C25 Check 
 Alert level C
PLAT213_ALERT_2_C Atom C26             has ADP max/min Ratio .....        3.2 prolat
PLAT220_ALERT_2_C Large Non-Solvent  C     Ueq(max)/Ueq(min) Range        4.6 Ratio 
PLAT222_ALERT_3_C Large Non-Solvent    H    Uiso(max)/Uiso(min) ..        5.8 Ratio 
PLAT230_ALERT_2_C Hirshfeld Test Diff for    C25    --  C27     ..        5.8 su    
PLAT241_ALERT_2_C High      Ueq as Compared to Neighbors for .....         C3 Check 
PLAT242_ALERT_2_C Low       Ueq as Compared to Neighbors for .....         C1 Check 
PLAT242_ALERT_2_C Low       Ueq as Compared to Neighbors for .....        C10 Check 
PLAT242_ALERT_2_C Low       Ueq as Compared to Neighbors for .....        C18 Check 
PLAT242_ALERT_2_C Low       Ueq as Compared to Neighbors for .....        C23 Check 
PLAT340_ALERT_3_C Low Bond Precision on  C-C Bonds ...............     0.0048 Ang.  
 Alert level G
PLAT005_ALERT_5_G No _iucr_refine_instructions_details  in the CIF     Please Do ! 
PLAT791_ALERT_4_G The Model has Chirality at C7      .............          S Verify
PLAT791_ALERT_4_G The Model has Chirality at C9      .............          S Verify
   0 ALERT level A = Most likely a serious problem - resolve or explain
   2 ALERT level B = A potentially serious problem, consider carefully
  10 ALERT level C = Check. Ensure it is not caused by an omission or oversight
   3 ALERT level G = General information/check it is not something unexpected
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data
   9 ALERT type 2 Indicator that the structure model may be wrong or deficient
   2 ALERT type 3 Indicator that the structure quality may be low
   2 ALERT type 4 Improvement, methodology, query or suggestion
   1 ALERT type 5 Informative message, check
It is advisable to attempt to resolve as many as possible of the alerts in all categories. Often the
minor alerts point to easily fixed oversights, errors and omissions in your CIF or refinement
strategy, so attention to these fine details can be worthwhile. In order to resolve some of the more
serious problems it may be necessary to carry out additional measurements or structure
refinements. However, the purpose of your study may justify the reported deviations and the more
serious of these should normally be commented upon in the discussion or experimental section of a
paper or in the "special_details" fields of the CIF. checkCIF was carefully designed to identify
outliers and unusual parameters, but every test has its limitations and alerts that are not important
in a particular case may appear. Conversely, the absence of alerts does not guarantee there are no
aspects of the results needing attention. It is up to the individual to critically assess their own
results and, if necessary, seek expert advice.
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic checks will be run on all CIFs
submitted for publication in IUCr journals (Acta Crystallographica, Journal of Applied 
Crystallography, Journal of Synchrotron Radiation); however, if you intend to submit to Acta
Crystallographica Section C or E, you should make sure that full publication checks are run on the
final version of your CIF prior to submission.
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any special instructions relating to
CIF submission.
PLATON version of 05/02/2014; check.def file version of 05/02/2014 
Datablock I - ellipsoid plot
  
 
Crystallographic data for (S)-N-(3-hydroxy-4,4-dimethyl-1-phenylpentyl)-2-methylpropane-
2-sulfinamide (S)-278  
 
 
 
  
  
 
  
checkCIF/PLATON report 
You have not supplied any structure factors. As a result the full set of tests cannot be run.
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW PROCEDURE
FOR PUBLICATION, IT SHOULD NOT REPLACE THE EXPERTISE OF AN EXPERIENCED
CRYSTALLOGRAPHIC REFEREE.
No syntax errors found.        CIF dictionary        Interpreting this report
Datablock: I 
Bond precision: C-C = 0.0095 A Wavelength=0.71073
Cell: a=10.200(9) b=9.406(8) c=10.462(9)
alpha=90 beta=116.167(13) gamma=90
Temperature: 296 K
Calculated Reported
Volume 900.9(14) 900.9(13)
Space group P 21 P 1 21 1 
Hall group P 2yb P 2yb 
Moiety formula C17 H25 N O2 S C17 H25 N O2 S
Sum formula C17 H25 N O2 S C17 H25 N O2 S
Mr 307.44 307.44
Dx,g cm-3 1.133 1.133
Z 2 2
Mu (mm-1) 0.184 0.184
F000 332.0 332.0
F000’ 332.37
h,k,lmax 12,11,13 12,11,13
Nref 3892[ 2067] 3707 
Tmin,Tmax 0.970,0.978 0.910,0.980
Tmin’ 0.950
Correction method= MULTI-SCAN
Data completeness= 1.79/0.95 Theta(max)= 26.920
R(reflections)= 0.0632( 1776) wR2(reflections)= 0.2204( 3707)
S = 1.058 Npar= 195
The following ALERTS were generated. Each ALERT has the format
       test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.
 Alert level B
            Crystal system given = monoclinic
PLAT201_ALERT_2_B Isotropic non-H Atoms in Main Residue(s) .......          3 Report
 Alert level C
PLAT026_ALERT_3_C Ratio Observed / Unique Reflections too Low ....         48 %     
PLAT029_ALERT_3_C _diffrn_measured_fraction_theta_full Low .......      0.979 Note  
PLAT230_ALERT_2_C Hirshfeld Test Diff for    C17    --  C18     ..        5.2 su    
PLAT242_ALERT_2_C Low       Ueq as Compared to Neighbors for .....        C10 Check 
PLAT242_ALERT_2_C Low       Ueq as Compared to Neighbors for .....        C17 Check 
PLAT340_ALERT_3_C Low Bond Precision on  C-C Bonds ...............     0.0095 Ang.  
 Alert level G
PLAT002_ALERT_2_G Number of Distance or Angle Restraints on AtSite         10 Note  
PLAT003_ALERT_2_G Number of Uiso or Uij Restrained non-H Atoms ...          1 Report
PLAT072_ALERT_2_G SHELXL First  Parameter in WGHT Unusually Large.       0.11 Report
PLAT172_ALERT_4_G The CIF-Embedded .res File Contains DFIX Records          2 Report
PLAT301_ALERT_3_G Main Residue  Disorder ............ Percentage =         14 Note  
PLAT860_ALERT_3_G Number of Least-Squares Restraints .............         35 Note  
   0 ALERT level A = Most likely a serious problem - resolve or explain
   1 ALERT level B = A potentially serious problem, consider carefully
   6 ALERT level C = Check. Ensure it is not caused by an omission or oversight
   6 ALERT level G = General information/check it is not something unexpected
   0 ALERT type 1 CIF construction/syntax error, inconsistent or missing data
   7 ALERT type 2 Indicator that the structure model may be wrong or deficient
   5 ALERT type 3 Indicator that the structure quality may be low
   1 ALERT type 4 Improvement, methodology, query or suggestion
   0 ALERT type 5 Informative message, check
It is advisable to attempt to resolve as many as possible of the alerts in all categories. Often the
minor alerts point to easily fixed oversights, errors and omissions in your CIF or refinement
strategy, so attention to these fine details can be worthwhile. In order to resolve some of the more
serious problems it may be necessary to carry out additional measurements or structure
refinements. However, the purpose of your study may justify the reported deviations and the more
serious of these should normally be commented upon in the discussion or experimental section of a
paper or in the "special_details" fields of the CIF. checkCIF was carefully designed to identify
outliers and unusual parameters, but every test has its limitations and alerts that are not important
in a particular case may appear. Conversely, the absence of alerts does not guarantee there are no
aspects of the results needing attention. It is up to the individual to critically assess their own
results and, if necessary, seek expert advice.
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic checks will be run on all CIFs
submitted for publication in IUCr journals (Acta Crystallographica, Journal of Applied 
Crystallography, Journal of Synchrotron Radiation); however, if you intend to submit to Acta
Crystallographica Section C or E, you should make sure that full publication checks are run on the
final version of your CIF prior to submission.
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any special instructions relating to
CIF submission.
PLATON version of 20/08/2014; check.def file version of 18/08/2014 
Datablock I - ellipsoid plot
  
 
Crystallographic data for 2-heptylquinolin-4(1H)-one.HCl 307 
 
  
  
 
  
checkCIF/PLATON report 
You have not supplied any structure factors. As a result the full set of tests cannot be run.
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW PROCEDURE
FOR PUBLICATION, IT SHOULD NOT REPLACE THE EXPERTISE OF AN EXPERIENCED
CRYSTALLOGRAPHIC REFEREE.
No syntax errors found.        CIF dictionary        Interpreting this report
Datablock: I 
Bond precision: C-C = 0.0049 A Wavelength=0.71073
Cell: a=10.221(7) b=13.132(8) c=12.143(8)
alpha=90 beta=106.090(18) gamma=90
Temperature: 296 K
Calculated Reported
Volume 1566.0(18) 1566.0(17)
Space group P 21/n P 1 21/n 1 
Hall group -P 2yn -P 2yn 
Moiety formula C16 H22 N O, Cl C16 H22 N O, Cl
Sum formula C16 H22 Cl N O C16 H22 Cl N O
Mr 279.80 279.80
Dx,g cm-3 1.187 1.187
Z 4 4
Mu (mm-1) 0.237 0.237
F000 600.0 600.0
F000’ 600.79
h,k,lmax 12,16,15 12,16,15
Nref 3245 3226 
Tmin,Tmax 0.961,0.974 0.637,0.745
Tmin’ 0.951
Correction method= MULTI-SCAN
Data completeness= 0.994 Theta(max)= 26.510
R(reflections)= 0.0559( 1682) wR2(reflections)= 0.1690( 3226)
S = 1.087 Npar= 177
The following ALERTS were generated. Each ALERT has the format
       test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.
 Alert level C
PLAT230_ALERT_2_C Hirshfeld Test Diff for    C5     --  C6      ..        6.0 su    
PLAT340_ALERT_3_C Low Bond Precision on  C-C Bonds ...............     0.0049 Ang.  
 Alert level G
PLAT003_ALERT_2_G Number of Uiso or Uij Restrained non-H Atoms ...          1 Report
PLAT007_ALERT_5_G Number of Unrefined Donor-H Atoms ..............          1 Report
PLAT860_ALERT_3_G Number of Least-Squares Restraints .............          6 Note  
   0 ALERT level A = Most likely a serious problem - resolve or explain
   0 ALERT level B = A potentially serious problem, consider carefully
   2 ALERT level C = Check. Ensure it is not caused by an omission or oversight
   3 ALERT level G = General information/check it is not something unexpected
   0 ALERT type 1 CIF construction/syntax error, inconsistent or missing data
   2 ALERT type 2 Indicator that the structure model may be wrong or deficient
   2 ALERT type 3 Indicator that the structure quality may be low
   0 ALERT type 4 Improvement, methodology, query or suggestion
   1 ALERT type 5 Informative message, check
It is advisable to attempt to resolve as many as possible of the alerts in all categories. Often the
minor alerts point to easily fixed oversights, errors and omissions in your CIF or refinement
strategy, so attention to these fine details can be worthwhile. In order to resolve some of the more
serious problems it may be necessary to carry out additional measurements or structure
refinements. However, the purpose of your study may justify the reported deviations and the more
serious of these should normally be commented upon in the discussion or experimental section of a
paper or in the "special_details" fields of the CIF. checkCIF was carefully designed to identify
outliers and unusual parameters, but every test has its limitations and alerts that are not important
in a particular case may appear. Conversely, the absence of alerts does not guarantee there are no
aspects of the results needing attention. It is up to the individual to critically assess their own
results and, if necessary, seek expert advice.
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic checks will be run on all CIFs
submitted for publication in IUCr journals (Acta Crystallographica, Journal of Applied 
Crystallography, Journal of Synchrotron Radiation); however, if you intend to submit to Acta
Crystallographica Section C or E, you should make sure that full publication checks are run on the
final version of your CIF prior to submission.
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any special instructions relating to
CIF submission.
PLATON version of 20/08/2014; check.def file version of 18/08/2014 
Datablock I - ellipsoid plot
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The asymmetric alkylation of dimethylhydrazones;
intermolecular chirality transfer using sparteine as
chiral ligand†
Christina M. McSweeney, Vera M. Foley and Gerard P. McGlacken*
The asymmetric alkylation of ketones represents a fundamental
transformation in organic chemistry. Chiral auxiliaries have been used
almost exclusively for this transformation. Herein we describe a
strategy for the generation of enantiomerically enriched a-alkylated
ketones up to an er of 83 : 17, using a chiral ligand protocol.
A large number of optically active drugs and natural products
contain a-functionalized ketones, or simple derivatives there-of.
Furthermore, chiral a-alkylated ketones are very useful synthons
and have found widespread use in total synthesis.1 Thus, the
asymmetric alkylation of ketones represents a very useful trans-
formation in organic chemistry. Surprisingly however, only one
eﬀective methodology is available for acyclic systems, and this
involves the use of chiral auxiliaries.
The well-known, proline derived, SAMP/RAMP auxiliaries
(Scheme 1(i)) have found numerous applications in asymmetric
alkylation.1c For example, Nicolaou et al. applied the SAMP
auxiliary of 3-pentanone in an asymmetric alkylation en route to
swinholide A.2 More recently Coltart has introduced N-amino cyclic
carbamate (ACC) chiral auxiliaries (Scheme 1(ii)).3 These auxiliaries
do not require the extremely low alkylation temperatures used
with SAMP/RAMP hydrazones. The ACC methodology has
already been utilized in the synthesis of several biologically
important compounds.4
Moreover, it is worth noting that despite the advances in the use
of homo chiral lithium amide bases,5 transitionmetal catalysis6 and
organocatalysis,7 none of these areas of research have managed to
achieve the asymmetric a-alkylation of acyclic ketones.
Our approach to chiral a-alkylated ketones involves the use of
simple non-chiral dimethylhydrazones and eﬀecting their asym-
metric alkylation using a chiral diamine ligand (Scheme 1(iii)).
The use of lithium bases to furnish small aliphatic
a-alkylated ketones, often proceeds in poor yield.8 In light of
this, we chose the dimethylhydrazone methodology.9 Addition-
ally, we postulated that deprotonation using an alkyl lithium–
chiral diamine system would furnish a highly structured azae-
nolate benefiting from added chelation of the dimethylamino
group (Scheme 2). Subsequent alkylation with high facial
selectivity could provide chiral, alkylated dimethylhydrazones.
Of the numerous chiral diamines available,10 ()-sparteine
(()-sp) was chosen due to its eﬃciency and breadth of applica-
tion.11 For example, ()-sp/lithium systems have proven useful in a
number transformations involving asymmetric deprotonations
and substitutions.12 O’Brien and co-workers have used ()-sp in
the catalytic asymmetric deprotonation of N-Boc pyrrolidine.13
Firstly, 3-pentanone dimethylhydrazone 1, 4-heptanone
dimethylhydrazone 2 and cycloheptanone dimethylhydrazone
Scheme 1 Comparison of previously used methodology and our work.
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3 were prepared in near quantitative yields using dimethyl-
hydrazine in the presence of a catalytic amount of AcOH.
We focused our initial studies on establishing an optimum solvent
for these reactions. Hydrazone 1 was subjected to ()-sp/sec-BuLi
deprotonation (room temperature for 6 h) and alkylated with
either benzyl bromide or 1-iodopentane (30 1C for 18 h), in a
range of solvents (Table 1). The resultant alkylated hydrazones
were hydrolysed using a biphasic 4 M HCl–diethyl ether system
and the enantiomeric excess of the ketones 4 and 5 determined.14
The enantioselectivity showed a high solvent dependence. The use
of THF as solvent, afforded ketone 4 with no enantioenrichment
(entry 1), probably due to competing coordination with ()-sp to
lithium.15 Cumene as solvent gave good conversion to alkylated
ketone (62% NMR yield over 2 steps) (entry 3).16 The use of
benzene, cyclohexane and MTBE gave poor enantioselectivity
(entries 4, 5 and 7, Table 1). Diethyl ether afforded ketone 5 in
good enantioselectivity (78 : 22 er) and moderate yield (43%) over
2 steps (entry 8). In this case, to demonstrate the accessibility of
both enantiomers of the chiral ketone, (+)-sp was utilised.
Toluene was found to be the prime solvent for these reactions
giving the best enantioenrichment of both 4 and 5, 24 : 76 er
(entry 2) and 17 : 83 er (entry 6), respectively. While conversion to
product in toluene was high, yields remained moderate, most
likely due to the high volatility of the resulting ketones.17
Next we probed the scope of the reaction with a range of
simple alkyl halides (Table 2). A clear trend is apparent, with
the long chain alkyl halides proving less reactive (entries 1, 2, 8
and 9) compared with benzyl bromides (entries 3 and 5–7).
Introduction of n-pentyl and n-hexyl moieties require an iodide
leaving group. However, these slower reacting electrophiles did
result in products (5, 10, 11) displaying the highest enantio-
enrichment.
The introduction of a methyl group at the 2-position of
benzyl bromide (entry 5) had no eﬀect on enantioselectivity in
comparison to the unsubstituted benzyl bromide (entry 3), but
the use of pentamethyl benzyl bromide showed a distinct
increase in enantioselectivity (entry 6) in the final ketone. Also
increased yields were observed for electrophiles resulting in
less volatile ketone products (entries 6 and 7). Finally, cyclo-
heptanone dimethylhydrazone was subjected to the standard
conditions. The resulting allylated ketone 12 was isolated in
19% yield with an er of 68 : 32.
Interestingly, deprotonation of hydrazone 2 with LDA, fol-
lowed by subsequent addition of ()-sp, n-iodopentane and
hydrolysis gave 10 in an er of 21 : 79 (Scheme 3). Significantly,
only a slight drop in enantiomeric excess and yield is noticed in
comparison to reaction when ()-sp is added prior to deproto-
nation (entry 8, Table 2). In light of this we postulate that
Scheme 2 General scheme for asymmetric alkylations via intermolecular
chirality transfer.
Table 1 Solvent optimization studies on the dimethylhydrazones of
3-pentanone
Entry Ligand R3X Solvent Yielda (%) Ketone erc R : S
1 ()-sp BnBr THF 40 4 Racemic
2 ()-sp BnBr Toluene 57 4 24 : 76
3 ()-sp BnBr Cumene 62b 4 25 : 75
4 ()-sp BnBr Benzene 45 4 31 : 69
5 ()-sp BnBr Cyclohexane 23 4 31 : 69
6 ()-sp n-PeI Toluene 34 5 17 : 83
7 ()-sp n-PeI MTBE 32 5 33 : 67
8 (+)-sp n-PeI Et2O 43 5 78 : 22
a Isolated yields over 2 steps after purification by column chromato-
graphy. b Yield determined using NMR and 1,3,5-trimethoxybenzene as
internal standard. c er determined by chiral GC and absolute configu-
ration assigned based on the optical rotation data of 4 and inferred for
the others.
Table 2 Substrate scope in asymmetric alkylations using sparteine as
chiral ligand
Entrya Ligand
Hydra-
zone R3X
Yieldb
(%) Ketone
erc
R : S
1 ()-sp 1 n-PeI 34 5 17 : 83
2 (+)-sp 1 n-PeI 31 5 81 : 19
3 ()-sp 1 BnBr 57 4 24 : 76
4 ()-sp 1 C6H5CHQCHCH2Br 30 6 21 : 79
5 (+)-sp 1 2-CH3C6H4CH2Br 54 7 76 : 24
6 (+)-sp 1 C6(CH3)5CH2Br 60 8 81 : 19
7 (+)-sp 1 4-t-BuC6H4CH2Br 62 9 71 : 29
8 ()-sp 2 n-PeI 39 10 18 : 82
9 (+)-sp 2 n-HexI 53 11 80 : 20
10 (+)-sp 3 AllylBr 19 12 68 : 32d
a All reactions were performed in anhydrous toluene using optimized
conditions as shown in Scheme 2. b Isolated yields over 2 steps after
purification by column chromatography. c er determined by chiral
GC. d Absolute configuration not determined.
Scheme 3 Deprotonation prior to ()-sp addition.
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asymmetric alkylation rather than (or at least in addition to)
asymmetric deprotonation is operative.18 Interestingly, the low
nucleophilicity of LDA indicates that this methodology could be
extended to the a-substitution of hydrazones derived from
aldehydes, and esters.
Preliminary investigations show that easily-prepared chiral
diamines such as 1319 can mediate these transformations also
(Scheme 4). In contrast to sparteine, these ligands can be easily
modified. Optimisation of ligands such as 13 and application to
asymmetric alkylation reactions are currently underway.
In summary, to the best of our knowledge this report details
the first example of asymmetric alkylation to a non-chiral
acyclic aza(enolate). Optimisation studies involving the use of
other chiral diamines are ongoing and will be reported in due
course.
We thank Science Foundation Ireland (09/RFP/CHS2353)
and the Irish Research Council for funding.
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a b s t r a c t
A novel chiral auxiliary containing a pyrrolidine ring has been utilised in the preparation of various chiral
ketones with good to excellent enantioselectivities (up to 92%). It has been successfully employed in aldol
and Michael reactions giving moderate to high selectivity.
 2014 Elsevier Ltd. All rights reserved.
1. Introduction
The a-alkylation of ketones is a fundamental reaction in organic
synthesis. However there exists a very limited number of methods
to carry out this transformation in an asymmetric manner. The use
of SAMP/RAMP methodology almost exclusively accounts for these
types of transformations.1 SAMP/RAMP hydrazones have been
widely employed as key steps in the synthesis of numerous natural
products, for example, indanomycine,2 (+)-eremophilenolide3 and
stigmatellin A.4 Previous alteration of the basic SAMP/RAMP
framework has included the use of more sterically hindered groups
on the arm to give chiral auxiliaries such as SADP, SAEP, SAPP5 and
RAMBO.6 Replacement of the terminal methoxy group with a trim-
ethylsiloxy group showed comparable enantioselectivities to SAMP
in asymmetric a-alkylation reactions and very good selectivities
with aldol reactions.7 More recently, Coltart has successfully used
chiral N-amino cyclic carbamate hydrazones as an alternative to
SAMP-type hydrazones, allowing the preparation of both a-alkyl-
ated and a,a-bisalkylated ketones in a convenient and scalable
manner.8
With such a limited number of routes available to chiral
a-alkylated ketones, there remains signiﬁcant scope for the explo-
ration of new, easily prepared chiral auxiliaries for use in their syn-
thesis. We set out to investigate if a nitrogen (as part of a
pyrrolidine system) could ligate to lithium as effectively as in the
SAMP/RAMP system (where a –OMe group is utilised). We herein
report the chromatography-free synthesis of a novel chiral auxil-
iary incorporating a pyrrolidine ring. The chiral hydrazine is avail-
able in four steps from N-protected proline 1 or only two steps
from commercially available (S)-(+)-1-(2-pyrrolidinylmethyl)pyr-
rolidine 3. Subsequent reaction with symmetrical and unsymmet-
rical ketones followed by deprotonation, alkylation (using both
alkyl and the rarely reported benzyl electrophiles) and hydrolysis
gave valuable chiral ketones in very good ee and moderate yields.
The chiral auxiliary can be applied to both aldol and Michael
reactions.
2. Results and discussion
Chiral auxiliary 5was formed in a ﬁve step sequence from com-
mercially available (S)-N-(benzyloxycarbonyl)proline 1 via DCC
coupling to provide amide 2 in 81% yield. Two reduction steps
afforded chiral diamine 3 in good yield. Nitrosation gave 4 and a
ﬁnal LiAlH4 reduction furnished hydrazine 5. Chiral auxiliary 5
was reacted with 3-pentanone to give chiral hydrazone 6 in 80%
yield (46% yield after puriﬁcation by distillation) (Scheme 1). In a
similar manner, 5 was combined with propiophenone, p-methoxy-
propiophenone and p-ﬂuoropropiophenone to afford hydrazones
7a, 7b and 7c in 52%, 54% and 48% yields, respectively (Scheme 2).
Chiral hydrazone 6 was then subjected to LDA (5 h, room tem-
perature) deprotonation and alkylated with benzyl bromide (addi-
tion at 110 C, temperature held for 1 h at 110 C then for 5 h at
70 C) in either diethyl ether, toluene or tetrahydrofuran. The
resultant alkylated hydrazone 8 was hydrolysed using a biphasic
4 M HCl/diethyl ether system and ketone 9 was analysed for
enantioselectivity using chiral gas chromatography (Scheme 3).
The use of diethyl ether as the solvent for the alkylation step affor-
ded 9 with very good enantioselectivity (89% ee) in comparison to
toluene and tetrahydrofuran (66% and 61% ee, respectively) albeit
in moderate yields (20–30%).9
Improved yields were obtained on extension of the deprotona-
tion time to 16 h and by decreasing the temperature to 0 C. In
these cases complete conversion to the alkylated hydrazone was
observed. Yields remained moderate, most likely due to the high
volatility of the resulting ketones.10
Various methods for the cleavage of a-substituted hydrazones
to the corresponding ketones have been utilised.11 Oxalic acid is re-
ported as a convenient, high yielding, racemisation-free method
for the hydrolytic cleavage of SAMP hydrazones.12 However, when
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we employed oxalic acid as a hydrazone cleavage method only
moderate enantioselectivity was observed in the chiral ketones.13
We suspected that racemisation was occurring, possibly due to
some protonation of the pyrrolidine and increased solubility and
exposure to the aqueous acidic layer. In order to investigate this
possibility, both chiral hydrazone 7a and the corresponding SAMP
variant 11were prepared and subjected to LDA and benzylbromide
(Scheme 4). Both hydrazones were hydrolysed using oxalic acid
and HCl/diethyl ether. Using the SAMP hydrazine, benzylated pro-
piophenone 10 was obtained in 92% and 88% ee using oxalic acid
and HCl/diethyl ether cleavage methods, respectively. A larger var-
iation in the enantioselectivity was observed between the two
cleavage methods when chiral auxiliary 7a was employed in the
reaction (51% and 78% ee). This clearly indicates that racemisation
does occur when oxalic acid is used in combination with our chiral
auxiliary and underlines the need for a thorough investigation of
cleavage methods in such cases. To the best of our knowledge,
the enzymatic cleavage of chiral hydrazones has not been reported.
Porcine pancreatic lipase (PPL) was chosen as an appropriate en-
zyme because of its use in the cleavage of dimethylhydrazones.14
Its use furnished ketone 9 in low (ca. 10%) yield (over two steps)
albeit in 83% ee (Table 1, entry 8). Finally, a biphasic hydrolysis
method (HCl/diethylether) was attempted. Clean conversion from
alkylated hydrazones to ketones was observed with little or no rac-
emisation occurring.
With usable hydrolysis conditions in hand, a variety of electro-
philes were reacted with the azaenolate derived from 6. The reac-
tion of 3-pentanone hydrazone 6 with LDA and pentyliodide gave
ketone 12 with 92% ee, albeit in moderate yield (Table 1, entry
1). When t-BuLi was employed as the base instead of LDA, the
selectivity dropped to 82% ee (entry 2). Various other aliphatic
electrophiles were employed to afford ketones 13–16 (entries
3–6) with very good enantioselectivities. We next turned our
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Scheme 1. Synthesis of the chiral auxiliary and the corresponding 3-pentanone hydrazone.
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Scheme 2. Synthesis of propiophenone-based hydrazones.
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Scheme 3. Solvent screen for the alkylation step of a chiral hydrazone.
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Scheme 4. Racemisation studies of chiral hydrazone 7a and the SAMP variant 11 using oxalic acid (OA) or a biphasic 4 M HCl mediated cleavage. Isolated yields quoted over
two steps.
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attention to the use of benzyl bromides as electrophiles. Their use in
hydrazone chiral auxiliary methodology has been very limited. In
fact, no thorough investigation of benzyl based electrophiles has
been reported using chiral hydrazone methodology. A plethora of
electrophiles were used affording ketones 9, and 17–23, all with
good enantioselectivity. Substituted benzyl groups allowed us to
probe the effect of electron withdrawing and donating groups pres-
ent on the electrophiles. The presence of electron withdrawing
groups on the benzyl moiety caused a decrease in the enantioselec-
tivity of the resultant ketone when compared to the unsubstituted
benzyl bromide (entry 7, 89%), which is most apparent with the
use of perﬂuorobenzyl bromide (entry 9, 48%). The presence of an
electron donating group, for example the use of p-methoxybenzyl
bromide (entry 10, 84%), had little effect on the enantioselectivity
observed.
Further to these studies it was decided to investigate the effect
of the electronic substituents on the hydrazone moiety. Propiophe-
none, p-methyoxypropiophenone and p-ﬂuoropropiophenone
hydrazones 7a–c were chosen as substrates and subjected to the
standard conditions using allyl bromide as the electrophile. The
resultant ketones 24–26 demonstrate that the presence of an elec-
tron donating substituent on the ring (entry 18, 79% ee) results in a
decrease in the enantioselectivity when compared to the unsubsti-
tuted ketone (entry 17, 89% ee). The presence of an electron with-
drawing substituent (entry 19, 90% ee), had little effect on the
enantioselectivity.
We then applied our methodology to an aldol reaction
(Scheme 5). Hydrazone 6 was deprotonated using LDA, reacted
with benzaldehyde and hydrolysed using Amberlyst to afford 27
in 39% yield over two steps. Enantiomeric excesses of 63% and
Table 1
Results of alkylation reactions of hydrazones
Entry Hydrazone Electrophile Product ketone % Yield (over two steps) % eee
1 6 I 12 13 92a
2 6 12 29 82a,b
3 6 I 13 63 55
c
4 6 Br 14 23 90
a
5 6
Br
15 15 86a
6 6
Br
16 19 89a
7 6 Br 9 7 89
a
8 6 9 10 83d
9 6
Br
F
F
F
F
F
17 34 48a
10 6
Br
O
18 24 84a
11 6 Br
Br
19 21 86a
12 6
Br
Br
20 19 62c
13 6
Br
F3C
21 14 73c
14 6
Br
O2N
22 6 58a
15 6
Br
23 28 87a
16 7a
Br
10 15 78a
17 7a
Br
24 25 89a
18 7b 25 29 79a
19 7c 26 33 90a
Yield is calculated over two steps; alkylation of the parent hydrazone and hydrolysis of the alkylated hydrazone to the product ketone. Alkylated hydrazone is not isolated.
a HCl/diethyl ether hydrolysis.
b t-BuLi used as the base.
c Satd aq oxalic acid/diethyl ether hydrolysis.
d PPL hydrolysis. The ketone products have been assigned as (S) by comparison of the speciﬁc rotation value of 24 with that reported in the literature and others by
analogy.15
e All ee values were determined using chiral GC analysis and conﬁrmed by comparison with independently prepared racemic ketones.
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15% were obtained for anti- and syn-27, respectively. A diastereo-
meric ratio of 86:14 anti/syn, determined by GC, was identical to
that observed by 1H NMR.16 The relative stereochemistry observed
(anti) was opposite to that usually seen in aldol reactions using
SAMP (syn).
Our novel chiral auxiliary was then applied to a Michael reac-
tion (Scheme 5). Hydrazone 6 was treated with LDA and trans-b-
nitrostyrene followed by subsequent hydrolysis to afford crude
28, which was subjected to GC analysis. Enantiomeric excesses of
84% and 47% were determined for syn- and anti-28, respectively,
with an excellent diastereomeric ratio of 94:6 syn/anti as deter-
mined by GC and NMR analysis. Again the relative orientation
was opposite to that usually formed when using a SAMP chiral
auxiliary in Michael reactions.1c,17 Puriﬁcation using column chro-
matography allowed isolation of syn-28 in 84% ee and 13% yield
over two steps.
3. Conclusion
A novel hydrazone-based chiral auxiliary has been established
involving a pyrrolidine arm. The chiral auxiliary has been formed
in good yields in ﬁve steps from commercially available (S)-N-
(benzyloxycarbonyl)proline 1 (or only two steps from commer-
cially available (S)-(+)-1-(2-pyrrolidinylmethyl)pyrrolidine 3)
without the need for silica column chromatography puriﬁcation.
Enantiomeric excesses of up to 92% were achieved in the a-alkyl-
ated aliphatic ketones formed and up to 89% in the less studied
aromatic ketones. While the overall yields were moderate (in many
cases due to product volatility), comparison studies with the SAMP
chiral auxiliary showed comparable yields (Scheme 4). However,
given the remarkably few methods available to access these com-
pounds and the excellent enantioselectivities observed, we are
pleased to report our novel chiral auxiliary as a viable route to
these chiral synthons. Initial unoptimised studies into the use of
our chiral auxiliary in Michael reactions have proven to be
successful.
4. Experimental
4.1. Procedure for synthesis of the chiral auxiliary:
4.1.1. (S)-1-[N-(benzyloxycarbonyl)proly]-pyrrolidine 218
To a CH2Cl2 solution (120 mL) of (S)-N-(benzyloxycarbonyl)pro-
line (74.57 g, 0.3 mol) was added dropwise a CH2Cl2 solution
(120 mL) of DCC (61.69 g, 0.3 mol) at 0 C under a nitrogen atmo-
sphere. After stirring for 30 min, a CH2Cl2 solution (120 mL) of pyr-
rolidine (24.7 mL, 0.3 mol) was slowly added dropwise to the
reaction mixture at 0 C via an addition funnel. The reaction mix-
ture was allowed to warm to room temperature overnight. The
precipitate was removed by ﬁltration through a pad of Celite
and washed with CH2Cl2. The ﬁltrate was washed with 0.5 M HCl
(2  150 mL), satd aq NaHCO3 solution (150 mL), H2O (150 mL)
and brine (150 mL). The organic layer was dried over MgSO4, con-
centrated in vacuo and the crude product recrystallised from ethyl
acetate to yield product 2 as a white, crystalline solid (73.52 g, 81%
yield). ½a22D ¼ 13:3 (c 1.60, MeOH) {lit.19 ½a22D ¼ 14:1 (c 1.61,
MeOH)}. Mp 123–125 C [lit.19 130–130 C]. dH (CDCl3, 300 MHz)
(mixture of rotamers) 1.56–2.20 (8H, m, 4 CH2), 3.25–3.75 (6H,
m, 3 CH2), 4.39–4.54 (1H, m, CH), 4.97–5.22 (2H, m, CH2), 7.28–
7.37 (5H, m, ArH). dC (CDCl3, 75.5 MHz) (mixture of rotamers)
23.8, 23.9 (CH2), 24.1, 24.4 (CH2), 26.0, 26.3 (CH2), 29.5, 30.5
(CH2), 46.0, 46.0 (CH2), 46.1, 46.3 (CH2), 46.7, 47.3 (CH2), 57.7,
58.2 (CH2), 66.9, 67.1 (CH), 127.8, 127.9 (2 ArCH), 128.0, 128.1
(ArCH), 128.4, 128.4 (2 ArCH), 136.7, 136.8 (quaternary C),
154.2, 154.9 (C@O), 170.7, 171.0 (C@O). m/z (ES+) 303 [(M+H)+,
100%].
4.1.2. (S)-2-(1-Pyrrolidinylmethyl)-pyrrolidine 320
To a methanol (350 mL) solution of 2 (75.40 g, 250 mmol) was
added Pd/C (5%, 4.78 g). The reaction mixture was then stirred un-
der hydrogen at atmospheric pressure for 22 h while monitoring
the reaction progress by TLC analysis. The crude reaction mixture
was ﬁltered through a pad of Celite and washed with methanol
to elute the product. The ﬁltrate was concentrated in vacuo to yield
the crude amide as a yellow oil (39.84 g, 95% yield). ½a26D ¼ 89:6
(c 1.7, EtOH) {lit.21 ½a26D ¼ 112:2 (c 1.7, EtOH)}. dH (CDCl3,
300 MHz) 1.60–2.02 (7H, m, 7 CH2), 2.05–2.14 (1H, m, CH2),
2.77–2.85 (1H, m, CH2), 2.93 (1H, br s, NH), 3.15–3.22 (1H, m,
CH2), 3.36–3.57 (4H, m, 2 CH2), 3.73–3.77 (1H, dd, J = 6.5,
8.6 Hz, CH). dC (CDCl3, 75.5 MHz) 24.0, 26.0, 26.5, 30.4, 45.9, 46.0,
47.7 (7 CH2), 59.5 (CH), 172.7 (C@O). m/z (ES+) 169 [(M+H)+,
100%]. A solution of amide (19.02 g, 113 mmol) in dry THF
(80 mL) was added dropwise over 3 h to LiAlH4 (15.00 g,
396 mmol) in dry THF (140 mL) under a nitrogen atmosphere at
0 C. The reaction mixture was allowed to stir at room temperature
overnight, heated at reﬂux for 4 h, then allowed to stir at room
temperature overnight. The reaction mixture was quenched by
the dropwise addition of satd aq Na2SO4 solution (20 mL). The
crude reaction mixture was ﬁltered through a pad of Celite and
washed with ethyl acetate. The mother liquor was concentrated
in vacuo to give the crude product as a yellow oil (14.54 g, 83%
yield). Additional puriﬁcation was achieved by Kugelrohr distilla-
tion yielding 3 as a colourless oil (11.22 g, 64% yield).
½a20D ¼ þ5:2 (c 2.4, EtOH) [lit.21 ½a20D ¼ þ8:9 (c 2.4, EtOH)]. dH
(CDCl3, 300 MHz) 1.22–1.43 (1H, m, CH2), 1.68–1.81 (6H, m, 3
CH2), 1.82–1.95 (1H, m, CH2), 2.31–2.37 (1H, dd, J = 5.2, 11.9 Hz,
CH2), 2.45–2.61 (6H, m, 3 CH2, NH), 2.81–2.89 (1H, m, CH2),
2.94–3.02 (1H, m, CH2), 3.17–3.26 (1H, m, CH). dC (CDCl3,
75.5 MHz) 23.4 (2 CH2), 25.0, 30.1, 46.1 (3 CH2), 54.6 (2
CH2), 57.4 (CH), 62.1 (CH2). m/z (ES+) 155 [(M+H)+, 100%].
4.1.3. (S)-1-Nitroso-2-(pyrrolidin-1-ylmethyl)pyrrolidine 4
At ﬁrst, 10–20% ethyl nitrite in ethanol (taken to be 15%)
(5.45 mL, 8.63 mmol) was added to 3 (1.065 g, 6.90 mmol). The
reaction vessel was covered in aluminium foil and allowed to stir
at room temperature with progress monitored by 1H NMR
spectroscopy. After 45 h, ethanol was removed in vacuo to yield
4 as a yellow oil (1.15 g, 91% yield). dH (CDCl3, 300 MHz) 1.76–
N
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Scheme 5. Aldol and Michael reactions. Absolute stereochemistry unknown.
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1.81 (4H, m, 2 CH2), 1.91–2.25 (4H, m, 2 CH2), 2.54–2.67 (4H, m,
2 CH2), 2.80 (1H, dd, J = 8.8, 12.2 Hz, CH2), 3.00 (1H, dd, J = 5.1,
12.2 Hz, CH2), 3.52–3.75 (2H, m, CH2), 4.59–4.67 (1H, m, CH). dC
(CDCl3, 75.5 MHz) 20.7 (CH2), 23.5 (2 CH2), 28.7, 45.6 (2 CH2),
54.7 (2 CH2), 59.5 (CH2), 60.3 (CH). Since nitrosamines are poten-
tially carcinogenic, no further data was obtained and the crude
reaction mixture was used without puriﬁcation in the next step.
4.1.4. (S)-2-(Pyrrolidin-1-ylmethyl)pyrrolidin-1-amine 5
To a solution of LiAlH4 (2.61 g, 69 mmol) in dry THF (120 mL)
was added dropwise a solution of 4 (6.30 g, 34 mmol) in dry THF
(60 mL) under a nitrogen atmosphere at 0 C. The reaction mixture
was allowed to stir at 0 C for 1 h, then at room temperature for 1 h
before being heated at reﬂux for 4.5 h and stirred at room temper-
ature overnight. The reaction progress was monitored by 1H NMR
spectroscopy. On completion, the reaction vessel was transferred
to an ice bath and quenched by the dropwise addition of H2O
(2.6 mL), 3 M aq NaOH (2.6 mL) and H2O (7.2 mL). The reaction
mixture was ﬁltered through a pad of Celite using ether to elute
the product. The mother liquor was concentrated in vacuo to yield
5 as a yellow oil (4.98 g, 86%). ½a20D ¼ 11:4 (c 1, EtOH). mmax/cm1
(KBr): 3306 (N–H stretch, m), 1591 (N–H bending, m), 1137 (C–N
stretch, m). dH (CDCl3, 300 MHz) 1.41–1.54 (1H, m, CH2), 1.68–
1.85 (6H, m, 3 CH2), 1.93–2.07 (1H, m, CH2), 2.26–2.41 (3H, m,
2 CH2), 2.45–2.53 (2H, m, CH2), 2.54–2.62 (2H, m, CH2), 2.69–
2.72 (3H, m/br s, CH2/NH2), 2.85–2.91 (1H, m, CH2), 3.22–3.29
(1H, m, CH). dC (CDCl3, 75.5 MHz) 20.6 (CH2), 23.5 (2 CH2), 28.7
(CH2), 54.8 (2 CH2), 59.6 (CH2), 61.5 (CH2), 67.8 (CH). Exact mass
calcd for C8H11IO2 [(M+H)+], 170.1657. Found 170.1674.
4.1.5. (S)-N-(Pentan-3-ylidine)-2-(pyrrolidin-1-ylmethyl)pyrroli-
din-1-amine 6
3-Pentanone (9.34 mL, 88 mmol) was added dropwise to a stir-
red solution of 5 (4.98 g, 29 mmol) in cyclohexane (8 mL) under an
atmosphere of nitrogen. The reaction mixture was then allowed to
stir at room temperature overnight and reaction progress moni-
tored by 1H NMR spectroscopy. On completion, the reaction mix-
ture was poured into 6:1 DCM/H2O and the organic layer
extracted. The organic layer was dried over MgSO4 and concen-
trated in vacuo to give the crude product as a yellow oil (5.61 g,
80% yield). Puriﬁcation was achieved by Kugelrohr distillation to
yield the product as a colourless oil (4.52 g, 65% yield).
½a20D ¼ þ114 (c 1, EtOH). mmax/cm1 (NaCl): 1637 (C@N stretch, s),
1342, 1138 (C–N stretch, m). dH (CDCl3, 300 MHz) 1.07 (6H, q, 2
CH3), 1.53–1.66 (1H, m, CH2), 1.69–1.91 (6H, m, 3 CH2),
2.02–2.14 (1H, m, CH2), 2.17–2.29 (2H, m, CH2), 2.30–2.55 (9H,
m, 4 CH2, CH), 2.97–3.10 (2H, m, CH2). dC (CDCl3, 75.5 MHz)
10.9 (2 CH3), 11.8, 21.8, 23.5, 23.5, 28.6, 28.7, 54.8, 55.0, 61.4
(10 CH2), 66.1 (CH), 173.3 (CN). Exact mass calcd for C14H27N3
[(M+H)+], 238.2277. Found 238.2283.
4.2. General procedure for synthesis of racemic ketones
To THF (5 mL)was added commercially available LDA (1.1 equiv)
at 78 C. The reaction was stirred for 5 min and 3-pentanone was
added dropwise. The reaction was stirred at 78 C for 30 min and
the electrophile (1.1 equiv) was added (in 3 mL THF if solid). The
reactionwas allowed towarm to room temperature overnight. Next,
at. aq NH4Cl solution (10 mL) was added and the crude product ex-
tractedwith ethyl acetateor ether (315 mL), dried overMgSO4 and
concentrated invacuo toyield the crudeproduct,whichwaspuriﬁed
by silica column chromatography.
4.3. General procedure for HCl/diethyl ether hydrolysis
At ﬁrst, 4 M HCl (0.5 mL) and water (0.5 mL) were added to a
vigorously stirred solution of alkylated hydrazone in diethyl ether
(5 mL). The reaction progress was monitored by TLC analysis every
10 min. On completion, water (10 mL) was added, followed by
extraction with diethyl ether (3 25 mL). The organic layers were
combined and washed with water (2 10 mL), dried over MgSO4
and concentrated in vacuo to yield the ketone, which was puriﬁed
by silica column chromatography.
4.4. Procedure for PPL hydrolysis
To a solution of PPL (100 mg) in water (10 mL) was added a
solution of alkylated hydrazone (1.05 mmol) in acetone (6 mL).
The reaction was allowed to stir at room temperature for 23 h, di-
luted with diethyl ether (20 mL), washed with brine (3 15 mL),
dried over MgSO4 and concentrated in vacuo. Puriﬁcation was
achieved using silica column chromatography to yield 9 as a yellow
oil (19.3 mg, 10% yield over two steps).
4.5. General procedure for oxalic acid hydrolysis
At ﬁrst, satd aq oxalic acid (1.5 vol with respect to mmol hydra-
zone) was added to a vigorously stirred solution of alkylated
hydrazone in diethyl ether (4 vol with respect to mmol hydrazone).
The reaction progress was monitored by TLC analysis and on com-
pletion were added water (5 mL) and diethyl ether (3 20 mL). Or-
ganic extracts were combined, dried over MgSO4 and concentrated
in vacuo to yield the ketone which was puriﬁed by silica column
chromatography.
4.6. Example procedure for the alkylation of chiral hydrazone
To a stirred solution of dry diisopropylamine (0.16 mL,
1.16 mmol) in dry diethyl ether (4 mL) in an N2 ﬁlled Schlenk tube
at 78 C was added 1.6 M n-BuLi (0.86 mL, 1.21 mmol). The solu-
tion was allowed to stir at 0 C for 30 min to generate a solution of
LDA. Hydrazone 6 (250 mg, 1.05 mmol) was added slowly drop-
wise at 78 C and allowed to stir at 0 C for 16 h. A solution of
n-pentyl iodide (250 mg, 1.26 mmol) in dry diethyl ether (2 mL)
in a separate Schlenk, which was previously evacuated and ﬁlled
with N2 three times, was added dropwise to a solution of deproto-
nated hydrazone at 110 C. The temperature of the reaction was
kept at 110 C for 1 h, then at 70 C for 5 h before being allowed
to warm gradually to room temperature overnight. Next, satd aq
NH4Cl solution (10 mL) was added to quench the reaction followed
by extraction with diethyl ether (3  20 mL). The organic layers
were combined, dried over MgSO4 and concentrated in vacuo to
yield the crude alkylated hydrazone as a yellow oil, which was
hydrolysed using HCl/diethyl ether to yield the crude product as
a yellow oil. Puriﬁcation was carried out using silica column chro-
matography eluting with 95:5 hexane/diethyl ether to afford 12 as
a pale yellow oil (22 mg, 13% and 92% ee). ½a20D ¼ þ5:5 (c 0.2, Et2O).
mmax/cm1 (ﬁlm) 2961, 2932 (alkane CH stretches), 1714 (C@O). dH
(CDCl3, 300 MHz) 0.88 (3H, t, J = 6.8 Hz, CH3), 1.04 (3H, t, J = 7.3 Hz,
CH3) 1.06 (3H, d, J = 6.9 Hz, CH3), 1.17–1.35 (8H, m, 4 CH2), 2.46
(2H, dq, J = 1.5, 7.3 Hz, CH2), 2.48–2.58 (1H, m, CH). dC (CDCl3,
125 MHz) 7.8, 14.1, 16.5 (3 CH3), 22.5, 27.0, 31.9, 33.1, 34.2 (5
CH2), 46.1 (CH), 215.7 (C@O). Exact mass calcd for C10H21O
[(M+H)+], 157.1592. Found 157.1584. Sample for GC made up at
1 mg/mL in dry dichloromethane and run on Agilent Technologies
7820A GC System using G4513A Injector and Astec Chiraldex G-TA
fused silica capillary column purchased from Sigma Aldrich Supe-
lco using conditions 105 C hold 10 min, ramp 10 C/min to
140 C hold 5 min, ﬂow 1 mL/min, inj. vol. 0.2 lL, split ratio 10:1,
front inlet 150 C, detector 155 C. Retention time: 3.63 min (min-
or), 3.87 min (major).
4.7. Example of the procedure for the Michael reaction
To a stirred solution of dry diisopropylamine (0.2 mL,
1.39 mmol) in dry diethyl ether (4 mL) in an N2 ﬁlled Schlenk tube
at 78 C was added 1.6 M n-BuLi (0.91 mL, 1.45 mmol). The
solution was then allowed to stir at 0 C for 30 min to generate a
360 S. L. Clarke et al. / Tetrahedron: Asymmetry 25 (2014) 356–361
solution of LDA. Hydrazone 6 (299 mg, 1.26 mmol) was slowly
added dropwise at 78 C and allowed to stir at 0 C for 16 h. Next,
trans-b-nitrostyrene (245 mg, 1.64 mmol) was dissolved in dry
diethyl ether (3 mL), cooled to 78 C and then slowly added drop-
wise to a solution of deprotonated hydrazone at 110 C via a can-
nula. The temperature of the reaction was kept at 110 C for 1 h,
then at 70 C for 5 h before being allowed to warm gradually to
room temperature overnight. Next, satd aq NH4Cl solution
(10 mL) was added to quench the reaction followed by extraction
with diethyl ether (3 20 mL). The organic layers were combined,
dried over MgSO4 and concentrated in vacuo to yield a product as a
dark yellow solid, which was hydrolysed using HCl/diethyl ether to
yield the crude product as a pale brown oil (GC analysis of crude
obtained), which was puriﬁed using silica column chromatography
eluting with 90:10 hexane/diethyl ether to afford syn-28 as a yel-
low oil (37 mg, 13% and 84% ee). ½a22D ¼ þ3:5 (c 0.2, CHCl3). {lit.22
½a22D ¼ þ8:9 (c 0.2, CHCl3)}. dH (CDCl3, 300 MHz) 0.97 (3H, d,
J = 7.1 Hz, CH3), 1.07 (3H, t, J = 7.3 Hz, CH3), 2.41 (1H, dq, J = 7.3,
18.0 Hz, CH3CH2), 2.61 (1H, dq, J = 7.3, 18.0 Hz, CH3CH2), 2.94–
3.05 (1H, m, CH3CH), 3.66–3.73 (1H, m, CHAr), 4.57–4.71 (2H, m,
CH2NO2), 7.14–7.17 (2H, m, ArH), 7.29–7.33 (3H, m, ArH). dC
(CDCl3, 75.5 MHz) 7.6, 16.3 (2 CH3), 35.4 (CH2), 46.1, 48.3 (2
CH), 78.3 (CH2), 127.9, 129.0 (5 ArC), 137.6 (quaternary C),
213.6 (C@O). m/z (ES+) 235 [(M+H)+, 78%]. Samples for GC made
up at 1 mg/mL in dry dichloromethane and ran on Agilent Technol-
ogies 7820A GC System using G4513A Injector and Astec Chiraldex
G-TA fused silica capillary column purchased from Sigma Aldrich
Supelco using conditions 140 C hold 70 min, ﬂow 1 mL/min, inj.
vol. 0.2 lL, split ratio 10:1, front inlet 150 C, detector 155 C.
anti-28 could not be isolated. Retention times: 44.95 min (syn),
51.05 min (anti), 52.40 min (syn), 55.53 min (anti).
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Abstract
The Pseudomonas quinolone signal (PQS), and its precursor 2-heptyl-4-quinolone
(HHQ), play a key role in coordinating virulence in the important cystic fibrosis
pathogen Pseudomonas aeruginosa. The discovery of HHQ analogues in Burkhol-
deria and other microorganisms led us to investigate the possiblity that these
compounds can influence interspecies behaviour. We found that surface-asso-
ciated phenotypes were repressed in Gram-positive and Gram-negative bacteria as
well as in pathogenic yeast in response to PQS and HHQ. Motility was repressed in
a broad range of bacteria, while biofilm formation in Bacillus subtilis and Candida
albicans was repressed in the presence of HHQ, though initial adhesion was
unaffected. Furthermore, HHQ exhibited potent bacteriostatic activity against
several Gram-negative bacteria, including pathogenic Vibrio vulnificus. Structure–
function analysis using synthetic analogues provided an insght into the molecular
properties that underpin the ability of these compounds to influence microbial
behaviour, revealing the alkyl chain to be fundamental. Defining the influence of
these molecules on microbial–eukaryotic-host interactions will facilitate future
therapeutic strategies which seek to combat microorganisms that are recalcitrant
to conventional antimicrobial agents.
Introduction
Cooperative behaviour has changed our perception of how
bacteria interact and cohabit within diverse ecological and
clinical environments. The mobilization of diffusible signal
molecules among populations of bacteria facilitates coordi-
nation of cellular activities towards the benefit of the
population as a whole rather than the individual cell. While
these signalling molecules are often species-specific, the
ability to ‘listen in’ and decipher a competitor’s messages is
a valuable asset in mixed microbial communites, such as
those that exist during infection of the cystic fibrosis (CF)
lung. This phenomenon, often referred as interspecies or
interkingdom signalling, is emerging as a key influence on
the outcome of infectious diseases, although currently a
dearth of knowledge exists regarding the signals involved in
many of these interactions.
Pseudomonas aeruginosa is a highly adaptable organism,
capable of colonizing a wide variety of niches including burn
wounds and immunocompromised patients and it is the
main pathogen associated with morbidity and mortality in
CF patients (Govan & Deretic, 1996). Pseudomonas aerugi-
nosa produces 4 50 alkylquinolones that differ structurally
on the basis of substitution at the C3 position, N-oxide
substitution of the quinolone nitrogen and modification of
the alkyl side chain (Pesci et al., 1999; Lepine et al., 2004).
Many of these alkylquinolones have been characterized with
respect to their antibiotic activities (Wratten et al., 1977;
Leisinger and Margraff, 1979; Lepine et al., 2004), while a
role as signal molecules in cell–cell communication has been
revealed for 2-heptyl-3-hydroxy-4-quinolone [Pseudomonas
quinolone signal (PQS)] and its immediate precursor 2-
heptyl-4-quinolone (HHQ) (Pesci et al., 1999; McKnight
et al., 2000; Diggle et al., 2003; Deziel et al., 2004).
PQS signalling is pleiotropic, regulating biofilm forma-
tion, secondary metabolite production, pigment and viru-
lence factor production, motility and membrane vesicle
formation (Diggle et al., 2003, 2007b; Dubern & Diggle,
FEMS Microbiol Ecol 77 (2011) 413–428 c 2011 Federation of European Microbiological Societies
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2008; Mashburn-Warren et al., 2009). Many of these pheno-
types are mediated through the LysR-type transcriptional
regulator PqsR, for which both HHQ and PQS act as
coinducers (Wade et al., 2005; Xiao et al., 2006). Several
important phenotypes such as iron chelation and pro-
oxidant activities have since been attributed to PQS (Diggle
et al., 2003; Bredenbruch et al., 2006; Haussler and Becker,
2008). While PQS has poor solubility in aqueous solution
and is packaged into self-promoted vesicles to facilitate
trafficking (Mashburn-Warren et al., 2009), HHQ is known
to passively diffuse out of the cell into the extracellular
milieu (Deziel et al., 2004).
Recent studies have identified HHQ biosynthetic systems
in non-Pseudomonas species (Diggle et al., 2006; Vial et al.,
2008). While the function of HHQ analogues in these
species remains to be elucidated, strong structural simila-
rities with P. aeruginosa HHQ suggest the existence of a
conserved interspecies signalling system. However, although
the spectrum of influence of alkylquinolones has been
extensively reviewed in recent years (most recently by Heeb
et al., 2010 and Huse & Whiteley, 2010), the question
remains as to whether HHQ and PQS signal molecules have
an interspecies/interkingdom communication role.
In this study we reveal a role for both PQS and HHQ as
modulators of key phenotypes in Gram-positive and Gram-
negative bacteria, as well as towards the eukaryotic yeast
Candida albicans. In addition, we provide evidence for the
structural requirements that define the interkingdom role of
these molecules.
Materials and methods
Strains and growth conditions
Strains, media composition and growth conditions are
described in Table 1. One of the Bacillus subtilis strains used
in this study, NCTC 10073, has been renamed Bacillus
atrophaeus, with both species being indistinguishable using
standard characterization methods (Fritze & Pukall 2001).
However, as this strain is still listed as B. subtilis in the NCTC
collection, we have used that designation throughout the
paper. Trypticase soy agar (TSA) (Merck, Germany) was
routinely used to culture Bacillus, Escherichia and Staphylo-
coccus species. Listeria monocytogenes was cultured on
brain–heart infusion (BHI) agar. Vibrio cholerae, Vibrio
vulnificus and Vibrio parahaemolyticus were cultured on
Luria–Bertani (LB) [tryptone 1% (w/v), yeast extract 0.5%
(w/v), agar 1.5% (w/v)] supplemented with 0.5%, 2% and
3% (w/v) NaCl, respectively. Vibrio fischeri was cultured on
LBS [Tryptone 1% (w/v), yeast extract 0.5% (w/v), NaCl 2%
(w/v), agar 1.5% (w/v) and 20mM Tris-HCl (pH 7.5)].
Marine agar was used to culture sea-sponge isolates and was
constituted as 10 g of soluble starch, 4 g of yeast extract, 2 g
of peptone, 15 g of Bacto agar, 33.3 g of InstantOcean
(Aquarium Systems, Mentor, OH) and 1 L of distilled water.
Candida albicans was grown in non-filament-inducing
media; YPD [2% (w/v) Bacto peptone, 1% (w/v) yeast
extract and 2% (w/v) glucose] or YNB [1YNB salts with
ammonium sulphate (Difco 291940), 0.2% (w/v) glucose
and 0.1% (w/v) maltose] and filament-inducing media;
YNBNP [YNB supplemented with 25mM phosphate buffer
(pH 7) and 2.5mM N-acetylglucosamine (Sigma A-8625)],
or Spider media (10 g of nutrient broth, 10 g of mannitol
and 2 g of K2HPO4 in 1 L distilled water pH 7.2) as described
previously (Liu et al., 1994; McAlester et al., 2008).
Chemical synthesis of alkylquinolone derivatives
HHQ was prepared using a procedure we have recently
reported (McGlacken et al., 2010) starting with Meldrum’s
acid in a four-step procedure. Conversion to the aldehyde
proceeded using a Duff formylation reaction using a mod-
ified method to that described by Pesci et al. (1999).
Transformation to PQS occurred as described previously
(Pesci et al., 1999). Synthesis of the methyl derivative of PQS
was achieved through reaction of the appropriate anthrani-
lic acid with chloroacetone under basic conditions followed
by cyclization of the corresponding anthranilate in refluxing
N-methylpyrrolidone. This procedure described by Hradil
et al. (1999) gave the quinolone in good yield (4 50% over
two steps). Synthesis of the methyl derivative of HHQ was
achieved by reaction of ethyl acetoacetate and aniline
followed by cyclization in refluxing diphenylether. All alkyl-
quinolone compounds (Supporting Information, Table S1)
were solubilized in methanol and stored at  20 1C.
Antibacterial activity assays
Antibacterial activity of all alkylquinolone derivatives was
initially investigated using agar plate assays. Bacteria were
streaked onto growth agar (Table 1) and incubated over-
night at an appropriate temperature (Table 1). Where
growth was altered on plates, kinetics were measured in
liquid culture in microtitre plates using a BioScreen C
analyser (Oy Growth Curves Ab Ltd, Helsinki). To initiate
time kill-curve assays, overnight cultures were standardized
to OD600 nm 0.2, to which HHQwas added at 1, 10 or 50 mM.
Equal volumes of methanol were added to control cultures.
Samples were taken at 1 h intervals and viable cell counts
were enumerated on LBS (V. fischeri) or LB (Escherichia coli
and V. cholerae) agar.
Semi-solid motility assays
Motility of B. subtilis and Bacillus cereus was analysed on LB
and TSA 0.3% (w/v) agar, Staphylococcus aureus colony
spreading was assessed on LB and TSA 0.24% (w/v) agar,
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and L. monocytogenes motility was analysed on BHI 0.3%
(w/v) agar. Swarming motility in Gram-negative bacteria
was analysed on Eiken Agar [0.6% (w/v) supplemented with
0.5% (w/v) glucose], while swimming motility was assessed
on LB and TSA 0.3% (w/v) agar. Vibrio fischeri motility was
assayed on TB-SW 0.25% (w/v) agar, while P. aeruginosa
twitching motility was assessed on LB agar [1% (w/v)].
Alkylquinolone derivatives were added to the molten med-
ium at a final concentration of 10 mM immediately before
pouring plates. FeCl3 was added to molten agar medium at
a final concentration of 100mM. Aliquots of overnight
cultures (3 mL) were spotted into the centre of the plate and
the zone of motility was measured against control plates
containing methanol. Alternatively, toothpicks were used to
inoculate colonies from plates, incubated overnight, onto
the centre of Eiken agar plates. All experiments were
performed in triplicate and data presented is the result of at
least three independent biological replicates.
Attachment and pellicle formation analysis
Bacterial cultures were incubated overnight and transferred
into fresh TSB to an OD600 nm of 0.05. Aliquots (1mL) were
transferred into 24-well plates and alkylquinolone derivates
or controls added at a final concentration of 10 mM. Plates
were incubated overnight and attachment/biofilm was eval-
uated by crystal violet staining after washing to quantify
attached cells. For analysis of migration from the air–liquid
surface interface, plates were prepared as described above
and incubated at a 451 angle overnight. Liquid was removed
Table 1. List of strains and routine growth conditions used in this study
Strain Description Temperature ( 1C) Media Source/reference
Gram negative
Pseudomonas aeruginosa PA14 37 LB Liberati et al. (2006)
P. aeruginosa PA14 pqsH pqsH<TnM 37 LB Liberati et al. (2006)
Escherichia coli NCIMB11943 37 LB NCIMB
Vibrio fischeri ES114 E. scolopes, Hawai’i 25 LBS E. Ruby lab, UW
V. fischeri MJ11 M. japonica, Japan 25 LBS E. Ruby lab, UW
V. cholerae 0395 O1 Classical, India 30 LB UCC Collection
V. vulnificus YJ016 Biotype 1, Taiwan 30 LB 2% NaCl UCC Collection
V. parahaemolyticus RIMD2210633 03:K6, Japan 30 LB 3% NaCl UCC Collection
Salmonella Typhimurium LT2 37 LB UCC Collection
Serratia marcescens Clinical isolate 58272 30 LB J. Clair, Mercy Hospital
Serratia sp. 39006 30 LB Poulter et al. (2010)
Proteus vulgaris NCIMB12426 37 LB NCIMB
Gram positive
Bacillus subtilis NCTC10073 Renamed Bacillus atrophaeus
(Fritze & Ru¨diger 2001)
30 TSB NCTC
B. subtilis NCDO1789 30 TSB NCDO
B. cereus NCIMB9373 30 TSB NCIMB
Staphylococcus aureus NCDO949 37 TSB NCDO
S. epidermidis DMSZ3095 37 TSB DMSZ
S. gallinarum DMSZ4616 37 TSB DMSZ
Micrococcus luteus NCIMB9278 37 TSB NCIMB
Listeria monocytogenes LO28 Serotype 1/2c 37 BHI C. Hill lab, UCC
Marine sponge isolates
Vibrio sp. P. boletiformis isolate 23 MA UCC Collection
Algoriphagus sp. P. boletiformis isolate 23 MA UCC Collection
Bacillus sp. P. boletiformis isolate 23 MA UCC Collection
Pseudoalteromonas sp. P. boletiformis isolate 23 MA UCC Collection
Spongibacter sp. P. boletiformis isolate 23 MA UCC Collection
Shewanella sp. P. boletiformis isolate 23 MA UCC Collection
Micrococcus sp. P. boletiformis isolate 23 MA UCC Collection
Pseudovibrio sp. A. dissimilis isolate 23 MA UCC Collection
Yeast
Candida albicans SC5314 37 YPD Gillum et al. (1984)
C. albicans BCa2-10 tup1/tup1 37 YPD Braun & Johnson (1997)
C. glabrata ATCC2001 37 YPD ATCC
Kluyveromyces marxianus CBS608 37 YPD CBS
Saccharomyces cerevisiae BY4741 37 YPD Brachmann et al. (1998)
Marine sponges were collected at the Lough Hyne Marine Nature Reserve, Co. Cork. Ireland.
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preserving the attached pellicle, and plates were visualized
microscopically. To analyse the impact of HHQ on the
specific stages of B. subtilis pellicle formation, six-well plates
were prepared as above and incubated at 30 1C. Aliquots
(2mL) were removed from the bottom of the wells at 4 h
intervals, stained with crystal violet on glass slides, and
visualized under a microscope.
Cultivation of bioflms using flow-cell
technology
Biofilms were grown at room-temperature in flow chambers
with individual channel dimensions of 1 4 40mm. The
flow system was assembled and prepared as described
previously by Moller et al. (1998). Before inoculation, cells
were pre-exposed to 10 mM HHQ or methanol control for
12 h, with a starting OD600 nm of 0.05, shaking at 30 1C in
TSB. Subsequently, the flow channels were inoculated with
250mL of these cells diluted to an OD600 nm of 0.05 in TSB
media. After inoculation, the flow chambers were inverted
without flow for 1 h, after which the flow was started using a
Watson Marlow 205S peristaltic pump at a mean flow
velocity of 0.2mm s1, and the flow chambers were reverted
again. The chambers were either supplied with TSB contain-
ing either 10mM HHQ, 10mM PQS or an equal volume of
methanol. Biofilms were visualized 9 h postinoculation
following addition of 250 mL of 5 mM SYTO9 (Invitrogen)
into the flow cells. The flow was stopped for the incubation
period of the dye (15min), after which the flow was
reinstated and the biofilm was visualized. Three indepen-
dent experiments were performed.
Microscopy and image acquisition
Microscopic observations and image acquisition of the
biofilms were performed with a Zeiss LSM 5 Exciter (Carl
Zeiss, Jena, Germany) equipped with an argon laser and
detector and filter sets for monitoring green fluorescence
from SYTO9 (excitation, 488 nm; emission 505–550 nm).
Images and Z-stacks were obtained using a  40/0.75 NA
objective and images were generated using the IMARIS Soft-
ware package (Bitplane AG, Zu¨rich, Switzerland). Images of
C. albicans were captured using a Leica DM1000 microscope
( 40/0.65 objective lens) attached to a Leica DFC290 HD
camera (Solms, Germany).
Candida albicans biofilm assay
Biofilm formation in C. albicans was measured in 96-well
polystyrene plates (Sarstedt) as described previously
(Ramage et al., 2001). Briefly, C. albicans cells were grown
as yeast cultures at 30 1C in YNB medium overnight. Yeast
cells were diluted in YNBNP filament inducing medium to
OD600 nm 0.05, treated with HHQ, PQS or cHHQ (10, 50 or
100 mM) and 100 mL cultures were placed in the wells of the
plate for an initial incubation period of 1 h at 37 1C. The
media and nonadherent cells were removed and the wells
were washed twice with 100 mL of fresh growth medium to
remove nonadhered cells. Fresh growth medium (100mL)
supplemented with HHQ, PQS or cHHQ, was added to the
wells, and the plates were reincubated statically for 24 h.
Biofilm formation was measured using a semi-quantitative
XTT (Sigma) reduction assay (Hawser, 1996; Tunney et al.,
2004). Cultures with no added supernatant and cultures
containing an equivalent volume of methanol were used as
controls. Experiments were repeated in triplicate with six
technical replicates. Means were compared using pairwise
t-tests (P  0.05).
Phenazine quantification assay
Overnight cultures of PA14 wild-type and the pqsHmutant
obtained from the nonredundant PA14 TnMmutant library
were inoculated 1 : 100 into fresh LB containing 10mM
HHQ, PQS, cHHQ, HHQ-C1, PQS-C1 or methanol and
incubated overnight at 37 1C, 200 r.p.m. Pyocyanin was
extracted as previously described and quantified spectro-
photometrically at A520 nm (Essar et al., 1990).
Thin layer chromatography (TLC) analysis
TLC analysis of HHQ, PQS and derivative molecules was
performed using the protocol described by Fletcher et al.
(2007). The stationary phase silica plate (Merck) was soaked
for 30min in KH2PO4 and activated at 100 1C for 1 h before
use, while the mobile phase used was dichloromethane : -
methanol 95 : 5. As controls, extracts were obtained from
PA14 wild-type, PA14 TnM pqsH and PA14 TnM pqsA.
Results
HHQ exhibits species-specific antibacterial
activity
The consequences of interspecies and interkingdom
communication vary from coercive growth inhibition to
more subtle signal related modulation of microbial beha-
viour. Initially, it was necessary to determine if physiological
concentrations of HHQ and PQS [10mM (Calfee et al.,
2005)] exhibited antimicrobial activity against a range of
Gram-negative and Gram-positive microorganisms, which
were chosen to reflect the diverse ecological niches occupied
by P. aeruginosa isolates. HHQ and PQS were also tested for
antimicrobial activity against several yeast species including
the pathogens C. albicans and Candida glabrata (results are
summarized in Table 2). Growth inhibition ranged from
complete inhibition, to partial inhibition, and finally to no
alteration in growth. The growth of V. fischeri, V. vulnificus
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and a marine sponge isolate Algoriphagus sp. was completely
inhibited on agar plates supplemented with 10 mM HHQ
(Fig. 1a and Table 2). Growth of the human pathogen V.
cholerae and several marine sponge isolates was also altered,
though not completely inhibited, in the presence of HHQ
(Table 2). Addition of 10 mM HHQ to both agar and broth
had no effect on the growth of the other Gram-negative and
Gram-positive bacteria tested, including the pathogens S.
aureus and V. parahaemolyticus, or on any of the yeast
species (Fig. 1a and Table 2). Subsequently, the kinetics of
HHQ-induced growth inhibition were investigated using a
BioScreen C multiwell system and confirmed the spectrum
of HHQ-sensitive species (Fig. S1 and data not shown).
Growth of V. cholerae and V. fischeri was inhibited in the
presence of 10mM HHQ, with the latter being almost
completely repressed (Fig. S1) and time kill-curve analysis
revealed the activity to be bacteriostatic (Fig. 1b).
PQS and HHQ repress microbial motility
Bacterial motility and chemotaxis have been associated with
virulence in several bacterial species (Josenhans and Suer-
baum, 2002; Krukonis and DiRita, 2003). To investigate the
impact of HHQ and PQS on microbial motility, both
Table 2. Summary of HHQ and PQS influences on microbial behaviour
Phenotype
Growth Motility Biofilm
Species M P cH H mP mH M P cH H mP mH M P cH H mP mH
Gram negative
P. aeruginosaI PA14 1 1 1 1 1 1 1 - -w ntw 1 1 1 1 1 1 1 1 1
E. coli NCIMB11943 1 1 1 1 1 1 1 - - -w ntw 1 1 1 1 1 1 1 1 1
Serratia sp. 39006 1 1 1 1 1 1 1 - -w ntw 1 1 1 1 1 1 1 1 1
Serratia marcescens 1 1 1 1 1 1 1 - -w ntw 1 1 1 1 1 1 1 1 1
S. Typhimurium LT2 1 1 1 1 1 1 nm nm nm nm nm nm 1 1 1 1 1 1
P. vulgaris NCIMB12426 1 1 1 1 1 1 nm nm nm nm nm nm 1 1 1 1 1 1
V. cholerae O395 1 1 1 - 1 1 1 1 1 - 1 1 1 1 1 1 1 1
V. fischeri ES114 1 1 1 - - - 1 1 1 1 1 - - - 1 1 1 1 1 1 1 1
V. fischeri MJ11 1 1 1 - - - 1 1 1 1 1 - - - 1 1 1 1 1 1 1 1
V. vulnificus YJ016 1 1 1 - - - 1 1 1 1 1 1 1 1 1 1 1 1 1 1
V. parahaemolyticus RIMD2210633 1 1 1 1 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
Shewanella sp. 1 1 1 - 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
Vibrio sp. 1 1 1 - 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
Pseudovibrio sp. 1 1 1 1 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
Algoriphagus sp. 1 1 1 - - - 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
Pseudoalteromonas sp. 1 1 1 - 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
Spongibacter sp. 1 1 1 1 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
Gram positive
B. subtilis NCTC10073 1 1 1 1 1 1 1 - - - - - - 1 1 1 1 - - - - - 1 1
B. subtilis NCDO1789 1 1 1 1 1 1 1 - - - - - - 1 1 1 1 - - - - - 1 1
B. cereus NCIMB9373 1 1 1 1 1 1 1 - - - - - - 1 1 1 1 1 1 1 1
Bacillus sp. 1 1 1 1 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
S. aureus NCDO949 1 1 1 1 1 1 1 - - - - - - - - - 1 1 1 1 1 1 1 1
S. epidermidis DMSZ3095 1 1 1 1 1 1 1 - - - - - - - 1 1 1 1 1 1 1 1
S. gallinarum DMSZ4616 1 1 1 1 1 1 1 - - - 1 1 1 1 1 1 1 1 1 1
L. monocytogenes LO28 1 1 1 1 1 1 1 - - - - - 1 1 1 1 1 1 1 1
M. luteus NCIMB9278 1 1 1 1 1 1 nm nm nm nm nm nm 1 1 1 1 1 1
Micrococcus sp. 1 1 1 1 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
Yeast
C. albicans SC5314 1 1 1 1 1 1 1 1 1 1 1 1 1 1 - - - - - 1 1
C. glabrata ATCC2001 1 1 1 1 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
S. cerevisiae BY4741 1 1 1 1 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
K. marxianus CBS608 1 1 1 1 1 1 nt nt nt nt nt nt nt nt nt nt nt nt
Growth inhibiting.
wDenotes swarming motility. Swimming motility was unaffected in these organisms.
1, Normal phenotype; - - -, 80–100% reduction; - -, 50–79% reduction; -, 20–49% reduction; nt, not tested; nm, nonmotile; M, MeOH; P, PQS; cH,
cHHQ; H, HHQ; mP, PQS-C1; mH, HHQ-C1.
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compounds were added to semi-solid motility agar. Motility
of all Gram-positive bacteria tested was significantly
repressed in the presence of PQS, independent of any growth
defect (Fig. 2 and Fig. S2; Table 2). With the exception of
S. aureus, HHQ exhibited a less potent repression of motility
than PQS (Fig. 2a and Fig. S2). Repression of S. aureus
spreading motility by HHQ was not due to small colony
variation and correlated with increased production of an
orange pigment, likely to be staphyloxanthin, which became
more pronounced after storage at 4 1C (Fig. S3). As PQS has
previously been shown to act as an iron-trap (Bredenbruch
et al., 2006; Diggle et al., 2007b), and several studies report
that bacterial motility is reduced under iron-limiting condi-
tions (Matilla et al., 2007; Tang and Grossart, 2007; Glick
et al., 2010), we investigated the possibility that motility
could be repressed in Gram-positive bacteria as a conse-
quence of iron limitation. However, addition of 100 mM
FeCl3 to semi-solid agar plates did not restore motility, and
repression in the presence of both FeCl3 and PQS was
comparable to that observed in the presence of PQS alone
(Fig. 2c and Fig. S2). Swarming motility of Gram-negative
bacteria was also reduced in the presence of PQS (Fig. 2a),
while swimming motility and P. aeruginosa twitching moti-
lity was not influenced by the presence of PQS, HHQ or any
of their derivatives (Fig. S2, data not shown and Table 2).
HHQ interferes with pellicle and biofilm
formation in B. subtilis
The ability to form biofilms is another key cooperative trait
that enables bacteria to persist in extreme and hostile
environments, and is closely associated with motility in
Fig. 1. HHQ but not PQS exhibits potent
species-specific bacteriostatic activity. (a) Growth
of Vibrio fischeri ES114 (VfE), V. fischeri MJ11
(VfM), Vibrio vulnificus YJ016 (Vv), Vibrio
parahaemolyticus RIMD2210663 (Vp), Listeria
monocytogenes LO28 (Lm), Staphylococcus
aureus NCDO949 (Sa), Pseudomonas aeruginosa
PA14 (Pa) and S. enterica serovar Typhimurium
LT2 (St) in the presence of either HHQ or PQS
(10 mM). (b) Time kill-curve analysis of HHQ
towards Escherichia coli, Vibrio cholerae and
V. fischeri.
FEMS Microbiol Ecol 77 (2011) 413–428c 2011 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
418 F.J. Reen et al.
several organisms. We therefore assessed the impact of the
alkylquinolone signal molecules on biofilm formation in a
range of Gram-negative and Gram-positive bacteria. A
significant reduction in biofilm attachment/formation was
observed upon addition of HHQ to B. subtilis cultures, while
this phenotype was unaffected in several other Gram-positive
and Gram-negative organisms, including S. aureus and B.
cereus (Fig. S4 and Table 2). Microscopic visualization of 24-
well assay plates incubated overnight at a 45o angle confirmed
the impact of HHQ on formation of the B. subtilis pellicle
(Fig. 3a). As pellicle formation in B. subtilis is known to
progress through distinct genetic steps, involving defined
groups of transcriptional regulators (Kobayashi, 2007), the
biofilm assay was repeated in six-well plates and cells were
visualized microscopically at 4 h intervals. This revealed that
the early stages of biofilm development, including head-to-tail
chain formation of B. subtilis cells and aggregation into
clusters, were unaffected in the presence of HHQ (Fig. 3b).
Biofilm formation was also dramatically reduced in flow
chambers through which HHQ-treated cultures were passed
(Fig. 3c). The biofilm structures were less frequent and
ordered during HHQ treatment and this correlated with the
reduced attachment observed after 1 h in HHQ-treated cul-
tures (Fig. 3c). Interestingly, HHQ was unable to cause
dispersal of preformed B. subtilis biofilms (data not shown)
indicating that this compound exclusively targets formation of
the mature biofilm. Consistent withmicrotitre assays, addition
of PQS to flow cell cultures did not reduce pellicle formation,
attachment or formation of mature biofilms (Fig. 3 and data
not shown). The biofilmmodulating activity of HHQ revealed
in this analysis adds another layer of complexity to the
capacity of this compound to influence microbial behaviour.
HHQ interferes with biofilm formation in
C. albicans
Having established an interspecies influence for HHQ and
PQS, we subsequently sought to address the possibilty that
these compounds may also influence behaviour of eukaryotic
pathogens. Bidirectional signalling between prokaryotes and
eukaryotes is emerging as a key trait of the clinically important
Pseudomonas–Candida interaction (Cugini et al., 2007; Cugini
et al., 2010) and several molecules produced by P. aeruginosa
have been shown to impact on C. albicans (Hogan and Kolter,
2002; Hogan et al., 2004; Davies and Marques, 2009;
Holcombe et al., 2010). There was a significant reduction in
the ability of C. albicans to form biofilms in the presence of
HHQ, revealing an interkingdom dimension to HHQ func-
tion. Biofilm reduction could be observed at 10mMHHQ but
the phenomenonwas greatly enhanced at concentrations of 50
or 100mMHHQ (Fig. 4a and Fig. S5a). To further analyse the
biofilm-specific effects of HHQ, and in particular whether the
yeast-hyphal switch is implicated in biofilm inhibition, we
used a constitutively filamenting tup1/tup1mutant. This strain
Fig. 2. HHQ and PQS influence microbial
motility. (a) Motility of Gram-positive and
Gram-negative bacteria on semi-solid TSA and
Eiken agar plates supplemented with 10 mM HHQ
or PQS. (b) Growth kinetics analysis of Bacillus
subtilis in the presence of 10 mM HHQ or PQS on
a BioScreen C analyser. (c) Motility of B. subtilis
on semi-solid TSA plates supplemented with
10 mM PQS 100mM FeCl3.
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lacks the hyphal repressor TUP1 and as a result is ‘locked’ in
the hyphal form. In contrast to the wild-type strain, no
reduction in biofilm formation was observed in this strain
after treatment with 100mM HHQ (Fig. 4a). Biofilm reduc-
tion by HHQ in microtitre wells was not due to a decrease in
the total cellular growth, supported by measurements of
growth on solid media and in liquid shaking culture (Fig 4b
and data not shown). When HHQ was present only during
adhesion there was no effect on biofilms (Fig. S5b), however,
when HHQ was added only during development there was a
reduction in biofilm formation similar to that observed when
HHQ was present throughout the assay (Fig. S5b), suggesting
that initial adhesion is not a target of HHQ. Filamentation is
crucial for the virulence of C. albicans, and the P. aeruginosa
N-acylhomoserine lactone (AHL) molecule 3-oxo-C12 has
been shown to target this morphological switch from yeast to
hyphal growth (Hogan et al., 2004). Using filamentation-
inducing media, HHQ or PQS did not influence C. albicans
morphology or the morphological switch during planktonic
growth. Hyphae were produced normally on solid spider
media and in liquid culture (Fig. 4c) and there was no
difference in hyphal biomass production in response to HHQ
(data not shown). Thus, in addition to the interspecies role
revealed for HHQ and PQS, our analysis reveals an interking-
dom role for HHQ, influencing biofilm formation in the
major pathogenic yeast C. albicans.
Fig. 3. Pellicle formation in Bacillus subtilis is
disrupted by HHQ. (a) Pellicle formation assay of
static B. subtilis cultures incubated at a 451 angle
in 24-well plates supplemented with 10mM HHQ
or PQS. The migration and attachment of cells
from the liquid–air interface was visualized after
removal of unattached cells. (b) Cells sampled at
8 h to assess cell-morphological changes
associated with pellicle formation in B. subtilis:
(i) methanol, (ii) PQS, (iii) untreated, and (iv) HHQ.
This figure is representative of six biological
replicates. (c) Visualization of SYTO9-stained B.
subtilis biofilms grown in TSB media for 9 h (i) in
the presence of HHQ or (ii) in the presence an
equal volume of methanol. Attachment was
evaluated in cells treated with HHQ (iii) or
methanol (iv) for 1 h. Air–liquid interface.
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Structure--function analysis of HHQ and PQS
analogues provides insight into their influence
on interkingdom behaviour
To gain an insight into the molecular characteristics that
delineate the interspecies and interkingdom influence of
HHQ and PQS uncovered in this study, we prepared
analogues of HHQ and PQS for phenotypic analysis. These
consisted of a C3 formyl substituted HHQ (cHHQ) and
derivatives of HHQ and PQS where the C7 alkyl side chain
was replaced with a C1 methyl group (Table S1). In contrast
to the bacteriostatic activity of HHQ, addition of cHHQ,
Fig. 4. HHQ interferes with biofilm formation in
the eukaryotic yeast pathogen C. albicans. (a)
Candida albicans SC5314 (wild type) and tup1/
tup1 mutant (constitutively hyphal) biofilm for-
mation in filament-inducing medium with
100mM PQS, HHQ or methanol in polystyrene
microtitre wells. The y-axis represents A492 nm
values for each condition normalized to
untreated YNBNP. Statistical differences are
shown compared with methanol control
(P  0.001 t-test). Error bars represent  SD
(three biological replicates). (b) Serial dilutions of
wild-type C. albicans plated on YPD media
containing 100mM HHQ or an equivalent volume
of methanol. (c) Microscopic visualization of the
morphological transition from yeast to hyphae in
planktonic cells. Filamentation on solid spider
media in the presence of 100mM HHQ (left
panel). Filament-inducing media containing
100mM HHQ or equivalent methanol (right
panel). Images were captured after 4 h
incubation with aeration at 37 1C.
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HHQ-C1, and PQS-C1 to solid media did not influence the
growth of any of the organisms tested (Table 2). Addition of
10mM cHHQ to semi-solid agar did, however, reduce
motility in Gram-positive bacteria to an extent that was
intermediate between that observed in the presence of HHQ
and PQS (Fig. 5a). The cHHQ molecule was also capable of
interfering with biofilm formation/attachment in B. subtilis
and C. albicans, albeit to a lesser degree than HHQ (Fig.
5b–d and Fig. S6; Table 2). TLC analysis revealed that the C1
derivatives exhibited a markedly lower Rf-value than their
parent compounds in a mobile phase of dichloromethane:-
methanol (95 : 5) (Fig. 6a). Interestingly, although the Rf
value of cHHQ was comparable to PQS, reflecting simliar
polarities in this solvent, the dark colour of the cHHQ
compound was comparable to that of HHQ possibly reflect-
ing similar chemical properties (Fig. 6b). Structure analysis
suggests that while both PQS and cHHQ possess moieties
capable of an inductive electron-withdrawing effect, the
potential aromaticity of the system would introduce reso-
nance effects. In such cases the ring system of PQS would be
expected to possess increased electron density compared
with the aldehyde, with the ring of HHQ possessing inter-
mediate electron density (Fig. 6c). Furthermore, while the
C-3 hydroxyl group of PQS has the capacity to act as a
H-bond donor, the C-3 aldehyde group of cHHQ does not
have this function. However, the oxygen group at C-3 in
both PQS and the aldehyde form could potentially act as a
H-bond acceptor in biological systems. Interestingly, when
supplied to a P. aeruginosa PA14 pqsH mutant, which is
capable of synthesizing HHQ but not PQS, the biological
activity of cHHQ and the methyl analogues was consistent
with their influence on microbial behaviour (Fig. 6d). While
PQS was capable of restoring phenazine production in this
mutant, HHQ and the two C1 derivatives were deficient in
this regard. In contrast, the cHHQ molecule restored
phenazine production almost to wild-type levels (Fig. 6d).
Fig. 5. Influence of HHQ structural analogues on microbial behaviour. (a) Motility of Gram-positive bacteria on semi-solid agar supplemented with
cHHQ, HHQ-C1 and PQS-C1. (b) Pellicle formation and migration from the air–liquid surface interface in Bacillus subtilis, in the presence of cHHQ, HHQ-
C1 and PQS-C1. (c) Pellicle formation in B. subtilis in the presence of cHHQ (i), HHQ (ii), methanol (iii) and HHQ-C1 (iv). (d) Biofilm formation in Candida
albicans in the presence of cHHQ and a methanol control (P  0.001 t-test). Air–liquid interface.
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Therefore, the alkyl side chain and the H-bond accepting
ability of the hydroxyl group are potentially defining features
of the interkingdom modulating capacity of these signal
compounds, while the hydrophobicity of both compounds
must also be considered.
Discussion
Our analysis has revealed a novel interkingdom role for the
PQS and its precursor HHQ, two P. aeruginosa signal mole-
cules that have been shown to coordinate molecular circuitry
and cellular function in this important opportunistic human
pathogen. Pseudomonas aeruginosa inhabits a diverse array of
niches, including soil and water, as well as being the principal
nosocomial pathogen associated with mortality in CF patients
(Janda and Bottone, 1981; Govan and Deretic, 1996). Many
other important human pathogens are also found in both
environmental and host niches where interaction with
P. aeruginosa signal molecules is a strong possibility. Both
Listeria and Bacillus species are soil- and water-borne human
pathogens, with Bacillus in particular being an important
colonizer of the plant rhizosphere (Berg et al., 2005; Bottone,
2010). Staphylococci have also been isolated from the plant
rhizosphere, which is emerging as a possible reservoir for
opportunistic human pathogens (Berg et al., 2005). A role for
PQS andHHQ inmoderating the polymicrobial communities
that inhabit these environmentally and biotechnologically
important niches must now be considered.
Pseudomonas aeruginosa is the predominant organism in
chronic lung infection of CF patients, with up to 80% of the
Fig. 6. Structure–function analysis of
alkylquinolone compounds used in this study.
(a) TLC analysis of the alkylquinolone compounds
compared with PA14, PA14 pqsA and
PA14 pqsH supernatant extracts. (b) Bar graph
representation of TLC analysis revealing that both
PQS and cHHQ have similar Rf values in the
dichloromethane : methanol (95 : 5) mobile
phase. (c) Resonance structure analysis of PQS
and cHHQ molecules. In PQS, electron density
would be released into the ring system. In
contrast, an aldehyde group is more likely to act
as a resonance electronic withdrawing group.
HHQ would be close to ‘neutral’ in this respect.
(d) Quantification of phenazine production in a
Pseudomonas aeruginosa PA14 pqsHmutant
supplemented with the HHQ, PQS and their
derivatives. Data presented is the SD of three
independent experiments (P  0.05,
P  0.005).
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adult CF population being chronically infected (Hansen
et al., 2008). Staphylococcus aureus, Burkholderia cepacia
and C. albicans are also strongly associated with CF-infec-
tions and successfully colonize the CF-lung, often forming
mixed biofilms with P. aeruginosa (FitzSimmons, 1993;
Govan & Deretic, 1996; Hoiby, 1998; Bakare et al., 2003).
PQS has been detected at 2 mM in CF samples from sputum,
bronchoalveolar lavage fluid and mucopurulent fluid from
distal airways of end-stage lungs removed at transplant, and
this is considered to be an underestimate due to limitations
of the extraction technique (Collier et al., 2002). Subse-
quently, isolates obtained from infant CF-patients under 3
years of age were found to overproduce PQS, suggesting that
it may be instrumental in adaptation of P. aeruginosa to the
airways of young CF-patients (Guina et al., 2003a). Tran-
scriptomic and functional genomic studies have provided
further evidence for the importance of PQS and HHQ
during adaptation to the CF-lung (Palmer et al., 2005;
Lindsey et al., 2008) and have also revealed several environ-
mental and host-related stimuli that influence production of
alkylquinolones in P. aeruginosa (Guina et al., 2003b; Jensen
et al., 2006; Cummins et al., 2009; Schertzer et al., 2010).
More recently, PQS has been implicated in P. aeruginosa
pathogenesis in animal models of infection (Zaborin et al.,
2009), while Kim et al. (2010a, b) reported immunomodu-
lation and inhibition of macrophage activation by HHQ and
PQS. These findings, and the scope of the modulation of
microbial behaviour described in this study, suggest that
both HHQ and PQS may be more influential during
infection than previously thought.
The complexity of bacterial–fungal biofilms during infec-
tion has a major influence on the host response, in particular
during the chronic stage of infection (Cugini et al., 2007;
McAlester et al., 2008; Allard et al., 2009; Gibson et al.,
2009). We have recently shown that supernatants from P.
aeruginosa could inhibit C. albicans biofilms in an HSL-
independent manner, an effect that was also observed in a
constitutively hyphal tup1/tup1 mutant (Holcombe et al.,
2010). The finding that HHQ inhibits biofilm formation in
C. albicans wild type, but not in a tup1/tup1mutant, implies
that yet another mechanism is involved. Tup1 regulates
many different sets of genes involved in hyphal and biofilm
development, and one possibility is that HHQ may poten-
tially modulate the interactions of Tup1 with some of its
binding partners leading to the observed biofilm-specific
effects. Previous studies have shown that production of PQS
and HHQ is influenced by farnesol, a C. albicans derived
signalling molecule involved in interspecies and intraspecies
interactions, highlighting the intricacy of the interactions
surrounding these organisms (Cugini et al., 2007; Cugini
et al., 2010).
The role of HHQ and PQS uncovered in this study
mirrors the expanding influence of P. aeruginosa AHL signal
molecules on microbial and eukaryotic systems. 3-oxo-C12-
HSL has been shown to be involved in bacterial cross-talk
(Riedel et al., 2001; Qazi et al., 2006) and also interferes with
the yeast-hyphal transition in C. albicans (Hogan et al.,
2004). AHLs share structural homology with many eukar-
yotic hormones, and influence gene expression in a number
of cell types (Telford et al., 1998; Lawrence et al., 1999;
Tateda et al., 2003; Li et al., 2004) modulating the host
inflammatory and immune response in mammals (Hooi
et al., 2004; Kim et al., 2010a, b). While recent studies have
implicated peroxisome proliferator-activated receptors as
binding receptors for 3-oxo-C12-HSL (Jahoor et al., 2008;
Cooley et al., 2010), the targets of HHQ and PQS remain to
be elucidated. Along with AHLs, the alkylquinolone signal
molecules are typically internalized (Williams, 2007), sugge-
sting that receptors for these compounds may, at least in
some species, be intracellular. Recently, PQS has been shown
to mediate membrane vesicle formation in E. coli and
B. subtilis, indicating that the Gram-negative membrane
structure may not be a limiting determinant for interaction
with PQS (Tashiro et al., 2010). An exciting new finding
reports that microorganisms may communicate both intra-
and interspecies through nanotubes (Dubey & Ben-Yehuda,
2011), although P. aeruginosa remains to be characterized in
this regard.
Several studies have discussed the requirements for true
signal molecules (Winzer et al., 2002; Diggle et al., 2007a;
Atkinson and Williams, 2009). Basic conditions are that the
molecule must (1) diffuse from the cell, (2) be taken up by a
neighbouring cell, (3) trigger an evolved response from that
cell beyond that required to simply metabolize the molecule,
and (4) benefit both the producer and the receiver (Diggle
et al., 2007a). While PQS and HHQ conform to these rules
in P. aeruginosa, future studies will seek to determine the
response networks that exist in other species. While the
influence described in this study would suggest an antag-
onistic action towards other microorganisms, the species-
specific response observed to the presence of HHQ and PQS
suggests that their interspecies communication role cannot
simply be explained by metabolism of the signal.
So, how might other species perceive and respond to the
presence of HHQ and PQS in their extracellular milieu?
Although the mechanisms through which both HHQ and
PQS mediate their interkingdom modulation remains
unknown, the fact that Gram-negative swimming motility
was not affected by either compound suggests that flagellar
activity is not targeted directly. Furthermore, the species-
specific influence of HHQ on biofilm formation raises the
possibility that other human pathogens such as S. aureus,
which responds to HHQ by increasing pigment production
and repressing spreading motility, may have adapted to its
presence. Some further insight into how microorganisms
perceive and respond to these compounds may be gleaned
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from the formyl derivative molecule cHHQ, which influ-
enced Gram-positive behaviour to an extent that was inter-
mediate relative to HHQ and PQS. Structure function
analysis suggests that hydrophobicity and H-bond accepting
potential may be important in delineating PQS and HHQ
effects, while the evidence for polarity and resonance effects
is not supported by the phenotypic data. An indication of
the diverse functionality of these alkylquinolone com-
pounds has arisen from recent structure–function analysis
performed on HHQ and PQS analogues in P. aeruginosa,
where the anthranilate ring was altered by substitution
(Hodgkinson et al., 2010). The authors reported a different
structure–activity profile for each phenotype investigated,
further evidence that the signalling mechanism of HHQ and
PQS may be multifactorial.
The ability of HHQ and PQS to influence cross-kingdom
behaviour suggests that alkylquinolone-signalling may play
a fundamental role in the interspecies interactions that are
the hallmark of polymicrobial communities. Furthermore,
the diversity of clinically and biotechnologically relevant
niches inhabited by the species investigated in this study
highlights the potential for developing novel therapeutic
and commercial strategies based on these compounds.
Defining the interkingdom influence of HHQ and PQS will
require a systems based approach that encompasses the
physiology and complexity of both the producing and
responding organisms. Furthermore, the insights gained
through structure–function and multispecies analysis will
facilitate mechanistic studies that seek to identify the
molecular pathways responsible for transducing the PQS
and HHQ influence and lead to a better understanding of
how the alkylquinolone signal molecules influence gene
expression in microbial pathogens.
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a b s t r a c t
2-Aryl- and 2-alkyl-quinolin-4-ones and their N-substituted derivatives have several important biologi-
cal functions such as the Pseudomonas quinolone signal (PQS) molecule participation in quorum sensing.
Herein, we report the synthesis of its biological precursor, 2-heptyl-4-hydroxy-quinoline (HHQ) and pos-
sible isosteres of PQS; the C-3 Cl, Br and I analogues. N-Methylation of the iodide was also feasible and the
usefulness of this compound showcased in Pd-catalysed cross-coupling reactions, thus allowing access to
a diverse set of biologically important molecules. The ﬁrst crystal structure of PQS is also included.
 2010 Elsevier Ltd. All rights reserved.
Quinolones are best known as broad-spectrum antibacterial
agents,1 for example, ﬂuoroquinolone sales accounted for 18% of
the antibacterial market in 2006.2 An attractive feature of these
molecules is their ability to kill bacteria very rapidly; an ability
not widely attributable to other antibacterial agents. The related
2-aryl and 2-alkylquinolin-4-ones have recently received consider-
able attention due to their more wide ranging pharmacological
applications. For example, 2-arylquinolin-4-one derivatives also
exhibit anti-bacterial3 and anti-tumour properties.4 N-Substituted
2-arylquinoline derivatives can act as anti-malarial agents,
immunostimulants and non-nucleoside HIV-1 inhibitors.5 2-Hep-
tyl-4-hydroxyquinoline N-oxide (HHQNO) is effective against
Staphylococcus aureus.6 2-Heptyl-3-hydroxy-4-quinolone,7 other-
wise known as the Pseudomonas quinolone signal (PQS, Fig. 1),
has emerged as a key regulator of bacterial cooperative behaviour
known as quorum sensing in the antibiotic resistant human path-
ogen Pseudomonas aeruginosa.8 Derived from its biological precur-
sor, 2-heptyl-4-quinolone (HHQ), PQS has a vast and varied array
of biological functions9 inﬂuencing iron homeostasis,10 vesicle for-
mation,11 secondary metabolite production and bioﬁlm forma-
tion.12 P. aeruginosa PQS signaling is highly responsive to
environmental and host-speciﬁc cues, including Mg2+ and the CF
therapeutic colistin.13 Recent evidence has revealed that PQS is
capable of modulating immune responses and human T-cell
proliferation.14
Our interest is twofold; ﬁrstly, in the synthesis of 3-haloquino-
lin-4-ones as analogues of PQS. These substrates will facilitate
mechanistic studies into PQS signaling in virulent Pseudomonas
populations with important clinical applications. Secondly, to
explore if a new N-methyl version can be used in palladium
cross-coupling reactions, thus providing access to an array of
new biologically important quinolones. Importantly, the 2-heptyl
chain is essential for certain biological functions such as the
stimulation of outer vesicle formation in P. aeruginosa11 and thus
synthetic procedures on compounds bearing this bulky and hydro-
phobic substituent are important. There are no reports of haloge-
nation or subsequent cross-coupling of HHQ. From a synthetic
viewpoint, the presence of the long hydrophobic chain represents
a challenge due to low solubility and the obvious steric hindrance.
0040-4039/$ - see front matter  2010 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetlet.2010.09.013
⇑ Corresponding author. Fax: +353 021 427 4097.
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Our initial goal was the synthesis of multi-gram quantities of the
useful precursor HHQ and to investigate if HHQ could be haloge-
nated at the 3-position. A modiﬁed route was designed. Initially
Meldrum’s acid (0.14 mol) was reacted with octanoyl chloride giv-
ing compound 1 followed by boiling in MeOH affording b-ketoester
2 in excellent yield (Scheme 1).15 Formation of the enamine by
reaction with aniline using Dean–Stark apparatus occurred with
>98% conversion (1H NMR) over 16 h.16 Conrad–Limpach cyclisa-
tion occurred best using a method described by Bangdiwala and
Desai.17 An alternative cyclisation method reported by Woschek
et al. failed to give any product in our hands.18 As quantities of
PQS were also required for biological testing, we carried out our
synthesis based on conditions described by Pesci et al.7
The Duff formylation reaction proved problematic. In fact no
isolable aldehyde could be obtained using the experimental condi-
tions reported. We found using two equivalents of hexamine
(HMTA) crucial to obtain a decent yield of aldehyde 3. Oxidation
of precursor 3 proceeded with moderate yield to give PQS as de-
scribed.7 For the ﬁrst time X-ray crystallographic data were ob-
tained for PQS (Fig. 2).19 Interesting dimeric H-bonding indicates
the potential for similar interactions in biological systems.
Chlorination of HHQ occurred smoothly using sodium dichloroi-
socyanurate.20 Bromination also proceeded in reasonable yield
with either pyridinium tribromide (PTB) or Br2. Iodination with I2
in basic THF afforded 6.21 The anticipated low reactivity associated
with the sterically demanding neighbouring alkyl chain never
materialised in these reactions. Furthermore, iodide 6 could be eas-
ily methylated under standard conditions affording 7 in 67% yield
(Scheme 2).22 To our delight, Pd-cross-coupling reactions could be
carried out on 7. Using Pd(PPh3)4 as catalyst a phenyl group could
be introduced at the 3-position.23
After heating at 130 C for 30 min, palladium black was seen to
precipitate and the reaction was stopped. The coupled product 8
was isolated in 50% yield.24 An alkenyl group was also introduced
using the Mizoroki–Heck reaction, iodide 7 and styrene giving al-
kene 9. Two catalytic systems were tried over 16 h at 100 C using
Pd2(dba)3.dba and Pd(PPh3)4 with NMR analysis indicating conver-
sions of ca. 15% and 30%, respectively. Using Pd(PPh3)4 at 120 C
only improved the conversion to 60% with an isolated yield of
52% (Scheme 3). No further optimisation was carried out.
In conclusion, we have described the synthesis of >10 g
quantities of HHQ, its halogenation at the 3-position, subsequent
N
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O
6
>10 g HHQ (33% over 2 steps)
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Scheme 1. Synthesis of HHQ and PQS.
Figure 2. X-ray crystal structure of PQS depicting dimeric H-bonding.19
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50% (b) styrene, Pd(PPh3)4, NMP, Et3N, 52%.
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N-methylation and ﬁnally Pd-cross coupling of 3-iodo-HHQ. The
crystal structure of the prominent biological agent PQS is also de-
scribed. These compounds and analogues are currently undergoing
full biological evaluation, which will be reported in due course.
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Structure–function analysis of the C-3 position in analogues of microbial
behavioural modulators HHQ and PQS†
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2-Heptyl-3-hydroxy-4-quinolone (PQS) and its precursor 2-heptyl-4-quinolone (HHQ) are key signalling
molecules of the important nosocomial pathogen Pseudomonas aeruginosa. We have recently reported an
interkingdom dimension to these molecules, inﬂuencing key virulence traits in a broad spectrum of
microbial species and in the human pathogenic yeast Candida albicans. For the ﬁrst time, targeted
chemical derivatisation of the C-3 position was undertaken to investigate the structural and molecular
properties underpinning the biological activity of these compounds in P. aeruginosa, and using Bacillus
subtilis as a suitable model system for investigating modulation of interspecies behaviour.
Microbial populations coordinate cellular behaviour through the
mobilisation of diffusible signal molecules, which activate gene
expression upon accumulation above a threshold or quorum.1
This phenomenon (quorum sensing), is an essential communi-
cation system utilised by a broad spectrum of Gram-negative and
Gram-positive bacteria, and is a central control mechanism for
virulence and pathogenesis.2 2-Heptyl-3-hydroxy-4-quinolone,
the Pseudomonas Quinolone Signal (PQS) is a key regulator of
quorum sensing in Pseudomonas aeruginosa.1,3,4 P. aeruginosa
is best known as an antibiotic resistant human pathogen associ-
ated with hospital-acquired infections and is the primary cause
of morbidity and mortality in people with cystic ﬁbrosis (CF).5
Controlling P. aeruginosa infection is thus of great clinical
importance.6–9 Research into PQS activity has revealed a vast
and varied array of biological functions.10–16 In addition to con-
trolling expression of key components of the QS regulon, PQS
also modulates bioﬁlm formation, secondary metabolite pro-
duction, pigment and virulence factor production, motility and
membrane vesicle formation.11–13,15 2-Heptyl-4-quinolone
(HHQ), the biological precursor of PQS, also possesses a
plethora of roles including quorum sensing responsibilities.13
PQS has been detected at 2 μM in CF samples from sputum,
bronchoalveolar lavage ﬂuid and mucopurulent ﬂuid from distal
airways of end-stage lungs removed at transplant.17 Isolates
obtained from infant CF-patients under 3 years of age overpro-
duce PQS, suggesting that it may be instrumental in adaptation
of P. aeruginosa to the airways of young CF-patients.18 Trans-
criptomic and functional genomics studies have provided further
evidence for the importance of PQS and its precursor HHQ
during adaptation to the CF-lung19,20 while Kim et al.21,22
reported immunomodulation and inhibition of macrophage acti-
vation by HHQ and PQS. Diggle et al. reported that pathogenic
bacteria other than P. aeruginosa synthesise 2-alkyl-4-quinolones
(AQs). Burkholderia pseudomallei, for example, produces AQs
and employs a structurally similar molecule to HHQ but does
not produce PQS.13,23 Intriguingly, it has recently been shown
that both PQS and HHQ can also control the behaviour of other
bacterial and fungal species.24,25 We found that surface-associ-
ated phenotypes were repressed in a number of Gram-positive
and Gram-negative bacteria as well as in pathogenic yeast in
response to PQS and HHQ.24 Motility was repressed in a broad
range of bacteria, while bioﬁlm formation in Bacillus subtilis
and Candida albicans was repressed in the presence of HHQ,
though initial adhesion was unaffected. Furthermore, HHQ
exhibited potent bacteriostatic activity against several marine
species of Gram-negative bacteria, including pathogenic Vibrio
vulniﬁcus.
To take advantage of signalling pathways in a clinical setting
we take two routes: (1) the early detection of biomarkers such as
HHQ and PQS26–28 and (2) interference with bacterial signals by
the synthesis of molecular analogues capable of interrupting key
virulence traits such as bioﬁlm formation and motility. To date,
the limited structure–function analysis performed on HHQ and
PQS has centred on the alkyl chain length7,29 and substitution of
the anthranilate ring.7 The crucial C-3 position has not been
investigated, notwithstanding the divergent biological activities
†Electronic supplementary information (ESI) available: Full experimen-
tal procedures, biological data, 1H spectra of novel compounds and
additional crystallographical data are included. CCDC 885400. For ESI
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identiﬁed for HHQ and PQS towards other bacterial and fungal
pathogens. Therefore, the structure–function analysis detailed in
this study was designed to provide key insights into the activity
of the HHQ and PQS compounds both within P. aeruginosa and
also towards non-pseudomonal bacterial and fungal species.
These included several key cystic ﬁbrosis pathogens such as
Staphylococcus aureus and C. albicans, for which B. subtilis
proved to be a suitable model for single species analysis of
swarming motility and bioﬁlm formation. Assigning the struc-
tural modules of the quinolone compounds to biological func-
tions would provide signiﬁcant insight into their underlying
mechanism of action. This would form the basis for develop-
ment of innovative therapies, for example where disruption of
bioﬁlm formation would expose microbial pathogens to normal
antibacterial action. In this report we present our ﬁndings on the
biological activity of eight molecules of interest, 2-heptyl-4-
quinolone (3, HHQ), aldehyde 4, 2-heptyl-3-hydroxyquinolin-
4(1H)-one (5, PQS), 3-methyl analogue 8, halogenated versions
9, 10 and 11 and ﬁnally 12 which possesses a potential hydrogen
donor/acceptor at the 3-position.
Chemical synthesis
HHQ was prepared starting with Meldrum’s acid (0.14 mol)
which was reacted with octanoyl chloride followed by boiling in
methanol (MeOH), reaction with aniline30 and a Conrad–
Umpach cyclisation (Scheme 1).†31 An alternative cyclisation
method reported by Woschek et al. failed to give any product in
our hands.32 As quantities of 4 and PQS were also required, their
synthesis from HHQ was achieved using conditions described by
Pesci et al.33 although an excellent method for the direct syn-
thesis of PQS has recently been reported.34 The Duff formylation
of HHQ proved problematic and 2 equivalents of hexamine
(HMTA) was found to be crucial to obtaining decent yields.35
Reaction of aldehyde 4 with MCPBA gave PQS in 29% yield.
The 3-methyl analogue 8 was synthesised in a similar fashion
over ﬁve steps (Scheme 2).† Again Meldrum’s acid was reacted
with octanoyl chloride followed by β-ketoester formation.
Methylation was carried out using K2CO3 and MeI giving 6.
Reaction with aniline gave enamine 7 and a ﬁnal Conrad–
Limpach cyclisation in diphenyl ether afforded analogue 8.31,35
Bromo-analogue 9 was prepared using N-bromosuccinimide
in 37% yield (after recrystallisation) or using Br2 in 47% yield
(Scheme 3). The 3-chloro-quinolone 10 was synthesised in one
step using sodium dichloroisocyanurate (DCIC).36 Recrystallisa-
tion afforded 10 in 46% yield. Iodo-analogue 11 was formed in
the presence of N-iodosuccinimide in 48% yield (halogenation
yields not optimised).
Novel 2-heptylquinazolin-4-one 12 was synthesised via a con-
venient one-step synthesis by reaction of anthranilamide with
octanal, and following recrystallisation from ethanol, afforded
the product in 76% yield (Scheme 4).
Given that both the quinolone and quinoline tautomeric struc-
tures (both structures have been arbitrarily depicted in the litera-
ture37) of HHQ were accessible, the latter as its hydrochloride
salt (Fig. 1), we felt it would be valuable to conﬁrm that both
Scheme 1 Synthesis of HHQ and PQS. Conditions: (a) octanoyl chloride, pyridine, DCM (b) MeOH, reﬂux, 34% over 2 steps (c) PhNH2, reﬂux,
79% (d) Ph2O, reﬂux, 33% (e) HMTA, TFA, reﬂux, 56% (f) H2O2, NaOH, 29%.
Scheme 2 Synthesis of 3-Me analogue 8. Conditions: (a) K2CO3, MeI,
reﬂux, 40%. (b) PhNH2, reﬂux, 79% (c) Ph2O, reﬂux, 10%.
Scheme 3 Halogenation of HHQ. Conditions: (a) NBS, MeOH, 37%
(b) Br2, AcOH, 47% (c) DCIC, H2O, 46% (d) NIS, AcOH, 48%.
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the free quinolone and quinoline hydrochloride exhibited identi-
cal biological activities. Both compounds 3 (HHQ) and 3·HCl
(HHQ·HCl) were found to be interchangeable when used in
biological systems and exerted a common inﬂuence on inter-
kingdom behaviour. Both motility and bioﬁlm formation were
similarly inﬂuenced in B. subtilis in the presence of 3 and 3·HCl
when tested under physiological pH (Fig. 3 and 4).
Biological studies
In order to assess the importance of the C-3 position to the bio-
logical activity of HHQ and PQS, the capacity for analogues
functionalised at this position to replace the native compounds in
P. aeruginosa was investigated. The PQS signalling system, a
key component of QS in P. aeruginosa, is known to control pro-
duction of a range of virulence factors, including elastase,
rhamnolipid and the phenazine redox compound pyocyanin.11,38
Therefore, the analogues were ﬁrst assessed for restoration of
phenazine production in a pqsA mutant, in which the biosyn-
thetic steps required for AQ production have been disrupted.
While both HHQ and PQS restored phenazine production in the
pqsA mutant strain, the analogues were signiﬁcantly less effec-
tive in triggering production of the pigment, with 12 being the
least effective (Fig. 2A), suggesting that the C-3 position is
crucial for control of phenazine production in P. aeruginosa.
Interestingly, addition of equimolar concentrations of the ana-
logues to the wild-type PAO1 and PA14 strains, which produce
both HHQ and PQS, did not interfere with phenazine production
(Fig. 2B). In P. aeruginosa, PQS also plays a fundamental role
in the structural formation of bioﬁlms and PQS-deﬁcient mutants
have been shown to produce thin ﬂat bioﬁlms, which are mark-
edly different to the mushroom shaped structures produced by
the wild-type strain.39 However, neither mutation of pqsA nor
addition of analogues markedly inﬂuenced the initial stages of
bioﬁlm formation in P. aeruginosa as seen in crystal violet
multi-well assays (ESI†).
Aside from their key role as signalling compounds in P. aeru-
ginosa, both HHQ and PQS exert distinct inﬂuences on the be-
haviour of a range of microbial pathogens.24 Differing only at
the 3-position, yet displaying diverse biological functionalities
suggests a key role for the C-3 position in modulating inter-
species microbial behaviour. Microbial swarming motility and
bioﬁlm formation require cooperative multicellular behaviour
and provide a mechanism for bacterial cells to establish and
persist during infection. While motility was shown to be altered
in S. aureus in the presence of HHQ and PQS, C. albicans
bioﬁlm formation was repressed in the presence of HHQ. As we
have previously shown both phenotypes to be affected in B.
subtilis in the presence of HHQ, this species was chosen as a
model organism upon which to test the interspecies inﬂuence of
the alkylquinolone compounds.
Scheme 4 Synthesis of PQS analogue. Conditions: (a) NaSO3H,
DMA, reﬂux, 76%.
Fig. 1 Crystal structure of 3·HCl (HHQ·HCl).†
Fig. 2 Inﬂuence of functionalised derivatives on PQS-dependent phenotypes in P. aeruginosa. (A) The ability of HHQ and PQS (10 μM) to restore
phenazine production in a pqsA mutant was lost to the derivative compounds indicating that the C-3 position is crucial in this regard. (B) Addition of
10 μM concentrations of derivative compounds did not interfere with phenazine production in the wild-type PAO1 strain. Data presented is representa-
tive of three independent experiments (Students t-test, **p-value ≤ 0.005).
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 8903–8910 | 8905
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Unlike 3 and 3·HCl, analogues 6–12 did not exhibit anti-
bioﬁlm activity towards B. subtilis (Fig. 3A), highlighting the
importance of the C-3 position in underpinning the biological
role of these compounds. Furthermore, the inability of 10 to
affect bioﬁlm formation in C. albicans, a human pathogenic
yeast and an important CF pathogen (data not shown), underlines
the importance of the C-3 position for biological functionality of
the AQ compounds. The inﬂuence of 6–12 on microbial swarm-
ing motility was negligible compared to HHQ and PQS
(Fig. 3B). Interestingly, the methyl and halogen substituted com-
pounds 8–11 retained antimicrobial activity towards an Algori-
phagus marine isolate, which was previously shown to be
susceptible to HHQ, while PQS and quinazolinone 12 did not
suppress growth of this species (Fig. 3C).
HHQ and PQS have previously been shown to inﬂuence trans-
cription in a mouse monocyte/macrophage cell line.40 However,
although PQS has been found in CF sputum,17 the impact and
potential cytotoxic effects of these compounds on airway epi-
thelial cells has not been investigated. Therefore, HHQ, PQS and
compounds 8–12 were tested for cytotoxicity towards a human
airway epithelial cell line (IB3-1 cells) for 16 h at concentrations
ranging from 10 to 100 μM by quantiﬁcation of the lactate dehy-
drogenase (LDH) release, in comparison with treatment by 0.1%
Triton X-100, used as a positive control for cytotoxicity. Interest-
ingly, HHQ was found to be cytotoxic towards IB3-1 cells while
PQS did not exhibit any cytotoxic activity (Fig. 4). The cytotox-
icity of HHQ decreased with decreasing concentrations and was
less than 10% at 10 μM (data not shown). As above, the cytotox-
icity of both the quinolone and quinoline compounds towards
IB3-1 cells was comparable (∼60%). With the exception of quin-
azolinone 12 which exhibited a signiﬁcant level of cytotoxicity,
the C-3 substituted analogues (8–11) did not exhibit cytotoxicity
towards IB3-1 cells, reinforcing the importance of the C-3 pos-
ition in the functionality of the HHQ and PQS molecules.
Notably, IB3-1 cellular morphological analysis revealed massive
cellular damage caused by HHQ at a concentration of 100 μM
(Fig. 4) and signiﬁcant cellular change for 12. While PQS
(Fig. 4) and to a lesser extent 8–11 (data not shown) caused
moderate changes in cellular morphology, the plasma membrane
remained intact, consistent with the lack of LDH release, com-
pared to 0.1% Triton X-100.
Conclusions
The P. aeruginosa AQ signalling molecules are emerging as key
components of the highly dynamic and bidirectional molecular
dialogue that exists between pathogen and host and within the
mixed microbial populations that are characteristic of infection.
This is the ﬁrst report highlighting the strict structural require-
ments at the C-3 position underpinning the biological activity of
HHQ and PQS. The control of phenazine production in P. aeru-
ginosa involves a complex interplay between PqsR, AQs and the
last component of the PQS biosynthetic operon, PqsE.38,41,42
The inability of any of the AQ analogues described in this study
to restore phenazine production in a P. aeruginosa pqsA mutant
suggests that the C-3 position is crucial for HHQ and PQS
activity in this important nosocomial pathogen. Interestingly,
addition of the analogues to wild-type cultures did not interfere
with phenazine production, suggesting that they may not be
effective inhibitors in P. aeruginosa. Multi-well bioﬁlm assays
suggest that the analogues do not interfere with the initial stages
Fig. 3 Structural variation of the C-3 position interferes with the bio-
logical activity of P. aeruginosa AQ molecules. (A) Crystal violet stain-
ing of 18 h cultures grown static in multi-well plates revealed that HHQ
interferes with B. subtilis bioﬁlm formation irrespective of its tautomeric
form (HHQone and HHQine). Furthermore, the anti-bioﬁlm activity of
the HHQ chloride salt was comparable to HHQ. However, this anti-
bioﬁlm activity was abolished upon substitution at the C-3 position, irre-
spective of the nature of that substitution (8–12). All compounds were
added at a ﬁnal concentration of 10 μM and statistical signiﬁcance was
provided by paired Student’s t-test (***, p-value ≤ 0.001). (B) B. subtilis
swarming motility was assessed after 16 h on 0.3% (w/v) TSA plates.
Notably, substitution with methyl and halogen groups (8–11) which
would be sterically consistent with PQS, was enough to abolish the anti-
swarming activity of the parent compounds, again highlighting the struc-
tural speciﬁcity underpinning the biological activity of these compounds.
All images are provided to scale. (C) The ability of HHQ to repress the
growth of a marine isolate on SYP agar was maintained in both tauto-
meric forms, and upon substitution with methyl and halogen groups
(8–11). However, 12 did not exhibit antibacterial activity towards the
marine bacteria, similar to PQS. Data presented is representative of at
least three independent biological replicates.
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of bioﬁlm formation in P. aeruginosa, which is perhaps unsur-
prising as attachment and microcolony formation in pqsA
mutants have previously been shown to be largely comparable to
wild-type.43,44 Flow-cell technology and confocal laser
microscopy will be required to assess the full impact of these
analogues on P. aeruginosa bioﬁlm architecture and maturation.
Notwithstanding this, the correlation between loss of function
both within P. aeruginosa and towards other microbial species
upon functionalisation of the C-3 position is striking. While the
molecular mechanism underpinning the response to HHQ and
PQS in other microbial species remains to be deﬁned, it is inter-
esting to speculate that some structural conservation may exist.
If a simple electron withdrawing group was required at C-3
then halogenation at this point (9–11) would be expected to
produce molecules with similar biological activity. Alternatively
introduction of an NH-group as in 12 (another tautomer can exist
here also) could mimic the –OH group in PQS. However in both
cases the capacity to modulate either P. aeruginosa or interking-
dom behaviour was lost in these compounds. Therefore it is
clear that the 3-H and 3-OH groups in HHQ and PQS respecti-
vely, play a more complex role in these biological systems.
Methylation of the C-3 position (8) led to the generation of a
known signal molecule produced by several Burkholderia
species, which do not have the capacity to produce PQS.
Interestingly, 8 appeared to have lost its ability to restore phen-
azine production or inﬂuence interspecies multicellular behaviour,
although it did retain antibacterial activity against Algoriphagus
sp. Therefore, although both compounds are structurally similar,
and produced by important pathogens of the CF-lung, their inter-
species activity proﬁles are distinct. Again introduction of a
nitrogen at C-3 (12) led to complete loss of biological activity
relative to HHQ, while we have previously shown that an alde-
hyde substituted analogue (4) had intermediate activity relative
to both compounds.24 Although from a chemical perspective,
bacterial conversion of HHQ to PQS would go some way to
explaining this observation, the evolutionary rationale underpin-
ning this has yet to be established. Future structural studies will
involve further manipulation of the 3-site with a view towards
attaining a deeper understanding of the complex roles of these
molecules in bacterial and fungal species.
Experimental (see ESI† for full details)
Preparation of 6
To 3-oxo-methyl-decanoate45 (2.74 g, 13.7 mmol) was added
dry acetone (35 mL). This solution was added to a ﬂask contain-
ing dry potassium carbonate (1.76 g, 12.7 mmol) over a N2
Fig. 4 C-3 substitution abrogates cytotoxic activity of HHQ. Cytotoxicity is expressed as a percentage of the total amount of LDH released from
cells treated with 0.1% Triton X-100 (given the percentage of 100). The release of LDH was measured in cell culture medium of IB3-1 cells treated
with methanol or ethanol, or with 100 μM of HHQ, the HHQ chloride salt, PQS, methylated HHQ analogue 8, halogenated HHQ analogues 9–11 or
analogue 12. Data (means ± SD) are representative of three independent biological experiments. Two-tailed unpaired student’s t-test was performed by
comparison of IB3-1 cells treated with HHQ analogue molecules with IB3-1 cells treated with methanol or ethanol (**, p-value ≤ 0.01; ***, p-value
≤ 0.001). Phase-contrast microscopy of IB3-1 cells untreated (CONT) or treated with HHQ, PQS, or 12 at a concentration of 100 μM for 16 h. Triton
X-100 (0.1%) was used as a control in these studies. Original magniﬁcation 40×.
This journal is © The Royal Society of Chemistry 2012 Org. Biomol. Chem., 2012, 10, 8903–8910 | 8907
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atmosphere. The reaction mixture was allowed stir for 20 min
before the addition of methyliodide (1.02 mL, 16.4 mmol). Stir-
ring was continued at room temperature overnight before being
heated at reﬂux for 6 h. The mixture was allowed to cool and the
solvent was removed in vacuo to yield the crude product as a
yellow oil. Puriﬁcation was carried out using silica column
chromatography to yield 6 as a pale yellow oil (1.17 g, 40%).
(Found: C, 67.15; H, 10.2. C12H22O3 requires C, 67.3; H,
10.35%.) νmax (ﬁlm)/cm
−1 2930 (CH stretch), 2857 (CH
stretch), 1749 (CvO ketone), 1717 (CvO ester), 1456 (CH
scissor, bending), 1204 (C–O ester). δH (CDCl3, 300 MHz) 0.88
(3H, t, J = 6.7 Hz, CH3), 1.23–1.27 (8H, m, 4 × CH2), 1.33 (3H,
d, J = 7.2 Hz, CO–CH(CH3)–CO), 1.53–1.66 (2H, m,
CH2CH2CO), 2.52 (2H, qt, J = 7.4, 17.2, 27.4, 44.6 Hz,
CH2CO), 3.53 (1H, q, J = 7.1 Hz, CO–CH(CH3)–CO), 3.73
(3H, s, OCH3). δC (CDCl3, 75.5 MHz) 12.8, 14.0 (2 × CH3),
22.6, 23.5, 28.98, 29.00, 31.6, 41.4 (6 × CH2), 52.3 (CO–CH–
CO), 52.7 (OCH3), 171.1 (CvO ester), 205.9 (CvO ketone).
Exact mass calculated for C12H23O3 [(M + H)
+], 215.1647.
Found 215.1642, m/z (ES+) 215 [(M + H)+, 30%].
Preparation of 7
To a solution of 2-methyl-3-oxo-methyl-decanoate (1.27 g,
5.94 mmol) in dry hexane (30 mL) was added aniline (0.57 mL,
6.24 mmol) and p-toluene sulfonic acid (0.023 g, 0.12 mmol).
The reaction mixture was heated at reﬂux under a N2 atmosphere
for 16 h. The reaction was allowed to cool and the solvent was
removed in vacuo yielding 7 as an orange oil (1.35 g, 79%).
(Found: C, 74.3; H, 9.2; N, 5.2. C18H27NO2 requires C, 74.7; H,
9.4; N, 4.8%.) νmax (ﬁlm)/cm
−1 3216 (NH stretch), 2952 (CH
stretch), 2928 (CH stretch), 2856 (CH stretch), 1744 (CvO),
1657 (CvC), 1612, 1594 (NH bend), 1252 (C–O), 1229 (C–O),
1164 (C–O). δH (CDCl3, 400 MHz) 0.84 (3H, t, J = 7.0 Hz,
CH3), 1.17–1.29 (8H, m, 4 × CH2), 1.37–1.46 (2H, m, CH2),
1.59 (1H, s, CH3), 1.86 (1H, s, CH3), 2.26–2.30 (1H, m, CH2),
2.34–2.38 (1H, m, CH2), 3.52–3.75 (4H, m, CH3), 7.03–7.10
(2H, m, 2 × ArH), 7.13–7.19 (1H, m, ArH), 7.26–7.35 (2H, m, 2
× ArH), 10.81 (1H, bs, OH). δC (CDCl3, 75.5 MHz) 12.5, 14.0
(2 × CH3), 22.6, 27.7, 28.7, 28.8, 29.4, 31.6 (6 × CH2), 50.7
(CH3), 124.8 (quaternary C), 125.1, 125.6, 128.9, 129.1, 129.3
(5 × ArC), 160.8 (ArC–N), 163.8 (C–N), 171.7 (CvO). Exact
mass calculated for C18H28NO2 [(M + H)
+], 290.2120. Found
290.2116, m/z (ES+) 290 [(M + H)+, 56%].
Preparation of 8
Diphenyl ether (45 mL) was heated at reﬂux (270 °C) and the
enamine (1.35 g, 4.68 mmol) was added dropwise over 90 min
ensuring reﬂux was maintained and the mixture was heated for
an additional 1 h. The mixture was then allowed cool to room
temperature and the formed methanol was removed in vacuo.
4 M HCl (6 mL) was then added and the organic layer extracted
with ethyl acetate (2 × 8 mL) dried over anhydrous MgSO4,
ﬁltered and the solvent removed in vacuo to yield crude product
as a brown oil. Puriﬁcation was achieved using silica column
chromatography to yield product as a dark brown solid followed
by two recrystallisations from methanol to yield 8 as a white
crystalline solid (10.6 mg, 10%). δH (CD3OD, 400 MHz) 0.88
(3H, t, J = 6.8 Hz, CH3), 1.30–1.46 (8H, m, 4 × CH2),
1.68–1.75 (2H, m, CH2), 2.15 (3H, s, CH3), 2.81 (2H, t, J =
7.9 Hz, CH2), 7.33 (1H, t, J = 8.1 Hz, ArH), 7.53–7.55 (1H, m,
ArH), 7.60–7.64 (1H, m, ArH), 8.22 (1H, d, J = 7.5 Hz, ArH).
δC (CD3OD, 75.5 MHz) 10.8, 14.4 (2 × CH3), 23.7, 30.0, 30.2,
30.5, 32.9, 33.5 (6 × CH2), 116.2 (quaternary C), 118.7 (ArC),
124.4 (quaternary C), 124.5, 126.2, 132.7 (3 × ArC), 140.6,
153.4 (2 × quaternary C), 179.5 (CvO), m/z (ES+) 258
[(M + H)+, 100%].
Preparation of 3-bromo-2-heptylquinolin-4(1H)-one, 9
Method A. To a stirred solution of 3 (0.5 g, 2.05 mmol) in
dichloromethane (10 mL) and methanol (2.5 mL) was added
portionwise N-bromosuccinimide (0.73 g, 4.1 mmol) and the
reaction was stirred at room temperature for 24 h. The solvent
was removed in vacuo and the crude product was puriﬁed by
recrystallisation in ethanol yielding 9 as a white solid (0.245 g,
37%).
Method B. To a stirred solution of 3 (0.389 g, 1.6 mmol) in
acetic acid (4 mL) was added dropwise over 30 min, a solution
of bromine (0.1 mL, 1.8 mmol) in acetic acid (1 mL). Reaction
progress was monitored by TLC analysis. After 1 h, the reaction
mixture was poured into 1% aqueous sodium sulﬁte (100 mL).
The precipitate was ﬁltered and washed with water yielding the
product 9 as a white solid (0.245 g, 47%). Mp 245–248 °C
(EtOH). νmax (KBr)/cm
−1 3432 (OH stretch), 2926 (CH stretch),
2855 (CH stretch), 1631 (CvN), 1607 (aromatic), 1559 (CvN
conjugated), 1475 (CvC stretch aromatic), 572 (C–Br). δH
([CD3]2SO, 300 MHz) 0.85 (3H, s, CH3), 1.26–1.34 (8H, m, 4 ×
CH2), 1.70 (2H, m, CH2), 2.84–2.89 (2H, m, CH2), 7.33–7.38
(1H, m, ArH), 7.57–7.70 (2H, m, 2 × ArH), 8.09 (1H, d, J =
7.9 Hz, ArH), 12.03 (1H, bs, OH). δC ([CD3]2SO, 75 MHz) 13.9
(CH3), 22.0, 27.6, 28.3, 28.6, 31.1, 34.5 (6 × CH2), 105.5
(C–Br), 117.8 (ArC), 122.7 (quaternary C), 123.6, 125.2 131.9
(3 × ArC), 138.7 (quaternary C), 152.0 (CvN), 171.24 (C–OH).
Exact mass calculated for C16H21NOBr [(M + H)
+], 322.0807.
Found 322.0792, m/z ES+ 322.3 [(M + H)+, 100%].
Preparation of 3-chloro-2-heptylquinolin-4(1H)-one, 10
HHQ·HCl (3·HCl)† (0.839 g, 3.0 mmol) was dissolved in
methanol (50 mL) before addition of 2 M NaOH until neutral
followed by water (10 mL). Sodium dichloroisocyanurate
(0.363 g, 1.65 mmol) was then added to the reaction mixture.
The reaction was allowed stir at room temperature overnight. The
precipitate was ﬁltered and washed with methanol. The ﬁltrate
was then acidiﬁed to pH 4 and placed in the fridge overnight.
The precipitate was ﬁltered to give an off-white solid. Puriﬁ-
cation by recrystallisation in ethanol yielded 10 as a white crys-
talline solid (0.167 g, 46%). Mp 269–272 °C (EtOH). (Found:
C, 68.7; H, 7.1; N, 5.1; Cl, 12.5. C16H20ONCl requires C, 69.2;
H, 7.3; N, 5.0; Cl, 12.8%.) νmax (KBr)/cm
−1 3454 (OH stretch),
2927 (CH stretch), 2857 (CH stretch), 1634 (CvC stretch, con-
jugated), 1563 (CvN conjugated), 1504 (C–C stretch, in ring,
aromatic), 1477 (CvC stretch, aromatic), 1356 (CN stretch),
584 (C–Cl). δH ([CD3]2SO, 300 MHz) 0.88 (3H, t, J = 6.7 Hz,
8908 | Org. Biomol. Chem., 2012, 10, 8903–8910 This journal is © The Royal Society of Chemistry 2012
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CH3), 1.26–1.34 (8H, m, 4 × CH2), 1.65–1.75 (2H, m, CH2),
2.84 (2H, t, J = 7.8 Hz, CH2), 7.32–7.37 (1H, m, ArH),
7.57–7.70 (2H, m, 2 × ArH), 8.1 (1H, d, J = 8.1 Hz, ArH),
12.03 (1H, bs, OH). δC ([CD3]2SO, 150 MHz) 13.9 (CH3), 22.0,
27.5, 28.4, 28.6, 31.1, 32.1 (6 × CH2), 113.3 (C–Cl), 118.0 (Ar–
CH), 123.4 (quaternary C), 123.5, 125.1, 131.8 (3 × Ar–CH),
138.6 (quaternary C), 150.7 (ArC), 170.9 (CvO). Exact mass
calculated for C16H21NOCl [(M + H)
+], 278.1312. Found
278.1317, m/z (ES+) 278 [(M + H)+, 100%].
Preparation of 3-iodo-2-heptylquinolin-4(1H)-one, 11
To a stirred solution of 3 (0.333 g, 1.37 mmol) in glacial acetic
acid (10 mL) was added portionwise N-iodosuccinimide
(0.315 g, 1.40 mmol). Reaction progress was monitored by TLC
analysis and after 2 h, the precipitate was ﬁltered, washed with
acetic acid and acetonitrile. Puriﬁcation was achieved by silica
column chromatography (80/20 ethyl acetate/hexane, ramping to
100% ethyl acetate) to yield 11 as a white crystalline solid
(0.22 g, 48%). Mp 221–225 °C (EtOAc). (Found: C, 52.4; H,
5.4; N, 3.9. C16H20INO requires C, 52.0; H, 5.5; N, 3.8%.) νmax
(ﬁlm)/cm−1 3419 (OH stretch), 2921 (CH stretch), 1627 (CvN),
1557 (CvN conjugated), 1474 (CvC stretch aromatic), 1134
(C–O alcohol), 571 (C–I). δH ([CD3]2SO, 300 MHz) 0.84–0.88
(3H, m, CH3). 1.27–1.37 (8H, m, 4 × CH2), 1.63–1.71 (2H, m,
CH2), 2.88–2.93 (2H, m, CH2), 7.30–7.35 (1H, m, ArH),
7.57–7.68 (2H, m, 2 × ArH), 8.05–8.08 (1H, d, J = 8.1 Hz,
ArH). δC ([CD3]2SO, 75 MHz) 13.9 (CH3), 22.0, 27.9, 28.3,
28.7, 31.1, 38.7 (6 × CH2), 85.8 (C–I), 117.8 (ArC), 120.6 (qua-
ternary C), 123.8, 125.4, 131.9 (3 × ArC), 139.0 (quaternary C),
154.5 (CvN), 173.1 (C–OH). Exact mass calculated for
C16H21NOI [(M + H)
+], 370.0668. Found 370.0664, m/z ES+
370.3 [(M + H)+, 100%]. (Assigned as the quinoline tautomer.)
Preparation of 12
A mixture of anthranilamide (20.5 mmol, 2.791 g), n-octanal
(20.5 mmol, 3.2 mL) and sodium bisulﬁte (30.75 mmol, 3.2 g)
in dimethylacetamide (30 mL) was stirred at 150 °C for 2 h.
Reaction progress was monitored by TLC analysis. The reaction
mixture was poured into water (500 mL) and the precipitate
ﬁltered. The precipitate was recrystallised from ethanol to give
product 12 as an off-white crystalline solid (3.82 g, 76%). Mp
124–127 °C (EtOH). (Found: C, 73.4; H, 8.2; N, 11.4.
C15H20N2O requires C, 73.7; H, 8.25; N, 11.5%.) νmax (KBr)/
cm−1 3448 (OH stretch), 3034 (C–H stretch aromatic), 2919 (CH
stretch), 2855 (CH stretch) 1674 (CvC), 1616 (CvN), 1470
(CH2 bend), 1341 (C–N stretch), 1149 (C–O alcohol). δH
(CDCl3, 300 MHz) 0.88 (3H, t, J = 6.8 Hz, CH3), 1.25–1.51
(8H, m, 4 × CH2), 1.82–1.92 (2H, m, CH2), 2.74–2.79 (2H, m,
CH2), 7.44–7.49 (1H, m, ArH), 7.68–7.80 (2H, m, 2 × ArH),
8.29 (1H, dd, J = 1.1, 8.0 Hz, ArH), 11.10 (1H, bs, OH). δC
(CDCl3, 75 MHz) 14.1 (CH3), 22.6, 27.6, 29.0, 29.2, 31.7, 36.1
(6 × CH2), 120.5 (quaternary C), 126.3, 126.4, 127.2, 134.8 (4 ×
ArC), 149.4 (quaternary C), 156.8 (CvN), 164.0 (C–OH).
Exact mass calculated for C15H20N2O [(M + H)
+], 245.1654.
Found 245.1654, m/z ES+ 245 [(M + H)+, 80%].
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